戸井 雅和

最終更新日時: 2020/07/29 10:20:34

印刷する

氏名(漢字/フリガナ/アルファベット表記)
戸井 雅和/トイ マサカズ/Toi, Masakazu
所属部署・職名(部局/所属/講座等/職名)
医学研究科/医学専攻外科学講座乳腺外科学/教授
学部兼担
部局 所属 講座等 職名
医学部
連絡先住所
種別 住所(日本語) 住所(英語)
職場 京都市左京区聖護院川原町54 54 Shogoin-Kawara-cho, Sakyo, Kyoto, Japan
連絡先電話番号
種別 番号
職場 81-75-751-3660
取得学位
学位名(日本語) 学位名(英語) 大学(日本語) 大学(英語) 取得区分
医学博士 広島大学
プロフィール
(日本語)
乳癌に関する診療、研究、教育を行っている。 腫瘍血管新生の研究を行っている。
(英語)
Involved in oncology clinic, oncology research and clinical education. Special field: breast cancer
使用言語
言語名(japanese) 言語名(english) コード
英語 English eng
researchmap URL
https://researchmap.jp/3660
研究テーマ
(日本語)
乳癌診療の最適化、血管新生、乳癌の新規診断法、新規癌治療法の開発、意思決定過程の数理モデル化、乳癌予防
論文
著者 著者(日本語) 著者(英語) タイトル タイトル(日本語) タイトル(英語) 書誌情報等 書誌情報等(日本語) 書誌情報等(英語) 出版年月 査読の有無 記述言語 掲載種別 公開
Sunao Tanaka, Tomoko Ishii, Fumiaki Sato, Masakazu Toi, Junji Itou Sunao Tanaka, Tomoko Ishii, Fumiaki Sato, Masakazu Toi, Junji Itou Sunao Tanaka, Tomoko Ishii, Fumiaki Sato, Masakazu Toi, Junji Itou Eribulin mesylate-induced c-Fos upregulation enhances cell survival in breast cancer cell lines Eribulin mesylate-induced c-Fos upregulation enhances cell survival in breast cancer cell lines Eribulin mesylate-induced c-Fos upregulation enhances cell survival in breast cancer cell lines Biochemical and Biophysical Research Communications, 526, 1, 154-157 Biochemical and Biophysical Research Communications, 526, 1, 154-157 Biochemical and Biophysical Research Communications, 526, 1, 154-157 2020/05 研究論文(学術雑誌) 公開
Ayami Ohno Kishimoto, Masako Kataoka, Mami Iima, Maya Honda, Kanae Kawai Miyake, Akane Ohashi, Rie Ota, Tatsuki Kataoka, Takaki Sakurai, Masakazu Toi, Kaori Togashi Ayami Ohno Kishimoto, Masako Kataoka, Mami Iima, Maya Honda, Kanae Kawai Miyake, Akane Ohashi, Rie Ota, Tatsuki Kataoka, Takaki Sakurai, Masakazu Toi, Kaori Togashi Ayami Ohno Kishimoto, Masako Kataoka, Mami Iima, Maya Honda, Kanae Kawai Miyake, Akane Ohashi, Rie Ota, Tatsuki Kataoka, Takaki Sakurai, Masakazu Toi, Kaori Togashi The comparison of high-resolution diffusion weighted imaging (DWI) with high-resolution contrast-enhanced MRI in the evaluation of breast cancers. The comparison of high-resolution diffusion weighted imaging (DWI) with high-resolution contrast-enhanced MRI in the evaluation of breast cancers. The comparison of high-resolution diffusion weighted imaging (DWI) with high-resolution contrast-enhanced MRI in the evaluation of breast cancers. Magnetic resonance imaging Magnetic resonance imaging Magnetic resonance imaging 2020/04/19 英語 公開
Akane Ohashi, Masako Kataoka, Mami Iima, Shotaro Kanao, Maya Honda, Yuta Urushibata, Marcel Dominik Nickel, Ayami Ohno Kishimoto, Rie Ota, Masakazu Toi, Kaori Togashi Akane Ohashi, Masako Kataoka, Mami Iima, Shotaro Kanao, Maya Honda, Yuta Urushibata, Marcel Dominik Nickel, Ayami Ohno Kishimoto, Rie Ota, Masakazu Toi, Kaori Togashi Akane Ohashi, Masako Kataoka, Mami Iima, Shotaro Kanao, Maya Honda, Yuta Urushibata, Marcel Dominik Nickel, Ayami Ohno Kishimoto, Rie Ota, Masakazu Toi, Kaori Togashi A multiparametric approach to diagnosing breast lesions using diffusion-weighted imaging and ultrafast dynamic contrast-enhanced MRI. A multiparametric approach to diagnosing breast lesions using diffusion-weighted imaging and ultrafast dynamic contrast-enhanced MRI. A multiparametric approach to diagnosing breast lesions using diffusion-weighted imaging and ultrafast dynamic contrast-enhanced MRI. Magnetic resonance imaging Magnetic resonance imaging Magnetic resonance imaging 2020/04/14 英語 公開
Saseem Poudel, Satoshi Hirano, Yo Kurashima, Dimitrios Stefanidis, Hirotoshi Akiyama, Susumu Eguchi, Toshihiro Fukui, Masaru Hagiwara, Daisuke Hashimoto, Koya Hida, Tomoko Izaki, Hirotaka Iwase, Shunsuke Kawamoto, Yasuhiro Otomo, Eishi Nagai, Mitsue Saito, Hideki Takami, Yuko Takeda, Masakazu Toi, Hiroki Yamaue, Motofumi Yoshida, Shigetoshi Yoshida, Yasuhiro Kodera Saseem Poudel, Satoshi Hirano, Yo Kurashima, Dimitrios Stefanidis, Hirotoshi Akiyama, Susumu Eguchi, Toshihiro Fukui, Masaru Hagiwara, Daisuke Hashimoto, Koya Hida, Tomoko Izaki, Hirotaka Iwase, Shunsuke Kawamoto, Yasuhiro Otomo, Eishi Nagai, Mitsue Saito, Hideki Takami, Yuko Takeda, Masakazu Toi, Hiroki Yamaue, Motofumi Yoshida, Shigetoshi Yoshida, Yasuhiro Kodera Saseem Poudel, Satoshi Hirano, Yo Kurashima, Dimitrios Stefanidis, Hirotoshi Akiyama, Susumu Eguchi, Toshihiro Fukui, Masaru Hagiwara, Daisuke Hashimoto, Koya Hida, Tomoko Izaki, Hirotaka Iwase, Shunsuke Kawamoto, Yasuhiro Otomo, Eishi Nagai, Mitsue Saito, Hideki Takami, Yuko Takeda, Masakazu Toi, Hiroki Yamaue, Motofumi Yoshida, Shigetoshi Yoshida, Yasuhiro Kodera Are graduating residents sufficiently competent? Results of a national gap analysis survey of program directors and graduating residents in Japan Are graduating residents sufficiently competent? Results of a national gap analysis survey of program directors and graduating residents in Japan Are graduating residents sufficiently competent? Results of a national gap analysis survey of program directors and graduating residents in Japan SURGERY TODAY SURGERY TODAY SURGERY TODAY 2020/03 英語 研究論文(学術雑誌) 公開
Md. Rasel Al Mahmud,, Kenichiro Ishii,, Cristina Bernal-Lozano,, Irene Delgado-Sainz,, Masakazu Toi,, Shusuke Akamatsu,, Manabu Fukumoto,, Masatoshi Watanabe,, Shunichi Takeda,, Felipe Cortés-Ledesma,, Hiroyuki Sasanuma Md. Rasel Al Mahmud,, Kenichiro Ishii,, Cristina Bernal-Lozano,, Irene Delgado-Sainz,, Masakazu Toi,, Shusuke Akamatsu,, Manabu Fukumoto,, Masatoshi Watanabe,, Shunichi Takeda,, Felipe Cortés-Ledesma,, Hiroyuki Sasanuma Md. Rasel Al Mahmud, Kenichiro Ishii, Cristina Bernal-Lozano, Irene Delgado-Sainz, Masakazu Toi, Shusuke Akamatsu, Manabu Fukumoto, Masatoshi Watanabe, Shunichi Takeda, Felipe Cortés-Ledesma, Hiroyuki Sasanuma TDP2 suppresses genomic instability induced by androgens in the epithelial cells of prostate glands TDP2 suppresses genomic instability induced by androgens in the epithelial cells of prostate glands TDP2 suppresses genomic instability induced by androgens in the epithelial cells of prostate glands Genes to Cells, in press Genes to Cells, in press Genes to Cells, in press 2020/03 公開
Ishiguro H, Masuda N, Sato N, Higaki K, Morimoto T, Yanagita Y, Mizutani M, Ohtani S, Kaneko k, Fujisawa T, Takahashi M, Kadoya T, Matsunami M, Yamamoto Y, Ohno S, Takano T, Morita S, , Tanaka-Mizuno S, Toi M Ishiguro H, Masuda N, Sato N, Higaki K, Morimoto T, Yanagita Y, Mizutani M, Ohtani S, Kaneko k, Fujisawa T, Takahashi M, Kadoya T, Matsunami M, Yamamoto Y, Ohno S, Takano T, Morita S, , Tanaka-Mizuno S, Toi M Ishiguro H, Masuda N, Sato N, Higaki K, Morimoto T, Yanagita Y, Mizutani M, Ohtani S, Kaneko k, Fujisawa T, Takahashi M, Kadoya T, Matsunami M, Yamamoto Y, Ohno S, Takano T, Morita S, , Tanaka-Mizuno S, Toi M A randomized study comparing docetaxel/cyclophosphamide (TC), 5-fluorouracil/epirubicin/cyclophosphamide (FEC) followed by TC, and TC followed by FEC for patients with hormone receptor-positive HER2-negative primary breast cancer A randomized study comparing docetaxel/cyclophosphamide (TC), 5-fluorouracil/epirubicin/cyclophosphamide (FEC) followed by TC, and TC followed by FEC for patients with hormone receptor-positive HER2-negative primary breast cancer A randomized study comparing docetaxel/cyclophosphamide (TC), 5-fluorouracil/epirubicin/cyclophosphamide (FEC) followed by TC, and TC followed by FEC for patients with hormone receptor-positive HER2-negative primary breast cancer Breast Cancer Res and Treat Breast Cancer Res and Treat Breast Cancer Res and Treat 2020/03 英語 研究論文(学術雑誌) 公開
Junji Itou, Rei Takahashi, Hiroyuki Sasanuma, Masataka Tsuda, Suguru Morimoto, Yoshiaki Matsumoto, Tomoko Ishii, Fumiaki Sato, Shunichi Takeda, Masakazu Toi Junji Itou, Rei Takahashi, Hiroyuki Sasanuma, Masataka Tsuda, Suguru Morimoto, Yoshiaki Matsumoto, Tomoko Ishii, Fumiaki Sato, Shunichi Takeda, Masakazu Toi Junji Itou, Rei Takahashi, Hiroyuki Sasanuma, Masataka Tsuda, Suguru Morimoto, Yoshiaki Matsumoto, Tomoko Ishii, Fumiaki Sato, Shunichi Takeda, Masakazu Toi Estrogen Induces Mammary Ductal Dysplasia via the Upregulation of Myc Expression in a DNA-Repair-Deficient Condition. Estrogen Induces Mammary Ductal Dysplasia via the Upregulation of Myc Expression in a DNA-Repair-Deficient Condition. Estrogen Induces Mammary Ductal Dysplasia via the Upregulation of Myc Expression in a DNA-Repair-Deficient Condition. iScience, 23, 2, 100821-100821 iScience, 23, 2, 100821-100821 iScience, 23, 2, 100821-100821 2020/02/21 英語 公開
Noriko Senda, Nobuko Kawaguchi-Sakita, Masahiro Kawashima, Yukiko Inagaki-Kawata, Kenichi Yoshida, Tomomi Nishimura, Masahiro Takada, Eiji Suzuki, Yuki Kataoka, Fumiaki Sato, Yoshiaki Matsumoto, Masae Torii, Hiroshi Yoshibayashi, Kazuhiro Yamagami, Shigeru Tsuyuki, Akira Yamauchi, Nobuhiko Shinkura, Hironori Kato, Yoshio Moriguchi, Ryuji Okamura, Norimichi Kan, Hirofumi Suwa, Shingo Sakata, Susumu Mashima, Fumiaki Yotsumoto, Tsuyoshi Tachibana, Mitsuru Tanaka, Takashi Inamoto, Masahiro Sugimoto, Seishi Ogawa, Masakazu Toi Noriko Senda, Nobuko Kawaguchi-Sakita, Masahiro Kawashima, Yukiko Inagaki-Kawata, Kenichi Yoshida, Tomomi Nishimura, Masahiro Takada, Eiji Suzuki, Yuki Kataoka, Fumiaki Sato, Yoshiaki Matsumoto, Masae Torii, Hiroshi Yoshibayashi, Kazuhiro Yamagami, Shigeru Tsuyuki, Akira Yamauchi, Nobuhiko Shinkura, Hironori Kato, Yoshio Moriguchi, Ryuji Okamura, Norimichi Kan, Hirofumi Suwa, Shingo Sakata, Susumu Mashima, Fumiaki Yotsumoto, Tsuyoshi Tachibana, Mitsuru Tanaka, Takashi Inamoto, Masahiro Sugimoto, Seishi Ogawa, Masakazu Toi Noriko Senda, Nobuko Kawaguchi-Sakita, Masahiro Kawashima, Yukiko Inagaki-Kawata, Kenichi Yoshida, Tomomi Nishimura, Masahiro Takada, Eiji Suzuki, Yuki Kataoka, Fumiaki Sato, Yoshiaki Matsumoto, Masae Torii, Hiroshi Yoshibayashi, Kazuhiro Yamagami, Shigeru Tsuyuki, Akira Yamauchi, Nobuhiko Shinkura, Hironori Kato, Yoshio Moriguchi, Ryuji Okamura, Norimichi Kan, Hirofumi Suwa, Shingo Sakata, Susumu Mashima, Fumiaki Yotsumoto, Tsuyoshi Tachibana, Mitsuru Tanaka, Takashi Inamoto, Masahiro Sugimoto, Seishi Ogawa, Masakazu Toi Abstract P2-10-12: Relationship between predicted risks of carrying breast cancer susceptibility genes and the presence of germline variants in Japanese patients with primary breast cancer Abstract P2-10-12: Relationship between predicted risks of carrying breast cancer susceptibility genes and the presence of germline variants in Japanese patients with primary breast cancer Abstract P2-10-12: Relationship between predicted risks of carrying breast cancer susceptibility genes and the presence of germline variants in Japanese patients with primary breast cancer Poster Session Abstracts Poster Session Abstracts Poster Session Abstracts 2020/02/15 研究論文(国際会議プロシーディングス) 公開
Kawaguchi H, Masuda N, Nakayama T, Aogi K, Anan K, Ito Y, Ohtani S, Sato N, Saji S, Takano T, Tokunaga E, Nakamura S, Hasegawa Y, Hattori M, Fujisawa T, Morita S, Yamaguchi M, Yamashita H, Yamashita T, Yamamoto Y, Yotsumoto D, Toi M, Ohno S Kawaguchi H, Masuda N, Nakayama T, Aogi K, Anan K, Ito Y, Ohtani S, Sato N, Saji S, Takano T, Tokunaga E, Nakamura S, Hasegawa Y, Hattori M, Fujisawa T, Morita S, Yamaguchi M, Yamashita H, Yamashita T, Yamamoto Y, Yotsumoto D, Toi M, Ohno S Kawaguchi H, Masuda N, Nakayama T, Aogi K, Anan K, Ito Y, Ohtani S, Sato N, Saji S, Takano T, Tokunaga E, Nakamura S, Hasegawa Y, Hattori M, Fujisawa T, Morita S, Yamaguchi M, Yamashita H, Yamashita T, Yamamoto Y, Yotsumoto D, Toi M, Ohno S Factors associated with prolonged overall survival in patients with postmenopausal estrogen receptor-positive advanced breast cancer using real-world data: a follow-up analysis of the JBCRG-C06 Safari study. Factors associated with prolonged overall survival in patients with postmenopausal estrogen receptor-positive advanced breast cancer using real-world data: a follow-up analysis of the JBCRG-C06 Safari study. Factors associated with prolonged overall survival in patients with postmenopausal estrogen receptor-positive advanced breast cancer using real-world data: a follow-up analysis of the JBCRG-C06 Safari study. Breast Cancer Breast Cancer Breast Cancer 2019/12 英語 研究論文(学術雑誌) 公開
Saseem Poudel, Satoshi Hirano, Yo Kurashima, Dimitrios Stefanidis, Hirotoshi Akiyama, Susumu Eguchi, Toshihiro Fukui, Masaru Hagiwara, Daisuke Hashimoto, Koya Hida, Tomoko Izaki, Hirotaka Iwase, Shunsuke Kawamoto, Yasuhiro Otomo, Eishi Nagai, Mitsue Saito, Hideki Takami, Yuko Takeda, Masakazu Toi, Hiroki Yamaue, Motofumi Yoshida, Shigetoshi Yoshida, Yasuhiro Kodera Saseem Poudel, Satoshi Hirano, Yo Kurashima, Dimitrios Stefanidis, Hirotoshi Akiyama, Susumu Eguchi, Toshihiro Fukui, Masaru Hagiwara, Daisuke Hashimoto, Koya Hida, Tomoko Izaki, Hirotaka Iwase, Shunsuke Kawamoto, Yasuhiro Otomo, Eishi Nagai, Mitsue Saito, Hideki Takami, Yuko Takeda, Masakazu Toi, Hiroki Yamaue, Motofumi Yoshida, Shigetoshi Yoshida, Yasuhiro Kodera Saseem Poudel, Satoshi Hirano, Yo Kurashima, Dimitrios Stefanidis, Hirotoshi Akiyama, Susumu Eguchi, Toshihiro Fukui, Masaru Hagiwara, Daisuke Hashimoto, Koya Hida, Tomoko Izaki, Hirotaka Iwase, Shunsuke Kawamoto, Yasuhiro Otomo, Eishi Nagai, Mitsue Saito, Hideki Takami, Yuko Takeda, Masakazu Toi, Hiroki Yamaue, Motofumi Yoshida, Shigetoshi Yoshida, Yasuhiro Kodera A snapshot of surgical resident training in Japan: results of a national-level needs assessment survey. A snapshot of surgical resident training in Japan: results of a national-level needs assessment survey. A snapshot of surgical resident training in Japan: results of a national-level needs assessment survey. Surgery today, 49, 10, 870-876 Surgery today, 49, 10, 870-876 Surgery today, 49, 10, 870-876 2019/10 英語 公開
Ishiguro H, Ohno S, Yamamoto Y, Takao S, Sato N, Fujisawa T, Kadoya T, Kuroi K, Bando H, Teramura Y, Iwata H, Tanaka S, Toi M Ishiguro H, Ohno S, Yamamoto Y, Takao S, Sato N, Fujisawa T, Kadoya T, Kuroi K, Bando H, Teramura Y, Iwata H, Tanaka S, Toi M Ishiguro H, Ohno S, Yamamoto Y, Takao S, Sato N, Fujisawa T, Kadoya T, Kuroi K, Bando H, Teramura Y, Iwata H, Tanaka S, Toi M Pharmacogenomic-pharmacokinetic study of selective estrogen-receptor modulators with intra-patient dose escalation in breast cancer. Pharmacogenomic-pharmacokinetic study of selective estrogen-receptor modulators with intra-patient dose escalation in breast cancer. Pharmacogenomic-pharmacokinetic study of selective estrogen-receptor modulators with intra-patient dose escalation in breast cancer. Breast Cancer, 26, 5, 535-543 Breast Cancer, 26, 5, 535-543 Breast Cancer, 26, 5, 535-543 2019/09 英語 研究論文(学術雑誌) 公開
Sato N, Masuda N, Morimoto T, Ueno T, Kanbayashi C, Kaneko K, Yasojima H, Saji S, Sasano H, Morita S, Ohno S, Toi M Sato N, Masuda N, Morimoto T, Ueno T, Kanbayashi C, Kaneko K, Yasojima H, Saji S, Sasano H, Morita S, Ohno S, Toi M Sato N, Masuda N, Morimoto T, Ueno T, Kanbayashi C, Kaneko K, Yasojima H, Saji S, Sasano H, Morita S, Ohno S, Toi M Neoadjuvant exemestane or exemestane plus docetaxel and cyclophosphamide tailored by clinicopathological response to 12 weeks' exemestane exposure in patients with estrogen receptor-positive breast cancer: A multicenter, open-label, phase II study. Neoadjuvant exemestane or exemestane plus docetaxel and cyclophosphamide tailored by clinicopathological response to 12 weeks' exemestane exposure in patients with estrogen receptor-positive breast cancer: A multicenter, open-label, phase II study. Neoadjuvant exemestane or exemestane plus docetaxel and cyclophosphamide tailored by clinicopathological response to 12 weeks' exemestane exposure in patients with estrogen receptor-positive breast cancer: A multicenter, open-label, phase II study. Cancer medicine, 8, 12, 5468-5481 Cancer medicine, 8, 12, 5468-5481 Cancer medicine, 8, 12, 5468-5481 2019/09 公開
Kinoshita T, Nakayama T, Fukuma E, Inokuchi M, Ishiguro H, Ogo E, Kikuchi M, Jinno H, Yamazaki N, Toi M Kinoshita T, Nakayama T, Fukuma E, Inokuchi M, Ishiguro H, Ogo E, Kikuchi M, Jinno H, Yamazaki N, Toi M Kinoshita T, Nakayama T, Fukuma E, Inokuchi M, Ishiguro H, Ogo E, Kikuchi M, Jinno H, Yamazaki N, Toi M The Efficacy of Scalp Cooling in Preventing and Recovering from Chemotherapy-induced alopecia in Breast Cancer Patients: The HOPE study The Efficacy of Scalp Cooling in Preventing and Recovering from Chemotherapy-induced alopecia in Breast Cancer Patients: The HOPE study The Efficacy of Scalp Cooling in Preventing and Recovering from Chemotherapy-induced alopecia in Breast Cancer Patients: The HOPE study Frontiers in Oncology, 1-9 Frontiers in Oncology, 1-9 Frontiers in Oncology, 1-9 2019/08 英語 研究論文(学術雑誌) 公開
Ohashi A, Kataoka M, Kanao S, Iima M, Murata K, Weiland E, Onishi N, Kawai M, Toi M, Togashi K Ohashi A, Kataoka M, Kanao S, Iima M, Murata K, Weiland E, Onishi N, Kawai M, Toi M, Togashi K Ohashi A, Kataoka M, Kanao S, Iima M, Murata K, Weiland E, Onishi N, Kawai M, Toi M, Togashi K Diagnostic performance of maximum slope: A kinetic parameter obtained from ultrafast dynamic contrast-enhanced magnetic resonance imaging of the breast using k-space weighted image contrast (KWIC). Diagnostic performance of maximum slope: A kinetic parameter obtained from ultrafast dynamic contrast-enhanced magnetic resonance imaging of the breast using k-space weighted image contrast (KWIC). Diagnostic performance of maximum slope: A kinetic parameter obtained from ultrafast dynamic contrast-enhanced magnetic resonance imaging of the breast using k-space weighted image contrast (KWIC). European journal of radiology, 118, 285-292 European journal of radiology, 118, 285-292 European journal of radiology, 118, 285-292 2019/06 公開
Honda M, Kataoka M, Onishi N, Iima M, Ohashi A, Kanao S, Nickel MD, Toi M, Togashi K Honda M, Kataoka M, Onishi N, Iima M, Ohashi A, Kanao S, Nickel MD, Toi M, Togashi K Honda M, Kataoka M, Onishi N, Iima M, Ohashi A, Kanao S, Nickel MD, Toi M, Togashi K New parameters of ultrafast dynamic contrast-enhanced breast MRI using compressed sensing. New parameters of ultrafast dynamic contrast-enhanced breast MRI using compressed sensing. New parameters of ultrafast dynamic contrast-enhanced breast MRI using compressed sensing. Journal of magnetic resonance imaging : JMRI Journal of magnetic resonance imaging : JMRI Journal of magnetic resonance imaging : JMRI 2019/06 公開
Takada M, Toi M Takada M, Toi M Takada M, Toi M Cryosurgery for primary breast cancers, its biological impact, and clinical outcomes. Cryosurgery for primary breast cancers, its biological impact, and clinical outcomes. Cryosurgery for primary breast cancers, its biological impact, and clinical outcomes. International Journal of Clinical Oncology, 24, 6, 608-613 International Journal of Clinical Oncology, 24, 6, 608-613 International Journal of Clinical Oncology, 24, 6, 608-613 2019/06 公開
Masuda N, Mukai H, Inoue K, Rai Y, Ohno S, Mori Y, Hashigaki S, Muramatsu Y, Umeyama Y, Iwata H, Toi M Masuda N, Mukai H, Inoue K, Rai Y, Ohno S, Mori Y, Hashigaki S, Muramatsu Y, Umeyama Y, Iwata H, Toi M Masuda N, Mukai H, Inoue K, Rai Y, Ohno S, Mori Y, Hashigaki S, Muramatsu Y, Umeyama Y, Iwata H, Toi M Correction to: Neutropenia management with palbociclib in Japanese patients with advanced breast cancer. Correction to: Neutropenia management with palbociclib in Japanese patients with advanced breast cancer. Correction to: Neutropenia management with palbociclib in Japanese patients with advanced breast cancer. Breast Cancer (Tokyo, Japan) Breast Cancer (Tokyo, Japan) Breast Cancer (Tokyo, Japan) 2019/06 公開
Yap YS, Lu YS, Tamura K, Lee JE, Ko EY, Park YH, Cao AY, Lin CH, Toi M, Wu J, Lee SC Yap YS, Lu YS, Tamura K, Lee JE, Ko EY, Park YH, Cao AY, Lin CH, Toi M, Wu J, Lee SC Yap YS, Lu YS, Tamura K, Lee JE, Ko EY, Park YH, Cao AY, Lin CH, Toi M, Wu J, Lee SC Insights Into Breast Cancer in the East vs the West: A Review. Insights Into Breast Cancer in the East vs the West: A Review. Insights Into Breast Cancer in the East vs the West: A Review. JAMA oncology JAMA oncology JAMA oncology 2019/05 公開
Sakaguchi R, Kataoka M, Kanao S, Miyake KK, Nakamoto Y, Sugie T, Toi M, Mikami Y, Togashi K Sakaguchi R, Kataoka M, Kanao S, Miyake KK, Nakamoto Y, Sugie T, Toi M, Mikami Y, Togashi K Sakaguchi R, Kataoka M, Kanao S, Miyake KK, Nakamoto Y, Sugie T, Toi M, Mikami Y, Togashi K Distribution pattern of FDG uptake using ring-type dedicated breast PET in comparison to whole-body PET/CT scanning in invasive breast cancer. Distribution pattern of FDG uptake using ring-type dedicated breast PET in comparison to whole-body PET/CT scanning in invasive breast cancer. Distribution pattern of FDG uptake using ring-type dedicated breast PET in comparison to whole-body PET/CT scanning in invasive breast cancer. Annals of Nuclear Medicine Annals of Nuclear Medicine Annals of Nuclear Medicine 2019/05 公開
Im SA, Mukai H, Park IH, Masuda N, Shimizu C, Kim SB, Im YH, Ohtani S, Huang Bartlett C, Lu DR, Iyer S, Mori Y, Mori A, Gauthier E, Finn RS, Toi M Im SA, Mukai H, Park IH, Masuda N, Shimizu C, Kim SB, Im YH, Ohtani S, Huang Bartlett C, Lu DR, Iyer S, Mori Y, Mori A, Gauthier E, Finn RS, Toi M Im SA, Mukai H, Park IH, Masuda N, Shimizu C, Kim SB, Im YH, Ohtani S, Huang Bartlett C, Lu DR, Iyer S, Mori Y, Mori A, Gauthier E, Finn RS, Toi M Palbociclib Plus Letrozole as First-Line Therapy in Postmenopausal Asian Women With Metastatic Breast Cancer: Results From the Phase III, Randomized PALOMA-2 Study. Palbociclib Plus Letrozole as First-Line Therapy in Postmenopausal Asian Women With Metastatic Breast Cancer: Results From the Phase III, Randomized PALOMA-2 Study. Palbociclib Plus Letrozole as First-Line Therapy in Postmenopausal Asian Women With Metastatic Breast Cancer: Results From the Phase III, Randomized PALOMA-2 Study. Journal of Global Oncology, 5, 1-19 Journal of Global Oncology, 5, 1-19 Journal of Global Oncology, 5, 1-19 2019/05 公開
Perez EA, de Haas SL, Eiermann W, Barrios CH, Toi M, Im YH, Conte PF, Martin M, Pienkowski T, Pivot XB, Burris HA, Stanzel S, Patre M, Ellis PA Perez EA, de Haas SL, Eiermann W, Barrios CH, Toi M, Im YH, Conte PF, Martin M, Pienkowski T, Pivot XB, Burris HA, Stanzel S, Patre M, Ellis PA Perez EA, de Haas SL, Eiermann W, Barrios CH, Toi M, Im YH, Conte PF, Martin M, Pienkowski T, Pivot XB, Burris HA, Stanzel S, Patre M, Ellis PA Relationship between tumor biomarkers and efficacy in MARIANNE, a phase III study of trastuzumab emtansine ± pertuzumab versus trastuzumab plus taxane in HER2-positive advanced breast cancer. Relationship between tumor biomarkers and efficacy in MARIANNE, a phase III study of trastuzumab emtansine ± pertuzumab versus trastuzumab plus taxane in HER2-positive advanced breast cancer. Relationship between tumor biomarkers and efficacy in MARIANNE, a phase III study of trastuzumab emtansine ± pertuzumab versus trastuzumab plus taxane in HER2-positive advanced breast cancer. BMC cancer, 19, 1, 517 BMC cancer, 19, 1, 517 BMC cancer, 19, 1, 517 2019/05 公開
Benson JR, Jatoi I, Toi M Benson JR, Jatoi I, Toi M Benson JR, Jatoi I, Toi M Surgical management of multiple ipsilateral breast cancers. Surgical management of multiple ipsilateral breast cancers. Surgical management of multiple ipsilateral breast cancers. Future oncology (London, England), 15, 11, 1185-1191 Future oncology (London, England), 15, 11, 1185-1191 Future oncology (London, England), 15, 11, 1185-1191 2019/04 公開
Ueno T, Masuda N, Kamigaki S, Morimoto T, Saji S, Imoto S, Sasano H, Toi M Ueno T, Masuda N, Kamigaki S, Morimoto T, Saji S, Imoto S, Sasano H, Toi M Ueno T, Masuda N, Kamigaki S, Morimoto T, Saji S, Imoto S, Sasano H, Toi M Differential Involvement of Autophagy and Apoptosis in Response to Chemoendocrine and Endocrine Therapy in Breast Cancer: JBCRG-07TR. Differential Involvement of Autophagy and Apoptosis in Response to Chemoendocrine and Endocrine Therapy in Breast Cancer: JBCRG-07TR. Differential Involvement of Autophagy and Apoptosis in Response to Chemoendocrine and Endocrine Therapy in Breast Cancer: JBCRG-07TR. International journal of molecular sciences, 20, 4 International journal of molecular sciences, 20, 4 International journal of molecular sciences, 20, 4 2019/02 公開
Kawaguchi K, Sakurai M, Yamamoto Y, Suzuki E, Tsuda M, Kataoka TR, Hirata M, Nishie M, Nojiri T, Kumazoe M, Saito K, Toi M Kawaguchi K, Sakurai M, Yamamoto Y, Suzuki E, Tsuda M, Kataoka TR, Hirata M, Nishie M, Nojiri T, Kumazoe M, Saito K, Toi M Kawaguchi K, Sakurai M, Yamamoto Y, Suzuki E, Tsuda M, Kataoka TR, Hirata M, Nishie M, Nojiri T, Kumazoe M, Saito K, Toi M Alteration of specific cytokine expression patterns in patients with breast cancer. Alteration of specific cytokine expression patterns in patients with breast cancer. Alteration of specific cytokine expression patterns in patients with breast cancer. Scientific reports, 9, 1, 2924 Scientific reports, 9, 1, 2924 Scientific reports, 9, 1, 2924 2019/02 公開
Kawashima M, Tokiwa M, Nishimura T, Kawata Y, Sugimoto M, Kataoka T, Sakurai T, Iwaisako K, Suzuki E, Hagiwara M, Harris A, Toi M Kawashima M, Tokiwa M, Nishimura T, Kawata Y, Sugimoto M, Kataoka T, Sakurai T, Iwaisako K, Suzuki E, Hagiwara M, Harris A, Toi M Eizi Suzuki High-resolution imaging mass spectrometry combined with transcriptomic analysis identified a link between fatty acid composition of phosphatidylinositols and the immune checkpoint pathway at the primary tumour site of breast cancer High-resolution imaging mass spectrometry combined with transcriptomic analysis identified a link between fatty acid composition of phosphatidylinositols and the immune checkpoint pathway at the primary tumour site of breast cancer High-resolution imaging mass spectrometry combined with transcriptomic analysis identified a link between fatty acid composition of phosphatidylinositols and the immune checkpoint pathway at the primary tumour site of breast cancer British Journal of Cancer British Journal of Cancer British Journal of Cancer 2019 公開
Ono Y, Yoshimura M, Hirata K, Yamauchi C, Toi M, Suzuki E, Takada M, Hiraoka M, Mizowaki T Ono Y, Yoshimura M, Hirata K, Yamauchi C, Toi M, Suzuki E, Takada M, Hiraoka M, Mizowaki T Eizi Suzuki The impact of age on the risk of ipsilateral breast tumor recurrence after breastconserving therapy in breast cancer patients with a > 5 mm margin treated without boost irradiation The impact of age on the risk of ipsilateral breast tumor recurrence after breastconserving therapy in breast cancer patients with a > 5 mm margin treated without boost irradiation The impact of age on the risk of ipsilateral breast tumor recurrence after breastconserving therapy in breast cancer patients with a > 5 mm margin treated without boost irradiation Radiation Oncology Radiation Oncology Radiation Oncology 2019 公開
Tanaka S, Senda N, Iida A, Sehara-Fujisawa A, Ishii T, Sato F, Toi M, Itou J Tanaka S, Senda N, Iida A, Sehara-Fujisawa A, Ishii T, Sato F, Toi M, Itou J Tanaka S, Senda N, Iida A, Sehara-Fujisawa A, Ishii T, Sato F, Toi M, Itou J In silico analysis-based identification of the target residue of integrin α6 for metastasis inhibition of basal-like breast cancer. In silico analysis-based identification of the target residue of integrin α6 for metastasis inhibition of basal-like breast cancer. In silico analysis-based identification of the target residue of integrin α6 for metastasis inhibition of basal-like breast cancer. Genes to Cells, 24, 596-607 Genes to Cells, 24, 596-607 Genes to Cells, 24, 596-607 2019 英語 研究論文(学術雑誌) 公開
Ueno T, Saji S, Masuda N, Iwata H, Kuroi K, Sato N, Takei H, Yamamoto Y, Ohno S, Yamashita H, Hisamatsu K, Aogi K, Sasano H, Toi M Ueno T, Saji S, Masuda N, Iwata H, Kuroi K, Sato N, Takei H, Yamamoto Y, Ohno S, Yamashita H, Hisamatsu K, Aogi K, Sasano H, Toi M Ueno T, Saji S, Masuda N, Iwata H, Kuroi K, Sato N, Takei H, Yamamoto Y, Ohno S, Yamashita H, Hisamatsu K, Aogi K, Sasano H, Toi M Changes in Recurrence Score by neoadjuvant endocrine therapy of breast cancer and their prognostic implication. Changes in Recurrence Score by neoadjuvant endocrine therapy of breast cancer and their prognostic implication. Changes in Recurrence Score by neoadjuvant endocrine therapy of breast cancer and their prognostic implication. ESMO open, 4, 1, e000476 ESMO open, 4, 1, e000476 ESMO open, 4, 1, e000476 2019 公開
Kiso M, Tanaka S, Saji S, Toi M, Sato F Kiso M, Tanaka S, Saji S, Toi M, Sato F Kiso M, Tanaka S, Saji S, Toi M, Sato F Long isoform of VEGF stimulates cell migration of breast cancer by filopodia formation via NRP1/ARHGAP17/Cdc42 regulatory network. Long isoform of VEGF stimulates cell migration of breast cancer by filopodia formation via NRP1/ARHGAP17/Cdc42 regulatory network. Long isoform of VEGF stimulates cell migration of breast cancer by filopodia formation via NRP1/ARHGAP17/Cdc42 regulatory network. Int J Cancer, 1;143, 11, 2905-2918 Int J Cancer, 1;143, 11, 2905-2918 Int J Cancer, 1;143, 11, 2905-2918 2018/12 公開
Masahiro Takada, Masahiro Sugimoto, Norikazu Masuda, Hiroji Iwata, Katsumasa Kuroi, Hiroyasu Yamashiro, Shinji Ohno, Hiroshi Ishiguro, Takashi Inamoto, Masakazu Toi Masahiro Takada, Masahiro Sugimoto, Norikazu Masuda, Hiroji Iwata, Katsumasa Kuroi, Hiroyasu Yamashiro, Shinji Ohno, Hiroshi Ishiguro, Takashi Inamoto, Masakazu Toi Masahiro Takada, Masahiro Sugimoto, Norikazu Masuda, Hiroji Iwata, Katsumasa Kuroi, Hiroyasu Yamashiro, Shinji Ohno, Hiroshi Ishiguro, Takashi Inamoto, Masakazu Toi Prediction of postoperative disease-free survival and brain metastasis for HER2-positive breast cancer patients treated with neoadjuvant chemotherapy plus trastuzumab using a machine learning algorithm Prediction of postoperative disease-free survival and brain metastasis for HER2-positive breast cancer patients treated with neoadjuvant chemotherapy plus trastuzumab using a machine learning algorithm Prediction of postoperative disease-free survival and brain metastasis for HER2-positive breast cancer patients treated with neoadjuvant chemotherapy plus trastuzumab using a machine learning algorithm Breast Cancer Research and Treatment, 172, 3, 611-618 Breast Cancer Research and Treatment, 172, 3, 611-618 Breast Cancer Research and Treatment, 172, 3, 611-618 2018/12 研究論文(学術雑誌) 公開
Hiroyuki Sasanuma, Masataka Tsuda, Suguru Morimoto, Liton Kumar Saha, Md Maminur Rahman, Yusuke Kiyooka, Haruna Fujiike, Andrew D Cherniack, Junji Itou, Elsa Callen Moreu, Masakazu Toi, Shinichiro Nakada, Hisashi Tanaka, Ken Tsutsui, Shintaro Yamada, Andre Nussenzweig, Shunichi Takeda Hiroyuki Sasanuma, Masataka Tsuda, Suguru Morimoto, Liton Kumar Saha, Md Maminur Rahman, Yusuke Kiyooka, Haruna Fujiike, Andrew D Cherniack, Junji Itou, Elsa Callen Moreu, Masakazu Toi, Shinichiro Nakada, Hisashi Tanaka, Ken Tsutsui, Shintaro Yamada, Andre Nussenzweig, Shunichi Takeda Hiroyuki Sasanuma, Masataka Tsuda, Suguru Morimoto, Liton Kumar Saha, Md Maminur Rahman, Yusuke Kiyooka, Haruna Fujiike, Andrew D Cherniack, Junji Itou, Elsa Callen Moreu, Masakazu Toi, Shinichiro Nakada, Hisashi Tanaka, Ken Tsutsui, Shintaro Yamada, Andre Nussenzweig, Shunichi Takeda BRCA1 ensures genome integrity by eliminating estrogen-induced pathological topoisomerase II-DNA complexes. BRCA1 ensures genome integrity by eliminating estrogen-induced pathological topoisomerase II-DNA complexes. BRCA1 ensures genome integrity by eliminating estrogen-induced pathological topoisomerase II-DNA complexes. Proceedings of the National Academy of Sciences of the United States of America, 115, 45, E10642-E10651-E10651 Proceedings of the National Academy of Sciences of the United States of America, 115, 45, E10642-E10651-E10651 Proceedings of the National Academy of Sciences of the United States of America, 115, 45, E10642-E10651-E10651 2018/11/06 英語 公開
Ueno T, Saji S, Chiba T, Kamma H, Isaka H, Itoh H, Imi K, Miyamoto K, Tada M, Sasano H, Toi M, Imoto S Ueno T, Saji S, Chiba T, Kamma H, Isaka H, Itoh H, Imi K, Miyamoto K, Tada M, Sasano H, Toi M, Imoto S Ueno T, Saji S, Chiba T, Kamma H, Isaka H, Itoh H, Imi K, Miyamoto K, Tada M, Sasano H, Toi M, Imoto S Progesterone receptor expression in proliferating cancer cells of hormone-receptor-positive breast cancer. Progesterone receptor expression in proliferating cancer cells of hormone-receptor-positive breast cancer. Progesterone receptor expression in proliferating cancer cells of hormone-receptor-positive breast cancer. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 40, 10, 1010428318811025 Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 40, 10, 1010428318811025 Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 40, 10, 1010428318811025 2018/11 公開
Sagawa H, Kataoka M, Kanao S, Onishi N, Nickel MD, Toi M, Togashi K Sagawa H, Kataoka M, Kanao S, Onishi N, Nickel MD, Toi M, Togashi K Sagawa H, Kataoka M, Kanao S, Onishi N, Nickel MD, Toi M, Togashi K Impact of the Number of Iterations in Compressed Sensing Reconstruction on Ultrafast Dynamic Contrast-enhanced Breast MR Imaging. Impact of the Number of Iterations in Compressed Sensing Reconstruction on Ultrafast Dynamic Contrast-enhanced Breast MR Imaging. Impact of the Number of Iterations in Compressed Sensing Reconstruction on Ultrafast Dynamic Contrast-enhanced Breast MR Imaging. Magn Reson Med Sci, 9, doi: 10.2463/mrms.mp.2018-0015 Magn Reson Med Sci, 9, doi: 10.2463/mrms.mp.2018-0015 Magn Reson Med Sci, 9, doi: 10.2463/mrms.mp.2018-0015 2018/11 公開
Sagara Y, Takada M, Ohi Y, Ohtani S, Kurozumi S, Inoue K, Kosaka Y, Hattori M, Yamashita T, Takao S, Sato N, Iwata H, Kurosumi M, Toi M Sagara Y, Takada M, Ohi Y, Ohtani S, Kurozumi S, Inoue K, Kosaka Y, Hattori M, Yamashita T, Takao S, Sato N, Iwata H, Kurosumi M, Toi M Sagara Y, Takada M, Ohi Y, Ohtani S, Kurozumi S, Inoue K, Kosaka Y, Hattori M, Yamashita T, Takao S, Sato N, Iwata H, Kurosumi M, Toi M Effectiveness of neo-adjuvant systemic therapy with trastuzumab for basal HER2 type breast cancer: results from retrospective cohort study of Japan Breast Cancer Research Group (JBCRG)-C03. Effectiveness of neo-adjuvant systemic therapy with trastuzumab for basal HER2 type breast cancer: results from retrospective cohort study of Japan Breast Cancer Research Group (JBCRG)-C03. Effectiveness of neo-adjuvant systemic therapy with trastuzumab for basal HER2 type breast cancer: results from retrospective cohort study of Japan Breast Cancer Research Group (JBCRG)-C03. Breast Cancer Res Treat, 171, 3, 675-683 Breast Cancer Res Treat, 171, 3, 675-683 Breast Cancer Res Treat, 171, 3, 675-683 2018/10 公開
Matsumoto Y, Asao Y, Sekiguchi H, Yoshikawa A, Ishii T, Nagae KI, Kobayashi S, Tsuge I, Saito S, Takada M, Ishida Y, Kataoka M, Sakurai T, Yagi T, Kabashima K, Suzuki S, Togashi K, Shiina T, Toi M Matsumoto Y, Asao Y, Sekiguchi H, Yoshikawa A, Ishii T, Nagae KI, Kobayashi S, Tsuge I, Saito S, Takada M, Ishida Y, Kataoka M, Sakurai T, Yagi T, Kabashima K, Suzuki S, Togashi K, Shiina T, Toi M Matsumoto Y, Asao Y, Sekiguchi H, Yoshikawa A, Ishii T, Nagae KI, Kobayashi S, Tsuge I, Saito S, Takada M, Ishida Y, Kataoka M, Sakurai T, Yagi T, Kabashima K, Suzuki S, Togashi K, Shiina T, Toi M Visualising peripheral arterioles and venules through high-resolution and large-area photoacoustic imaging. Visualising peripheral arterioles and venules through high-resolution and large-area photoacoustic imaging. Visualising peripheral arterioles and venules through high-resolution and large-area photoacoustic imaging. Sci Rep, 8;8, 1, 14930-doi: 10.1038/s41598-018-33255- Sci Rep, 8;8, 1, 14930-doi: 10.1038/s41598-018-33255- Sci Rep, 8;8, 1, 14930-doi: 10.1038/s41598-018-33255- 2018/10 公開
Suzuki E, Sugimoto M, Kawaguchi K, Pu F, Uozumi R, Yamaguchi A, Nishie M, Tsuda M, Kotake T, Morita S, Toi M Suzuki E, Sugimoto M, Kawaguchi K, Pu F, Uozumi R, Yamaguchi A, Nishie M, Tsuda M, Kotake T, Morita S, Toi M Suzuki E, Sugimoto M, Kawaguchi K, Pu F, Uozumi R, Yamaguchi A, Nishie M, Tsuda M, Kotake T, Morita S, Toi M Gene expression profile of peripheral blood mononuclear cells may contribute to the identification and immunological classification of breast cancer patients. Gene expression profile of peripheral blood mononuclear cells may contribute to the identification and immunological classification of breast cancer patients. Gene expression profile of peripheral blood mononuclear cells may contribute to the identification and immunological classification of breast cancer patients. Breast Cancer, 13, doi: 10.1007/s12282-018-0920-2 Breast Cancer, 13, doi: 10.1007/s12282-018-0920-2 Breast Cancer, 13, doi: 10.1007/s12282-018-0920-2 2018/10 公開
Saito S, Bise R, Yoshikawa A, Sekiguchi H, Tsuge I, Toi M Saito S, Bise R, Yoshikawa A, Sekiguchi H, Tsuge I, Toi M Saito S, Bise R, Yoshikawa A, Sekiguchi H, Tsuge I, Toi M Digital artery deformation on movement of the proximal interphalangeal joint Digital artery deformation on movement of the proximal interphalangeal joint Digital artery deformation on movement of the proximal interphalangeal joint J Hand Surg Eur, 18:1753193418807833, doi: 10.1177/1753193418807833. J Hand Surg Eur, 18:1753193418807833, doi: 10.1177/1753193418807833. J Hand Surg Eur, 18:1753193418807833, doi: 10.1177/1753193418807833. 2018/10 公開
Yamamoto Y, Iwata H, Ueno T, Taira N, Kashiwaba M, Takahashi M, Tada H, Tsugawa K, Toyama T, Niikura N, Hara F, Fujisawa T, Yoshinami T, Saji S, Takano T, Masuda N, Morita S, Toi M, Ohno S Yamamoto Y, Iwata H, Ueno T, Taira N, Kashiwaba M, Takahashi M, Tada H, Tsugawa K, Toyama T, Niikura N, Hara F, Fujisawa T, Yoshinami T, Saji S, Takano T, Masuda N, Morita S, Toi M, Ohno S Yamamoto Y, Iwata H, Ueno T, Taira N, Kashiwaba M, Takahashi M, Tada H, Tsugawa K, Toyama T, Niikura N, Hara F, Fujisawa T, Yoshinami T, Saji S, Takano T, Masuda N, Morita S, Toi M, Ohno S A randomized, open-label, Phase III trial of pertuzumab retreatment in HER2-positive locally advanced/metastatic breast cancer patients previously treated with pertuzumab, trastuzumab and chemotherapy: the Japan Breast Cancer Research Group-M05 PRECIOUS s A randomized, open-label, Phase III trial of pertuzumab retreatment in HER2-positive locally advanced/metastatic breast cancer patients previously treated with pertuzumab, trastuzumab and chemotherapy: the Japan Breast Cancer Research Group-M05 PRECIOUS s A randomized, open-label, Phase III trial of pertuzumab retreatment in HER2-positive locally advanced/metastatic breast cancer patients previously treated with pertuzumab, trastuzumab and chemotherapy: the Japan Breast Cancer Research Group-M05 PRECIOUS s Jpn J Clin Oncol, 1;48, 9, 855-859 Jpn J Clin Oncol, 1;48, 9, 855-859 Jpn J Clin Oncol, 1;48, 9, 855-859 2018/09 公開
Fukui Y, Kawashima M, Kawaguchi K, Takeuchi M, Hirata M, Kataoka TR, Sakurai T, Kataoka M, Kanao S, Nakamoto Y, Hirata K, Yoshimura M, Yoshikawa K, Ishiguro H, Toi M Fukui Y, Kawashima M, Kawaguchi K, Takeuchi M, Hirata M, Kataoka TR, Sakurai T, Kataoka M, Kanao S, Nakamoto Y, Hirata K, Yoshimura M, Yoshikawa K, Ishiguro H, Toi M Fukui Y, Kawashima M, Kawaguchi K, Takeuchi M, Hirata M, Kataoka TR, Sakurai T, Kataoka M, Kanao S, Nakamoto Y, Hirata K, Yoshimura M, Yoshikawa K, Ishiguro H, Toi M Granulocyte-colony-stimulating factor-producing metaplastic carcinoma of the breast with significant elevation of serum interleukin-17 and vascular endothelial growth factor levels. Granulocyte-colony-stimulating factor-producing metaplastic carcinoma of the breast with significant elevation of serum interleukin-17 and vascular endothelial growth factor levels. Granulocyte-colony-stimulating factor-producing metaplastic carcinoma of the breast with significant elevation of serum interleukin-17 and vascular endothelial growth factor levels. International cancer conference journal, 7, 3, 107-113 International cancer conference journal, 7, 3, 107-113 International cancer conference journal, 7, 3, 107-113 2018/07 公開
Mackenzie LJ, Carey ML, Suzuki E, Sanson-Fisher RW, Asada H, Ogura M, D'Este C, Yoshimura M, Toi M Mackenzie LJ, Carey ML, Suzuki E, Sanson-Fisher RW, Asada H, Ogura M, D'Este C, Yoshimura M, Toi M Mackenzie LJ, Carey ML, Suzuki E, Sanson-Fisher RW, Asada H, Ogura M, D'Este C, Yoshimura M, Toi M Agreement between patients' and radiation oncologists' cancer diagnosis and prognosis perceptions: A cross sectional study in Japan. Agreement between patients' and radiation oncologists' cancer diagnosis and prognosis perceptions: A cross sectional study in Japan. Agreement between patients' and radiation oncologists' cancer diagnosis and prognosis perceptions: A cross sectional study in Japan. PLoS One, 8;13, 6, :e0198437. doi: 10.1371/journa PLoS One, 8;13, 6, :e0198437. doi: 10.1371/journa PLoS One, 8;13, 6, :e0198437. doi: 10.1371/journa 2018/06 公開
Sato N, Masuda N, Morimoto T, Ueno T, Kanbayashi C, Kaneko K, Yasojima H, Saji S, Sasano H, Morita S, Ohno S, Toi M Sato N, Masuda N, Morimoto T, Ueno T, Kanbayashi C, Kaneko K, Yasojima H, Saji S, Sasano H, Morita S, Ohno S, Toi M Sato N, Masuda N, Morimoto T, Ueno T, Kanbayashi C, Kaneko K, Yasojima H, Saji S, Sasano H, Morita S, Ohno S, Toi M Neoadjuvant endocrine therapy with exemestane followed by response-guided combination therapy with low-dose cyclophosphamide in postmenopausal patients with estrogen receptor-positive breast cancer: A multicenter, open-label, phase II study. Neoadjuvant endocrine therapy with exemestane followed by response-guided combination therapy with low-dose cyclophosphamide in postmenopausal patients with estrogen receptor-positive breast cancer: A multicenter, open-label, phase II study. Neoadjuvant endocrine therapy with exemestane followed by response-guided combination therapy with low-dose cyclophosphamide in postmenopausal patients with estrogen receptor-positive breast cancer: A multicenter, open-label, phase II study. Cancer Med, 14, 1002/cam4.1600. [Epub ahead of Cancer Med, 14, 1002/cam4.1600. [Epub ahead of Cancer Med, 14, 1002/cam4.1600. [Epub ahead of 2018/06 公開
Yamaga I, Kawaguchi-Sakita N, Asao Y, Matsumoto Y, Yoshikawa A, Fukui T, Takada M, Kataoka M, Kawashima M, Fakhrejahani E, Kanao S, Nakayama Y, Tokiwa M, Torii M, Yagi T, Sakurai T, Haga H, Togashi K, Shiina T, Toi M Yamaga I, Kawaguchi-Sakita N, Asao Y, Matsumoto Y, Yoshikawa A, Fukui T, Takada M, Kataoka M, Kawashima M, Fakhrejahani E, Kanao S, Nakayama Y, Tokiwa M, Torii M, Yagi T, Sakurai T, Haga H, Togashi K, Shiina T, Toi M Yamaga I, Kawaguchi-Sakita N, Asao Y, Matsumoto Y, Yoshikawa A, Fukui T, Takada M, Kataoka M, Kawashima M, Fakhrejahani E, Kanao S, Nakayama Y, Tokiwa M, Torii M, Yagi T, Sakurai T, Haga H, Togashi K, Shiina T, Toi M Vascular branching point counts using photoacoustic imaging in the superficial layer of the breast: A potential biomarker for breast cancer. Vascular branching point counts using photoacoustic imaging in the superficial layer of the breast: A potential biomarker for breast cancer. Vascular branching point counts using photoacoustic imaging in the superficial layer of the breast: A potential biomarker for breast cancer. Photoacoustics, 20;11, 6-13 Photoacoustics, 20;11, 6-13 Photoacoustics, 20;11, 6-13 2018/06 公開
Iima M, Kataoka M, Kanao S, Onishi N, Kawai M, Ohashi A, Sakaguchi R, Toi M, Togashi K Iima M, Kataoka M, Kanao S, Onishi N, Kawai M, Ohashi A, Sakaguchi R, Toi M, Togashi K Iima M, Kataoka M, Kanao S, Onishi N, Kawai M, Ohashi A, Sakaguchi R, Toi M, Togashi K Intravoxel Incoherent Motion and Quantitative Non-Gaussian Diffusion MR Imaging: Evaluation of the Diagnostic and Prognostic Value of Several Markers of Malignant and Benign Breast Lesions. Intravoxel Incoherent Motion and Quantitative Non-Gaussian Diffusion MR Imaging: Evaluation of the Diagnostic and Prognostic Value of Several Markers of Malignant and Benign Breast Lesions. Intravoxel Incoherent Motion and Quantitative Non-Gaussian Diffusion MR Imaging: Evaluation of the Diagnostic and Prognostic Value of Several Markers of Malignant and Benign Breast Lesions. Radiology, 287, 2, 432-441 Radiology, 287, 2, 432-441 Radiology, 287, 2, 432-441 2018/05 公開
Miyake O, Murata K, Tanaka S, Ishiguro H, Toi M, Tamura K, Kawakami K Miyake O, Murata K, Tanaka S, Ishiguro H, Toi M, Tamura K, Kawakami K Miyake O, Murata K, Tanaka S, Ishiguro H, Toi M, Tamura K, Kawakami K Costs associated with febrile neutropenia in Japanese patients with primary breast cancer: post-hoc analysis of a randomized clinical trial. Costs associated with febrile neutropenia in Japanese patients with primary breast cancer: post-hoc analysis of a randomized clinical trial. Costs associated with febrile neutropenia in Japanese patients with primary breast cancer: post-hoc analysis of a randomized clinical trial. Jpn J Clin Oncol, 1;48, 5, 410-416 Jpn J Clin Oncol, 1;48, 5, 410-416 Jpn J Clin Oncol, 1;48, 5, 410-416 2018/05 公開
Tsuge I, Saito S, Sekiguchi H, Yoshikawa A, Matsumoto Y, Toi M, Suzuki S Tsuge I, Saito S, Sekiguchi H, Yoshikawa A, Matsumoto Y, Toi M, Suzuki S Tsuge I, Saito S, Sekiguchi H, Yoshikawa A, Matsumoto Y, Toi M, Suzuki S Photoacoustic Tomography Shows the Branching Pattern of Anterolateral Thigh Perforators In Vivo. Photoacoustic Tomography Shows the Branching Pattern of Anterolateral Thigh Perforators In Vivo. Photoacoustic Tomography Shows the Branching Pattern of Anterolateral Thigh Perforators In Vivo. Plast Reconstr Surg, 141, 5, 1288-1292 Plast Reconstr Surg, 141, 5, 1288-1292 Plast Reconstr Surg, 141, 5, 1288-1292 2018/05 公開
Curigliano G, Burstein HJ, Winer EP, Gnant M, Dubsky P, Loibl S, Colleoni M, Regan MM, Piccart-Gebhart M, Senn HJ, Thürlimann B, Panel Members of the, St. Gallen International Expert, Consensus on the, Primary Therapy of Early Breast Cancer Curigliano G, Burstein HJ, Winer EP, Gnant M, Dubsky P, Loibl S, Colleoni M, Regan MM, Piccart-Gebhart M, Senn HJ, Thürlimann B, Panel Members of the, St. Gallen International Expert, Consensus on the, Primary Therapy of Early Breast Cancer Curigliano G, Burstein HJ, Winer EP, Gnant M, Dubsky P, Loibl S, Colleoni M, Regan MM, Piccart-Gebhart M, Senn HJ, Thürlimann B, Panel Members of the, St. Gallen International Expert, Consensus on the, Primary Therapy of Early Breast Cancer De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017. De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017. De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017. Ann Oncol, 3, doi: 10.1093/annonc/mdx806. [E Ann Oncol, 3, doi: 10.1093/annonc/mdx806. [E Ann Oncol, 3, doi: 10.1093/annonc/mdx806. [E 2018/05 公開
Ueno T, Masuda N, Kamigaki S, Morimoto T, Akiyama F, Kurosumi M, Tsuda H, Mikami Y, Tanaka S, Morita S, Toi M Ueno T, Masuda N, Kamigaki S, Morimoto T, Akiyama F, Kurosumi M, Tsuda H, Mikami Y, Tanaka S, Morita S, Toi M Ueno T, Masuda N, Kamigaki S, Morimoto T, Akiyama F, Kurosumi M, Tsuda H, Mikami Y, Tanaka S, Morita S, Toi M A multicenter phase II trial of neoadjuvant letrozole plus low-dose cyclophosphamide in postmenopausal patients with estrogen receptor-positive breast cancer (JBCRG-07): therapeutic efficacy and clinical implications of circulating endothelial cells. A multicenter phase II trial of neoadjuvant letrozole plus low-dose cyclophosphamide in postmenopausal patients with estrogen receptor-positive breast cancer (JBCRG-07): therapeutic efficacy and clinical implications of circulating endothelial cells. A multicenter phase II trial of neoadjuvant letrozole plus low-dose cyclophosphamide in postmenopausal patients with estrogen receptor-positive breast cancer (JBCRG-07): therapeutic efficacy and clinical implications of circulating endothelial cells. Cancer Med, 7, . doi: 10.1002/cam4.1516. [Epu Cancer Med, 7, . doi: 10.1002/cam4.1516. [Epu Cancer Med, 7, . doi: 10.1002/cam4.1516. [Epu 2018/05 公開
Takada M, Takeuchi M, Suzuki E, Sato F, Matsumoto Y, Torii M, Kawaguchi-Sakita N, Nishino H, Seo S, Hatano E, Toi M Takada M, Takeuchi M, Suzuki E, Sato F, Matsumoto Y, Torii M, Kawaguchi-Sakita N, Nishino H, Seo S, Hatano E, Toi M Takada M, Takeuchi M, Suzuki E, Sato F, Matsumoto Y, Torii M, Kawaguchi-Sakita N, Nishino H, Seo S, Hatano E, Toi M Real-time navigation system for sentinel lymph node biopsy in breast cancer patients using projection mapping with indocyanine green fluorescence. Real-time navigation system for sentinel lymph node biopsy in breast cancer patients using projection mapping with indocyanine green fluorescence. Real-time navigation system for sentinel lymph node biopsy in breast cancer patients using projection mapping with indocyanine green fluorescence. Breast Cancer, 9, doi: 10.1007/s12282-018-0868-2 Breast Cancer, 9, doi: 10.1007/s12282-018-0868-2 Breast Cancer, 9, doi: 10.1007/s12282-018-0868-2 2018/05 公開
Shiina T, Toi M, Yagi T Shiina T, Toi M, Yagi T Shiina T, Toi M, Yagi T Development and clinical translation of photoacoustic mammography. Development and clinical translation of photoacoustic mammography. Development and clinical translation of photoacoustic mammography. Biomed Eng Lett., 7;8, 2, 157-165 Biomed Eng Lett., 7;8, 2, 157-165 Biomed Eng Lett., 7;8, 2, 157-165 2018/05 公開
Tomoharu Sugie, Eiji Suzuki, Akira Yamauchi, Kazuhiko Yamagami, Norikazu Masuda, Naomi Gondo, Eriko Sumi, Takafumi Ikeda, Harue Tada, Ryuji Uozumi, Shotaro Kanao, Yoshimasa Tanaka, Yoko Hamazaki, Nagahiro Minato, Masakazu Toi Tomoharu Sugie, Eiji Suzuki, Akira Yamauchi, Kazuhiko Yamagami, Norikazu Masuda, Naomi Gondo, Eriko Sumi, Takafumi Ikeda, Harue Tada, Ryuji Uozumi, Shotaro Kanao, Yoshimasa Tanaka, Yoko Hamazaki, Nagahiro Minato, Masakazu Toi Tomoharu Sugie, Eiji Suzuki, Akira Yamauchi, Kazuhiko Yamagami, Norikazu Masuda, Naomi Gondo, Eriko Sumi, Takafumi Ikeda, Harue Tada, Ryuji Uozumi, Shotaro Kanao, Yoshimasa Tanaka, Yoko Hamazaki, Nagahiro Minato, Masakazu Toi Combined effects of neoadjuvant letrozole and zoledronic acid on γδT cells in postmenopausal women with early-stage breast cancer Combined effects of neoadjuvant letrozole and zoledronic acid on γδT cells in postmenopausal women with early-stage breast cancer Combined effects of neoadjuvant letrozole and zoledronic acid on γδT cells in postmenopausal women with early-stage breast cancer Breast, 38, 114-119 Breast, 38, 114-119 Breast, 38, 114-119 2018/04/01 公開
Itou J, Li W, Ito S, Tanaka S, Matsumoto Y, Sato F, Toi M Itou J, Li W, Ito S, Tanaka S, Matsumoto Y, Sato F, Toi M Itou J, Li W, Ito S, Tanaka S, Matsumoto Y, Sato F, Toi M Sal-like 4 protein levels in breast cancer cells are post-translationally down-regulated by tripartite motif-containing 21. Sal-like 4 protein levels in breast cancer cells are post-translationally down-regulated by tripartite motif-containing 21. Sal-like 4 protein levels in breast cancer cells are post-translationally down-regulated by tripartite motif-containing 21. J Biological Chemostry, 27;293, 17, 6556-6564 J Biological Chemostry, 27;293, 17, 6556-6564 J Biological Chemostry, 27;293, 17, 6556-6564 2018/04 公開
Kotake T, Toi M Kotake T, Toi M Kotake T, Toi M Abemaciclib for the treatment of breast cancer. Abemaciclib for the treatment of breast cancer. Abemaciclib for the treatment of breast cancer. Expert Opin Pharmacother., 19, 5, 517-524 Expert Opin Pharmacother., 19, 5, 517-524 Expert Opin Pharmacother., 19, 5, 517-524 2018/04 公開
Bidard FC, Michiels S, Riethdorf S, Mueller V, Esserman LJ, Lucci A, Naume B, Horiguchi J, Gisbert-Criado R, Sleijfer S, Toi M, Garcia-Saenz JA, Hartkopf A, Generali D, Rothé F, Smerage J, Muinelo-Romay L, Stebbing J, Viens P, Magbanua MJM, Hall CS, Engebraaten O, Takata D, Vidal-Martínez J, Onstenk W, Fujisawa N, Diaz-Rubio E, Taran FA, Cappelletti MR, Ignatiadis M, Proudhon C, Wolf DM, Bauldry JB, Borgen E, Nagaoka R, Carañana V, Kraan J, Maestro M, Brucker SY, Weber K, Reyal F, Amara D, Karhade MG, Mathiesen RR, Tokiniwa H, Llombart-Cussac A, Meddis A, Blanche P, d'Hollander K, Cottu P, Park JW, Loibl S, Latouche A, Pierga JY, Pantel K Bidard FC, Michiels S, Riethdorf S, Mueller V, Esserman LJ, Lucci A, Naume B, Horiguchi J, Gisbert-Criado R, Sleijfer S, Toi M, Garcia-Saenz JA, Hartkopf A, Generali D, Rothé F, Smerage J, Muinelo-Romay L, Stebbing J, Viens P, Magbanua MJM, Hall CS, Engebraaten O, Takata D, Vidal-Martínez J, Onstenk W, Fujisawa N, Diaz-Rubio E, Taran FA, Cappelletti MR, Ignatiadis M, Proudhon C, Wolf DM, Bauldry JB, Borgen E, Nagaoka R, Carañana V, Kraan J, Maestro M, Brucker SY, Weber K, Reyal F, Amara D, Karhade MG, Mathiesen RR, Tokiniwa H, Llombart-Cussac A, Meddis A, Blanche P, d'Hollander K, Cottu P, Park JW, Loibl S, Latouche A, Pierga JY, Pantel K Bidard FC, Michiels S, Riethdorf S, Mueller V, Esserman LJ, Lucci A, Naume B, Horiguchi J, Gisbert-Criado R, Sleijfer S, Toi M, Garcia-Saenz JA, Hartkopf A, Generali D, Rothé F, Smerage J, Muinelo-Romay L, Stebbing J, Viens P, Magbanua MJM, Hall CS, Engebraaten O, Takata D, Vidal-Martínez J, Onstenk W, Fujisawa N, Diaz-Rubio E, Taran FA, Cappelletti MR, Ignatiadis M, Proudhon C, Wolf DM, Bauldry JB, Borgen E, Nagaoka R, Carañana V, Kraan J, Maestro M, Brucker SY, Weber K, Reyal F, Amara D, Karhade MG, Mathiesen RR, Tokiniwa H, Llombart-Cussac A, Meddis A, Blanche P, d'Hollander K, Cottu P, Park JW, Loibl S, Latouche A, Pierga JY, Pantel K Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis. Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis. Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis. J Natl Cancer Inst, 12, doi: 10.1093/jnci/djy018. [Ep J Natl Cancer Inst, 12, doi: 10.1093/jnci/djy018. [Ep J Natl Cancer Inst, 12, doi: 10.1093/jnci/djy018. [Ep 2018/04 公開
Mackenzie L, Carey M, Suzuki E, Yoshimura M, Toi M, D'Este C, Sanson-Fisher R Mackenzie L, Carey M, Suzuki E, Yoshimura M, Toi M, D'Este C, Sanson-Fisher R Mackenzie L, Carey M, Suzuki E, Yoshimura M, Toi M, D'Este C, Sanson-Fisher R A cross-sectional study of agreement between the Hospital Anxiety and Depression Scale and patient- and radiation oncologist-reported single-item assessment of depression and anxiety. A cross-sectional study of agreement between the Hospital Anxiety and Depression Scale and patient- and radiation oncologist-reported single-item assessment of depression and anxiety. A cross-sectional study of agreement between the Hospital Anxiety and Depression Scale and patient- and radiation oncologist-reported single-item assessment of depression and anxiety. Psychooncology, 16, doi: 10.1002/pon.4736. [Epub Psychooncology, 16, doi: 10.1002/pon.4736. [Epub Psychooncology, 16, doi: 10.1002/pon.4736. [Epub 2018/04 公開
Mukai H, Shimizu C, Masuda N, Ohtani S, Ohno S, Takahashi M, Yamamoto Y, Nishimura R, Sato N, Ohsumi S, Iwata H, Mori Y, Hashigaki S, Muramatsu Y, Nagasawa T, Umeyama Y, Lu DR, Toi M Mukai H, Shimizu C, Masuda N, Ohtani S, Ohno S, Takahashi M, Yamamoto Y, Nishimura R, Sato N, Ohsumi S, Iwata H, Mori Y, Hashigaki S, Muramatsu Y, Nagasawa T, Umeyama Y, Lu DR, Toi M Mukai H, Shimizu C, Masuda N, Ohtani S, Ohno S, Takahashi M, Yamamoto Y, Nishimura R, Sato N, Ohsumi S, Iwata H, Mori Y, Hashigaki S, Muramatsu Y, Nagasawa T, Umeyama Y, Lu DR, Toi M Palbociclib in combination with letrozole in patients with estrogen receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: PALOMA-2 subgroup analysis of Japanese patients. Palbociclib in combination with letrozole in patients with estrogen receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: PALOMA-2 subgroup analysis of Japanese patients. Palbociclib in combination with letrozole in patients with estrogen receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: PALOMA-2 subgroup analysis of Japanese patients. Int J Clin Oncol, doi: 10.1007/s10147-018-1353-9 Int J Clin Oncol, doi: 10.1007/s10147-018-1353-9 Int J Clin Oncol, doi: 10.1007/s10147-018-1353-9 2018/04 公開
Yoshimasa Tanaka, Kaoru Murata-Hirai, Masashi Iwasaki, Kenji Matsumoto, Kosuke Hayashi, Asuka Kumagai, Mohanad, H. Nada, Hong Wang, Hirohito Kobayashi, Hiroshi Kamitakahara, Haruki Okamura, Tomoharu Sugie, Nagahiro Minato, Masakazu Toi, Craig T. Morita Yoshimasa Tanaka, Kaoru Murata-Hirai, Masashi Iwasaki, Kenji Matsumoto, Kosuke Hayashi, Asuka Kumagai, Mohanad, H. Nada, Hong Wang, Hirohito Kobayashi, Hiroshi Kamitakahara, Haruki Okamura, Tomoharu Sugie, Nagahiro Minato, Masakazu Toi, Craig T. Morita Yoshimasa Tanaka, Kaoru Murata-Hirai, Masashi Iwasaki, Kenji Matsumoto, Kosuke Hayashi, Asuka Kumagai, Mohanad, H. Nada, Hong Wang, Hirohito Kobayashi, Hiroshi Kamitakahara, Haruki Okamura, Tomoharu Sugie, Nagahiro Minato, Masakazu Toi, Craig T. Morita Expansion of human γδ T cells for adoptive immunotherapy using a bisphosphonate prodrug Expansion of human γδ T cells for adoptive immunotherapy using a bisphosphonate prodrug Expansion of human γδ T cells for adoptive immunotherapy using a bisphosphonate prodrug Cancer Science, 109, 587-599 Cancer Science, 109, 587-599 Cancer Science, 109, 587-599 2018/03/01 公開
Filipits M, Dafni U, Gnant M, Polydoropoulou V, Hills M, Kiermaier A, de Azambuja E, Larsimont D, Rojo F, Viale G, Toi M, Harbeck N, Prichard KI, Gelber RD, Dinh P, Zardavas D, Leyla, Jones B, Piccart-Gebhart MJ, Dowsett M, TransHERA investigators Filipits M, Dafni U, Gnant M, Polydoropoulou V, Hills M, Kiermaier A, de Azambuja E, Larsimont D, Rojo F, Viale G, Toi M, Harbeck N, Prichard KI, Gelber RD, Dinh P, Zardavas D, Leyla, Jones B, Piccart-Gebhart MJ, Dowsett M, TransHERA investigators Filipits M, Dafni U, Gnant M, Polydoropoulou V, Hills M, Kiermaier A, de Azambuja E, Larsimont D, Rojo F, Viale G, Toi M, Harbeck N, Prichard KI, Gelber RD, Dinh P, Zardavas D, Leyla, Jones B, Piccart-Gebhart MJ, Dowsett M, TransHERA investigators Association of p27 and Cyclin D1 Expression and Benefit from Adjuvant Trastuzumab Treatment in HER2-Positive Early Breast Cancer: A TransHERA Study. Association of p27 and Cyclin D1 Expression and Benefit from Adjuvant Trastuzumab Treatment in HER2-Positive Early Breast Cancer: A TransHERA Study. Association of p27 and Cyclin D1 Expression and Benefit from Adjuvant Trastuzumab Treatment in HER2-Positive Early Breast Cancer: A TransHERA Study. Clin Cancer Res, 12, doi: 10.1158/1078-0432.CCR-17- Clin Cancer Res, 12, doi: 10.1158/1078-0432.CCR-17- Clin Cancer Res, 12, doi: 10.1158/1078-0432.CCR-17- 2018/03 公開
Kanao S, Kataoka M, Iima M, Ikeda DM, Toi M, Togashi K Kanao S, Kataoka M, Iima M, Ikeda DM, Toi M, Togashi K Kanao S, Kataoka M, Iima M, Ikeda DM, Toi M, Togashi K Differentiating benign and malignant inflammatory breast lesions: Value of T2 weighted and diffusion weighted MR images. Differentiating benign and malignant inflammatory breast lesions: Value of T2 weighted and diffusion weighted MR images. Differentiating benign and malignant inflammatory breast lesions: Value of T2 weighted and diffusion weighted MR images. Magn Reson Imaging, 12;50, 38-44 doi: 10.1016/j.mri.2018.03. Magn Reson Imaging, 12;50, 38-44 doi: 10.1016/j.mri.2018.03. Magn Reson Imaging, 12;50, 38-44 doi: 10.1016/j.mri.2018.03. 2018/03 公開
Tada, Hiroshi, Miyashita, Minoru, Gonda, Kohsuke, Watanabe, Mika, Suzuki, Akihiko, Watanabe, Go, Harada, Narumi, Sato, Akiko, Hamanaka, Yohei, Masuda, Norikazu, Toi, Masakazu, Ohno, Shinji, Bando, Hiroko, Ishiguro, Hiroshi, Inoue, Kenichi, Yamamoto, Naohito, Kuroi, Katsumasa, Ohuchi, Noriaki, Ishida, Takanori Tada, Hiroshi, Miyashita, Minoru, Gonda, Kohsuke, Watanabe, Mika, Suzuki, Akihiko, Watanabe, Go, Harada, Narumi, Sato, Akiko, Hamanaka, Yohei, Masuda, Norikazu, Toi, Masakazu, Ohno, Shinji, Bando, Hiroko, Ishiguro, Hiroshi, Inoue, Kenichi, Yamamoto, Naohito, Kuroi, Katsumasa, Ohuchi, Noriaki, Ishida, Takanori Tada, Hiroshi, Miyashita, Minoru, Gonda, Kohsuke, Watanabe, Mika, Suzuki, Akihiko, Watanabe, Go, Harada, Narumi, Sato, Akiko, Hamanaka, Yohei, Masuda, Norikazu, Toi, Masakazu, Ohno, Shinji, Bando, Hiroko, Ishiguro, Hiroshi, Inoue, Kenichi, Yamamoto, Naohito, Kuroi, Katsumasa, Ohuchi, Noriaki, Ishida, Takanori New quantitative diagnostic method by fluorescence nanoparticle for HER2 positive breast cancer treated with neoadjuvant lapatinib and trastuzumab: The Neo LaTH study (JBCRG-16TR) New quantitative diagnostic method by fluorescence nanoparticle for HER2 positive breast cancer treated with neoadjuvant lapatinib and trastuzumab: The Neo LaTH study (JBCRG-16TR) New quantitative diagnostic method by fluorescence nanoparticle for HER2 positive breast cancer treated with neoadjuvant lapatinib and trastuzumab: The Neo LaTH study (JBCRG-16TR) CANCER RESEARCH, 78, 4::S CANCER RESEARCH, 78, 4::S CANCER RESEARCH, 78, 4::S 2018/02 英語 研究論文(学術雑誌) 公開
Kawaguchi, Hidetoshi, Yamashita, Toshinari, Masuda, Norikazu, Kitada, Masahiro, Narui, Kazutaka, Hattori, Masaya, Yoshinami, Tetsuhiro, Matsunami, Nobuki, Yanagihara, Kazuhiro, Kawasoe, Teru, Nagashima, Takeshi, Bando, Hiroko, Yano, Hiroshi, Hasegawa, Yoshie, Nakamura, Rikiya, Kashiwaba, Masahiro, Morita, Satoshi, Ohno, Shinji, Toi, Masakazu Kawaguchi, Hidetoshi, Yamashita, Toshinari, Masuda, Norikazu, Kitada, Masahiro, Narui, Kazutaka, Hattori, Masaya, Yoshinami, Tetsuhiro, Matsunami, Nobuki, Yanagihara, Kazuhiro, Kawasoe, Teru, Nagashima, Takeshi, Bando, Hiroko, Yano, Hiroshi, Hasegawa, Yoshie, Nakamura, Rikiya, Kashiwaba, Masahiro, Morita, Satoshi, Ohno, Shinji, Toi, Masakazu Kawaguchi, Hidetoshi, Yamashita, Toshinari, Masuda, Norikazu, Kitada, Masahiro, Narui, Kazutaka, Hattori, Masaya, Yoshinami, Tetsuhiro, Matsunami, Nobuki, Yanagihara, Kazuhiro, Kawasoe, Teru, Nagashima, Takeshi, Bando, Hiroko, Yano, Hiroshi, Hasegawa, Yoshie, Nakamura, Rikiya, Kashiwaba, Masahiro, Morita, Satoshi, Ohno, Shinji, Toi, Masakazu Phase II study of eribulin in combination with pertuzumab plus trastuzumab for human epidermal growth factor receptor 2 (HER2)-positive advanced or metastatic breast cancer Phase II study of eribulin in combination with pertuzumab plus trastuzumab for human epidermal growth factor receptor 2 (HER2)-positive advanced or metastatic breast cancer Phase II study of eribulin in combination with pertuzumab plus trastuzumab for human epidermal growth factor receptor 2 (HER2)-positive advanced or metastatic breast cancer CANCER RESEARCH, 78, 4::S CANCER RESEARCH, 78, 4::S CANCER RESEARCH, 78, 4::S 2018/02 英語 研究論文(学術雑誌) 公開
戸井 雅和 戸井 雅和 Masuda N, Nishimura R, Takahashi M, Inoue K, Ohno S, Iwata H, Mori Y, Hashigaki S, Muramatsu Y, Nagasawa T, Umeyama Y, Toi M Palbociclib in combination with letrozole as first-line treatment for advanced breast cancer: A Japanese phase II study. Palbociclib in combination with letrozole as first-line treatment for advanced breast cancer: A Japanese phase II study. Palbociclib in combination with letrozole as first-line treatment for advanced breast cancer: A Japanese phase II study. Cancer Sci, 109(3), 803-813 Cancer Sci, 109(3), 803-813 Cancer Sci, 109(3), 803-813 2018/02 公開
Förnvik D, Kataoka M, Iima M, Ohashi A, Kanao S, Toi M, Togashi K Förnvik D, Kataoka M, Iima M, Ohashi A, Kanao S, Toi M, Togashi K Förnvik D, Kataoka M, Iima M, Ohashi A, Kanao S, Toi M, Togashi K The role of breast tomosynthesis in a predominantly dense breast population at a tertiary breast centre: breast density assessment and diagnostic performance in comparison with MRI. The role of breast tomosynthesis in a predominantly dense breast population at a tertiary breast centre: breast density assessment and diagnostic performance in comparison with MRI. The role of breast tomosynthesis in a predominantly dense breast population at a tertiary breast centre: breast density assessment and diagnostic performance in comparison with MRI. Eur Radiol, 19, doi: 10.1007/s00330-017-52-1846 Eur Radiol, 19, doi: 10.1007/s00330-017-52-1846 Eur Radiol, 19, doi: 10.1007/s00330-017-52-1846 2018/02 公開
Ueno T, Saji S, Masuda N, Kuroi K, Sato N, Takei H, Yamamoto Y, Ohno S, Yamashita H, Hisamatsu K, Aogi K, Iwata H, Yamanaka T, Sasano H, Toi M Ueno T, Saji S, Masuda N, Kuroi K, Sato N, Takei H, Yamamoto Y, Ohno S, Yamashita H, Hisamatsu K, Aogi K, Iwata H, Yamanaka T, Sasano H, Toi M Ueno T, Saji S, Masuda N, Kuroi K, Sato N, Takei H, Yamamoto Y, Ohno S, Yamashita H, Hisamatsu K, Aogi K, Iwata H, Yamanaka T, Sasano H, Toi M Impact of clinical response to neoadjuvant endocrine therapy on patient outcomes: a follow-up study of JFMC34-0601 multicentre prospective neoadjuvant endocrine trial. Impact of clinical response to neoadjuvant endocrine therapy on patient outcomes: a follow-up study of JFMC34-0601 multicentre prospective neoadjuvant endocrine trial. Impact of clinical response to neoadjuvant endocrine therapy on patient outcomes: a follow-up study of JFMC34-0601 multicentre prospective neoadjuvant endocrine trial. ESMO Open, 14;3, 2, e000314. doi: 10.1136/esmoopen ESMO Open, 14;3, 2, e000314. doi: 10.1136/esmoopen ESMO Open, 14;3, 2, e000314. doi: 10.1136/esmoopen 2018/02 公開
Akiko Hanai, Hiroshi Ishiguro, Takashi Sozu, Moe Tsuda, Ikuko Yano, Takayuki Nakagawa, Satoshi Imai, Yoko Hamabe, Masakazu Toi, Hidenori Arai, Tadao Tsuboyama Akiko Hanai, Hiroshi Ishiguro, Takashi Sozu, Moe Tsuda, Ikuko Yano, Takayuki Nakagawa, Satoshi Imai, Yoko Hamabe, Masakazu Toi, Hidenori Arai, Tadao Tsuboyama Akiko Hanai, Hiroshi Ishiguro, Takashi Sozu, Moe Tsuda, Ikuko Yano, Takayuki Nakagawa, Satoshi Imai, Yoko Hamabe, Masakazu Toi, Hidenori Arai, Tadao Tsuboyama Effects of Cryotherapy on Objective and Subjective Symptoms of Paclitaxel-Induced Neuropathy: Prospective Self-Controlled Trial Effects of Cryotherapy on Objective and Subjective Symptoms of Paclitaxel-Induced Neuropathy: Prospective Self-Controlled Trial Effects of Cryotherapy on Objective and Subjective Symptoms of Paclitaxel-Induced Neuropathy: Prospective Self-Controlled Trial JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 110, 2, 141-148 JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 110, 2, 141-148 JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 110, 2, 141-148 2018/02 英語 研究論文(学術雑誌) 公開
Osamu Miyake, Kyoko Murata, Shiro Tanaka, Hiroshi Ishiguro, Masakazu Toi, Kazuo Tamura, Koji Kawakami Osamu Miyake, Kyoko Murata, Shiro Tanaka, Hiroshi Ishiguro, Masakazu Toi, Kazuo Tamura, Koji Kawakami Osamu Miyake, Kyoko Murata, Shiro Tanaka, Hiroshi Ishiguro, Masakazu Toi, Kazuo Tamura, Koji Kawakami Cost analysis with febrile neutropenia in Japanese patients with primary breast cancer: retrospective analysis of a randomized clinical trial. Cost analysis with febrile neutropenia in Japanese patients with primary breast cancer: retrospective analysis of a randomized clinical trial. Cost analysis with febrile neutropenia in Japanese patients with primary breast cancer: retrospective analysis of a randomized clinical trial. Japanese Journal of Clinical Oncology, 48, 5, 410-416 Japanese Journal of Clinical Oncology, 48, 5, 410-416 Japanese Journal of Clinical Oncology, 48, 5, 410-416 2018 公開
Kawaguchi H, Masuda N, Nakayama T, Aogi K, Anan K, Ito Y, Ohtani S, Sato N, Saji S, Takano T, Tokunaga E, Nakamura S, Hasegawa Y, Hattori M, Fujisawa T, Morita S, Yamaguchi M, Yamashita H, Yamashita T, Yamamoto Y, Yotsumoto D, Toi M, Ohno S Kawaguchi H, Masuda N, Nakayama T, Aogi K, Anan K, Ito Y, Ohtani S, Sato N, Saji S, Takano T, Tokunaga E, Nakamura S, Hasegawa Y, Hattori M, Fujisawa T, Morita S, Yamaguchi M, Yamashita H, Yamashita T, Yamamoto Y, Yotsumoto D, Toi M, Ohno S Kawaguchi H, Masuda N, Nakayama T, Aogi K, Anan K, Ito Y, Ohtani S, Sato N, Saji S, Takano T, Tokunaga E, Nakamura S, Hasegawa Y, Hattori M, Fujisawa T, Morita S, Yamaguchi M, Yamashita H, Yamashita T, Yamamoto Y, Yotsumoto D, Toi M, Ohno S Factors associated with prolonged time to treatment failure with fulvestrant 500 mg in patients with post-menopausal estrogen receptor-positive advanced breast cancer: a sub-group analysis of the JBCRG-C06 Safari study. Factors associated with prolonged time to treatment failure with fulvestrant 500 mg in patients with post-menopausal estrogen receptor-positive advanced breast cancer: a sub-group analysis of the JBCRG-C06 Safari study. Factors associated with prolonged time to treatment failure with fulvestrant 500 mg in patients with post-menopausal estrogen receptor-positive advanced breast cancer: a sub-group analysis of the JBCRG-C06 Safari study. Current medical research and opinion, 34, 1, 49-54 Current medical research and opinion, 34, 1, 49-54 Current medical research and opinion, 34, 1, 49-54 2018/01 公開
Nagae K, Asao Y, Sudo Y, Murayama N, Tanaka Y, Ohira K, Ishida Y, Otsuka A, Matsumoto Y, Saito S, Furu M, Murata K, Sekiguchi H, Kataoka M, Yoshikawa A, Ishii T, Togashi K, Shiina T, Kabashima K, Toi M, Yagi T Nagae K, Asao Y, Sudo Y, Murayama N, Tanaka Y, Ohira K, Ishida Y, Otsuka A, Matsumoto Y, Saito S, Furu M, Murata K, Sekiguchi H, Kataoka M, Yoshikawa A, Ishii T, Togashi K, Shiina T, Kabashima K, Toi M, Yagi T Nagae K, Asao Y, Sudo Y, Murayama N, Tanaka Y, Ohira K, Ishida Y, Otsuka A, Matsumoto Y, Saito S, Furu M, Murata K, Sekiguchi H, Kataoka M, Yoshikawa A, Ishii T, Togashi K, Shiina T, Kabashima K, Toi M, Yagi T Real-time 3D Photoacoustic Visualization System with a Wide Field of View for Imaging Human Limbs. Real-time 3D Photoacoustic Visualization System with a Wide Field of View for Imaging Human Limbs. Real-time 3D Photoacoustic Visualization System with a Wide Field of View for Imaging Human Limbs. F1000Research, 7, 1813 F1000Research, 7, 1813 F1000Research, 7, 1813 2018 公開
Tomohiro Shibata, Eriko Tokunaga, Satoshi Hattori, Kosuke Watari, Yuichi Murakami, Nami Yamashita, Eiji Oki, Junji Itou, Masakazu Toi, Yoshihiko Maehara, Michihiko Kuwano, Mayumi Ono Tomohiro Shibata, Eriko Tokunaga, Satoshi Hattori, Kosuke Watari, Yuichi Murakami, Nami Yamashita, Eiji Oki, Junji Itou, Masakazu Toi, Yoshihiko Maehara, Michihiko Kuwano, Mayumi Ono Y-box binding protein YBX1 and its correlated genes as biomarkers for poor outcomes in patients with breast cancer. Y-box binding protein YBX1 and its correlated genes as biomarkers for poor outcomes in patients with breast cancer. Oncotarget, 9, 98, 37216-37228 Oncotarget, 9, 98, 37216-37228 , 9, 98, 37216-37228 2018 英語 研究論文(学術雑誌) 公開
Hiroyasu Yamashiro, Masataka Sawaki, Norikazu Masuda, Yasuhiro Okumura, Toshimi Takano, Eriko Tokunaga, Tsuyoshi Saito, Yasuaki Sagara, Kosuke Yamazaki, Yoshihiro Kawaguchi, Tecchuu Lee, Shinji Ozaki, Kazuhiko Yamagami, Naohito Yamamoto, Katsumasa Kuroi, Hirofumi Suwa, Shoichiro Ohtani, Toshikazu Ito, Shinji Yasuno, Satoshi Morita, Shinji Ohno, Masakazu Toi Hiroyasu Yamashiro, Masataka Sawaki, Norikazu Masuda, Yasuhiro Okumura, Toshimi Takano, Eriko Tokunaga, Tsuyoshi Saito, Yasuaki Sagara, Kosuke Yamazaki, Yoshihiro Kawaguchi, Tecchuu Lee, Shinji Ozaki, Kazuhiko Yamagami, Naohito Yamamoto, Katsumasa Kuroi, Hirofumi Suwa, Shoichiro Ohtani, Toshikazu Ito, Shinji Yasuno, Satoshi Morita, Shinji Ohno, Masakazu Toi Hiroyasu Yamashiro, Masataka Sawaki, Norikazu Masuda, Yasuhiro Okumura, Toshimi Takano, Eriko Tokunaga, Tsuyoshi Saito, Yasuaki Sagara, Kosuke Yamazaki, Yoshihiro Kawaguchi, Tecchuu Lee, Shinji Ozaki, Kazuhiko Yamagami, Naohito Yamamoto, Katsumasa Kuroi, Hirofumi Suwa, Shoichiro Ohtani, Toshikazu Ito, Shinji Yasuno, Satoshi Morita, Shinji Ohno, Masakazu Toi Survival Outcomes of Retreatment with Trastuzumab and Cytotoxic Chemotherapy for HER2-Positive Recurrent Patients With Breast Cancer Who Had Been Treated with Neo/adjuvant Trastuzumab Plus Multidrug Chemotherapy: A Japanese Multicenter Observational Study. Survival Outcomes of Retreatment with Trastuzumab and Cytotoxic Chemotherapy for HER2-Positive Recurrent Patients With Breast Cancer Who Had Been Treated with Neo/adjuvant Trastuzumab Plus Multidrug Chemotherapy: A Japanese Multicenter Observational Study. Survival Outcomes of Retreatment with Trastuzumab and Cytotoxic Chemotherapy for HER2-Positive Recurrent Patients With Breast Cancer Who Had Been Treated with Neo/adjuvant Trastuzumab Plus Multidrug Chemotherapy: A Japanese Multicenter Observational Study. Breast cancer : basic and clinical research, 12, 1178223418786243-1178223418786243 Breast cancer : basic and clinical research, 12, 1178223418786243-1178223418786243 Breast cancer : basic and clinical research, 12, 1178223418786243-1178223418786243 2018 英語 公開
Hiroshi Ishiguro, Shigehira Saji, Shogo Nomura, Sunao Tanaka, Takayuki Ueno, Masahide Onoue, Hiroji Iwata, Takeharu Yamanaka, Yasutsuna Sasaki, Masakazu Toi Hiroshi Ishiguro, Shigehira Saji, Shogo Nomura, Sunao Tanaka, Takayuki Ueno, Masahide Onoue, Hiroji Iwata, Takeharu Yamanaka, Yasutsuna Sasaki, Masakazu Toi Hiroshi Ishiguro, Shigehira Saji, Shogo Nomura, Sunao Tanaka, Takayuki Ueno, Masahide Onoue, Hiroji Iwata, Takeharu Yamanaka, Yasutsuna Sasaki, Masakazu Toi A phase I/II pharmacokinetics/pharmacodynamics study of irinotecan combined with S-1 for recurrent/metastatic breast cancer in patients with selected UGT1A1 genotypes (the JBCRG-M01 study) A phase I/II pharmacokinetics/pharmacodynamics study of irinotecan combined with S-1 for recurrent/metastatic breast cancer in patients with selected UGT1A1 genotypes (the JBCRG-M01 study) A phase I/II pharmacokinetics/pharmacodynamics study of irinotecan combined with S-1 for recurrent/metastatic breast cancer in patients with selected UGT1A1 genotypes (the JBCRG-M01 study) CANCER MEDICINE, 6, 12, 2909-2917 CANCER MEDICINE, 6, 12, 2909-2917 CANCER MEDICINE, 6, 12, 2909-2917 2017/12 英語 研究論文(学術雑誌) 公開
Kawai M, Kataoka M, Kanao S, Iima M, Onishi N, Ohashi A, Sakaguchi R, Toi M, Togashi K Kawai M, Kataoka M, Kanao S, Iima M, Onishi N, Ohashi A, Sakaguchi R, Toi M, Togashi K Kawai M, Kataoka M, Kanao S, Iima M, Onishi N, Ohashi A, Sakaguchi R, Toi M, Togashi K The Value of Lesion Size as an Adjunct to the BI-RADS-MRI 2013 Descriptors in the Diagnosis of Solitary Breast Masses. The Value of Lesion Size as an Adjunct to the BI-RADS-MRI 2013 Descriptors in the Diagnosis of Solitary Breast Masses. The Value of Lesion Size as an Adjunct to the BI-RADS-MRI 2013 Descriptors in the Diagnosis of Solitary Breast Masses. Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine 2017/12 公開
Toi M, Masuda N, Lee SJ Toi M, Masuda N, Lee SJ Toi M, Masuda N, Lee SJ Capecitabine for primary breast cancer. Capecitabine for primary breast cancer. Capecitabine for primary breast cancer. Oncotarget, 6;8, 67, 110739-110740 Oncotarget, 6;8, 67, 110739-110740 Oncotarget, 6;8, 67, 110739-110740 2017/12 公開
Matthew P. Goetz, Masakazu Toi, Mario Campone, Joohyuk Sohn, Shani Paluch-Shimon, Jens Huober, In Hae Park, Olivier Tredan, Shin-Cheh Chen, Luis Manso, Orit C. Freedman, Georgina Garnica Jaliffe, Tammy Forrester, Martin Frenzel, Susana Barriga, Ian C. Smith, Nawel Bourayou, Angelo Di Leo Matthew P. Goetz, Masakazu Toi, Mario Campone, Joohyuk Sohn, Shani Paluch-Shimon, Jens Huober, In Hae Park, Olivier Tredan, Shin-Cheh Chen, Luis Manso, Orit C. Freedman, Georgina Garnica Jaliffe, Tammy Forrester, Martin Frenzel, Susana Barriga, Ian C. Smith, Nawel Bourayou, Angelo Di Leo Matthew P. Goetz, Masakazu Toi, Mario Campone, Joohyuk Sohn, Shani Paluch-Shimon, Jens Huober, In Hae Park, Olivier Tredan, Shin-Cheh Chen, Luis Manso, Orit C. Freedman, Georgina Garnica Jaliffe, Tammy Forrester, Martin Frenzel, Susana Barriga, Ian C. Smith, Nawel Bourayou, Angelo Di Leo MONARCH 3: Abemaciclib As Initial Therapy for Advanced Breast Cancer MONARCH 3: Abemaciclib As Initial Therapy for Advanced Breast Cancer MONARCH 3: Abemaciclib As Initial Therapy for Advanced Breast Cancer JOURNAL OF CLINICAL ONCOLOGY, 35, 32, 3638-+ JOURNAL OF CLINICAL ONCOLOGY, 35, 32, 3638-+ JOURNAL OF CLINICAL ONCOLOGY, 35, 32, 3638-+ 2017/11 英語 研究論文(学術雑誌) 公開
Ohgami M, Bando H, Ishiguro H, Tsuda M, Toriguchi N, Aogi K, Toi M, Masuda N, Mitsuhashi S, Kurosawa A, Homma M Ohgami M, Bando H, Ishiguro H, Tsuda M, Toriguchi N, Aogi K, Toi M, Masuda N, Mitsuhashi S, Kurosawa A, Homma M Ohgami M, Bando H, Ishiguro H, Tsuda M, Toriguchi N, Aogi K, Toi M, Masuda N, Mitsuhashi S, Kurosawa A, Homma M Effect of dose timing on the blood concentration of lapatinib in patients with breast cancer Effect of dose timing on the blood concentration of lapatinib in patients with breast cancer Effect of dose timing on the blood concentration of lapatinib in patients with breast cancer Ann Oncol, 28, 11, 2888-2889 Ann Oncol, 28, 11, 2888-2889 Ann Oncol, 28, 11, 2888-2889 2017/11 英語 研究論文(学術雑誌) 公開
George W. Sledge, Masakazu Toi, Patrick Neven, Joohyuk Sohn, Kenichi Inoue, Xavier Pivot, Olga Burdaeva, Meena Okera, Norikazu Masuda, Peter A. Kaufman, Han Koh, Eva-Maria Grischke, Martin Frenzel, Yong Lin, Susana Barriga, Ian C. Smith, Nawel Bourayou, Antonio Llombart-Cussac George W. Sledge, Masakazu Toi, Patrick Neven, Joohyuk Sohn, Kenichi Inoue, Xavier Pivot, Olga Burdaeva, Meena Okera, Norikazu Masuda, Peter A. Kaufman, Han Koh, Eva-Maria Grischke, Martin Frenzel, Yong Lin, Susana Barriga, Ian C. Smith, Nawel Bourayou, Antonio Llombart-Cussac George W. Sledge, Masakazu Toi, Patrick Neven, Joohyuk Sohn, Kenichi Inoue, Xavier Pivot, Olga Burdaeva, Meena Okera, Norikazu Masuda, Peter A. Kaufman, Han Koh, Eva-Maria Grischke, Martin Frenzel, Yong Lin, Susana Barriga, Ian C. Smith, Nawel Bourayou, Antonio Llombart-Cussac MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2-Advanced Breast Cancer Who Had Progressed While Receiving Endocrine Therapy MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2-Advanced Breast Cancer Who Had Progressed While Receiving Endocrine Therapy MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2-Advanced Breast Cancer Who Had Progressed While Receiving Endocrine Therapy JOURNAL OF CLINICAL ONCOLOGY, 35, 25, 2875-+ JOURNAL OF CLINICAL ONCOLOGY, 35, 25, 2875-+ JOURNAL OF CLINICAL ONCOLOGY, 35, 25, 2875-+ 2017/09 英語 研究論文(学術雑誌) 公開
Torii M, Fukui T, Inoue M, Kanao S, Umetani K, Shirai M, Inagaki T, Tsuchimochi H, Pearson JT, Toi M Torii M, Fukui T, Inoue M, Kanao S, Umetani K, Shirai M, Inagaki T, Tsuchimochi H, Pearson JT, Toi M Torii M, Fukui T, Inoue M, Kanao S, Umetani K, Shirai M, Inagaki T, Tsuchimochi H, Pearson JT, Toi M Analysis of the microvascular morphology and hemodynamics of breast cancer in mice using SPring-8 synchrotron radiation microangiography. Analysis of the microvascular morphology and hemodynamics of breast cancer in mice using SPring-8 synchrotron radiation microangiography. Analysis of the microvascular morphology and hemodynamics of breast cancer in mice using SPring-8 synchrotron radiation microangiography. Journal of synchrotron radiation, 24, Pt 5, 1039-1047 Journal of synchrotron radiation, 24, Pt 5, 1039-1047 Journal of synchrotron radiation, 24, Pt 5, 1039-1047 2017/09 公開
三宅 可奈江, 中本 裕士, 西松 佳代, 金尾 昌太郎, 片岡 正子, 石守 崇好, 戸井 雅和, 富樫 かおり 三宅 可奈江, 中本 裕士, 西松 佳代, 金尾 昌太郎, 片岡 正子, 石守 崇好, 戸井 雅和, 富樫 かおり 三宅 可奈江, 中本 裕士, 西松 佳代, 金尾 昌太郎, 片岡 正子, 石守 崇好, 戸井 雅和, 富樫 かおり 全身用PETと乳房専用PETにおける定量値の比較 全身用PETと乳房専用PETにおける定量値の比較 全身用PETと乳房専用PETにおける定量値の比較 核医学, 54, Suppl., S195-S195 核医学, 54, Suppl., S195-S195 核医学, 54, Suppl., S195-S195 2017/09 日本語 公開
Kosuke Kawaguchi, Eiji Suzuki, Mariko Nishie, Isao Kii, Tatsuki R. Kataoka, Masahiro Hirata, Masashi Inoue, Fengling Pu, Keiko Iwaisako, Moe Tsuda, Ayane Yamaguchi, Hironori Haga, Masatoshi Hagiwara, Masakazu Toi Kosuke Kawaguchi, Eiji Suzuki, Mariko Nishie, Isao Kii, Tatsuki R. Kataoka, Masahiro Hirata, Masashi Inoue, Fengling Pu, Keiko Iwaisako, Moe Tsuda, Ayane Yamaguchi, Hironori Haga, Masatoshi Hagiwara, Masakazu Toi Kosuke Kawaguchi, Eiji Suzuki, Mariko Nishie, Isao Kii, Tatsuki R. Kataoka, Masahiro Hirata, Masashi Inoue, Fengling Pu, Keiko Iwaisako, Moe Tsuda, Ayane Yamaguchi, Hironori Haga, Masatoshi Hagiwara, Masakazu Toi Downregulation of neuropilin-1 on macrophages modulates antibody-mediated tumoricidal activity Downregulation of neuropilin-1 on macrophages modulates antibody-mediated tumoricidal activity Downregulation of neuropilin-1 on macrophages modulates antibody-mediated tumoricidal activity CANCER IMMUNOLOGY IMMUNOTHERAPY, 66, 9, 1131-1142 CANCER IMMUNOLOGY IMMUNOTHERAPY, 66, 9, 1131-1142 CANCER IMMUNOLOGY IMMUNOTHERAPY, 66, 9, 1131-1142 2017/09 英語 研究論文(学術雑誌) 公開
Yoshimasa Tanaka, Masashi Iwasaki, Kaoru Murata-Hirai, Kenji Matsumoto, Kosuke Hayashi, Haruki Okamura, Tomoharu Sugie, Nagahiro Minato, Craig T. Morita, Masakazu Toi Yoshimasa Tanaka, Masashi Iwasaki, Kaoru Murata-Hirai, Kenji Matsumoto, Kosuke Hayashi, Haruki Okamura, Tomoharu Sugie, Nagahiro Minato, Craig T. Morita, Masakazu Toi Yoshimasa Tanaka, Masashi Iwasaki, Kaoru Murata-Hirai, Kenji Matsumoto, Kosuke Hayashi, Haruki Okamura, Tomoharu Sugie, Nagahiro Minato, Craig T. Morita, Masakazu Toi Anti-Tumor Activity and Immunotherapeutic Potential of a Bisphosphonate Prodrug Anti-Tumor Activity and Immunotherapeutic Potential of a Bisphosphonate Prodrug Anti-Tumor Activity and Immunotherapeutic Potential of a Bisphosphonate Prodrug SCIENTIFIC REPORTS, 7 SCIENTIFIC REPORTS, 7 SCIENTIFIC REPORTS, 7 2017/07 英語 研究論文(学術雑誌) 公開
H. Kawaguchi, N. Masuda, T. Nakayama, K. Aogi, K. Anan, Y. Ito, S. Ohtani, N. Sato, S. Saji, E. Tokunaga, S. Nakamura, Y. Hasegawa, M. Hattori, T. Fujisawa, S. Morita, M. Yamaguchi, T. Yamashita, Y. Yamamoto, S. Ohno, M. Toi H. Kawaguchi, N. Masuda, T. Nakayama, K. Aogi, K. Anan, Y. Ito, S. Ohtani, N. Sato, S. Saji, E. Tokunaga, S. Nakamura, Y. Hasegawa, M. Hattori, T. Fujisawa, S. Morita, M. Yamaguchi, T. Yamashita, Y. Yamamoto, S. Ohno, M. Toi H. Kawaguchi, N. Masuda, T. Nakayama, K. Aogi, K. Anan, Y. Ito, S. Ohtani, N. Sato, S. Saji, E. Tokunaga, S. Nakamura, Y. Hasegawa, M. Hattori, T. Fujisawa, S. Morita, M. Yamaguchi, T. Yamashita, Y. Yamamoto, S. Ohno, M. Toi Outcomes of fulvestrant therapy among japanese women with advanced breast cancer: a retrospective multicenter cohort study (JBCRG-C06; Safari) Outcomes of fulvestrant therapy among japanese women with advanced breast cancer: a retrospective multicenter cohort study (JBCRG-C06; Safari) Outcomes of fulvestrant therapy among japanese women with advanced breast cancer: a retrospective multicenter cohort study (JBCRG-C06; Safari) BREAST CANCER RESEARCH AND TREATMENT, 163, 3, 545-554 BREAST CANCER RESEARCH AND TREATMENT, 163, 3, 545-554 BREAST CANCER RESEARCH AND TREATMENT, 163, 3, 545-554 2017/06 英語 研究論文(学術雑誌) 公開
Amir Sonnenblick, Dominique Agbor-Tarh, Ian Bradbury, Serena Di Cosimo, Hatem A. Azim, Debora Fumagalli, Severine Sarp, Antonio C. Wolff, Michael Andersson, Judith Kroep, Tanja Cufer, Sergio D. Simon, Pamela Salman, Masakazu Toi, Lyndsay Harris, Julie Gralow, Maccon Keane, Alvaro Moreno-Aspitia, Martine Piccart-Gebhart, Evandro de Azambuja Amir Sonnenblick, Dominique Agbor-Tarh, Ian Bradbury, Serena Di Cosimo, Hatem A. Azim, Debora Fumagalli, Severine Sarp, Antonio C. Wolff, Michael Andersson, Judith Kroep, Tanja Cufer, Sergio D. Simon, Pamela Salman, Masakazu Toi, Lyndsay Harris, Julie Gralow, Maccon Keane, Alvaro Moreno-Aspitia, Martine Piccart-Gebhart, Evandro de Azambuja Amir Sonnenblick, Dominique Agbor-Tarh, Ian Bradbury, Serena Di Cosimo, Hatem A. Azim, Debora Fumagalli, Severine Sarp, Antonio C. Wolff, Michael Andersson, Judith Kroep, Tanja Cufer, Sergio D. Simon, Pamela Salman, Masakazu Toi, Lyndsay Harris, Julie Gralow, Maccon Keane, Alvaro Moreno-Aspitia, Martine Piccart-Gebhart, Evandro de Azambuja Impact of Diabetes, Insulin, and Metformin Use on the Outcome of Patients With Human Epidermal Growth Factor Receptor 2-Positive Primary Breast Cancer: Analysis From the ALTTO Phase III Randomized Trial Impact of Diabetes, Insulin, and Metformin Use on the Outcome of Patients With Human Epidermal Growth Factor Receptor 2-Positive Primary Breast Cancer: Analysis From the ALTTO Phase III Randomized Trial Impact of Diabetes, Insulin, and Metformin Use on the Outcome of Patients With Human Epidermal Growth Factor Receptor 2-Positive Primary Breast Cancer: Analysis From the ALTTO Phase III Randomized Trial JOURNAL OF CLINICAL ONCOLOGY, 35, 13, 1421-+ JOURNAL OF CLINICAL ONCOLOGY, 35, 13, 1421-+ JOURNAL OF CLINICAL ONCOLOGY, 35, 13, 1421-+ 2017/05 英語 研究論文(学術雑誌) 公開
Kayo Nishimatsu, Yuji Nakamoto, Kanae K. Miyake, Takayoshi Ishimori, Shotaro Kanao, Masakazu Toi, Kaori Togashi Kayo Nishimatsu, Yuji Nakamoto, Kanae K. Miyake, Takayoshi Ishimori, Shotaro Kanao, Masakazu Toi, Kaori Togashi Kayo Nishimatsu, Yuji Nakamoto, Kanae K. Miyake, Takayoshi Ishimori, Shotaro Kanao, Masakazu Toi, Kaori Togashi Higher breast cancer conspicuity on dbPET compared to WB-PET/CT Higher breast cancer conspicuity on dbPET compared to WB-PET/CT Higher breast cancer conspicuity on dbPET compared to WB-PET/CT EUROPEAN JOURNAL OF RADIOLOGY, 90, 138-145 EUROPEAN JOURNAL OF RADIOLOGY, 90, 138-145 EUROPEAN JOURNAL OF RADIOLOGY, 90, 138-145 2017/05 英語 研究論文(学術雑誌) 公開
Ryusuke Nakamoto, Yuji Nakamoto, Takayoshi Ishimori, Kayo Nishimatsu, Kanae K. Miyake, Shotaro Kanao, Mami Iima, Masakazu Toi, Kaori Togashi Ryusuke Nakamoto, Yuji Nakamoto, Takayoshi Ishimori, Kayo Nishimatsu, Kanae K. Miyake, Shotaro Kanao, Mami Iima, Masakazu Toi, Kaori Togashi Ryusuke Nakamoto, Yuji Nakamoto, Takayoshi Ishimori, Kayo Nishimatsu, Kanae K. Miyake, Shotaro Kanao, Mami Iima, Masakazu Toi, Kaori Togashi Diagnostic performance of a novel dedicated breast PET scanner with C-shaped ring detectors Diagnostic performance of a novel dedicated breast PET scanner with C-shaped ring detectors Diagnostic performance of a novel dedicated breast PET scanner with C-shaped ring detectors NUCLEAR MEDICINE COMMUNICATIONS, 38, 5, 388-395 NUCLEAR MEDICINE COMMUNICATIONS, 38, 5, 388-395 NUCLEAR MEDICINE COMMUNICATIONS, 38, 5, 388-395 2017/05 英語 研究論文(学術雑誌) 公開
Onishi N, Kataoka M, Kanao S, Sagawa H, Iima M, Nickel MD, Toi M, Togashi K Onishi N, Kataoka M, Kanao S, Sagawa H, Iima M, Nickel MD, Toi M, Togashi K Onishi N, Kataoka M, Kanao S, Sagawa H, Iima M, Nickel MD, Toi M, Togashi K Ultrafast dynamic contrast-enhanced mri of the breast using compressed sensing: breast cancer diagnosis based on separate visualization of breast arteries and veins. Ultrafast dynamic contrast-enhanced mri of the breast using compressed sensing: breast cancer diagnosis based on separate visualization of breast arteries and veins. Ultrafast dynamic contrast-enhanced mri of the breast using compressed sensing: breast cancer diagnosis based on separate visualization of breast arteries and veins. Journal of magnetic resonance imaging : JMRI, 47, 1, 97-104 Journal of magnetic resonance imaging : JMRI, 47, 1, 97-104 Journal of magnetic resonance imaging : JMRI, 47, 1, 97-104 2017/05 公開
Tanaka S, Ueno T, Ishiguro H, Morita S, Toi M Tanaka S, Ueno T, Ishiguro H, Morita S, Toi M Tanaka S, Ueno T, Ishiguro H, Morita S, Toi M The lack of increases in circulating endothelial progenitor cell as a negative predictor for pathological response to neoadjuvant chemotherapy in breast cancer patients The lack of increases in circulating endothelial progenitor cell as a negative predictor for pathological response to neoadjuvant chemotherapy in breast cancer patients The lack of increases in circulating endothelial progenitor cell as a negative predictor for pathological response to neoadjuvant chemotherapy in breast cancer patients NPJ Precis Oncol, 1, 6 NPJ Precis Oncol, 1, 6 NPJ Precis Oncol, 1, 6 2017/04 英語 公開
R. Bell, J. Brown, M. Parmar, M. Toi, T. Suter, G. G. Steger, X. Pivot, J. Mackey, C. Jackisch, R. Dent, P. Hall, N. Xu, L. Morales, L. Provencher, R. Hegg, L. Vanlemmens, A. Kirsch, A. Schneeweiss, N. Masuda, F. Overkamp, D. Cameron R. Bell, J. Brown, M. Parmar, M. Toi, T. Suter, G. G. Steger, X. Pivot, J. Mackey, C. Jackisch, R. Dent, P. Hall, N. Xu, L. Morales, L. Provencher, R. Hegg, L. Vanlemmens, A. Kirsch, A. Schneeweiss, N. Masuda, F. Overkamp, D. Cameron R. Bell, J. Brown, M. Parmar, M. Toi, T. Suter, G. G. Steger, X. Pivot, J. Mackey, C. Jackisch, R. Dent, P. Hall, N. Xu, L. Morales, L. Provencher, R. Hegg, L. Vanlemmens, A. Kirsch, A. Schneeweiss, N. Masuda, F. Overkamp, D. Cameron Final efficacy and updated safety results of the randomized phase III BEATRICE trial evaluating adjuvant bevacizumab-containing therapy in triple-negative early breast cancer Final efficacy and updated safety results of the randomized phase III BEATRICE trial evaluating adjuvant bevacizumab-containing therapy in triple-negative early breast cancer Final efficacy and updated safety results of the randomized phase III BEATRICE trial evaluating adjuvant bevacizumab-containing therapy in triple-negative early breast cancer ANNALS OF ONCOLOGY, 28, 4, 754-760 ANNALS OF ONCOLOGY, 28, 4, 754-760 ANNALS OF ONCOLOGY, 28, 4, 754-760 2017/04 英語 研究論文(学術雑誌) 公開
Takafumi Ikeda, Tomoharu Sugie, Akira Shimizu, Masakazu Toi Takafumi Ikeda, Tomoharu Sugie, Akira Shimizu, Masakazu Toi Takafumi Ikeda, Tomoharu Sugie, Akira Shimizu, Masakazu Toi Patterns of clinical practice for sentinel lymph node biopsy in women with node-negative breast cancer: the results of a national survey in Japan Patterns of clinical practice for sentinel lymph node biopsy in women with node-negative breast cancer: the results of a national survey in Japan Patterns of clinical practice for sentinel lymph node biopsy in women with node-negative breast cancer: the results of a national survey in Japan BREAST CANCER, 24, 2, 341-344 BREAST CANCER, 24, 2, 341-344 BREAST CANCER, 24, 2, 341-344 2017/03 英語 研究論文(学術雑誌) 公開
Tomoharu Sugie, Takafumi Ikeda, Atsushi Kawaguchi, Akira Shimizu, Masakazu Toi Tomoharu Sugie, Takafumi Ikeda, Atsushi Kawaguchi, Akira Shimizu, Masakazu Toi Tomoharu Sugie, Takafumi Ikeda, Atsushi Kawaguchi, Akira Shimizu, Masakazu Toi Sentinel lymph node biopsy using indocyanine green fluorescence in early-stage breast cancer: a meta-analysis Sentinel lymph node biopsy using indocyanine green fluorescence in early-stage breast cancer: a meta-analysis Sentinel lymph node biopsy using indocyanine green fluorescence in early-stage breast cancer: a meta-analysis INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 22, 1, 11-17 INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 22, 1, 11-17 INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 22, 1, 11-17 2017/02 英語 公開
M. Toi, Y. Asao, Y. Matsumoto, H. Sekiguchi, A. Yoshikawa, M. Takada, M. Kataoka, T. Endo, N. Kawaguchi-Sakita, M. Kawashima, E. Fakhrejahani, S. Kanao, I. Yamaga, Y. Nakayama, M. Tokiwa, M. Torii, T. Yagi, T. Sakurai, K. Togashi, T. Shiina M. Toi, Y. Asao, Y. Matsumoto, H. Sekiguchi, A. Yoshikawa, M. Takada, M. Kataoka, T. Endo, N. Kawaguchi-Sakita, M. Kawashima, E. Fakhrejahani, S. Kanao, I. Yamaga, Y. Nakayama, M. Tokiwa, M. Torii, T. Yagi, T. Sakurai, K. Togashi, T. Shiina M. Toi, Y. Asao, Y. Matsumoto, H. Sekiguchi, A. Yoshikawa, M. Takada, M. Kataoka, T. Endo, N. Kawaguchi-Sakita, M. Kawashima, E. Fakhrejahani, S. Kanao, I. Yamaga, Y. Nakayama, M. Tokiwa, M. Torii, T. Yagi, T. Sakurai, K. Togashi, T. Shiina Visualization of tumor-related blood vessels in human breast by photoacoustic imaging system with a hemispherical detector array Visualization of tumor-related blood vessels in human breast by photoacoustic imaging system with a hemispherical detector array Visualization of tumor-related blood vessels in human breast by photoacoustic imaging system with a hemispherical detector array SCIENTIFIC REPORTS, 7, 7;7:41970. doi: 10.1038/srep41 SCIENTIFIC REPORTS, 7, 7;7:41970. doi: 10.1038/srep41 SCIENTIFIC REPORTS, 7, 7;7:41970. doi: 10.1038/srep41 2017/02 英語 研究論文(学術雑誌) 公開
Sagara Y, Julia W, Golshan M, Toi M Sagara Y, Julia W, Golshan M, Toi M Sagara Y, Julia W, Golshan M, Toi M Paradigm Shift toward Reducing Overtreatment of Ductal Carcinoma <i>In Situ</i> of Breast. Paradigm Shift toward Reducing Overtreatment of Ductal Carcinoma <i>In Situ</i> of Breast. Paradigm Shift toward Reducing Overtreatment of Ductal Carcinoma <i>In Situ</i> of Breast. Frontiers in oncology, 7, 192 Frontiers in oncology, 7, 192 Frontiers in oncology, 7, 192 2017 公開
N. Masuda, S.-J. Lee, S. Ohtani, Y.-H. Im, E.-S. Lee, I. Yokota, K. Kuroi, S.-A. Im, B.-W. Park, S.-B. Kim, Y. Yanagita, S. Ohno, S. Takao, K. Aogi, H. Iwata, J. Jeong, A. Kim, K.-H. Park, H. Sasano, Y. Ohashi, M. Toi N. Masuda, S.-J. Lee, S. Ohtani, Y.-H. Im, E.-S. Lee, I. Yokota, K. Kuroi, S.-A. Im, B.-W. Park, S.-B. Kim, Y. Yanagita, S. Ohno, S. Takao, K. Aogi, H. Iwata, J. Jeong, A. Kim, K.-H. Park, H. Sasano, Y. Ohashi, M. Toi N. Masuda, S.-J. Lee, S. Ohtani, Y.-H. Im, E.-S. Lee, I. Yokota, K. Kuroi, S.-A. Im, B.-W. Park, S.-B. Kim, Y. Yanagita, S. Ohno, S. Takao, K. Aogi, H. Iwata, J. Jeong, A. Kim, K.-H. Park, H. Sasano, Y. Ohashi, M. Toi Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy N Engl J Med, 1;376, 22, 2147-2159 N Engl J Med, 1;376, 22, 2147-2159 N Engl J Med, 1;376, 22, 2147-2159 2017/01 公開
Edith A. Perez, Carlos Barrios, Wolfgang Eiermann, Masakazu Toi, Young-Hyuck Im, Pierfranco Conte, Miguel Martin, Tadeusz Pienkowski, Xavier Pivot, Howard Burris, Jennifer A. Petersen, Sven Stanzel, Alexander Strasak, Monika Patre, Paul Ellis Edith A. Perez, Carlos Barrios, Wolfgang Eiermann, Masakazu Toi, Young-Hyuck Im, Pierfranco Conte, Miguel Martin, Tadeusz Pienkowski, Xavier Pivot, Howard Burris, Jennifer A. Petersen, Sven Stanzel, Alexander Strasak, Monika Patre, Paul Ellis Edith A. Perez, Carlos Barrios, Wolfgang Eiermann, Masakazu Toi, Young-Hyuck Im, Pierfranco Conte, Miguel Martin, Tadeusz Pienkowski, Xavier Pivot, Howard Burris, Jennifer A. Petersen, Sven Stanzel, Alexander Strasak, Monika Patre, Paul Ellis Trastuzumab Emtansine With or Without Pertuzumab Versus Trastuzumab Plus Taxane for Human Epidermal Growth Factor Receptor 2-Positive, Advanced Breast Cancer: Primary Results From the Phase III MARIANNE Study Trastuzumab Emtansine With or Without Pertuzumab Versus Trastuzumab Plus Taxane for Human Epidermal Growth Factor Receptor 2-Positive, Advanced Breast Cancer: Primary Results From the Phase III MARIANNE Study Trastuzumab Emtansine With or Without Pertuzumab Versus Trastuzumab Plus Taxane for Human Epidermal Growth Factor Receptor 2-Positive, Advanced Breast Cancer: Primary Results From the Phase III MARIANNE Study JOURNAL OF CLINICAL ONCOLOGY, 35, 2, 141-+ JOURNAL OF CLINICAL ONCOLOGY, 35, 2, 141-+ JOURNAL OF CLINICAL ONCOLOGY, 35, 2, 141-+ 2017/01 英語 研究論文(学術雑誌) 公開
Natsuko Onishi, Masako Kataoka, Shotaro Kanao, Makiko Kawai, Mami Iima, Akane Ohashi, Masakazu Toi, Kaori Togashi Natsuko Onishi, Masako Kataoka, Shotaro Kanao, Makiko Kawai, Mami Iima, Akane Ohashi, Masakazu Toi, Kaori Togashi Natsuko Onishi, Masako Kataoka, Shotaro Kanao, Makiko Kawai, Mami Iima, Akane Ohashi, Masakazu Toi, Kaori Togashi A pilot study to determine the diagnostic criteria of spiculated masses for BI-RADS MRI category 5: when to perform re-biopsy after discordant pathologic result? A pilot study to determine the diagnostic criteria of spiculated masses for BI-RADS MRI category 5: when to perform re-biopsy after discordant pathologic result? A pilot study to determine the diagnostic criteria of spiculated masses for BI-RADS MRI category 5: when to perform re-biopsy after discordant pathologic result? BREAST CANCER, 24, 1, 69-78 BREAST CANCER, 24, 1, 69-78 BREAST CANCER, 24, 1, 69-78 2017/01 英語 研究論文(学術雑誌) 公開
Kosuke Kawaguchi, Eiji Suzuki, Ayane Yamaguchi, Michio Yamamoto, Satoshi Morita, Masakazu Toi Kosuke Kawaguchi, Eiji Suzuki, Ayane Yamaguchi, Michio Yamamoto, Satoshi Morita, Masakazu Toi Kosuke Kawaguchi, Eiji Suzuki, Ayane Yamaguchi, Michio Yamamoto, Satoshi Morita, Masakazu Toi Altered expression of major immune regulatory molecules in peripheral blood immune cells associated with breast cancer Altered expression of major immune regulatory molecules in peripheral blood immune cells associated with breast cancer Altered expression of major immune regulatory molecules in peripheral blood immune cells associated with breast cancer BREAST CANCER, 24, 1, 111-120 BREAST CANCER, 24, 1, 111-120 BREAST CANCER, 24, 1, 111-120 2017/01 英語 研究論文(学術雑誌) 公開
Kimiko Hirata, Michio Yoshimura, Minoru Inoue, Chikako Yamauchi, Masakazu Ogura, Masakazu Toi, Eiji Suzuki, Megumi Takeuchi, Masahiro Takada, Masahiro Hiraoka Kimiko Hirata, Michio Yoshimura, Minoru Inoue, Chikako Yamauchi, Masakazu Ogura, Masakazu Toi, Eiji Suzuki, Megumi Takeuchi, Masahiro Takada, Masahiro Hiraoka Kimiko Hirata, Michio Yoshimura, Minoru Inoue, Chikako Yamauchi, Masakazu Ogura, Masakazu Toi, Eiji Suzuki, Megumi Takeuchi, Masahiro Takada, Masahiro Hiraoka Regional recurrence in breast cancer patients with one to three positive axillary lymph nodes treated with breast-conserving surgery and whole breast irradiation Regional recurrence in breast cancer patients with one to three positive axillary lymph nodes treated with breast-conserving surgery and whole breast irradiation Regional recurrence in breast cancer patients with one to three positive axillary lymph nodes treated with breast-conserving surgery and whole breast irradiation JOURNAL OF RADIATION RESEARCH, 58, 1, 79-85 JOURNAL OF RADIATION RESEARCH, 58, 1, 79-85 JOURNAL OF RADIATION RESEARCH, 58, 1, 79-85 2017/01 英語 研究論文(学術雑誌) 公開
Itou J, Tanaka S, Li W, Iida A, Sehara-Fujisawa A, Sato F, Toi M Itou J, Tanaka S, Li W, Iida A, Sehara-Fujisawa A, Sato F, Toi M Junji Itou, Sunao Tanaka, Wenzhao Li, Atsuo Iida, Atsuko Sehara-Fujisawa, Fumiaki Sato, Masakazu Toi The Sal-like 4 - integrin α6β1 network promotes cell migration for metastasis via activation of focal adhesion dynamics in basal-like breast cancer cells. The Sal-like 4 - integrin α6β1 network promotes cell migration for metastasis via activation of focal adhesion dynamics in basal-like breast cancer cells. The Sal-like 4-integrin alpha 6 beta 1 network promotes cell migration for metastasis via activation of focal adhesion dynamics in basal-like breast cancer cells Biochim Biophys Acta., 1864, 1, 76-88 Biochim Biophys Acta., 1864, 1, 76-88 BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 1864, 1, 76-88 2017/01 英語 研究論文(学術雑誌) 公開
Gongping Shi, Yoko Yoshida, Kanako Yuki, Tomomi Nishimura, Yukiko Kawata, Masahiro Kawashima, Keiko Iwaisako, Kiyotsugu Yoshikawa, Junichi Kurebayashi, Masakazu Toi, Makoto Noda Gongping Shi, Yoko Yoshida, Kanako Yuki, Tomomi Nishimura, Yukiko Kawata, Masahiro Kawashima, Keiko Iwaisako, Kiyotsugu Yoshikawa, Junichi Kurebayashi, Masakazu Toi, Makoto Noda Gongping Shi, Yoko Yoshida, Kanako Yuki, Tomomi Nishimura, Yukiko Kawata, Masahiro Kawashima, Keiko Iwaisako, Kiyotsugu Yoshikawa, Junichi Kurebayashi, Masakazu Toi, Makoto Noda Pattern of RECK CpG methylation as a potential marker for predicting breast cancer prognosis and drug-sensitivity Pattern of RECK CpG methylation as a potential marker for predicting breast cancer prognosis and drug-sensitivity Pattern of RECK CpG methylation as a potential marker for predicting breast cancer prognosis and drug-sensitivity ONCOTARGET, 7, 50, 82158-82169 ONCOTARGET, 7, 50, 82158-82169 ONCOTARGET, 7, 50, 82158-82169 2016/12 英語 研究論文(学術雑誌) 公開
Natsue Uehiro, Fumiaki Sato, Fengling Pu, Sunao Tanaka, Masahiro Kawashima, Kosuke Kawaguchi, Masahiro Sugimoto, Shigehira Saji, Masakazu Toi Natsue Uehiro, Fumiaki Sato, Fengling Pu, Sunao Tanaka, Masahiro Kawashima, Kosuke Kawaguchi, Masahiro Sugimoto, Shigehira Saji, Masakazu Toi Natsue Uehiro, Fumiaki Sato, Fengling Pu, Sunao Tanaka, Masahiro Kawashima, Kosuke Kawaguchi, Masahiro Sugimoto, Shigehira Saji, Masakazu Toi Circulating cell-free DNA-based epigenetic assay can detect early breast cancer Circulating cell-free DNA-based epigenetic assay can detect early breast cancer Circulating cell-free DNA-based epigenetic assay can detect early breast cancer BREAST CANCER RESEARCH, 18, 1, 129 BREAST CANCER RESEARCH, 18, 1, 129 BREAST CANCER RESEARCH, 18, 1, 129 2016/12 英語 研究論文(学術雑誌) 公開
Ismail Jatoi, John R. Benson, Masakazu Toi Ismail Jatoi, John R. Benson, Masakazu Toi Ismail Jatoi, John R. Benson, Masakazu Toi De-escalation of axillary surgery in early breast cancer De-escalation of axillary surgery in early breast cancer De-escalation of axillary surgery in early breast cancer LANCET ONCOLOGY, 17, 10, E430-E441 LANCET ONCOLOGY, 17, 10, E430-E441 LANCET ONCOLOGY, 17, 10, E430-E441 2016/10 英語 研究論文(学術雑誌) 公開
John R. Benson, Ismail Jatoi, Masakazu Toi John R. Benson, Ismail Jatoi, Masakazu Toi John R. Benson, Ismail Jatoi, Masakazu Toi Treatment of low-risk ductal carcinoma in situ: is nothing better than something? Treatment of low-risk ductal carcinoma in situ: is nothing better than something? Treatment of low-risk ductal carcinoma in situ: is nothing better than something? LANCET ONCOLOGY, 17, 10, E442-E451 LANCET ONCOLOGY, 17, 10, E442-E451 LANCET ONCOLOGY, 17, 10, E442-E451 2016/10 英語 研究論文(学術雑誌) 公開
E. -S. Lee, W. Han, H. -C. Shin, M. Takada, H. S. Ryu, N. Cho, M. K. Kim, J. Kim, T. -k. Yoo, H. -G. Moon, M. Toi, W. K. Moon, I. -A. Park, D. -Y. Noh E. -S. Lee, W. Han, H. -C. Shin, M. Takada, H. S. Ryu, N. Cho, M. K. Kim, J. Kim, T. -k. Yoo, H. -G. Moon, M. Toi, W. K. Moon, I. -A. Park, D. -Y. Noh E. -S. Lee, W. Han, H. -C. Shin, M. Takada, H. S. Ryu, N. Cho, M. K. Kim, J. Kim, T. -k. Yoo, H. -G. Moon, M. Toi, W. K. Moon, I. -A. Park, D. -Y. Noh Clinical benefit of nomogram for predicting positive resection margins in breast conserving surgery Clinical benefit of nomogram for predicting positive resection margins in breast conserving surgery Clinical benefit of nomogram for predicting positive resection margins in breast conserving surgery EJSO, 42, 8, 1169-1175 EJSO, 42, 8, 1169-1175 EJSO, 42, 8, 1169-1175 2016/08 英語 研究論文(学術雑誌) 公開
Eiji Suzuki, Lisa Mackenzie, Robert Sanson-Fisher, Mariko Carey, Catherine D'Este, Hiromi Asada, Masakazu Toi Eiji Suzuki, Lisa Mackenzie, Robert Sanson-Fisher, Mariko Carey, Catherine D'Este, Hiromi Asada, Masakazu Toi Eiji Suzuki, Lisa Mackenzie, Robert Sanson-Fisher, Mariko Carey, Catherine D'Este, Hiromi Asada, Masakazu Toi Acceptability of a Touch Screen Tablet Psychosocial Survey Administered to Radiation Therapy Patients in Japan Acceptability of a Touch Screen Tablet Psychosocial Survey Administered to Radiation Therapy Patients in Japan Acceptability of a Touch Screen Tablet Psychosocial Survey Administered to Radiation Therapy Patients in Japan INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE, 23, 4, 485-491 INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE, 23, 4, 485-491 INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE, 23, 4, 485-491 2016/08 英語 研究論文(学術雑誌) 公開
Eiji Suzuki, Lisa Mackenzie, Robert Sanson-Fisher, Mariko Carey, Catherine D'Este, Hiromi Asada, Masakazu Toi Eiji Suzuki, Lisa Mackenzie, Robert Sanson-Fisher, Mariko Carey, Catherine D'Este, Hiromi Asada, Masakazu Toi Eiji Suzuki, Lisa Mackenzie, Robert Sanson-Fisher, Mariko Carey, Catherine D'Este, Hiromi Asada, Masakazu Toi Acceptability of a Touch Screen Tablet Psychosocial Survey Administered to Radiation Therapy Patients in Japan Acceptability of a Touch Screen Tablet Psychosocial Survey Administered to Radiation Therapy Patients in Japan Acceptability of a Touch Screen Tablet Psychosocial Survey Administered to Radiation Therapy Patients in Japan INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE, 23, 4, 485-491 INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE, 23, 4, 485-491 INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE, 23, 4, 485-491 2016/08 英語 研究論文(学術雑誌) 公開
大神 正宏, 坂東 裕子, 石黒 洋, 鳥口 尚子, 津田 萌, 戸井 雅和, 増田 慎三, 武井 敬司, Homma, Masato 大神 正宏, 坂東 裕子, 石黒 洋, 鳥口 尚子, 津田 萌, 戸井 雅和, 増田 慎三, 武井 敬司, Homma, Masato 大神 正宏, 坂東 裕子, 石黒 洋, 鳥口 尚子, 津田 萌, 戸井 雅和, 増田 慎三, 武井 敬司, Homma, Masato ラパチニブの血中濃度に及ぼす服用タイミングとタモキシフェン併用の影響(会議録) ラパチニブの血中濃度に及ぼす服用タイミングとタモキシフェン併用の影響(会議録) ラパチニブの血中濃度に及ぼす服用タイミングとタモキシフェン併用の影響(会議録) TDM研究, 33, 2, 192 TDM研究, 33, 2, 192 TDM研究, 33, 2, 192 2016/05 日本語 研究論文(研究会、シンポジウム資料等) 公開
Buyse M, Hurvitz SA, Andre F, Jiang Z, Burris HA, Toi M, Eiermann W, Lindsay MA, Slamon D Buyse M, Hurvitz SA, Andre F, Jiang Z, Burris HA, Toi M, Eiermann W, Lindsay MA, Slamon D M. Buyse, S. A. Hurvitz, F. Andre, Z. Jiang, H. A. Burris, M. Toi, W. Eiermann, M. -A. Lindsay, D. Slamon Statistical controversies in clinical research: statistical significance-too much of a good thing …. Statistical controversies in clinical research: statistical significance-too much of a good thing …. Statistical controversies in clinical research: statistical significance-too much of a good thing ... Ann Oncol, 27, 5, 760-762 Ann Oncol, 27, 5, 760-762 ANNALS OF ONCOLOGY, 27, 5, 760-762 2016/05 英語 研究論文(学術雑誌) 公開
Wenzhao Li, Junji Itou, Sunao Tanaka, Tomomi Nishimura, Fumiaki Sato, Masakazu Toi Wenzhao Li, Junji Itou, Sunao Tanaka, Tomomi Nishimura, Fumiaki Sato, Masakazu Toi Wenzhao Li, Junji Itou, Sunao Tanaka, Tomomi Nishimura, Fumiaki Sato, Masakazu Toi A homeobox protein, NKX6.1, up-regulates interleukin-6 expression for cell growth in basal-like breast cancer cells A homeobox protein, NKX6.1, up-regulates interleukin-6 expression for cell growth in basal-like breast cancer cells A homeobox protein, NKX6.1, up-regulates interleukin-6 expression for cell growth in basal-like breast cancer cells EXPERIMENTAL CELL RESEARCH, 343, 2, 177-189 EXPERIMENTAL CELL RESEARCH, 343, 2, 177-189 EXPERIMENTAL CELL RESEARCH, 343, 2, 177-189 2016/05 英語 研究論文(学術雑誌) 公開
松本純明, 浅尾恭史, 浅尾恭史, 金尾昌太郎, 片岡正子, 椎名隆, 戸井雅和 松本純明, 浅尾恭史, 浅尾恭史, 金尾昌太郎, 片岡正子, 椎名隆, 戸井雅和 松本 純明, 浅尾 恭史, 金尾 昌太郎, 片岡 正子, 椎名 毅, 戸井 雅和 新しい分子・光イメージング技術の開発と乳癌診断領域への応用 光超音波技術の乳癌診断への応用 新しい分子・光イメージング技術の開発と乳癌診断領域への応用 光超音波技術の乳癌診断への応用 【新しい分子・光イメージング技術の開発と乳癌診断領域への応用】 光超音波技術の乳癌診断への応用 乳癌の臨床, 31, 1, 7‐17-17 乳癌の臨床, 31, 1, 7‐17-17 乳癌の臨床, 31, 1, 7‐17-17 2016/03/25 日本語 公開
Masakazu Toi, Shinji Ohno, Toshiaki Saeki, Seigo Nakamura, Beat Thurlimann Masakazu Toi, Shinji Ohno, Toshiaki Saeki, Seigo Nakamura, Beat Thurlimann Masakazu Toi, Shinji Ohno, Toshiaki Saeki, Seigo Nakamura, Beat Thurlimann For choosing axillary treatment, and adjuvant hormonal treatment For choosing axillary treatment, and adjuvant hormonal treatment For choosing axillary treatment, and adjuvant hormonal treatment BREAST CANCER, 23, 2, 167-169 BREAST CANCER, 23, 2, 167-169 BREAST CANCER, 23, 2, 167-169 2016/03 英語 公開
Hayakawa Yoshihiro, Kawada Manabu, Nishikawa Hiroyoshi, Ochiya Takahiro, Saya Hideyuki, Seimiya Hiroyuki, Yao Ryoji, Hayashi Masahiro, Kai Chieko, Matsuda Akira, Naoe Tomoki, Ohtsu Atsushi, Okazaki Taku, Saji Hideo, Sata Masataka, Sugimura Haruhiko, Sugiyama Yuichi, Toi Masakazu, Irimura Tatsuro Hayakawa Yoshihiro, Kawada Manabu, Nishikawa Hiroyoshi, Ochiya Takahiro, Saya Hideyuki, Seimiya Hiroyuki, Yao Ryoji, Hayashi Masahiro, Kai Chieko, Matsuda Akira, Naoe Tomoki, Ohtsu Atsushi, Okazaki Taku, Saji Hideo, Sata Masataka, Sugimura Haruhiko, Sugiyama Yuichi, Toi Masakazu, Irimura Tatsuro Hayakawa Yoshihiro, Kawada Manabu, Nishikawa Hiroyoshi, Ochiya Takahiro, Saya Hideyuki, Seimiya Hiroyuki, Yao Ryoji, Hayashi Masahiro, Kai Chieko, Matsuda Akira, Naoe Tomoki, Ohtsu Atsushi, Okazaki Taku, Saji Hideo, Sata Masataka, Sugimura Haruhiko, Sugiyama Yuichi, Toi Masakazu, Irimura Tatsuro Report on the use of non-clinical studies in the regulatory evaluation of oncology drugs Report on the use of non-clinical studies in the regulatory evaluation of oncology drugs Report on the use of non-clinical studies in the regulatory evaluation of oncology drugs Cancer Science, 107, 2, 189-202 Cancer Science, 107, 2, 189-202 Cancer Science, 107, 2, 189-202 2016/02/01 英語 公開
Ohno,S, Ishiguro,H, Yamamoto,Y, Takao,S, Sato,N, Fujisawa,T, Kadoya,T, Kuroi,K, Bando,H, Teramura,Y, Iwata,H, Tanaka,S, Toi,M Ohno,S, Ishiguro,H, Yamamoto,Y, Takao,S, Sato,N, Fujisawa,T, Kadoya,T, Kuroi,K, Bando,H, Teramura,Y, Iwata,H, Tanaka,S, Toi,M Ohno,S, Ishiguro,H, Yamamoto,Y, Takao,S, Sato,N, Fujisawa,T, Kadoya,T, Kuroi,K, Bando,H, Teramura,Y, Iwata,H, Tanaka,S, Toi,M Pharmacogenomics-pharmacokinetics study of selective estrogen receptor modulators with intra-patient dose-escalation for Japanese breast cancer patients Pharmacogenomics-pharmacokinetics study of selective estrogen receptor modulators with intra-patient dose-escalation for Japanese breast cancer patients Pharmacogenomics-pharmacokinetics study of selective estrogen receptor modulators with intra-patient dose-escalation for Japanese breast cancer patients CANCER RESEARCH, 76, 4 CANCER RESEARCH, 76, 4 CANCER RESEARCH, 76, 4 2016/02 英語 研究論文(学術雑誌) 公開
Yoshihiro Hayakawa, Manabu Kawada, Hiroyoshi Nishikawa, Takahiro Ochiya, Hideyuki Saya, Hiroyuki Seimiya, Ryoji Yao, Masahiro Hayashi, Chieko Kai, Akira Matsuda, Tomoki Naoe, Atsushi Ohtsu, Taku Okazaki, Hideo Saji, Masataka Sata, Haruhiko Sugimura, Yuichi Sugiyama, Masakazu Toi, Tatsuro Irimura Yoshihiro Hayakawa, Manabu Kawada, Hiroyoshi Nishikawa, Takahiro Ochiya, Hideyuki Saya, Hiroyuki Seimiya, Ryoji Yao, Masahiro Hayashi, Chieko Kai, Akira Matsuda, Tomoki Naoe, Atsushi Ohtsu, Taku Okazaki, Hideo Saji, Masataka Sata, Haruhiko Sugimura, Yuichi Sugiyama, Masakazu Toi, Tatsuro Irimura Yoshihiro Hayakawa, Manabu Kawada, Hiroyoshi Nishikawa, Takahiro Ochiya, Hideyuki Saya, Hiroyuki Seimiya, Ryoji Yao, Masahiro Hayashi, Chieko Kai, Akira Matsuda, Tomoki Naoe, Atsushi Ohtsu, Taku Okazaki, Hideo Saji, Masataka Sata, Haruhiko Sugimura, Yuichi Sugiyama, Masakazu Toi, Tatsuro Irimura Report on the use of non-clinical studies in the regulatory evaluation of oncology drugs Report on the use of non-clinical studies in the regulatory evaluation of oncology drugs Report on the use of non-clinical studies in the regulatory evaluation of oncology drugs CANCER SCIENCE, 107, 2, 189-202 CANCER SCIENCE, 107, 2, 189-202 CANCER SCIENCE, 107, 2, 189-202 2016/02 英語 研究論文(学術雑誌) 公開
Fumiaki Sato, Shigehira Saji, Masakazu Toi Fumiaki Sato, Shigehira Saji, Masakazu Toi Fumiaki Sato, Shigehira Saji, Masakazu Toi Genomic tumor evolution of breast cancer Genomic tumor evolution of breast cancer Genomic tumor evolution of breast cancer BREAST CANCER, 23, 1, 4-11 BREAST CANCER, 23, 1, 4-11 BREAST CANCER, 23, 1, 4-11 2016/01 英語 研究論文(学術雑誌) 公開
Tomoharu Sugie, Takayuki Kinoshita, Norikazu Masuda, Terumasa Sawada, Akira Yamauchi, Katsumasa Kuroi, Tetsuya Taguchi, Hiroko Bando, Hiroyasu Yamashiro, Tecchuu Lee, Nobuhiko Shinkura, Hironori Kato, Takafumi Ikeda, Kenichi Yoshimura, Hanae Ueyama, Masakazu Toi Tomoharu Sugie, Takayuki Kinoshita, Norikazu Masuda, Terumasa Sawada, Akira Yamauchi, Katsumasa Kuroi, Tetsuya Taguchi, Hiroko Bando, Hiroyasu Yamashiro, Tecchuu Lee, Nobuhiko Shinkura, Hironori Kato, Takafumi Ikeda, Kenichi Yoshimura, Hanae Ueyama, Masakazu Toi Tomoharu Sugie, Takayuki Kinoshita, Norikazu Masuda, Terumasa Sawada, Akira Yamauchi, Katsumasa Kuroi, Tetsuya Taguchi, Hiroko Bando, Hiroyasu Yamashiro, Tecchuu Lee, Nobuhiko Shinkura, Hironori Kato, Takafumi Ikeda, Kenichi Yoshimura, Hanae Ueyama, Masakazu Toi Evaluation of the Clinical Utility of the ICG Fluorescence Method Compared with the Radioisotope Method for Sentinel Lymph Node Biopsy in Breast Cancer Evaluation of the Clinical Utility of the ICG Fluorescence Method Compared with the Radioisotope Method for Sentinel Lymph Node Biopsy in Breast Cancer Evaluation of the Clinical Utility of the ICG Fluorescence Method Compared with the Radioisotope Method for Sentinel Lymph Node Biopsy in Breast Cancer ANNALS OF SURGICAL ONCOLOGY, 23, 1, 44-50 ANNALS OF SURGICAL ONCOLOGY, 23, 1, 44-50 ANNALS OF SURGICAL ONCOLOGY, 23, 1, 44-50 2016/01 英語 研究論文(学術雑誌) 公開
Nobuko Kawaguchi-Sakita, Kaoru Kaneshiro-Nakagawa, Masahiro Kawashima, Masahiro Sugimoto, Mariko Tokiwa, Eiji Suzuki, Shigeki Kajihara, Yuichiro Fujita, Shinichi Iwamoto, Koichi Tanaka, Masakazu Toi Nobuko Kawaguchi-Sakita, Kaoru Kaneshiro-Nakagawa, Masahiro Kawashima, Masahiro Sugimoto, Mariko Tokiwa, Eiji Suzuki, Shigeki Kajihara, Yuichiro Fujita, Shinichi Iwamoto, Koichi Tanaka, Masakazu Toi Nobuko Kawaguchi-Sakita, Kaoru Kaneshiro-Nakagawa, Masahiro Kawashima, Masahiro Sugimoto, Mariko Tokiwa, Eiji Suzuki, Shigeki Kajihara, Yuichiro Fujita, Shinichi Iwamoto, Koichi Tanaka, Masakazu Toi Serum immunoglobulin G Fc region N-glycosylation profiling by matrix-assisted laser desorption/ionization mass spectrometry can distinguish breast cancer patients from cancer-free controls Serum immunoglobulin G Fc region N-glycosylation profiling by matrix-assisted laser desorption/ionization mass spectrometry can distinguish breast cancer patients from cancer-free controls Serum immunoglobulin G Fc region N-glycosylation profiling by matrix-assisted laser desorption/ionization mass spectrometry can distinguish breast cancer patients from cancer-free controls BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 469, 4, 1140-1145 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 469, 4, 1140-1145 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 469, 4, 1140-1145 2016/01 英語 研究論文(学術雑誌) 公開
Fumiaki Sato, Shigehira Saji, Masakazu Toi Fumiaki Sato, Shigehira Saji, Masakazu Toi Fumiaki Sato, Shigehira Saji, Masakazu Toi Genomic tumor evolution of breast cancer Genomic tumor evolution of breast cancer Genomic tumor evolution of breast cancer BREAST CANCER, 23, 1, 4-11 BREAST CANCER, 23, 1, 4-11 BREAST CANCER, 23, 1, 4-11 2016/01 英語 研究論文(学術雑誌) 公開
Katsumasa Kuroi, Masakazu Toi, Shinji Ohno, Seigo Nakamura, Hiroji Iwata, Norikazu Masuda, Nobuaki Sato, Hitoshi Tsuda, Masafumi Kurosumi, Futoshi Akiyama Katsumasa Kuroi, Masakazu Toi, Shinji Ohno, Seigo Nakamura, Hiroji Iwata, Norikazu Masuda, Nobuaki Sato, Hitoshi Tsuda, Masafumi Kurosumi, Futoshi Akiyama Katsumasa Kuroi, Masakazu Toi, Shinji Ohno, Seigo Nakamura, Hiroji Iwata, Norikazu Masuda, Nobuaki Sato, Hitoshi Tsuda, Masafumi Kurosumi, Futoshi Akiyama Comparison of different definitions of pathologic complete response in operable breast cancer: a pooled analysis of three prospective neoadjuvant studies of JBCRG Comparison of different definitions of pathologic complete response in operable breast cancer: a pooled analysis of three prospective neoadjuvant studies of JBCRG Comparison of different definitions of pathologic complete response in operable breast cancer: a pooled analysis of three prospective neoadjuvant studies of JBCRG BREAST CANCER, 22, 6, 586-595 BREAST CANCER, 22, 6, 586-595 BREAST CANCER, 22, 6, 586-595 2015/11 英語 研究論文(学術雑誌) 公開
Katsumasa Kuroi, Masakazu Toi, Shinji Ohno, Seigo Nakamura, Hiroji Iwata, Norikazu Masuda, Nobuaki Sato, Hitoshi Tsuda, Masafumi Kurosumi, Futoshi Akiyama Katsumasa Kuroi, Masakazu Toi, Shinji Ohno, Seigo Nakamura, Hiroji Iwata, Norikazu Masuda, Nobuaki Sato, Hitoshi Tsuda, Masafumi Kurosumi, Futoshi Akiyama Katsumasa Kuroi, Masakazu Toi, Shinji Ohno, Seigo Nakamura, Hiroji Iwata, Norikazu Masuda, Nobuaki Sato, Hitoshi Tsuda, Masafumi Kurosumi, Futoshi Akiyama Comparison of different definitions of pathologic complete response in operable breast cancer: a pooled analysis of three prospective neoadjuvant studies of JBCRG Comparison of different definitions of pathologic complete response in operable breast cancer: a pooled analysis of three prospective neoadjuvant studies of JBCRG Comparison of different definitions of pathologic complete response in operable breast cancer: a pooled analysis of three prospective neoadjuvant studies of JBCRG BREAST CANCER, 22, 6, 586-595 BREAST CANCER, 22, 6, 586-595 BREAST CANCER, 22, 6, 586-595 2015/11 英語 研究論文(学術雑誌) 公開
Hirofumi Mukai, Norikazu Masuda, Hiroshi Ishiguro, Ayako Mitsuma, Takashi Shibata, Jun Yamamura, Masakazu Toi, Aiko Watabe, Akiko Sarashina, Martina Uttenreuther-Fischer, Yuichi Ando Hirofumi Mukai, Norikazu Masuda, Hiroshi Ishiguro, Ayako Mitsuma, Takashi Shibata, Jun Yamamura, Masakazu Toi, Aiko Watabe, Akiko Sarashina, Martina Uttenreuther-Fischer, Yuichi Ando Hirofumi Mukai, Norikazu Masuda, Hiroshi Ishiguro, Ayako Mitsuma, Takashi Shibata, Jun Yamamura, Masakazu Toi, Aiko Watabe, Akiko Sarashina, Martina Uttenreuther-Fischer, Yuichi Ando Phase I trial of afatinib plus vinorelbine in Japanese patients with advanced solid tumors, including breast cancer Phase I trial of afatinib plus vinorelbine in Japanese patients with advanced solid tumors, including breast cancer Phase I trial of afatinib plus vinorelbine in Japanese patients with advanced solid tumors, including breast cancer CANCER CHEMOTHERAPY AND PHARMACOLOGY, 76, 4, 739-750 CANCER CHEMOTHERAPY AND PHARMACOLOGY, 76, 4, 739-750 CANCER CHEMOTHERAPY AND PHARMACOLOGY, 76, 4, 739-750 2015/10 英語 研究論文(学術雑誌) 公開
R. Coleman, T. Powles, A. Paterson, M. Gnant, S. Anderson, I. Diel, J. Gralow, G. von Minckwitz, V. Moebus, J. Bergh, K. I. Pritchard, J. Bliss, D. Cameron, V. Evans, H. Pan, R. Peto, R. Bradley, R. Gray, R. Bartsch, P. Dubsky, C. Fesl, H. Fohler, M. Gnant, R. Greil, R. Jakesz, A. Lang, G. Luschin-Ebengreuth, C. Marth, B. Mlineritsch, H. Samonigg, C. F. Singer, G. G. Steger, H. Stoeger, I. Olivotto, J. Ragaz, P. Christiansen, B. Ejlertsen, M. Ewertz, M-B Jensen, S. Moller, H. T. Mouridsen, W. Eiermann, J. Hilfrich, W. Jonat, M. Kaufmann, R. Kreienberg, M. Schumacher, J. U. Blohmer, S. D. Costa, H. Eidtmann, B. Gerber, C. Jackisch, S. Loibl, G. von Minckwitz, U. Dafni, C. Markopoulos, C. Blomqvist, T. Saarto, J-H Ahn, K. H. Jung, F. Perrone, S. Anderson, G. Bass, A. Brown, J. Bryant, J. Costantino, J. Dignam, B. Fisher, C. Geyer, E. P. Mamounas, S. Paik, C. Redmond, S. Swain, L. Wickerham, N. Wolmark, E. Perez, J. N. Ingle, V. J. Suman, P. Hadji, R. A'Hern, M. Dowsett, A. Makris, M. Parton, K. Pennert, T. J. Powles, I. E. Smith, J. R. Yarnold, G. Clack, C. Van Poznak, T. Safra, R. Bell, D. Cameron, R. E. Coleman, D. Dodwell, S. Hinsley, H. C. Marshall, E. Solomayer, T. Fehm, R. E. Coleman, J. Lester, M. C. Winter, J. M. Horsman, R. Aft, A. M. Brufsky, R. Coleman, H. A. Llombart R. Coleman, T. Powles, A. Paterson, M. Gnant, S. Anderson, I. Diel, J. Gralow, G. von Minckwitz, V. Moebus, J. Bergh, K. I. Pritchard, J. Bliss, D. Cameron, V. Evans, H. Pan, R. Peto, R. Bradley, R. Gray, R. Bartsch, P. Dubsky, C. Fesl, H. Fohler, M. Gnant, R. Greil, R. Jakesz, A. Lang, G. Luschin-Ebengreuth, C. Marth, B. Mlineritsch, H. Samonigg, C. F. Singer, G. G. Steger, H. Stoeger, I. Olivotto, J. Ragaz, P. Christiansen, B. Ejlertsen, M. Ewertz, M-B Jensen, S. Moller, H. T. Mouridsen, W. Eiermann, J. Hilfrich, W. Jonat, M. Kaufmann, R. Kreienberg, M. Schumacher, J. U. Blohmer, S. D. Costa, H. Eidtmann, B. Gerber, C. Jackisch, S. Loibl, G. von Minckwitz, U. Dafni, C. Markopoulos, C. Blomqvist, T. Saarto, J-H Ahn, K. H. Jung, F. Perrone, S. Anderson, G. Bass, A. Brown, J. Bryant, J. Costantino, J. Dignam, B. Fisher, C. Geyer, E. P. Mamounas, S. Paik, C. Redmond, S. Swain, L. Wickerham, N. Wolmark, E. Perez, J. N. Ingle, V. J. Suman, P. Hadji, R. A'Hern, M. Dowsett, A. Makris, M. Parton, K. Pennert, T. J. Powles, I. E. Smith, J. R. Yarnold, G. Clack, C. Van Poznak, T. Safra, R. Bell, D. Cameron, R. E. Coleman, D. Dodwell, S. Hinsley, H. C. Marshall, E. Solomayer, T. Fehm, R. E. Coleman, J. Lester, M. C. Winter, J. M. Horsman, R. Aft, A. M. Brufsky, R. Coleman, H. A. Llombart R. Coleman, T. Powles, A. Paterson, M. Gnant, S. Anderson, I. Diel, J. Gralow, G. von Minckwitz, V. Moebus, J. Bergh, K. I. Pritchard, J. Bliss, D. Cameron, V. Evans, H. Pan, R. Peto, R. Bradley, R. Gray, R. Bartsch, P. Dubsky, C. Fesl, H. Fohler, M. Gnant, R. Greil, R. Jakesz, A. Lang, G. Luschin-Ebengreuth, C. Marth, B. Mlineritsch, H. Samonigg, C. F. Singer, G. G. Steger, H. Stoeger, I. Olivotto, J. Ragaz, P. Christiansen, B. Ejlertsen, M. Ewertz, M-B Jensen, S. Moller, H. T. Mouridsen, W. Eiermann, J. Hilfrich, W. Jonat, M. Kaufmann, R. Kreienberg, M. Schumacher, J. U. Blohmer, S. D. Costa, H. Eidtmann, B. Gerber, C. Jackisch, S. Loibl, G. von Minckwitz, U. Dafni, C. Markopoulos, C. Blomqvist, T. Saarto, J-H Ahn, K. H. Jung, F. Perrone, S. Anderson, G. Bass, A. Brown, J. Bryant, J. Costantino, J. Dignam, B. Fisher, C. Geyer, E. P. Mamounas, S. Paik, C. Redmond, S. Swain, L. Wickerham, N. Wolmark, E. Perez, J. N. Ingle, V. J. Suman, P. Hadji, R. A'Hern, M. Dowsett, A. Makris, M. Parton, K. Pennert, T. J. Powles, I. E. Smith, J. R. Yarnold, G. Clack, C. Van Poznak, T. Safra, R. Bell, D. Cameron, R. E. Coleman, D. Dodwell, S. Hinsley, H. C. Marshall, E. Solomayer, T. Fehm, R. E. Coleman, J. Lester, M. C. Winter, J. M. Horsman, R. Aft, A. M. Brufsky, R. Coleman, H. A. Llombart Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials LANCET, 386, 10001, 1353-1361 LANCET, 386, 10001, 1353-1361 LANCET, 386, 10001, 1353-1361 2015/10 英語 研究論文(学術雑誌) 公開
M. Dowsett, J. F. Forbes, R. Bradley, J. Ingle, T. Aihara, J. Bliss, F. Boccardo, A. Coates, R. C. Coombes, J. Cuzick, P. Dubsky, M. Gnant, M. Kaufmann, L. Kilburn, F. Perrone, D. Rea, B. Thuerlimann, C. van de Velde, H. Pan, R. Peto, C. Davies, R. Gray, M. Baum, A. Buzdar, J. Cuzick, M. Dowsett, J. F. Forbes, I. Sestak, C. Markopoulos, P. Dubsky, C. Fesl, M. Gnant, R. Jakesz, A. Coates, M. Colleoni, J. F. Forbes, R. Gelber, M. Regan, M. Kaufmann, G. von Minckwitz, J. Bliss, A. Coates, R. C. Coombes, J. F. Forbes, L. Kilburn, C. Snowdon, F. Boccardo, F. Perrone, P. Goss, J. Ingle, K. Pritchard, S. Anderson, J. Costantino, E. Mamounas, T. Aihara, Y. Ohashi, T. Watanabe, E. Bastiaannet, C. van de Velde, D. Rea M. Dowsett, J. F. Forbes, R. Bradley, J. Ingle, T. Aihara, J. Bliss, F. Boccardo, A. Coates, R. C. Coombes, J. Cuzick, P. Dubsky, M. Gnant, M. Kaufmann, L. Kilburn, F. Perrone, D. Rea, B. Thuerlimann, C. van de Velde, H. Pan, R. Peto, C. Davies, R. Gray, M. Baum, A. Buzdar, J. Cuzick, M. Dowsett, J. F. Forbes, I. Sestak, C. Markopoulos, P. Dubsky, C. Fesl, M. Gnant, R. Jakesz, A. Coates, M. Colleoni, J. F. Forbes, R. Gelber, M. Regan, M. Kaufmann, G. von Minckwitz, J. Bliss, A. Coates, R. C. Coombes, J. F. Forbes, L. Kilburn, C. Snowdon, F. Boccardo, F. Perrone, P. Goss, J. Ingle, K. Pritchard, S. Anderson, J. Costantino, E. Mamounas, T. Aihara, Y. Ohashi, T. Watanabe, E. Bastiaannet, C. van de Velde, D. Rea M. Dowsett, J. F. Forbes, R. Bradley, J. Ingle, T. Aihara, J. Bliss, F. Boccardo, A. Coates, R. C. Coombes, J. Cuzick, P. Dubsky, M. Gnant, M. Kaufmann, L. Kilburn, F. Perrone, D. Rea, B. Thuerlimann, C. van de Velde, H. Pan, R. Peto, C. Davies, R. Gray, M. Baum, A. Buzdar, J. Cuzick, M. Dowsett, J. F. Forbes, I. Sestak, C. Markopoulos, P. Dubsky, C. Fesl, M. Gnant, R. Jakesz, A. Coates, M. Colleoni, J. F. Forbes, R. Gelber, M. Regan, M. Kaufmann, G. von Minckwitz, J. Bliss, A. Coates, R. C. Coombes, J. F. Forbes, L. Kilburn, C. Snowdon, F. Boccardo, F. Perrone, P. Goss, J. Ingle, K. Pritchard, S. Anderson, J. Costantino, E. Mamounas, T. Aihara, Y. Ohashi, T. Watanabe, E. Bastiaannet, C. van de Velde, D. Rea Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials LANCET, 386, 10001, 1341-1352 LANCET, 386, 10001, 1341-1352 LANCET, 386, 10001, 1341-1352 2015/10 英語 研究論文(学術雑誌) 公開
Elham Fakhrejahani, Masae Toii, Toshiyuki Kitai, Shotaro Kanao, Yasufumi Asao, Yohei Hashizume, Yoshiki Mikami, Iku Yamaga, Masako Kataoka, Tomoharu Sugie, Masahiro Takada, Hironori Haga, Kaori Togashi, Tsuyoshi Shiina, Masakazu Toi Elham Fakhrejahani, Masae Toii, Toshiyuki Kitai, Shotaro Kanao, Yasufumi Asao, Yohei Hashizume, Yoshiki Mikami, Iku Yamaga, Masako Kataoka, Tomoharu Sugie, Masahiro Takada, Hironori Haga, Kaori Togashi, Tsuyoshi Shiina, Masakazu Toi Elham Fakhrejahani, Masae Toii, Toshiyuki Kitai, Shotaro Kanao, Yasufumi Asao, Yohei Hashizume, Yoshiki Mikami, Iku Yamaga, Masako Kataoka, Tomoharu Sugie, Masahiro Takada, Hironori Haga, Kaori Togashi, Tsuyoshi Shiina, Masakazu Toi Clinical Report on the First Prototype of a Photoacoustic Tomography System with Dual Illumination for Breast Cancer Imaging Clinical Report on the First Prototype of a Photoacoustic Tomography System with Dual Illumination for Breast Cancer Imaging Clinical Report on the First Prototype of a Photoacoustic Tomography System with Dual Illumination for Breast Cancer Imaging PLOS ONE, 10, 10, e0139113 PLOS ONE, 10, 10, e0139113 PLOS ONE, 10, 10, e0139113 2015/10 英語 研究論文(学術雑誌) 公開
Bando,H, Masuda,N, Nakamura,R, Kondo,N, Kuroi,K, Akiyoshi,S, Ohtani,S, Toshimi,T, Inoue,K, Yanagida,Y, Ishiguro,H, Shimizu,S, Aogi,K, Amano,S, Ozaki,S, Iguchi-Manaka,A, Kasai,H, Morita,S, Kataoka,T. R, Toi,M Bando,H, Masuda,N, Nakamura,R, Kondo,N, Kuroi,K, Akiyoshi,S, Ohtani,S, Toshimi,T, Inoue,K, Yanagida,Y, Ishiguro,H, Shimizu,S, Aogi,K, Amano,S, Ozaki,S, Iguchi-Manaka,A, Kasai,H, Morita,S, Kataoka,T. R, Toi,M Bando,H, Masuda,N, Nakamura,R, Kondo,N, Kuroi,K, Akiyoshi,S, Ohtani,S, Toshimi,T, Inoue,K, Yanagida,Y, Ishiguro,H, Shimizu,S, Aogi,K, Amano,S, Ozaki,S, Iguchi-Manaka,A, Kasai,H, Morita,S, Kataoka,T. R, Toi,M Impact of lapatinib (La) treatment duration and endocrine therapy (ET) addition on the efficacy of primary dual HER2 blockage with La and trastuzumab (T) for HER2+breast cancer (BC) patients Impact of lapatinib (La) treatment duration and endocrine therapy (ET) addition on the efficacy of primary dual HER2 blockage with La and trastuzumab (T) for HER2+breast cancer (BC) patients Impact of lapatinib (La) treatment duration and endocrine therapy (ET) addition on the efficacy of primary dual HER2 blockage with La and trastuzumab (T) for HER2+breast cancer (BC) patients EUROPEAN JOURNAL OF CANCER, 51, 3, S316-S316 EUROPEAN JOURNAL OF CANCER, 51, 3, S316-S316 EUROPEAN JOURNAL OF CANCER, 51, 3, S316-S316 2015/09 英語 研究論文(国際会議プロシーディングス) 公開
Yamashita,T, Masuda,N, Yamamoto,N, Kondo,N, Bando,H, Akiyoshi,S, Ohtani,S, Takano,T, Inoue,K, Fujisawa,T, Ishiguro,H, Nakayama,H, Aogi,K, Amano,S, Ozaki,H, Yasojima,H, Kasai,H, Kataoka,T. R, Morita,S, Toi,M Yamashita,T, Masuda,N, Yamamoto,N, Kondo,N, Bando,H, Akiyoshi,S, Ohtani,S, Takano,T, Inoue,K, Fujisawa,T, Ishiguro,H, Nakayama,H, Aogi,K, Amano,S, Ozaki,H, Yasojima,H, Kasai,H, Kataoka,T. R, Morita,S, Toi,M Yamashita,T, Masuda,N, Yamamoto,N, Kondo,N, Bando,H, Akiyoshi,S, Ohtani,S, Takano,T, Inoue,K, Fujisawa,T, Ishiguro,H, Nakayama,H, Aogi,K, Amano,S, Ozaki,H, Yasojima,H, Kasai,H, Kataoka,T. R, Morita,S, Toi,M Primary systemic therapy by dual HER2 blockage with lapatinib (La) plus trastuzumab (T) for Japanese patients (pts) with HER2+breast cancer (BC): Association of La toxicity and dose with treatment efficacy Primary systemic therapy by dual HER2 blockage with lapatinib (La) plus trastuzumab (T) for Japanese patients (pts) with HER2+breast cancer (BC): Association of La toxicity and dose with treatment efficacy Primary systemic therapy by dual HER2 blockage with lapatinib (La) plus trastuzumab (T) for Japanese patients (pts) with HER2+breast cancer (BC): Association of La toxicity and dose with treatment efficacy EUROPEAN JOURNAL OF CANCER, 51, 3, S317-S318 EUROPEAN JOURNAL OF CANCER, 51, 3, S317-S318 EUROPEAN JOURNAL OF CANCER, 51, 3, S317-S318 2015/09 英語 研究論文(学術雑誌) 公開
Katsumasa Kuroi, Masakazu Toi, Shinji Ohno, Seigo Nakamura, Hiroji Iwata, Norikazu Masuda, Nobuaki Sato, Hitoshi Tsuda, Masafumi Kurosumi, Futoshi Akiyama Katsumasa Kuroi, Masakazu Toi, Shinji Ohno, Seigo Nakamura, Hiroji Iwata, Norikazu Masuda, Nobuaki Sato, Hitoshi Tsuda, Masafumi Kurosumi, Futoshi Akiyama Katsumasa Kuroi, Masakazu Toi, Shinji Ohno, Seigo Nakamura, Hiroji Iwata, Norikazu Masuda, Nobuaki Sato, Hitoshi Tsuda, Masafumi Kurosumi, Futoshi Akiyama Prognostic significance of subtype and pathologic response in operable breast cancer; a pooled analysis of prospective neoadjuvant studies of JBCRG Prognostic significance of subtype and pathologic response in operable breast cancer; a pooled analysis of prospective neoadjuvant studies of JBCRG Prognostic significance of subtype and pathologic response in operable breast cancer; a pooled analysis of prospective neoadjuvant studies of JBCRG BREAST CANCER, 22, 5, 486-495 BREAST CANCER, 22, 5, 486-495 BREAST CANCER, 22, 5, 486-495 2015/09 英語 研究論文(学術雑誌) 公開
Ueshima C, Kataoka TR, Hirata M, Furuhata A, Suzuki E, Toi M, Tsuruyama T, Okayama Y, Haga H Ueshima C, Kataoka TR, Hirata M, Furuhata A, Suzuki E, Toi M, Tsuruyama T, Okayama Y, Haga H Ueshima C, Kataoka TR, Hirata M, Furuhata A, Suzuki E, Toi M, Tsuruyama T, Okayama Y, Haga H The Killer Cell Ig-like Receptor 2DL4 Expression in Human Mast Cells and Its Potential Role in Breast Cancer Invasion. The Killer Cell Ig-like Receptor 2DL4 Expression in Human Mast Cells and Its Potential Role in Breast Cancer Invasion. The Killer Cell Ig-like Receptor 2DL4 Expression in Human Mast Cells and Its Potential Role in Breast Cancer Invasion. Cancer immunology research, 3, 8, 871-880 Cancer immunology research, 3, 8, 871-880 Cancer immunology research, 3, 8, 871-880 2015/08 公開
Hiroyasu Yamshiro, Hiroji Iwata, Norikazu Masuda, Naohito Yamamoto, Reiki Nishimura, Shoichiro Ohtani, Nobuki Sato, Masato Takahashi, Takako Kamio, Kosuke Yamazaki, Tsuyoshi Saito, Makoto Kato, Tecchuu Lee, Shinji Ohno, Katsumasa Kuroi, Toshimi Takano, Masahiro Takada, Shinji Yasuno, Satoshi Morita, Masakazu Toi Hiroyasu Yamshiro, Hiroji Iwata, Norikazu Masuda, Naohito Yamamoto, Reiki Nishimura, Shoichiro Ohtani, Nobuki Sato, Masato Takahashi, Takako Kamio, Kosuke Yamazaki, Tsuyoshi Saito, Makoto Kato, Tecchuu Lee, Shinji Ohno, Katsumasa Kuroi, Toshimi Takano, Masahiro Takada, Shinji Yasuno, Satoshi Morita, Masakazu Toi Hiroyasu Yamshiro, Hiroji Iwata, Norikazu Masuda, Naohito Yamamoto, Reiki Nishimura, Shoichiro Ohtani, Nobuki Sato, Masato Takahashi, Takako Kamio, Kosuke Yamazaki, Tsuyoshi Saito, Makoto Kato, Tecchuu Lee, Shinji Ohno, Katsumasa Kuroi, Toshimi Takano, Masahiro Takada, Shinji Yasuno, Satoshi Morita, Masakazu Toi Outcomes of trastuzumab therapy in HER2-positive early breast cancer patients Outcomes of trastuzumab therapy in HER2-positive early breast cancer patients Outcomes of trastuzumab therapy in HER2-positive early breast cancer patients INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 20, 4, 709-722 INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 20, 4, 709-722 INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 20, 4, 709-722 2015/08 英語 研究論文(学術雑誌) 公開
A. S. Coates, E. P. Winer, A. Goldhirsch, R. D. Gelber, M. Gnant, M. Piccart-Gebhart, B. Thuerlimann, H. -J. Senn A. S. Coates, E. P. Winer, A. Goldhirsch, R. D. Gelber, M. Gnant, M. Piccart-Gebhart, B. Thuerlimann, H. -J. Senn A. S. Coates, E. P. Winer, A. Goldhirsch, R. D. Gelber, M. Gnant, M. Piccart-Gebhart, B. Thuerlimann, H. -J. Senn Tailoring therapies-improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015 Tailoring therapies-improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015 Tailoring therapies-improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015 ANNALS OF ONCOLOGY, 26, 8, 1533-1546 ANNALS OF ONCOLOGY, 26, 8, 1533-1546 ANNALS OF ONCOLOGY, 26, 8, 1533-1546 2015/08 英語 研究論文(学術雑誌) 公開
Sara A. Hurvitz, Fabrice Andre, Zefei Jiang, Zhimin Shao, Max S. Mano, Silvia P. Neciosup, Ling-Min Tseng, Qingyuan Zhang, Kunwei Shen, Donggeng Liu, Lydia M. Dreosti, Howard A. Burris, Masakazu Toi, Marc E. Buyse, David Cabaribere, Mary-Ann Lindsay, Shantha Rao, Lida Bubuteishvili Pacaud, Tetiana Taran, Dennis Slamon Sara A. Hurvitz, Fabrice Andre, Zefei Jiang, Zhimin Shao, Max S. Mano, Silvia P. Neciosup, Ling-Min Tseng, Qingyuan Zhang, Kunwei Shen, Donggeng Liu, Lydia M. Dreosti, Howard A. Burris, Masakazu Toi, Marc E. Buyse, David Cabaribere, Mary-Ann Lindsay, Shantha Rao, Lida Bubuteishvili Pacaud, Tetiana Taran, Dennis Slamon Sara A. Hurvitz, Fabrice Andre, Zefei Jiang, Zhimin Shao, Max S. Mano, Silvia P. Neciosup, Ling-Min Tseng, Qingyuan Zhang, Kunwei Shen, Donggeng Liu, Lydia M. Dreosti, Howard A. Burris, Masakazu Toi, Marc E. Buyse, David Cabaribere, Mary-Ann Lindsay, Shantha Rao, Lida Bubuteishvili Pacaud, Tetiana Taran, Dennis Slamon Combination of everolimus with trastuzumab plus paclitaxel as first-line treatment for patients with HER2-positive advanced breast cancer (BOLERO-1): a phase 3, randomised, double-blind, multicentre trial Combination of everolimus with trastuzumab plus paclitaxel as first-line treatment for patients with HER2-positive advanced breast cancer (BOLERO-1): a phase 3, randomised, double-blind, multicentre trial Combination of everolimus with trastuzumab plus paclitaxel as first-line treatment for patients with HER2-positive advanced breast cancer (BOLERO-1): a phase 3, randomised, double-blind, multicentre trial LANCET ONCOLOGY, 16, 7, 816-829 LANCET ONCOLOGY, 16, 7, 816-829 LANCET ONCOLOGY, 16, 7, 816-829 2015/07 英語 研究論文(学術雑誌) 公開
Kawashima Masahiro, Yamaga Iku, Torii Masae, Tokiwa Mariko, Elham Fakhrejahani, Kataoka Masako, Kanao Shotaro, Takada Masahiro, Asao Yasufumi, Shiina Tsuyoshi, Toi Masakazu Kawashima Masahiro, Yamaga Iku, Torii Masae, Tokiwa Mariko, Elham Fakhrejahani, Kataoka Masako, Kanao Shotaro, Takada Masahiro, Asao Yasufumi, Shiina Tsuyoshi, Toi Masakazu Kawashima Masahiro, Yamaga Iku, Torii Masae, Tokiwa Mariko, Elham Fakhrejahani, Kataoka Masako, Kanao Shotaro, Takada Masahiro, Asao Yasufumi, Shiina Tsuyoshi, Toi Masakazu Evaluation of second-generation photoacoustic mammography in detecting the breast cancer vasculature and hypoxic status; a preliminary study Evaluation of second-generation photoacoustic mammography in detecting the breast cancer vasculature and hypoxic status; a preliminary study Evaluation of second-generation photoacoustic mammography in detecting the breast cancer vasculature and hypoxic status; a preliminary study CANCER RESEARCH, 75 CANCER RESEARCH, 75 CANCER RESEARCH, 75 2015/05/01 公開
Fakhrejahani Elham, Torii Masae, Asao Yasufumi, Yamaga Iku, Kitai Toshiyuki, Kataoka Masako, Kanao Shotaro, Takada Masahiro, Shiina Tsuyoshi, Toi Masakazu Fakhrejahani Elham, Torii Masae, Asao Yasufumi, Yamaga Iku, Kitai Toshiyuki, Kataoka Masako, Kanao Shotaro, Takada Masahiro, Shiina Tsuyoshi, Toi Masakazu Fakhrejahani Elham, Torii Masae, Asao Yasufumi, Yamaga Iku, Kitai Toshiyuki, Kataoka Masako, Kanao Shotaro, Takada Masahiro, Shiina Tsuyoshi, Toi Masakazu Clinical, anatomical and histological characteristics of breast lesions visualized by photoacoustic mammography; first clinical study in CK project Clinical, anatomical and histological characteristics of breast lesions visualized by photoacoustic mammography; first clinical study in CK project Clinical, anatomical and histological characteristics of breast lesions visualized by photoacoustic mammography; first clinical study in CK project CANCER RESEARCH, 75 CANCER RESEARCH, 75 CANCER RESEARCH, 75 2015/05/01 公開
Masakazu Toi, Norikazu Masuda, Hiroshi Ishiguro, Shigehira Saji, Shinji Ohno, Louis W. C. Chow Masakazu Toi, Norikazu Masuda, Hiroshi Ishiguro, Shigehira Saji, Shinji Ohno, Louis W. C. Chow Masakazu Toi, Norikazu Masuda, Hiroshi Ishiguro, Shigehira Saji, Shinji Ohno, Louis W. C. Chow Development of breast cancer therapy: biomarker-driven and response-guided approaches in a neoadjuvant setting Development of breast cancer therapy: biomarker-driven and response-guided approaches in a neoadjuvant setting Development of breast cancer therapy: biomarker-driven and response-guided approaches in a neoadjuvant setting INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 30, 2, E252-E253 INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 30, 2, E252-E253 INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 30, 2, E252-E253 2015/04 英語 研究論文(学術雑誌) 公開
Iwata,H, Yamamoto,N, Masuda,N, Bando,H, Kuroi,K, Ohno,S, Kasai,H, Morita,S, Sakurai,T, Toi,M Iwata,H, Yamamoto,N, Masuda,N, Bando,H, Kuroi,K, Ohno,S, Kasai,H, Morita,S, Sakurai,T, Toi,M Iwata,H, Yamamoto,N, Masuda,N, Bando,H, Kuroi,K, Ohno,S, Kasai,H, Morita,S, Sakurai,T, Toi,M Dual HER2 blockage with lapatinib and trastuzumab for Japanese patients with HER2+breast cancer Dual HER2 blockage with lapatinib and trastuzumab for Japanese patients with HER2+breast cancer Dual HER2 blockage with lapatinib and trastuzumab for Japanese patients with HER2+breast cancer BREAST, 24, 1, S95-S95 BREAST, 24, 1, S95-S95 BREAST, 24, 1, S95-S95 2015/03 英語 研究論文(学術雑誌) 公開
Natsuko Onishi, Shotaro Kanao, Masako Kataoka, Mami Iima, Rena Sakaguchi, Makiko Kawai, Tatsuki R. Kataoka, Yoshiki Mikami, Masakazu Toi, Kaori Togashi Natsuko Onishi, Shotaro Kanao, Masako Kataoka, Mami Iima, Rena Sakaguchi, Makiko Kawai, Tatsuki R. Kataoka, Yoshiki Mikami, Masakazu Toi, Kaori Togashi Natsuko Onishi, Shotaro Kanao, Masako Kataoka, Mami Iima, Rena Sakaguchi, Makiko Kawai, Tatsuki R. Kataoka, Yoshiki Mikami, Masakazu Toi, Kaori Togashi Apparent Diffusion Coefficient as a Potential Surrogate Marker for Ki-67 Index in Mucinous Breast Carcinoma Apparent Diffusion Coefficient as a Potential Surrogate Marker for Ki-67 Index in Mucinous Breast Carcinoma Apparent Diffusion Coefficient as a Potential Surrogate Marker for Ki-67 Index in Mucinous Breast Carcinoma JOURNAL OF MAGNETIC RESONANCE IMAGING, 41, 3, 610-615 JOURNAL OF MAGNETIC RESONANCE IMAGING, 41, 3, 610-615 JOURNAL OF MAGNETIC RESONANCE IMAGING, 41, 3, 610-615 2015/03 英語 研究論文(学術雑誌) 公開
Eiji Suzuki, Tatsuki R. Kataoka, Masahiro Hirata, Kosuke Kawaguchi, Mariko Nishie, Hironori Haga, Masakazu Toi Eiji Suzuki, Tatsuki R. Kataoka, Masahiro Hirata, Kosuke Kawaguchi, Mariko Nishie, Hironori Haga, Masakazu Toi Eiji Suzuki, Tatsuki R. Kataoka, Masahiro Hirata, Kosuke Kawaguchi, Mariko Nishie, Hironori Haga, Masakazu Toi Trogocytosis-mediated expression of HER2 on immune cells may be associated with a pathological complete response to trastuzumab-based primary systemic therapy in HER2-overexpressing breast cancer patients Trogocytosis-mediated expression of HER2 on immune cells may be associated with a pathological complete response to trastuzumab-based primary systemic therapy in HER2-overexpressing breast cancer patients Trogocytosis-mediated expression of HER2 on immune cells may be associated with a pathological complete response to trastuzumab-based primary systemic therapy in HER2-overexpressing breast cancer patients BMC CANCER, 15, 1, 39 BMC CANCER, 15, 1, 39 BMC CANCER, 15, 1, 39 2015/02 英語 研究論文(学術雑誌) 公開
Junji Itou, Sunao Tanaka, Wenzhao Li, Yoshiaki Matsumoto, Fumiaki Sato, Masakazu Toi, ual, contribution, corresponding author Junji Itou, Sunao Tanaka, Wenzhao Li, Yoshiaki Matsumoto, Fumiaki Sato, Masakazu Toi, ual, contribution, corresponding author Data of a fluorescent imaging-based analysis of anti-cancer drug effects on three-dimensional cultures of breast cancer cells Data of a fluorescent imaging-based analysis of anti-cancer drug effects on three-dimensional cultures of breast cancer cells Data in Brief, 5, 429-433 Data in Brief, 5, 429-433 , 5, 429-433 2015 英語 研究論文(学術雑誌) 公開
Yoko Goto, Lihua Zeng, Chan Joo Yeom, Yuxi Zhu, Akiyo Morinibu, Kazumi Shinomiya, Minoru Kobayashi, Kiichi Hirota, Satoshi Itasaka, Michio Yoshimura, Keiji Tanimoto, Masae Torii, Terumasa Sowa, Toshi Menju, Makoto Sonobe, Hideaki Kakeya, Masakazu Toi, Hiroshi Date, Ester M. Hammond, Masahiro Hiraoka, Hiroshi Harada Yoko Goto, Lihua Zeng, Chan Joo Yeom, Yuxi Zhu, Akiyo Morinibu, Kazumi Shinomiya, Minoru Kobayashi, Kiichi Hirota, Satoshi Itasaka, Michio Yoshimura, Keiji Tanimoto, Masae Torii, Terumasa Sowa, Toshi Menju, Makoto Sonobe, Hideaki Kakeya, Masakazu Toi, Hiroshi Date, Ester M. Hammond, Masahiro Hiraoka, Hiroshi Harada UCHL1 provides diagnostic and antimetastatic strategies due to its deubiquitinating effect on HIF-1α. Nat Commun. UCHL1 provides diagnostic and antimetastatic strategies due to its deubiquitinating effect on HIF-1α. Nat Commun. UCHL1 provides diagnostic and antimetastatic strategies due to its deubiquitinating effect on HIF-1 alpha Nature Communications, 6, 6, 6153 Nature Communications, 6, 6, 6153 Nature Communications, 6, 6, 6153 2015/01 英語 研究論文(学術雑誌) 公開
Takayuki Ueno, Jun Utsumi, Masakazu Toi, Kazuharu Shimizu Takayuki Ueno, Jun Utsumi, Masakazu Toi, Kazuharu Shimizu Takayuki Ueno, Jun Utsumi, Masakazu Toi, Kazuharu Shimizu Characteristic Gene Expression Profiles of Human Fibroblasts and Breast Cancer Cells in a Newly Developed Bilateral Coculture System Characteristic Gene Expression Profiles of Human Fibroblasts and Breast Cancer Cells in a Newly Developed Bilateral Coculture System Characteristic Gene Expression Profiles of Human Fibroblasts and Breast Cancer Cells in a Newly Developed Bilateral Coculture System BIOMED RESEARCH INTERNATIONAL, 11 BIOMED RESEARCH INTERNATIONAL, 11 BIOMED RESEARCH INTERNATIONAL, 11 2015 英語 研究論文(学術雑誌) 公開
Masakazu Toi, Eric P. Winer, John R. Benson, Takashi Inamoto, John F. Forbes, Gunter von Minckwitz, John F. R. Robertson, Stephen R. Grobmyer, Ismail Jatoi, Hironobu Sasano, Ian Kunkler, Alice Y. Ho, Chikako Yamauchi, Louis W. C. Chow, Chiun-Sheng Huang, Wonshik Han, Shinzaburo Noguchi, Mark D. Pegram, Hideko Yamauchi, Eun-Sook Lee, Alexey A. Larionov, Jose L. B. Bevilacqua, Michio Yoshimura, Tomoharu Sugie, Akira Yamauchi, Ian E. Krop, Dong Young Noh, V. Suzanne Klimberg Masakazu Toi, Eric P. Winer, John R. Benson, Takashi Inamoto, John F. Forbes, Gunter von Minckwitz, John F. R. Robertson, Stephen R. Grobmyer, Ismail Jatoi, Hironobu Sasano, Ian Kunkler, Alice Y. Ho, Chikako Yamauchi, Louis W. C. Chow, Chiun-Sheng Huang, Wonshik Han, Shinzaburo Noguchi, Mark D. Pegram, Hideko Yamauchi, Eun-Sook Lee, Alexey A. Larionov, Jose L. B. Bevilacqua, Michio Yoshimura, Tomoharu Sugie, Akira Yamauchi, Ian E. Krop, Dong Young Noh, V. Suzanne Klimberg Masakazu Toi, Eric P. Winer, John R. Benson, Takashi Inamoto, John F. Forbes, Gunter von Minckwitz, John F. R. Robertson, Stephen R. Grobmyer, Ismail Jatoi, Hironobu Sasano, Ian Kunkler, Alice Y. Ho, Chikako Yamauchi, Louis W. C. Chow, Chiun-Sheng Huang, Wonshik Han, Shinzaburo Noguchi, Mark D. Pegram, Hideko Yamauchi, Eun-Sook Lee, Alexey A. Larionov, Jose L. B. Bevilacqua, Michio Yoshimura, Tomoharu Sugie, Akira Yamauchi, Ian E. Krop, Dong Young Noh, V. Suzanne Klimberg Personalization of loco-regional care for primary breast cancer patients (part 1) Personalization of loco-regional care for primary breast cancer patients (part 1) Personalization of loco-regional care for primary breast cancer patients (part 1) FUTURE ONCOLOGY, 11, 9, 1297-1300 FUTURE ONCOLOGY, 11, 9, 1297-1300 FUTURE ONCOLOGY, 11, 9, 1297-1300 2015 英語 研究論文(学術雑誌) 公開
Masakazu Toi, Eric P. Winer, John R. Benson, Takashi Inamoto, John F. Forbes, Gunter von Minckwitz, John F. R. Robertson, Stephen R. Grobmyer, Ismail Jatoi, Hironobu Sasano, Ian Kunkler, Alice Y. Ho, Chikako Yamauchi, Louis W. C. Chow, Chiun-Sheng Huang, Wonshik Han, Shinzaburo Noguchi, Mark D. Pegram, Hideko Yamauchi, Eun-Sook Lee, Alexey A. Larionov, Jose L. B. Bevilacqua, Michio Yoshimura, Tomoharu Sugie, Akira Yamauchi, Ian E. Krop, Dong Young Noh, V. Suzanne Klimberg Masakazu Toi, Eric P. Winer, John R. Benson, Takashi Inamoto, John F. Forbes, Gunter von Minckwitz, John F. R. Robertson, Stephen R. Grobmyer, Ismail Jatoi, Hironobu Sasano, Ian Kunkler, Alice Y. Ho, Chikako Yamauchi, Louis W. C. Chow, Chiun-Sheng Huang, Wonshik Han, Shinzaburo Noguchi, Mark D. Pegram, Hideko Yamauchi, Eun-Sook Lee, Alexey A. Larionov, Jose L. B. Bevilacqua, Michio Yoshimura, Tomoharu Sugie, Akira Yamauchi, Ian E. Krop, Dong Young Noh, V. Suzanne Klimberg Masakazu Toi, Eric P. Winer, John R. Benson, Takashi Inamoto, John F. Forbes, Gunter von Minckwitz, John F. R. Robertson, Stephen R. Grobmyer, Ismail Jatoi, Hironobu Sasano, Ian Kunkler, Alice Y. Ho, Chikako Yamauchi, Louis W. C. Chow, Chiun-Sheng Huang, Wonshik Han, Shinzaburo Noguchi, Mark D. Pegram, Hideko Yamauchi, Eun-Sook Lee, Alexey A. Larionov, Jose L. B. Bevilacqua, Michio Yoshimura, Tomoharu Sugie, Akira Yamauchi, Ian E. Krop, Dong Young Noh, V. Suzanne Klimberg Personalization of loco-regional care for primary breast cancer patients (part 2) Personalization of loco-regional care for primary breast cancer patients (part 2) Personalization of loco-regional care for primary breast cancer patients (part 2) FUTURE ONCOLOGY, 11, 9, 1301-1305 FUTURE ONCOLOGY, 11, 9, 1301-1305 FUTURE ONCOLOGY, 11, 9, 1301-1305 2015 英語 研究論文(学術雑誌) 公開
Hirofumi Mukai, Shinzaburo Noguchi, Futoshi Akiyama, Hideo Inaji, Hirotaka Iwase, Jun Horiguchi, Junichi Kurebayashi, Koichi Hirata, Masakazu Toi, Masafumi Kurosumi, Norio Kohno, Reiki Nishimura, Seigo Nakamura, Shigeru Imoto, Takuji Iwase, Tokiko Endo, Toshiaki Saeki, Yasuhiro Ogawa, Yoshinori Ito, Yutaka Tokuda, Tadashi Ikeda Hirofumi Mukai, Shinzaburo Noguchi, Futoshi Akiyama, Hideo Inaji, Hirotaka Iwase, Jun Horiguchi, Junichi Kurebayashi, Koichi Hirata, Masakazu Toi, Masafumi Kurosumi, Norio Kohno, Reiki Nishimura, Seigo Nakamura, Shigeru Imoto, Takuji Iwase, Tokiko Endo, Toshiaki Saeki, Yasuhiro Ogawa, Yoshinori Ito, Yutaka Tokuda, Tadashi Ikeda Hirofumi Mukai, Shinzaburo Noguchi, Futoshi Akiyama, Hideo Inaji, Hirotaka Iwase, Jun Horiguchi, Junichi Kurebayashi, Koichi Hirata, Masakazu Toi, Masafumi Kurosumi, Norio Kohno, Reiki Nishimura, Seigo Nakamura, Shigeru Imoto, Takuji Iwase, Tokiko Endo, Toshiaki Saeki, Yasuhiro Ogawa, Yoshinori Ito, Yutaka Tokuda, Tadashi Ikeda 2013 clinical practice guidelines (The Japanese Breast Cancer Society): history, policy and mission 2013 clinical practice guidelines (The Japanese Breast Cancer Society): history, policy and mission 2013 clinical practice guidelines (The Japanese Breast Cancer Society): history, policy and mission BREAST CANCER, 22, 1, 1-4 BREAST CANCER, 22, 1, 1-4 BREAST CANCER, 22, 1, 1-4 2015/01 英語 公開
Junji Itou, Sunao Tanaka, Fumiaki Sato, Ryutaro Akiyama, Yasuhiko Kawakami, Masakazu Toi Junji Itou, Sunao Tanaka, Fumiaki Sato, Ryutaro Akiyama, Yasuhiko Kawakami, Masakazu Toi Junji Itou, Sunao Tanaka, Fumiaki Sato, Ryutaro Akiyama, Yasuhiko Kawakami, Masakazu Toi An optical labeling-based proliferation assay system reveals the paracrine effect of interleukin-6 in breast cancer An optical labeling-based proliferation assay system reveals the paracrine effect of interleukin-6 in breast cancer An optical labeling-based proliferation assay system reveals the paracrine effect of interleukin-6 in breast cancer BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 1853, 1, 27-40 BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 1853, 1, 27-40 BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 1853, 1, 27-40 2015/01 英語 研究論文(学術雑誌) 公開
Ran Ito, Naoki Morimoto, Pham Hieu Liem, Yoko Nakamura, Katsuya Kawai, Tsuguyoshi Taira, Wakako Tsuji, Masakazu Toi, Shigehiko Suzuki Ran Ito, Naoki Morimoto, Pham Hieu Liem, Yoko Nakamura, Katsuya Kawai, Tsuguyoshi Taira, Wakako Tsuji, Masakazu Toi, Shigehiko Suzuki Ran Ito, Naoki Morimoto, Pham Hieu Liem, Yoko Nakamura, Katsuya Kawai, Tsuguyoshi Taira, Wakako Tsuji, Masakazu Toi, Shigehiko Suzuki Adipogenesis using human adipose tissue-derived stromal cells combined with a collagen/gelatin sponge sustaining release of basic fibroblast growth factor Adipogenesis using human adipose tissue-derived stromal cells combined with a collagen/gelatin sponge sustaining release of basic fibroblast growth factor Adipogenesis using human adipose tissue-derived stromal cells combined with a collagen/gelatin sponge sustaining release of basic fibroblast growth factor JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE, 8, 12, 1000-1008 JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE, 8, 12, 1000-1008 JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE, 8, 12, 1000-1008 2014/12 英語 研究論文(学術雑誌) 公開
Eriko Sumi, Tomoharu Sugie, Kenichi Yoshimura, Harue Tada, Takafumi Ikeda, Eiji Suzuki, Yoshimasa Tanaka, Satoshi Teramukai, Akira Shimizu, Masakazu Toi, Nagahiro Minato Eriko Sumi, Tomoharu Sugie, Kenichi Yoshimura, Harue Tada, Takafumi Ikeda, Eiji Suzuki, Yoshimasa Tanaka, Satoshi Teramukai, Akira Shimizu, Masakazu Toi, Nagahiro Minato Effects of zoledronic acid and the association between its efficacy and γδT cells in postmenopausal women with breast cancer treated with preoperative hormonal therapy: a study protocol. Effects of zoledronic acid and the association between its efficacy and γδT cells in postmenopausal women with breast cancer treated with preoperative hormonal therapy: a study protocol. Effects of zoledronic acid and the association between its efficacy and γδT cells in postmenopausal women with breast cancer treated with preoperative hormonal therapy: a study protocol. J Transl Med, 12, 12, 310-310 J Transl Med, 12, 12, 310-310 Journal of translational medicine, 12, 12, 310-310 2014/11/25 英語 公開
Nishimura T, Ishiguro H, Kawaguchi K, Sigie T, Tokiwa M, Takeuchi M, Toi M Nishimura T, Ishiguro H, Kawaguchi K, Sigie T, Tokiwa M, Takeuchi M, Toi M Nishimura T, Ishiguro H, Kawaguchi K, Sigie T, Tokiwa M, Takeuchi M, Toi M Prevention of Chemotherapy-Induced Nausea and Vomiting by Olanzapine in Japanese Female patients with Early Breast Cancer who had Poor Control with the Standard Antiemetic Regimen Prevention of Chemotherapy-Induced Nausea and Vomiting by Olanzapine in Japanese Female patients with Early Breast Cancer who had Poor Control with the Standard Antiemetic Regimen Prevention of Chemotherapy-Induced Nausea and Vomiting by Olanzapine in Japanese Female patients with Early Breast Cancer who had Poor Control with the Standard Antiemetic Regimen Cancer Stud Open Access, 1, 2, 2014 Cancer Stud Open Access, 1, 2, 2014 Cancer Stud Open Access, 1, 2, 2014 2014/10 英語 公開
Masahiro Sugimoto, Masahiro Takada, Masakazu Toi Masahiro Sugimoto, Masahiro Takada, Masakazu Toi Masahiro Sugimoto, Masahiro Takada, Masakazu Toi Development of Web tools to predict axillary lymph node metastasis and pathological response to neoadjuvant chemotherapy in breast cancer patients Development of Web tools to predict axillary lymph node metastasis and pathological response to neoadjuvant chemotherapy in breast cancer patients Development of Web tools to predict axillary lymph node metastasis and pathological response to neoadjuvant chemotherapy in breast cancer patients INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 29, 4, E372-E379 INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 29, 4, E372-E379 INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 29, 4, E372-E379 2014/10 英語 研究論文(学術雑誌) 公開
Masahiro Sugimoto, Masahiro Takada, Masakazu Toi Masahiro Sugimoto, Masahiro Takada, Masakazu Toi Masahiro Sugimoto, Masahiro Takada, Masakazu Toi Development of Web tools to predict axillary lymph node metastasis and pathological response to neoadjuvant chemotherapy in breast cancer patients Development of Web tools to predict axillary lymph node metastasis and pathological response to neoadjuvant chemotherapy in breast cancer patients Development of Web tools to predict axillary lymph node metastasis and pathological response to neoadjuvant chemotherapy in breast cancer patients INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 29, 4, E372-E379 INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 29, 4, E372-E379 INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 29, 4, E372-E379 2014/10 英語 研究論文(学術雑誌) 公開
Hiroyasu Yamashiro, Masahiro Takada, Eiji Nakatani, Shiro Imai, Akira Yamauchi, Shigeru Tsuyuki, Yasuo Matsutani, Shingo Sakata, Yasuo Wada, Ryuji Okamura, Tomika Harada, Fumie Tanaka, Yoshio Moriguchi, Hironori Kato, Shunichi Higashide, Norimichi Kan, Hiroshi Yoshibayashi, Hirofumi Suwa, Takashi Okino, Ichiro Nakayama, You Ichinose, Kazuhiko Yamagami, Takashi Hashimoto, Takashi Inamoto, Masakazu Toi Hiroyasu Yamashiro, Masahiro Takada, Eiji Nakatani, Shiro Imai, Akira Yamauchi, Shigeru Tsuyuki, Yasuo Matsutani, Shingo Sakata, Yasuo Wada, Ryuji Okamura, Tomika Harada, Fumie Tanaka, Yoshio Moriguchi, Hironori Kato, Shunichi Higashide, Norimichi Kan, Hiroshi Yoshibayashi, Hirofumi Suwa, Takashi Okino, Ichiro Nakayama, You Ichinose, Kazuhiko Yamagami, Takashi Hashimoto, Takashi Inamoto, Masakazu Toi Hiroyasu Yamashiro, Masahiro Takada, Eiji Nakatani, Shiro Imai, Akira Yamauchi, Shigeru Tsuyuki, Yasuo Matsutani, Shingo Sakata, Yasuo Wada, Ryuji Okamura, Tomika Harada, Fumie Tanaka, Yoshio Moriguchi, Hironori Kato, Shunichi Higashide, Norimichi Kan, Hiroshi Yoshibayashi, Hirofumi Suwa, Takashi Okino, Ichiro Nakayama, You Ichinose, Kazuhiko Yamagami, Takashi Hashimoto, Takashi Inamoto, Masakazu Toi Prevalence and risk factors of bone metastasis and skeletal related events in patients with primary breast cancer in Japan Prevalence and risk factors of bone metastasis and skeletal related events in patients with primary breast cancer in Japan Prevalence and risk factors of bone metastasis and skeletal related events in patients with primary breast cancer in Japan INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 19, 5, 852-862 INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 19, 5, 852-862 INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 19, 5, 852-862 2014/10 英語 研究論文(学術雑誌) 公開
N. Masuda, K. Higaki, T. Takano, N. Matsunami, T. Morimoto, S. Ohtani, M. Mizutani, T. Miyamoto, K. Kuroi, S. Ohno, S. Morita, M. Toi N. Masuda, K. Higaki, T. Takano, N. Matsunami, T. Morimoto, S. Ohtani, M. Mizutani, T. Miyamoto, K. Kuroi, S. Ohno, S. Morita, M. Toi N. Masuda, K. Higaki, T. Takano, N. Matsunami, T. Morimoto, S. Ohtani, M. Mizutani, T. Miyamoto, K. Kuroi, S. Ohno, S. Morita, M. Toi A phase II study of metronomic paclitaxel/cyclophosphamide/capecitabine followed by 5-fluorouracil/epirubicin/cyclophosphamide as preoperative chemotherapy for triple-negative or low hormone receptor expressing/HER2-negative primary breast cancer A phase II study of metronomic paclitaxel/cyclophosphamide/capecitabine followed by 5-fluorouracil/epirubicin/cyclophosphamide as preoperative chemotherapy for triple-negative or low hormone receptor expressing/HER2-negative primary breast cancer A phase II study of metronomic paclitaxel/cyclophosphamide/capecitabine followed by 5-fluorouracil/epirubicin/cyclophosphamide as preoperative chemotherapy for triple-negative or low hormone receptor expressing/HER2-negative primary breast cancer CANCER CHEMOTHERAPY AND PHARMACOLOGY, 74, 2, 229-238 CANCER CHEMOTHERAPY AND PHARMACOLOGY, 74, 2, 229-238 CANCER CHEMOTHERAPY AND PHARMACOLOGY, 74, 2, 229-238 2014/08 英語 研究論文(学術雑誌) 公開
Kanae Kawai Miyake, Yuji Nakamoto, Shotaro Kanao, Shiro Tanaka, Tomoharu Sugie, Yoshiki Mikami, Masakazu Toi, Kaori Togashi Kanae Kawai Miyake, Yuji Nakamoto, Shotaro Kanao, Shiro Tanaka, Tomoharu Sugie, Yoshiki Mikami, Masakazu Toi, Kaori Togashi Kanae Kawai Miyake, Yuji Nakamoto, Shotaro Kanao, Shiro Tanaka, Tomoharu Sugie, Yoshiki Mikami, Masakazu Toi, Kaori Togashi Diagnostic Value of F-18-FDG PET/CT and MRI in Predicting the Clinicopathologic Subtypes of Invasive Breast Cancer Diagnostic Value of F-18-FDG PET/CT and MRI in Predicting the Clinicopathologic Subtypes of Invasive Breast Cancer Diagnostic Value of F-18-FDG PET/CT and MRI in Predicting the Clinicopathologic Subtypes of Invasive Breast Cancer AMERICAN JOURNAL OF ROENTGENOLOGY, 203, 2, 272-279 AMERICAN JOURNAL OF ROENTGENOLOGY, 203, 2, 272-279 AMERICAN JOURNAL OF ROENTGENOLOGY, 203, 2, 272-279 2014/08 英語 研究論文(学術雑誌) 公開
Ueno, Takayuki, Masuda, Norikazu, Yamanaka, Takeharu, Saji, Shigehira, Kuroi, Katsumasa, Sato, Nobuaki, Takei, Hiroyuki, Yamamoto, Yutaka, Ohno, Shinji, Yamashita, Hiroko, Hisamatsu, Kazufumi, Aogi, Kenjiro, Iwata, Hiroji, Sasano, Hironobu, Toi, Masakazu Ueno, Takayuki, Masuda, Norikazu, Yamanaka, Takeharu, Saji, Shigehira, Kuroi, Katsumasa, Sato, Nobuaki, Takei, Hiroyuki, Yamamoto, Yutaka, Ohno, Shinji, Yamashita, Hiroko, Hisamatsu, Kazufumi, Aogi, Kenjiro, Iwata, Hiroji, Sasano, Hironobu, Toi, Masakazu Takayuki Ueno, Norikazu Masuda, Takeharu Yamanaka, Shigehira Saji, Katsumasa Kuroi, Nobuaki Sato, Hiroyuki Takei, Yutaka Yamamoto, Shinji Ohno, Hiroko Yamashita, Kazufumi Hisamatsu, Kenjiro Aogi, Hiroji Iwata, Hironobu Sasano, Masakazu Toi Evaluating the 21-gene assay Recurrence Score(®) as a predictor of clinical response to 24 weeks of neoadjuvant exemestane in estrogen receptor-positive breast cancer. Evaluating the 21-gene assay Recurrence Score(®) as a predictor of clinical response to 24 weeks of neoadjuvant exemestane in estrogen receptor-positive breast cancer. Evaluating the 21-gene assay Recurrence Score(A (R)) as a predictor of clinical response to 24 weeks of neoadjuvant exemestane in estrogen receptor-positive breast cancer International journal of clinical oncology, 19, 4, 607-613 International journal of clinical oncology, 19, 4, 607-613 INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 19, 4, 607-613 2014/08 英語 研究論文(学術雑誌) 公開
Takuwa H, Ueno T, Ishiguro H, Mikami Y, Kanao S, Takada M, Sugie T, Toi M Takuwa H, Ueno T, Ishiguro H, Mikami Y, Kanao S, Takada M, Sugie T, Toi M Takuwa H, Ueno T, Ishiguro H, Mikami Y, Kanao S, Takada M, Sugie T, Toi M A case of metaplastic breast cancer that showed a good response to platinum-based preoperative chemotherapy A case of metaplastic breast cancer that showed a good response to platinum-based preoperative chemotherapy A case of metaplastic breast cancer that showed a good response to platinum-based preoperative chemotherapy Breast Cancer, 21, 4, 504-507 Breast Cancer, 21, 4, 504-507 Breast Cancer, 21, 4, 504-507 2014/07 英語 公開
Moe Tsuda, Hiroshi Ishiguro, Ikuko Yano, Masakazu Toi Moe Tsuda, Hiroshi Ishiguro, Ikuko Yano, Masakazu Toi Moe Tsuda, Hiroshi Ishiguro, Ikuko Yano, Masakazu Toi RE: Denosumab for Patients With Persistent or Relapsed Hypercalcemia of Malignancy Despite Recent Bisphosphonate Treatment RE: Denosumab for Patients With Persistent or Relapsed Hypercalcemia of Malignancy Despite Recent Bisphosphonate Treatment RE: Denosumab for Patients With Persistent or Relapsed Hypercalcemia of Malignancy Despite Recent Bisphosphonate Treatment JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 106, 7 JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 106, 7 JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 106, 7 2014/07 英語 公開
Elham Fakhrejahani, Yasufumi Asao, Masakazu Toi Elham Fakhrejahani, Yasufumi Asao, Masakazu Toi Elham Fakhrejahani, Yasufumi Asao, Masakazu Toi Tumor microvasculature characteristics studied by image analysis: Histologically-driven angiogenic profile Tumor microvasculature characteristics studied by image analysis: Histologically-driven angiogenic profile Tumor microvasculature characteristics studied by image analysis: Histologically-driven angiogenic profile INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 29, 3, E204-E207 INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 29, 3, E204-E207 INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 29, 3, E204-E207 2014/07 英語 研究論文(学術雑誌) 公開
Wakako Tsuji, Hiroshi Ishiguro, Sunao Tanaka, Megumi Takeuchi, Takayuki Ueno, Masakazu Toi Wakako Tsuji, Hiroshi Ishiguro, Sunao Tanaka, Megumi Takeuchi, Takayuki Ueno, Masakazu Toi Wakako Tsuji, Hiroshi Ishiguro, Sunao Tanaka, Megumi Takeuchi, Takayuki Ueno, Masakazu Toi Orally administered S-1 suppresses circulating endothelial cell counts in metastatic breast cancer patients Orally administered S-1 suppresses circulating endothelial cell counts in metastatic breast cancer patients Orally administered S-1 suppresses circulating endothelial cell counts in metastatic breast cancer patients INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 19, 3, 452-459 INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 19, 3, 452-459 INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 19, 3, 452-459 2014/06 英語 研究論文(学術雑誌) 公開
Saji Shigehira, Toi Masakazu, Ishikawa Takashi, Ishida Takanori, Ohtani Shoichiro, Kashiwaba Masahiro, Sagara Yasuaki, Nagai Shigenori E, Hasegawa Yoshie, Fujisawa Tomomi, Masuda Norikazu, Matsumoto Koji, Yamamoto Yutaka, Yoshibayashi Hiroshi, Taira Naruto, Morita Satoshi, Ohno Shinji Saji Shigehira, Toi Masakazu, Ishikawa Takashi, Ishida Takanori, Ohtani Shoichiro, Kashiwaba Masahiro, Sagara Yasuaki, Nagai Shigenori E, Hasegawa Yoshie, Fujisawa Tomomi, Masuda Norikazu, Matsumoto Koji, Yamamoto Yutaka, Yoshibayashi Hiroshi, Taira Naruto, Morita Satoshi, Ohno Shinji Saji Shigehira, Toi Masakazu, Ishikawa Takashi, Ishida Takanori, Ohtani Shoichiro, Kashiwaba Masahiro, Sagara Yasuaki, Nagai Shigenori E, Hasegawa Yoshie, Fujisawa Tomomi, Masuda Norikazu, Matsumoto Koji, Yamamoto Yutaka, Yoshibayashi Hiroshi, Taira Naruto, Morita Satoshi, Ohno Shinji Bevacizumah plus paclitaxel optimization study with interventional maintenance endocrine therapy in advanced or metastatic ER-positive HER2-negative breast cancer: JBCRG-M04 (BOOSTER) trial Bevacizumah plus paclitaxel optimization study with interventional maintenance endocrine therapy in advanced or metastatic ER-positive HER2-negative breast cancer: JBCRG-M04 (BOOSTER) trial Bevacizumah plus paclitaxel optimization study with interventional maintenance endocrine therapy in advanced or metastatic ER-positive HER2-negative breast cancer: JBCRG-M04 (BOOSTER) trial JOURNAL OF CLINICAL ONCOLOGY, 32, 15 JOURNAL OF CLINICAL ONCOLOGY, 32, 15 JOURNAL OF CLINICAL ONCOLOGY, 32, 15 2014/05/20 公開
Fabrice Andre, Ruth O'Regan, Mustafa Ozguroglu, Masakazu Toi, Binghe Xu, Guy Jerusalem, Norikazu Masuda, Sharon Wilks, Francis Arena, Claudine Isaacs, Yoon-Sim Yap, Zsuzsanna Papai, Istvan Lang, Anne Armstrong, Guillermo Lerzo, Michelle White, Kunwei Shen, Jennifer Litton, David Chen, Yufen Zhang, Shyanne Ali, Tetiana Taran, Luca Gianni Fabrice Andre, Ruth O'Regan, Mustafa Ozguroglu, Masakazu Toi, Binghe Xu, Guy Jerusalem, Norikazu Masuda, Sharon Wilks, Francis Arena, Claudine Isaacs, Yoon-Sim Yap, Zsuzsanna Papai, Istvan Lang, Anne Armstrong, Guillermo Lerzo, Michelle White, Kunwei Shen, Jennifer Litton, David Chen, Yufen Zhang, Shyanne Ali, Tetiana Taran, Luca Gianni Fabrice Andre, Ruth O'Regan, Mustafa Ozguroglu, Masakazu Toi, Binghe Xu, Guy Jerusalem, Norikazu Masuda, Sharon Wilks, Francis Arena, Claudine Isaacs, Yoon-Sim Yap, Zsuzsanna Papai, Istvan Lang, Anne Armstrong, Guillermo Lerzo, Michelle White, Kunwei Shen, Jennifer Litton, David Chen, Yufen Zhang, Shyanne Ali, Tetiana Taran, Luca Gianni Everolimus for women with trastuzumab-resistant, HER2-positive, advanced breast cancer (BOLERO-3): a randomised, double-blind, placebo-controlled phase 3 trial Everolimus for women with trastuzumab-resistant, HER2-positive, advanced breast cancer (BOLERO-3): a randomised, double-blind, placebo-controlled phase 3 trial Everolimus for women with trastuzumab-resistant, HER2-positive, advanced breast cancer (BOLERO-3): a randomised, double-blind, placebo-controlled phase 3 trial LANCET ONCOLOGY, 15, 6, 580-591 LANCET ONCOLOGY, 15, 6, 580-591 LANCET ONCOLOGY, 15, 6, 580-591 2014/05 英語 研究論文(学術雑誌) 公開
M. Takada, H. Ishiguro, S. Nagai, S. Ohtani, H. Kawabata, Y. Yanagita, Y. Hozumi, C. Shimizu, S. Takao, N. Sato, Y. Kosaka, Y. Sagara, H. Iwata, S. Ohno, K. Kuroi, N. Masuda, H. Yamashiro, M. Sugimoto, M. Kondo, Y. Naito, H. Sasano, T. Inamoto, S. Morita, M. Toi M. Takada, H. Ishiguro, S. Nagai, S. Ohtani, H. Kawabata, Y. Yanagita, Y. Hozumi, C. Shimizu, S. Takao, N. Sato, Y. Kosaka, Y. Sagara, H. Iwata, S. Ohno, K. Kuroi, N. Masuda, H. Yamashiro, M. Sugimoto, M. Kondo, Y. Naito, H. Sasano, T. Inamoto, S. Morita, M. Toi M. Takada, H. Ishiguro, S. Nagai, S. Ohtani, H. Kawabata, Y. Yanagita, Y. Hozumi, C. Shimizu, S. Takao, N. Sato, Y. Kosaka, Y. Sagara, H. Iwata, S. Ohno, K. Kuroi, N. Masuda, H. Yamashiro, M. Sugimoto, M. Kondo, Y. Naito, H. Sasano, T. Inamoto, S. Morita, M. Toi Survival of HER2-positive primary breast cancer patients treated by neoadjuvant chemotherapy plus trastuzumab: a multicenter retrospective observational study (JBCRG-C03 study) Survival of HER2-positive primary breast cancer patients treated by neoadjuvant chemotherapy plus trastuzumab: a multicenter retrospective observational study (JBCRG-C03 study) Survival of HER2-positive primary breast cancer patients treated by neoadjuvant chemotherapy plus trastuzumab: a multicenter retrospective observational study (JBCRG-C03 study) BREAST CANCER RESEARCH AND TREATMENT, 145, 1, 143-153 BREAST CANCER RESEARCH AND TREATMENT, 145, 1, 143-153 BREAST CANCER RESEARCH AND TREATMENT, 145, 1, 143-153 2014/05 英語 研究論文(学術雑誌) 公開
Elham Fakhrejahani, Masakazu Toi Elham Fakhrejahani, Masakazu Toi Elham Fakhrejahani, Masakazu Toi Antiangiogenesis Therapy for Breast Cancer: An Update and Perspectives from Clinical Trials Antiangiogenesis Therapy for Breast Cancer: An Update and Perspectives from Clinical Trials Antiangiogenesis Therapy for Breast Cancer: An Update and Perspectives from Clinical Trials JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 44, 3, 197-207 JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 44, 3, 197-207 JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 44, 3, 197-207 2014/03 英語 公開
Toshiyuki Kitai, Masae Torii, Tomoharu Sugie, Shotaro Kanao, Yoshiki Mikami, Tsuyoshi Shiina, Masakazu Toi Toshiyuki Kitai, Masae Torii, Tomoharu Sugie, Shotaro Kanao, Yoshiki Mikami, Tsuyoshi Shiina, Masakazu Toi Toshiyuki Kitai, Masae Torii, Tomoharu Sugie, Shotaro Kanao, Yoshiki Mikami, Tsuyoshi Shiina, Masakazu Toi Photoacoustic mammography: initial clinical results Photoacoustic mammography: initial clinical results Photoacoustic mammography: initial clinical results BREAST CANCER, 21, 2, 146-153 BREAST CANCER, 21, 2, 146-153 BREAST CANCER, 21, 2, 146-153 2014/03 英語 研究論文(学術雑誌) 公開
Wakako Tsuji, Satoshi Teramukai, Masaya Ueno, Masakazu Toi, Takashi Inamoto Wakako Tsuji, Satoshi Teramukai, Masaya Ueno, Masakazu Toi, Takashi Inamoto Wakako Tsuji, Satoshi Teramukai, Masaya Ueno, Masakazu Toi, Takashi Inamoto Prognostic factors for survival after first recurrence in breast cancer: a retrospective analysis of 252 recurrent cases at a single institution Prognostic factors for survival after first recurrence in breast cancer: a retrospective analysis of 252 recurrent cases at a single institution Prognostic factors for survival after first recurrence in breast cancer: a retrospective analysis of 252 recurrent cases at a single institution BREAST CANCER, 21, 1, 86-95 BREAST CANCER, 21, 1, 86-95 BREAST CANCER, 21, 1, 86-95 2014/01 英語 研究論文(学術雑誌) 公開
Masakazu Toi, Toshiaki Saeki, Hiroji Iwata, Kenichi Inoue, Yutaka Tokuda, Yasuyuki Sato, Yoshinori Ito, Kenjiro Aogi, Yuichi Takatsuka, Hitoshi Arioka Masakazu Toi, Toshiaki Saeki, Hiroji Iwata, Kenichi Inoue, Yutaka Tokuda, Yasuyuki Sato, Yoshinori Ito, Kenjiro Aogi, Yuichi Takatsuka, Hitoshi Arioka Masakazu Toi, Toshiaki Saeki, Hiroji Iwata, Kenichi Inoue, Yutaka Tokuda, Yasuyuki Sato, Yoshinori Ito, Kenjiro Aogi, Yuichi Takatsuka, Hitoshi Arioka A multicenter phase II study of TSU-68, an oral multiple tyrosine kinase inhibitor, in combination with docetaxel in metastatic breast cancer patients with anthracycline resistance A multicenter phase II study of TSU-68, an oral multiple tyrosine kinase inhibitor, in combination with docetaxel in metastatic breast cancer patients with anthracycline resistance A multicenter phase II study of TSU-68, an oral multiple tyrosine kinase inhibitor, in combination with docetaxel in metastatic breast cancer patients with anthracycline resistance BREAST CANCER, 21, 1, 20-27 BREAST CANCER, 21, 1, 20-27 BREAST CANCER, 21, 1, 20-27 2014/01 英語 研究論文(学術雑誌) 公開
Mikami Y, Ueno T, Yoshimura K, Tsuda H, Kurosumi M, Masuda S, Horii R, Toi M, Sasano H Mikami Y, Ueno T, Yoshimura K, Tsuda H, Kurosumi M, Masuda S, Horii R, Toi M, Sasano H Mikami Y, Ueno T, Yoshimura K, Tsuda H, Kurosumi M, Masuda S, Horii R, Toi M, Sasano H Interobserver concordance of Ki67 labeling index in breast cancer: Japan Breast Cancer Research Group Ki67 ring study. Interobserver concordance of Ki67 labeling index in breast cancer: Japan Breast Cancer Research Group Ki67 ring study. Interobserver concordance of Ki67 labeling index in breast cancer: Japan Breast Cancer Research Group Ki67 ring study. Cancer science, 104, 11, 1539-1543 Cancer science, 104, 11, 1539-1543 Cancer science, 104, 11, 1539-1543 2013/11 公開
S. Ohno, L. W. C. Chow, N. Sato, N. Masuda, H. Sasano, F. Takahashi, H. Bando, H. Iwata, T. Morimoto, S. Kamigaki, T. Nakayama, S. Nakamura, K. Kuroi, K. Aogi, M. Kashiwaba, H. Yamashita, K. Hisamatsu, Y. Ito, Y. Yamamoto, T. Ueno, E. Fakhrejahani, N. Yoshida, M. Toi S. Ohno, L. W. C. Chow, N. Sato, N. Masuda, H. Sasano, F. Takahashi, H. Bando, H. Iwata, T. Morimoto, S. Kamigaki, T. Nakayama, S. Nakamura, K. Kuroi, K. Aogi, M. Kashiwaba, H. Yamashita, K. Hisamatsu, Y. Ito, Y. Yamamoto, T. Ueno, E. Fakhrejahani, N. Yoshida, M. Toi S. Ohno, L. W. C. Chow, N. Sato, N. Masuda, H. Sasano, F. Takahashi, H. Bando, H. Iwata, T. Morimoto, S. Kamigaki, T. Nakayama, S. Nakamura, K. Kuroi, K. Aogi, M. Kashiwaba, H. Yamashita, K. Hisamatsu, Y. Ito, Y. Yamamoto, T. Ueno, E. Fakhrejahani, N. Yoshida, M. Toi Randomized trial of preoperative docetaxel with or without capecitabine after 4 cycles of 5-fluorouracil-epirubicin-cyclophosphamide (FEC) in early-stage breast cancer: exploratory analyses identify Ki67 as a predictive biomarker for response to neoadjuvant chemotherapy Randomized trial of preoperative docetaxel with or without capecitabine after 4 cycles of 5-fluorouracil-epirubicin-cyclophosphamide (FEC) in early-stage breast cancer: exploratory analyses identify Ki67 as a predictive biomarker for response to neoadjuvant chemotherapy Randomized trial of preoperative docetaxel with or without capecitabine after 4 cycles of 5-fluorouracil-epirubicin-cyclophosphamide (FEC) in early-stage breast cancer: exploratory analyses identify Ki67 as a predictive biomarker for response to neoadjuvant chemotherapy BREAST CANCER RESEARCH AND TREATMENT, 142, 1, 69-80 BREAST CANCER RESEARCH AND TREATMENT, 142, 1, 69-80 BREAST CANCER RESEARCH AND TREATMENT, 142, 1, 69-80 2013/11 英語 研究論文(学術雑誌) 公開
Arb-Aroon Lertkhachonsuk, Cheng Har Yip, Thiravud Khuhaprema, Ding-Shinn Chen, Martyn Plummer, Sun Ha Jee, Masakazu Toi, Sarikapan Wilailak Arb-Aroon Lertkhachonsuk, Cheng Har Yip, Thiravud Khuhaprema, Ding-Shinn Chen, Martyn Plummer, Sun Ha Jee, Masakazu Toi, Sarikapan Wilailak Arb-Aroon Lertkhachonsuk, Cheng Har Yip, Thiravud Khuhaprema, Ding-Shinn Chen, Martyn Plummer, Sun Ha Jee, Masakazu Toi, Sarikapan Wilailak Cancer prevention in Asia: resource-stratified guidelines from the Asian Oncology Summit 2013 Cancer prevention in Asia: resource-stratified guidelines from the Asian Oncology Summit 2013 Cancer prevention in Asia: resource-stratified guidelines from the Asian Oncology Summit 2013 LANCET ONCOLOGY, 14, 12, E497-E507 LANCET ONCOLOGY, 14, 12, E497-E507 LANCET ONCOLOGY, 14, 12, E497-E507 2013/11 英語 公開
S. Ohno, L. W. C. Chow, N. Sato, N. Masuda, H. Sasano, F. Takahashi, H. Bando, H. Iwata, T. Morimoto, S. Kamigaki, T. Nakayama, S. Nakamura, K. Kuroi, K. Aogi, M. Kashiwaba, H. Yamashita, K. Hisamatsu, Y. Ito, Y. Yamamoto, T. Ueno, E. Fakhrejahani, N. Yoshida, M. Toi S. Ohno, L. W. C. Chow, N. Sato, N. Masuda, H. Sasano, F. Takahashi, H. Bando, H. Iwata, T. Morimoto, S. Kamigaki, T. Nakayama, S. Nakamura, K. Kuroi, K. Aogi, M. Kashiwaba, H. Yamashita, K. Hisamatsu, Y. Ito, Y. Yamamoto, T. Ueno, E. Fakhrejahani, N. Yoshida, M. Toi S. Ohno, L. W. C. Chow, N. Sato, N. Masuda, H. Sasano, F. Takahashi, H. Bando, H. Iwata, T. Morimoto, S. Kamigaki, T. Nakayama, S. Nakamura, K. Kuroi, K. Aogi, M. Kashiwaba, H. Yamashita, K. Hisamatsu, Y. Ito, Y. Yamamoto, T. Ueno, E. Fakhrejahani, N. Yoshida, M. Toi Randomized trial of preoperative docetaxel with or without capecitabine after 4 cycles of 5-fluorouracil-epirubicin-cyclophosphamide (FEC) in early-stage breast cancer: exploratory analyses identify Ki67 as a predictive biomarker for response to neoadjuvant chemotherapy Randomized trial of preoperative docetaxel with or without capecitabine after 4 cycles of 5-fluorouracil-epirubicin-cyclophosphamide (FEC) in early-stage breast cancer: exploratory analyses identify Ki67 as a predictive biomarker for response to neoadjuvant chemotherapy Randomized trial of preoperative docetaxel with or without capecitabine after 4 cycles of 5-fluorouracil-epirubicin-cyclophosphamide (FEC) in early-stage breast cancer: exploratory analyses identify Ki67 as a predictive biomarker for response to neoadjuvant chemotherapy BREAST CANCER RESEARCH AND TREATMENT, 142, 1, 69-80 BREAST CANCER RESEARCH AND TREATMENT, 142, 1, 69-80 BREAST CANCER RESEARCH AND TREATMENT, 142, 1, 69-80 2013/11 英語 研究論文(学術雑誌) 公開
Chiaki Kaga, Akimitsu Takagi, Mitsuyoshi Kano, Shoichi Kado, Ikuo Kato, Masashi Sakai, Kouji Miyazaki, Masanobu Nanno, Fumiyasu Ishikawa, Yasuo Ohashi, Masakazu Toi Chiaki Kaga, Akimitsu Takagi, Mitsuyoshi Kano, Shoichi Kado, Ikuo Kato, Masashi Sakai, Kouji Miyazaki, Masanobu Nanno, Fumiyasu Ishikawa, Yasuo Ohashi, Masakazu Toi Chiaki Kaga, Akimitsu Takagi, Mitsuyoshi Kano, Shoichi Kado, Ikuo Kato, Masashi Sakai, Kouji Miyazaki, Masanobu Nanno, Fumiyasu Ishikawa, Yasuo Ohashi, Masakazu Toi Lactobacillus casei Shirota enhances the preventive efficacy of soymilk in chemically induced breast cancer Lactobacillus casei Shirota enhances the preventive efficacy of soymilk in chemically induced breast cancer Lactobacillus casei Shirota enhances the preventive efficacy of soymilk in chemically induced breast cancer CANCER SCIENCE, 104, 11, 1508-1514 CANCER SCIENCE, 104, 11, 1508-1514 CANCER SCIENCE, 104, 11, 1508-1514 2013/11 英語 研究論文(学術雑誌) 公開
Yoshiki Mikami, Takayuki Ueno, Kenichi Yoshimura, Hitoshi Tsuda, Masafumi Kurosumi, Shinobu Masuda, Rie Horii, Masakazu Toi, Hironobu Sasano Yoshiki Mikami, Takayuki Ueno, Kenichi Yoshimura, Hitoshi Tsuda, Masafumi Kurosumi, Shinobu Masuda, Rie Horii, Masakazu Toi, Hironobu Sasano Yoshiki Mikami, Takayuki Ueno, Kenichi Yoshimura, Hitoshi Tsuda, Masafumi Kurosumi, Shinobu Masuda, Rie Horii, Masakazu Toi, Hironobu Sasano Interobserver concordance of Ki67 labeling index in breast cancer: Japan Breast Cancer Research Group Ki67 Ring Study Interobserver concordance of Ki67 labeling index in breast cancer: Japan Breast Cancer Research Group Ki67 Ring Study Interobserver concordance of Ki67 labeling index in breast cancer: Japan Breast Cancer Research Group Ki67 Ring Study CANCER SCIENCE, 104, 11, 1539-1543 CANCER SCIENCE, 104, 11, 1539-1543 CANCER SCIENCE, 104, 11, 1539-1543 2013/11 英語 研究論文(学術雑誌) 公開
Masahiro Kawashima, Noriko Iwamoto, Nobuko Kawaguchi-Sakita, Masahiro Sugimoto, Takayuki Ueno, Yoshiki Mikami, Kazuya Terasawa, Taka-Aki Sato, Koichi Tanaka, Kazuharu Shimizu, Masakazu Toi Masahiro Kawashima, Noriko Iwamoto, Nobuko Kawaguchi-Sakita, Masahiro Sugimoto, Takayuki Ueno, Yoshiki Mikami, Kazuya Terasawa, Taka-Aki Sato, Koichi Tanaka, Kazuharu Shimizu, Masakazu Toi Masahiro Kawashima, Noriko Iwamoto, Nobuko Kawaguchi-Sakita, Masahiro Sugimoto, Takayuki Ueno, Yoshiki Mikami, Kazuya Terasawa, Taka-Aki Sato, Koichi Tanaka, Kazuharu Shimizu, Masakazu Toi High-resolution imaging mass spectrometry reveals detailed spatial distribution of phosphatidylinositols in human breast cancer High-resolution imaging mass spectrometry reveals detailed spatial distribution of phosphatidylinositols in human breast cancer High-resolution imaging mass spectrometry reveals detailed spatial distribution of phosphatidylinositols in human breast cancer CANCER SCIENCE, 104, 10, 1372-1379 CANCER SCIENCE, 104, 10, 1372-1379 CANCER SCIENCE, 104, 10, 1372-1379 2013/10 英語 研究論文(学術雑誌) 公開
Shinji Ohno, Katsumasa Kuroi, Masakazu Toi Shinji Ohno, Katsumasa Kuroi, Masakazu Toi Shinji Ohno, Katsumasa Kuroi, Masakazu Toi An overview of the Japan Breast Cancer Research Group (JBCRG) activities An overview of the Japan Breast Cancer Research Group (JBCRG) activities An overview of the Japan Breast Cancer Research Group (JBCRG) activities BREAST CANCER, 20, 4, 291-295 BREAST CANCER, 20, 4, 291-295 BREAST CANCER, 20, 4, 291-295 2013/10 英語 研究論文(学術雑誌) 公開
Junji Itou, Yoshiaki Matsumoto, Kiyotsugu Yoshikawa, Masakazu Toi Junji Itou, Yoshiaki Matsumoto, Kiyotsugu Yoshikawa, Masakazu Toi Junji Itou, Yoshiaki Matsumoto, Kiyotsugu Yoshikawa, Masakazu Toi Sal-like 4 (SALL4) suppresses CDH1 expression and maintains cell dispersion in basal-like breast cancer Sal-like 4 (SALL4) suppresses CDH1 expression and maintains cell dispersion in basal-like breast cancer Sal-like 4 (SALL4) suppresses CDH1 expression and maintains cell dispersion in basal-like breast cancer FEBS LETTERS, 587, 18, 3115-3121 FEBS LETTERS, 587, 18, 3115-3121 FEBS LETTERS, 587, 18, 3115-3121 2013/09 英語 研究論文(学術雑誌) 公開
A. Goldhirsch, E. P. Winer, A. S. Coates, R. D. Gelber, M. Piccart-Gebhart, B. Thuerlimann, H. -J. Senn A. Goldhirsch, E. P. Winer, A. S. Coates, R. D. Gelber, M. Piccart-Gebhart, B. Thuerlimann, H. -J. Senn A. Goldhirsch, E. P. Winer, A. S. Coates, R. D. Gelber, M. Piccart-Gebhart, B. Thuerlimann, H. -J. Senn Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013 Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013 Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013 ANNALS OF ONCOLOGY, 24, 9, 2206-2223 ANNALS OF ONCOLOGY, 24, 9, 2206-2223 ANNALS OF ONCOLOGY, 24, 9, 2206-2223 2013/09 英語 研究論文(学術雑誌) 公開
Yasuhiro Suzuki, Toshiaki Saeki, Kenjiro Aogi, Masakazu Toi, Hirofumi Fujii, Kenichi Inoue, Toru Watanabe, Yasuhiro Fujiwara, Yoshinori Ito, Yuichi Takatsuka, Hiroji Iwata, Hitoshi Arioka, Yutaka Tokuda Yasuhiro Suzuki, Toshiaki Saeki, Kenjiro Aogi, Masakazu Toi, Hirofumi Fujii, Kenichi Inoue, Toru Watanabe, Yasuhiro Fujiwara, Yoshinori Ito, Yuichi Takatsuka, Hiroji Iwata, Hitoshi Arioka, Yutaka Tokuda Yasuhiro Suzuki, Toshiaki Saeki, Kenjiro Aogi, Masakazu Toi, Hirofumi Fujii, Kenichi Inoue, Toru Watanabe, Yasuhiro Fujiwara, Yoshinori Ito, Yuichi Takatsuka, Hiroji Iwata, Hitoshi Arioka, Yutaka Tokuda A multicenter phase II study of TSU-68, a novel oral multiple tyrosine kinase inhibitor, in patients with metastatic breast cancer progressing despite prior treatment with an anthracycline-containing regimen and taxane A multicenter phase II study of TSU-68, a novel oral multiple tyrosine kinase inhibitor, in patients with metastatic breast cancer progressing despite prior treatment with an anthracycline-containing regimen and taxane A multicenter phase II study of TSU-68, a novel oral multiple tyrosine kinase inhibitor, in patients with metastatic breast cancer progressing despite prior treatment with an anthracycline-containing regimen and taxane INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 18, 4, 590-597 INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 18, 4, 590-597 INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 18, 4, 590-597 2013/08 英語 研究論文(学術雑誌) 公開
Hiroshi Ishiguro, Masakazu Toi Hiroshi Ishiguro, Masakazu Toi Hiroshi Ishiguro, Masakazu Toi Colony-Stimulating Factors for Febrile Neutropenia Colony-Stimulating Factors for Febrile Neutropenia Colony-Stimulating Factors for Febrile Neutropenia NEW ENGLAND JOURNAL OF MEDICINE, 369, 3, 284-284 NEW ENGLAND JOURNAL OF MEDICINE, 369, 3, 284-284 NEW ENGLAND JOURNAL OF MEDICINE, 369, 3, 284-284 2013/07 英語 公開
Tomoharu Sugie, Terumasa Sawada, Nobumi Tagaya, Takayuki Kinoshita, Kazuhiko Yamagami, Hirofumi Suwa, Takafumi Ikeda, Kenichi Yoshimura, Miyuki Niimi, Akira Shimizu, Masakazu Toi Tomoharu Sugie, Terumasa Sawada, Nobumi Tagaya, Takayuki Kinoshita, Kazuhiko Yamagami, Hirofumi Suwa, Takafumi Ikeda, Kenichi Yoshimura, Miyuki Niimi, Akira Shimizu, Masakazu Toi Tomoharu Sugie, Terumasa Sawada, Nobumi Tagaya, Takayuki Kinoshita, Kazuhiko Yamagami, Hirofumi Suwa, Takafumi Ikeda, Kenichi Yoshimura, Miyuki Niimi, Akira Shimizu, Masakazu Toi Comparison of the Indocyanine Green Fluorescence and Blue Dye Methods in Detection of Sentinel Lymph Nodes in Early-stage Breast Cancer Comparison of the Indocyanine Green Fluorescence and Blue Dye Methods in Detection of Sentinel Lymph Nodes in Early-stage Breast Cancer Comparison of the Indocyanine Green Fluorescence and Blue Dye Methods in Detection of Sentinel Lymph Nodes in Early-stage Breast Cancer ANNALS OF SURGICAL ONCOLOGY, 20, 7, 2213-2218 ANNALS OF SURGICAL ONCOLOGY, 20, 7, 2213-2218 ANNALS OF SURGICAL ONCOLOGY, 20, 7, 2213-2218 2013/07 英語 研究論文(学術雑誌) 公開
Anelia Horvath, Suresh Babu Pakala, Prakriti Mudvari, Sirigiri Divijendra Natha Reddy, Kazufumi Ohshiro, Sandra Casimiro, Ricardo Pires, Suzanne A. W. Fuqua, Masakazu Toi, Luis Costa, Sujit S. Nair, Saraswati Sukumar, Rakesh Kumar Anelia Horvath, Suresh Babu Pakala, Prakriti Mudvari, Sirigiri Divijendra Natha Reddy, Kazufumi Ohshiro, Sandra Casimiro, Ricardo Pires, Suzanne A. W. Fuqua, Masakazu Toi, Luis Costa, Sujit S. Nair, Saraswati Sukumar, Rakesh Kumar Anelia Horvath, Suresh Babu Pakala, Prakriti Mudvari, Sirigiri Divijendra Natha Reddy, Kazufumi Ohshiro, Sandra Casimiro, Ricardo Pires, Suzanne A. W. Fuqua, Masakazu Toi, Luis Costa, Sujit S. Nair, Saraswati Sukumar, Rakesh Kumar Novel Insights into Breast Cancer Genetic Variance through RNA Sequencing Novel Insights into Breast Cancer Genetic Variance through RNA Sequencing Novel Insights into Breast Cancer Genetic Variance through RNA Sequencing SCIENTIFIC REPORTS, 3 SCIENTIFIC REPORTS, 3 SCIENTIFIC REPORTS, 3 2013/07 英語 研究論文(学術雑誌) 公開
Masahito Komuro, Kenichi Suzuki, Makoto Kanebako, Takashi Kawahara, Takeshige Otoi, Kenji Kitazato, Toshio Inagi, Kimiko Makino, Masakazu Toi, Hiroshi Terada Masahito Komuro, Kenichi Suzuki, Makoto Kanebako, Takashi Kawahara, Takeshige Otoi, Kenji Kitazato, Toshio Inagi, Kimiko Makino, Masakazu Toi, Hiroshi Terada Masahito Komuro, Kenichi Suzuki, Makoto Kanebako, Takashi Kawahara, Takeshige Otoi, Kenji Kitazato, Toshio Inagi, Kimiko Makino, Masakazu Toi, Hiroshi Terada Novel iontophoretic administration method for local therapy of breast cancer Novel iontophoretic administration method for local therapy of breast cancer Novel iontophoretic administration method for local therapy of breast cancer JOURNAL OF CONTROLLED RELEASE, 168, 3, 298-306 JOURNAL OF CONTROLLED RELEASE, 168, 3, 298-306 JOURNAL OF CONTROLLED RELEASE, 168, 3, 298-306 2013/06 英語 研究論文(学術雑誌) 公開
A.S.M. Idrees, T. Sugie, C. Inoue, K. Murata-Hirai, H. Okamura, C.T. Morita, N. Minato, M. Toi, Y. Tanaka A.S.M. Idrees, T. Sugie, C. Inoue, K. Murata-Hirai, H. Okamura, C.T. Morita, N. Minato, M. Toi, Y. Tanaka Comparison of γδ T cell responses and farnesyl diphosphate synthase inhibition in tumor cells pretreated with zoledronic acid Comparison of γδ T cell responses and farnesyl diphosphate synthase inhibition in tumor cells pretreated with zoledronic acid Cancer Science, 104, 5, 536-542 Cancer Science, 104, 5, 536-542 , 104, 5, 536-542 2013/05 日本語 公開
Hiroshi Ishiguro, Kosuke Kawaguchi, Tomomi Nishimura, Masakazu Toi Hiroshi Ishiguro, Kosuke Kawaguchi, Tomomi Nishimura, Masakazu Toi Hiroshi Ishiguro, Kosuke Kawaguchi, Tomomi Nishimura, Masakazu Toi Antipsychotics-Containing Regimen As an Alternative to Standard Antiemetics for Delayed Nausea Induced by Highly Emetogenic Chemotherapy Antipsychotics-Containing Regimen As an Alternative to Standard Antiemetics for Delayed Nausea Induced by Highly Emetogenic Chemotherapy Antipsychotics-Containing Regimen As an Alternative to Standard Antiemetics for Delayed Nausea Induced by Highly Emetogenic Chemotherapy JOURNAL OF CLINICAL ONCOLOGY, 31, 10, 1377-1378 JOURNAL OF CLINICAL ONCOLOGY, 31, 10, 1377-1378 JOURNAL OF CLINICAL ONCOLOGY, 31, 10, 1377-1378 2013/04 英語 公開
Wenzhao Li, Shigehira Saji, Fumiaki Sato, Makoto Noda, Masakazu Toi Wenzhao Li, Shigehira Saji, Fumiaki Sato, Makoto Noda, Masakazu Toi Wenzhao Li, Shigehira Saji, Fumiaki Sato, Makoto Noda, Masakazu Toi Potential clinical applications of matrix metalloproteinase inhibitors and their future prospects Potential clinical applications of matrix metalloproteinase inhibitors and their future prospects Potential clinical applications of matrix metalloproteinase inhibitors and their future prospects INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 28, 2, 117-130 INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 28, 2, 117-130 INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 28, 2, 117-130 2013/04 英語 研究論文(学術雑誌) 公開
T. Sugie, K. Murata-Hirai, M. Iwasaki, C.T. Morita, W. Li, H. Okamura, N. Minato, M. Toi, Y. Tanaka T. Sugie, K. Murata-Hirai, M. Iwasaki, C.T. Morita, W. Li, H. Okamura, N. Minato, M. Toi, Y. Tanaka Tomoharu Sugie, Kaoru Murata-Hirai, Masashi Iwasaki, Craig T. Morita, Wen Li, Haruki Okamura, Nagahiro Minato, Masakazu Toi, Yoshimasa Tanaka Zoledronic acid-induced expansion of γδ T cells from early-stage breast cancer patients: Effect of IL-18 on helper NK cells Zoledronic acid-induced expansion of γδ T cells from early-stage breast cancer patients: Effect of IL-18 on helper NK cells Zoledronic acid-induced expansion of gamma delta T cells from early-stage breast cancer patients: effect of IL-18 on helper NK cells Cancer Immunology, Immunotherapy, 62, 4, 677-687 Cancer Immunology, Immunotherapy, 62, 4, 677-687 CANCER IMMUNOLOGY IMMUNOTHERAPY, 62, 4, 677-687 2013/04 英語 研究論文(学術雑誌) 公開
Wakako Tsuji, Takashi Inamoto, Ran Ito, Naoki Morimoto, Yasuhiko Tabata, Masakazu Toi Wakako Tsuji, Takashi Inamoto, Ran Ito, Naoki Morimoto, Yasuhiko Tabata, Masakazu Toi Wakako Tsuji, Takashi Inamoto, Ran Ito, Naoki Morimoto, Yasuhiko Tabata, Masakazu Toi Simple and longstanding adipose tissue engineering in rabbits Simple and longstanding adipose tissue engineering in rabbits Simple and longstanding adipose tissue engineering in rabbits JOURNAL OF ARTIFICIAL ORGANS, 16, 1, 110-114 JOURNAL OF ARTIFICIAL ORGANS, 16, 1, 110-114 JOURNAL OF ARTIFICIAL ORGANS, 16, 1, 110-114 2013/03 英語 研究論文(学術雑誌) 公開
Louis W. C. Chow, Stewart Y. Tung, Ting-Ying Ng, Seock-Ah Im, Min-Hyuk Lee, Adrian Y. S. Yip, Masakazu Toi, Stefan Glueck Louis W. C. Chow, Stewart Y. Tung, Ting-Ying Ng, Seock-Ah Im, Min-Hyuk Lee, Adrian Y. S. Yip, Masakazu Toi, Stefan Glueck Louis W. C. Chow, Stewart Y. Tung, Ting-Ying Ng, Seock-Ah Im, Min-Hyuk Lee, Adrian Y. S. Yip, Masakazu Toi, Stefan Glueck Concurrent celecoxib with 5-fluorouracil/epirubicin/cyclophosphamide followed by docetaxel for stages II-III invasive breast cancer: the OOTR-N001 study Concurrent celecoxib with 5-fluorouracil/epirubicin/cyclophosphamide followed by docetaxel for stages II-III invasive breast cancer: the OOTR-N001 study Concurrent celecoxib with 5-fluorouracil/epirubicin/cyclophosphamide followed by docetaxel for stages II-III invasive breast cancer: the OOTR-N001 study EXPERT OPINION ON INVESTIGATIONAL DRUGS, 22, 3, 299-307 EXPERT OPINION ON INVESTIGATIONAL DRUGS, 22, 3, 299-307 EXPERT OPINION ON INVESTIGATIONAL DRUGS, 22, 3, 299-307 2013/03 英語 研究論文(学術雑誌) 公開
河口 浩介, 石黒 洋, 戸井 雅和 河口 浩介, 石黒 洋, 戸井 雅和 【キナーゼ阻害薬の新しい展開】 乳癌治療におけるキナーゼ阻害薬の新しい展開 【キナーゼ阻害薬の新しい展開】 乳癌治療におけるキナーゼ阻害薬の新しい展開 BIO Clinica, 28, 1, 28-32 BIO Clinica, 28, 1, 28-32 , 28, 1, 28-32 2013/01 公開
Masahiro Sugimoto, Masahiro Takada, Masakazu Toi Masahiro Sugimoto, Masahiro Takada, Masakazu Toi Masahiro Sugimoto, Masahiro Takada, Masakazu Toi Comparison of robustness against missing values of alternative decision tree and multiple logistic regression for predicting clinical data in primary breast cancer Comparison of robustness against missing values of alternative decision tree and multiple logistic regression for predicting clinical data in primary breast cancer Comparison of robustness against missing values of alternative decision tree and multiple logistic regression for predicting clinical data in primary breast cancer 2013 35TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY (EMBC), 3054-3057 2013 35TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY (EMBC), 3054-3057 2013 35TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY (EMBC), 3054-3057 2013 英語 研究論文(国際会議プロシーディングス) 公開
Shota Hamada, Shiro Hinotsu, Hiroshi Ishiguro, Masakazu Toi, Koji Kawakami Shota Hamada, Shiro Hinotsu, Hiroshi Ishiguro, Masakazu Toi, Koji Kawakami Shota Hamada, Shiro Hinotsu, Hiroshi Ishiguro, Masakazu Toi, Koji Kawakami Cross-National Comparison of Medical Costs Shared by Payers and Patients: A Study of Postmenopausal Women with Early-Stage Breast Cancer Based on Assumption Case Scenarios and Reimbursement Fees Cross-National Comparison of Medical Costs Shared by Payers and Patients: A Study of Postmenopausal Women with Early-Stage Breast Cancer Based on Assumption Case Scenarios and Reimbursement Fees Cross-National Comparison of Medical Costs Shared by Payers and Patients: A Study of Postmenopausal Women with Early-Stage Breast Cancer Based on Assumption Case Scenarios and Reimbursement Fees BREAST CARE, 8, 4, 282-288 BREAST CARE, 8, 4, 282-288 BREAST CARE, 8, 4, 282-288 2013 英語 研究論文(学術雑誌) 公開
M. Toi, S. Hirota, A. Tomotaki, N. Sato, Y. Hozumi, K. Anan, T. Nagashima, Y. Tokuda, N. Masuda, S. Ohsumi, S. Ohno, M. Takahashi, H. Hayashi, S. Yamamoto, Y. Ohashi M. Toi, S. Hirota, A. Tomotaki, N. Sato, Y. Hozumi, K. Anan, T. Nagashima, Y. Tokuda, N. Masuda, S. Ohsumi, S. Ohno, M. Takahashi, H. Hayashi, S. Yamamoto, Y. Ohashi M. Toi, S. Hirota, A. Tomotaki, N. Sato, Y. Hozumi, K. Anan, T. Nagashima, Y. Tokuda, N. Masuda, S. Ohsumi, S. Ohno, M. Takahashi, H. Hayashi, S. Yamamoto, Y. Ohashi Probiotic beverage with soy isoflavone consumption for breast cancer prevention: A case-control study Probiotic beverage with soy isoflavone consumption for breast cancer prevention: A case-control study Probiotic beverage with soy isoflavone consumption for breast cancer prevention: A case-control study Current Nutrition and Food Science, 9, 3, 194-200 Current Nutrition and Food Science, 9, 3, 194-200 Current Nutrition and Food Science, 9, 3, 194-200 2013 英語 公開
R. Kumar, A. Horvath, R. Mazumder, M. Toi, F. Sato, M.R. Pillai, L. Costa, M. Carmo-Fonseca, S. Knapp, A. Dutt, S. Gupta, R. Badwe R. Kumar, A. Horvath, R. Mazumder, M. Toi, F. Sato, M.R. Pillai, L. Costa, M. Carmo-Fonseca, S. Knapp, A. Dutt, S. Gupta, R. Badwe R. Kumar, A. Horvath, R. Mazumder, M. Toi, F. Sato, M.R. Pillai, L. Costa, M. Carmo-Fonseca, S. Knapp, A. Dutt, S. Gupta, R. Badwe The Global Cancer Genomics Consortium\\'s Second Annual Symposium: Genomics Medicine in Cancer Research The Global Cancer Genomics Consortium\\'s Second Annual Symposium: Genomics Medicine in Cancer Research The Global Cancer Genomics Consortium\\'s Second Annual Symposium: Genomics Medicine in Cancer Research Genes and Cancer, 4, 5-6, 196-200 Genes and Cancer, 4, 5-6, 196-200 Genes and Cancer, 4, 5-6, 196-200 2013 英語 公開
D. Cameron, J. Brown, R. Dent, C. Jackisch, J. Mackey, X. Pivot, G.G. Steger, T.M. Suter, M. Toi, M. Parmar, R. Laeufle, Y.-H. Im, G. Romieu, V. Harvey, O. Lipatov, T. Pienkowski, P. Cottu, A. Chan, S.-A. Im, P.S. Hall, L. Bubuteishvili-Pacaud, V. Henschel, R.J. Deurloo, C. Pallaud, R. Bell D. Cameron, J. Brown, R. Dent, C. Jackisch, J. Mackey, X. Pivot, G.G. Steger, T.M. Suter, M. Toi, M. Parmar, R. Laeufle, Y.-H. Im, G. Romieu, V. Harvey, O. Lipatov, T. Pienkowski, P. Cottu, A. Chan, S.-A. Im, P.S. Hall, L. Bubuteishvili-Pacaud, V. Henschel, R.J. Deurloo, C. Pallaud, R. Bell D. Cameron, J. Brown, R. Dent, C. Jackisch, J. Mackey, X. Pivot, G.G. Steger, T.M. Suter, M. Toi, M. Parmar, R. Laeufle, Y.-H. Im, G. Romieu, V. Harvey, O. Lipatov, T. Pienkowski, P. Cottu, A. Chan, S.-A. Im, P.S. Hall, L. Bubuteishvili-Pacaud, V. Henschel, R.J. Deurloo, C. Pallaud, R. Bell Adjuvant bevacizumab-containing therapy in triple-negative breast cancer (BEATRICE): Primary results of a randomised, phase 3 trial Adjuvant bevacizumab-containing therapy in triple-negative breast cancer (BEATRICE): Primary results of a randomised, phase 3 trial Adjuvant bevacizumab-containing therapy in triple-negative breast cancer (BEATRICE): Primary results of a randomised, phase 3 trial The Lancet Oncology, 14, 10, 933-942 The Lancet Oncology, 14, 10, 933-942 The Lancet Oncology, 14, 10, 933-942 2013 英語 公開
B. Zheng, R. Ishikawa, J. Takamatsu, K. Ikeuchi, T. Endo, K. Sato, T. Ueno, T. Sugie, M. Toi, S. Kanao, K. Togashi B. Zheng, R. Ishikawa, J. Takamatsu, K. Ikeuchi, T. Endo, K. Sato, T. Ueno, T. Sugie, M. Toi, S. Kanao, K. Togashi B. Zheng, R. Ishikawa, J. Takamatsu, K. Ikeuchi, T. Endo, K. Sato, T. Ueno, T. Sugie, M. Toi, S. Kanao, K. Togashi Breast MR Image fusion by deformable implicit polynomial (DIP) Breast MR Image fusion by deformable implicit polynomial (DIP) Breast MR Image fusion by deformable implicit polynomial (DIP) IPSJ Transactions on Computer Vision and Applications, 5, 99-103 IPSJ Transactions on Computer Vision and Applications, 5, 99-103 IPSJ Transactions on Computer Vision and Applications, 5, 99-103 2013 英語 公開
M. Chan, L. Wang, N. Chanplakorn, K. Tamaki, T. Ueno, M. Toi, W. Loo, L.W.C. Chow, T. Suzuki, H. Sasano M. Chan, L. Wang, N. Chanplakorn, K. Tamaki, T. Ueno, M. Toi, W. Loo, L.W.C. Chow, T. Suzuki, H. Sasano M. Chan, L. Wang, N. Chanplakorn, K. Tamaki, T. Ueno, M. Toi, W. Loo, L.W.C. Chow, T. Suzuki, H. Sasano Author\\'s response Author\\'s response Author\\'s response Expert Opinion on Therapeutic Targets, 17, 1, 106- Expert Opinion on Therapeutic Targets, 17, 1, 106- Expert Opinion on Therapeutic Targets, 17, 1, 106- 2013 英語 公開
河口 浩介, 石黒 洋, 戸井 雅和 河口 浩介, 石黒 洋, 戸井 雅和 【癌分子標的治療up to date】 乳癌分子標的治療薬の臨床応用 【癌分子標的治療up to date】 乳癌分子標的治療薬の臨床応用 癌の臨床, 58, 6, 321-327 癌の臨床, 58, 6, 321-327 , 58, 6, 321-327 2012/12 公開
Koshi Imami, Naoyuki Sugiyama, Haruna Imamura, Masaki Wakabayashi, Masaru Tomita, Masatoshi Taniguchi, Takayuki Ueno, Masakazu Toi, Yasushi Ishihama Koshi Imami, Naoyuki Sugiyama, Haruna Imamura, Masaki Wakabayashi, Masaru Tomita, Masatoshi Taniguchi, Takayuki Ueno, Masakazu Toi, Yasushi Ishihama Koshi Imami, Naoyuki Sugiyama, Haruna Imamura, Masaki Wakabayashi, Masaru Tomita, Masatoshi Taniguchi, Takayuki Ueno, Masakazu Toi, Yasushi Ishihama Temporal Profiling of Lapatinib-suppressed Phosphorylation Signals in EGFR/HER2 Pathways Temporal Profiling of Lapatinib-suppressed Phosphorylation Signals in EGFR/HER2 Pathways Temporal Profiling of Lapatinib-suppressed Phosphorylation Signals in EGFR/HER2 Pathways MOLECULAR & CELLULAR PROTEOMICS, 11, 12, 1741-1757 MOLECULAR & CELLULAR PROTEOMICS, 11, 12, 1741-1757 MOLECULAR & CELLULAR PROTEOMICS, 11, 12, 1741-1757 2012/12 英語 研究論文(学術雑誌) 公開
Masakazu Toi, John R. Benson, Eric P. Winer, John F. Forbes, Gunter von Minckwitz, Mehra Golshan, John F. R. Robertson, Hironobu Sasano, Bernard F. Cole, Louis W. C. Chow, Mark D. Pegram, Wonshik Han, Chiun-Sheng Huang, Tadashi Ikeda, Shotaro Kanao, Eun-Sook Lee, Shinzaburo Noguchi, Shinji Ohno, Ann H. Partridge, Roman Rouzier, Mitsuhiro Tozaki, Tomoharu Sugie, Akira Yamauchi, Takashi Inamoto Masakazu Toi, John R. Benson, Eric P. Winer, John F. Forbes, Gunter von Minckwitz, Mehra Golshan, John F. R. Robertson, Hironobu Sasano, Bernard F. Cole, Louis W. C. Chow, Mark D. Pegram, Wonshik Han, Chiun-Sheng Huang, Tadashi Ikeda, Shotaro Kanao, Eun-Sook Lee, Shinzaburo Noguchi, Shinji Ohno, Ann H. Partridge, Roman Rouzier, Mitsuhiro Tozaki, Tomoharu Sugie, Akira Yamauchi, Takashi Inamoto Masakazu Toi, John R. Benson, Eric P. Winer, John F. Forbes, Gunter von Minckwitz, Mehra Golshan, John F. R. Robertson, Hironobu Sasano, Bernard F. Cole, Louis W. C. Chow, Mark D. Pegram, Wonshik Han, Chiun-Sheng Huang, Tadashi Ikeda, Shotaro Kanao, Eun-Sook Lee, Shinzaburo Noguchi, Shinji Ohno, Ann H. Partridge, Roman Rouzier, Mitsuhiro Tozaki, Tomoharu Sugie, Akira Yamauchi, Takashi Inamoto Preoperative systemic therapy in locoregional management of early breast cancer: highlights from the Kyoto Breast Cancer Consensus Conference Preoperative systemic therapy in locoregional management of early breast cancer: highlights from the Kyoto Breast Cancer Consensus Conference Preoperative systemic therapy in locoregional management of early breast cancer: highlights from the Kyoto Breast Cancer Consensus Conference BREAST CANCER RESEARCH AND TREATMENT, 136, 3, 919-926 BREAST CANCER RESEARCH AND TREATMENT, 136, 3, 919-926 BREAST CANCER RESEARCH AND TREATMENT, 136, 3, 919-926 2012/12 英語 研究論文(学術雑誌) 公開
Koshi Imami, Naoyuki Sugiyama, Haruna Imamura, Masaki Wakabayashi, Masaru Tomita, Masatoshi Taniguchi, Takayuki Ueno, Masakazu Toi, Yasushi Ishihama Koshi Imami, Naoyuki Sugiyama, Haruna Imamura, Masaki Wakabayashi, Masaru Tomita, Masatoshi Taniguchi, Takayuki Ueno, Masakazu Toi, Yasushi Ishihama Koshi Imami, Naoyuki Sugiyama, Haruna Imamura, Masaki Wakabayashi, Masaru Tomita, Masatoshi Taniguchi, Takayuki Ueno, Masakazu Toi, Yasushi Ishihama Temporal Profiling of Lapatinib-suppressed Phosphorylation Signals in EGFR/HER2 Pathways Temporal Profiling of Lapatinib-suppressed Phosphorylation Signals in EGFR/HER2 Pathways Temporal Profiling of Lapatinib-suppressed Phosphorylation Signals in EGFR/HER2 Pathways MOLECULAR & CELLULAR PROTEOMICS, 11, 12, 1741-1757 MOLECULAR & CELLULAR PROTEOMICS, 11, 12, 1741-1757 MOLECULAR & CELLULAR PROTEOMICS, 11, 12, 1741-1757 2012/12 英語 研究論文(学術雑誌) 公開
石黒 洋, 佐治 重衡, 戸井 雅和 石黒 洋, 佐治 重衡, 戸井 雅和 【分子標的薬-がんから他疾患までの治癒をめざして-】 臨床研究 腫瘍性疾患の分子標的薬 乳がん 分子標的薬の臨床薬理学的特徴 【分子標的薬-がんから他疾患までの治癒をめざして-】 臨床研究 腫瘍性疾患の分子標的薬 乳がん 分子標的薬の臨床薬理学的特徴 日本臨床 (0047-1852)巻刊 Page-, 70, 増刊8, 分子標的薬443-446 日本臨床 (0047-1852)巻刊 Page-, 70, 増刊8, 分子標的薬443-446 , 70, 増刊8, 分子標的薬443-446 2012/11 公開
Megumi Takeuchi, Tomoharu Sugie, Kassim Abdelazeem, Hironori Kato, Nobuhiko Shinkura, Masahiro Takada, Hiroyasu Yamashiro, Takayuki Ueno, Masakazu Toi Megumi Takeuchi, Tomoharu Sugie, Kassim Abdelazeem, Hironori Kato, Nobuhiko Shinkura, Masahiro Takada, Hiroyasu Yamashiro, Takayuki Ueno, Masakazu Toi Megumi Takeuchi, Tomoharu Sugie, Kassim Abdelazeem, Hironori Kato, Nobuhiko Shinkura, Masahiro Takada, Hiroyasu Yamashiro, Takayuki Ueno, Masakazu Toi Lymphatic Mapping With Fluorescence Navigation Using Indocyanine Green and Axillary Surgery in Patients With Primary Breast Cancer Lymphatic Mapping With Fluorescence Navigation Using Indocyanine Green and Axillary Surgery in Patients With Primary Breast Cancer Lymphatic Mapping With Fluorescence Navigation Using Indocyanine Green and Axillary Surgery in Patients With Primary Breast Cancer BREAST JOURNAL, 18, 6, 535-541 BREAST JOURNAL, 18, 6, 535-541 BREAST JOURNAL, 18, 6, 535-541 2012/11 英語 研究論文(学術雑誌) 公開
Sunao Tanaka, Takayuki Ueno, Fumiaki Sato, Yoshitsugu Chigusa, Nobuko Kawaguchi-Sakita, Masahiro Kawashima, Noriyoshi Fujisawa, Kenichi Yoshimura, Satoshi Teramukai, Hiroshi Fujiwara, Masatoshi Fujita, Masakazu Toi Sunao Tanaka, Takayuki Ueno, Fumiaki Sato, Yoshitsugu Chigusa, Nobuko Kawaguchi-Sakita, Masahiro Kawashima, Noriyoshi Fujisawa, Kenichi Yoshimura, Satoshi Teramukai, Hiroshi Fujiwara, Masatoshi Fujita, Masakazu Toi Sunao Tanaka, Takayuki Ueno, Fumiaki Sato, Yoshitsugu Chigusa, Nobuko Kawaguchi-Sakita, Masahiro Kawashima, Noriyoshi Fujisawa, Kenichi Yoshimura, Satoshi Teramukai, Hiroshi Fujiwara, Masatoshi Fujita, Masakazu Toi Alterations of Circulating Endothelial Cell and Endothelial Progenitor Cell Counts around the Ovulation Alterations of Circulating Endothelial Cell and Endothelial Progenitor Cell Counts around the Ovulation Alterations of Circulating Endothelial Cell and Endothelial Progenitor Cell Counts around the Ovulation JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 97, 11, 4182-4192 JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 97, 11, 4182-4192 JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 97, 11, 4182-4192 2012/11 英語 研究論文(学術雑誌) 公開
Megumi Takeuchi, Tomoharu Sugie, Kassim Abdelazeem, Hironori Kato, Nobuhiko Shinkura, Masahiro Takada, Hiroyasu Yamashiro, Takayuki Ueno, Masakazu Toi Megumi Takeuchi, Tomoharu Sugie, Kassim Abdelazeem, Hironori Kato, Nobuhiko Shinkura, Masahiro Takada, Hiroyasu Yamashiro, Takayuki Ueno, Masakazu Toi Megumi Takeuchi, Tomoharu Sugie, Kassim Abdelazeem, Hironori Kato, Nobuhiko Shinkura, Masahiro Takada, Hiroyasu Yamashiro, Takayuki Ueno, Masakazu Toi Lymphatic Mapping With Fluorescence Navigation Using Indocyanine Green and Axillary Surgery in Patients With Primary Breast Cancer Lymphatic Mapping With Fluorescence Navigation Using Indocyanine Green and Axillary Surgery in Patients With Primary Breast Cancer Lymphatic Mapping With Fluorescence Navigation Using Indocyanine Green and Axillary Surgery in Patients With Primary Breast Cancer BREAST JOURNAL, 18, 6, 535-541 BREAST JOURNAL, 18, 6, 535-541 BREAST JOURNAL, 18, 6, 535-541 2012/11 英語 研究論文(学術雑誌) 公開
Monica S. M. Chan, Lin Wang, Saulo J. A. Felizola, Takayuki Ueno, Masakazu Toi, W. Loo, Louis W. C. Chow, Takashi Suzuki, Hironobu Sasano Monica S. M. Chan, Lin Wang, Saulo J. A. Felizola, Takayuki Ueno, Masakazu Toi, W. Loo, Louis W. C. Chow, Takashi Suzuki, Hironobu Sasano Monica S. M. Chan, Lin Wang, Saulo J. A. Felizola, Takayuki Ueno, Masakazu Toi, W. Loo, Louis W. C. Chow, Takashi Suzuki, Hironobu Sasano Changes of tumor infiltrating lymphocyte subtypes before and after neoadjuvant endocrine therapy in estrogen receptor-positive breast cancer patients - an immunohistochemical study of cd8+and foxp3+using double immunostaining with correlation to the pathobiological response of the patients Changes of tumor infiltrating lymphocyte subtypes before and after neoadjuvant endocrine therapy in estrogen receptor-positive breast cancer patients - an immunohistochemical study of cd8+and foxp3+using double immunostaining with correlation to the pathobiological response of the patients Changes of tumor infiltrating lymphocyte subtypes before and after neoadjuvant endocrine therapy in estrogen receptor-positive breast cancer patients - an immunohistochemical study of cd8+and foxp3+using double immunostaining with correlation to the pathobiological response of the patients INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 27, 4, E295-E304 INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 27, 4, E295-E304 INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 27, 4, E295-E304 2012/10 英語 研究論文(学術雑誌) 公開
Mami Iima, Yuji Nakamoto, Shotaro Kanao, Tomoharu Sugie, Takayuki Ueno, Mayumi Kawada, Yoshiki Mikami, Masakazu Toi, Kaori Togashi Mami Iima, Yuji Nakamoto, Shotaro Kanao, Tomoharu Sugie, Takayuki Ueno, Mayumi Kawada, Yoshiki Mikami, Masakazu Toi, Kaori Togashi Mami Iima, Yuji Nakamoto, Shotaro Kanao, Tomoharu Sugie, Takayuki Ueno, Mayumi Kawada, Yoshiki Mikami, Masakazu Toi, Kaori Togashi Clinical Performance of 2 Dedicated PET Scanners for Breast Imaging: Initial Evaluation Clinical Performance of 2 Dedicated PET Scanners for Breast Imaging: Initial Evaluation Clinical Performance of 2 Dedicated PET Scanners for Breast Imaging: Initial Evaluation JOURNAL OF NUCLEAR MEDICINE, 53, 10, 1534-1542 JOURNAL OF NUCLEAR MEDICINE, 53, 10, 1534-1542 JOURNAL OF NUCLEAR MEDICINE, 53, 10, 1534-1542 2012/10 英語 研究論文(学術雑誌) 公開
Kazuna Takeda, Shotaro Kanao, Tomohisa Okada, Masako Kataoka, Takayuki Ueno, Masakazu Toi, Hiroshi Ishiguro, Yoshiki Mikami, Kaori Togashi Kazuna Takeda, Shotaro Kanao, Tomohisa Okada, Masako Kataoka, Takayuki Ueno, Masakazu Toi, Hiroshi Ishiguro, Yoshiki Mikami, Kaori Togashi Kazuna Takeda, Shotaro Kanao, Tomohisa Okada, Masako Kataoka, Takayuki Ueno, Masakazu Toi, Hiroshi Ishiguro, Yoshiki Mikami, Kaori Togashi Assessment of CAD-generated tumor volumes measured using MRI in breast cancers before and after neoadjuvant chemotherapy Assessment of CAD-generated tumor volumes measured using MRI in breast cancers before and after neoadjuvant chemotherapy Assessment of CAD-generated tumor volumes measured using MRI in breast cancers before and after neoadjuvant chemotherapy EUROPEAN JOURNAL OF RADIOLOGY, 81, 10, 2627-2631 EUROPEAN JOURNAL OF RADIOLOGY, 81, 10, 2627-2631 EUROPEAN JOURNAL OF RADIOLOGY, 81, 10, 2627-2631 2012/10 英語 研究論文(学術雑誌) 公開
Louis W. C. Chow, Masakazu Toi Louis W. C. Chow, Masakazu Toi Louis W. C. Chow, Masakazu Toi The clinical trials of the Organisation for Oncology and Translational Research (OOTR) The clinical trials of the Organisation for Oncology and Translational Research (OOTR) The clinical trials of the Organisation for Oncology and Translational Research (OOTR) INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 27, 4, E353-E356 INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 27, 4, E353-E356 INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 27, 4, E353-E356 2012/10 英語 研究論文(学術雑誌) 公開
H. Ishiguro, S. Takashima, K. Yoshimura, I. Yano, T. Yamamoto, M. Niimi, H. Yamashiro, T. Ueno, M. Takeuchi, T. Sugie, K. Yanagihara, M. Toi, M. Fukushima H. Ishiguro, S. Takashima, K. Yoshimura, I. Yano, T. Yamamoto, M. Niimi, H. Yamashiro, T. Ueno, M. Takeuchi, T. Sugie, K. Yanagihara, M. Toi, M. Fukushima H. Ishiguro, S. Takashima, K. Yoshimura, I. Yano, T. Yamamoto, M. Niimi, H. Yamashiro, T. Ueno, M. Takeuchi, T. Sugie, K. Yanagihara, M. Toi, M. Fukushima Degree of freezing does not affect efficacy of frozen gloves for prevention of docetaxel-induced nail toxicity in breast cancer patients Degree of freezing does not affect efficacy of frozen gloves for prevention of docetaxel-induced nail toxicity in breast cancer patients Degree of freezing does not affect efficacy of frozen gloves for prevention of docetaxel-induced nail toxicity in breast cancer patients SUPPORTIVE CARE IN CANCER, 20, 9, 2017-2024 SUPPORTIVE CARE IN CANCER, 20, 9, 2017-2024 SUPPORTIVE CARE IN CANCER, 20, 9, 2017-2024 2012/09 英語 研究論文(学術雑誌) 公開
Kazuna Takeda, Shotaro Kanao, Tomohisa Okada, Takayuki Ueno, Masakazu Toi, Hiroshi Ishiguro, Yoshiki Mikami, Shiro Tanaka, Kaori Togashi Kazuna Takeda, Shotaro Kanao, Tomohisa Okada, Takayuki Ueno, Masakazu Toi, Hiroshi Ishiguro, Yoshiki Mikami, Shiro Tanaka, Kaori Togashi Kazuna Takeda, Shotaro Kanao, Tomohisa Okada, Takayuki Ueno, Masakazu Toi, Hiroshi Ishiguro, Yoshiki Mikami, Shiro Tanaka, Kaori Togashi MRI evaluation of residual tumor size after neoadjuvant endocrine therapy vs. neoadjuvant chemotherapy MRI evaluation of residual tumor size after neoadjuvant endocrine therapy vs. neoadjuvant chemotherapy MRI evaluation of residual tumor size after neoadjuvant endocrine therapy vs. neoadjuvant chemotherapy EUROPEAN JOURNAL OF RADIOLOGY, 81, 9, 2148-2153 EUROPEAN JOURNAL OF RADIOLOGY, 81, 9, 2148-2153 EUROPEAN JOURNAL OF RADIOLOGY, 81, 9, 2148-2153 2012/09 英語 研究論文(学術雑誌) 公開
H. Ishiguro, S. Takashima, K. Yoshimura, I. Yano, T. Yamamoto, M. Niimi, H. Yamashiro, T. Ueno, M. Takeuchi, T. Sugie, K. Yanagihara, M. Toi, M. Fukushima H. Ishiguro, S. Takashima, K. Yoshimura, I. Yano, T. Yamamoto, M. Niimi, H. Yamashiro, T. Ueno, M. Takeuchi, T. Sugie, K. Yanagihara, M. Toi, M. Fukushima H. Ishiguro, S. Takashima, K. Yoshimura, I. Yano, T. Yamamoto, M. Niimi, H. Yamashiro, T. Ueno, M. Takeuchi, T. Sugie, K. Yanagihara, M. Toi, M. Fukushima Degree of freezing does not affect efficacy of frozen gloves for prevention of docetaxel-induced nail toxicity in breast cancer patients Degree of freezing does not affect efficacy of frozen gloves for prevention of docetaxel-induced nail toxicity in breast cancer patients Degree of freezing does not affect efficacy of frozen gloves for prevention of docetaxel-induced nail toxicity in breast cancer patients SUPPORTIVE CARE IN CANCER, 20, 9, 2017-2024 SUPPORTIVE CARE IN CANCER, 20, 9, 2017-2024 SUPPORTIVE CARE IN CANCER, 20, 9, 2017-2024 2012/09 英語 研究論文(学術雑誌) 公開
Jeyanthy Eswaran, Sudeep Gupta, Amit Dutt, Masakazu Toi, M. Radhakrishna Pillai, Luis Costa, Stefan Knapp, Rajendra Badwe, Rakesh Kumar Jeyanthy Eswaran, Sudeep Gupta, Amit Dutt, Masakazu Toi, M. Radhakrishna Pillai, Luis Costa, Stefan Knapp, Rajendra Badwe, Rakesh Kumar Jeyanthy Eswaran, Sudeep Gupta, Amit Dutt, Masakazu Toi, M. Radhakrishna Pillai, Luis Costa, Stefan Knapp, Rajendra Badwe, Rakesh Kumar The Global Cancer Genomics Consortium: Interfacing Genomics and Cancer Medicine The Global Cancer Genomics Consortium: Interfacing Genomics and Cancer Medicine The Global Cancer Genomics Consortium: Interfacing Genomics and Cancer Medicine CANCER RESEARCH, 72, 15, 3720-3724 CANCER RESEARCH, 72, 15, 3720-3724 CANCER RESEARCH, 72, 15, 3720-3724 2012/08 英語 公開
Jeyanthy Eswaran, Sudeep Gupta, Amit Dutt, Masakazu Toi, M. Radhakrishna Pillai, Luis Costa, Stefan Knapp, Rajendra Badwe, Rakesh Kumar Jeyanthy Eswaran, Sudeep Gupta, Amit Dutt, Masakazu Toi, M. Radhakrishna Pillai, Luis Costa, Stefan Knapp, Rajendra Badwe, Rakesh Kumar Jeyanthy Eswaran, Sudeep Gupta, Amit Dutt, Masakazu Toi, M. Radhakrishna Pillai, Luis Costa, Stefan Knapp, Rajendra Badwe, Rakesh Kumar The Global Cancer Genomics Consortium: Interfacing Genomics and Cancer Medicine The Global Cancer Genomics Consortium: Interfacing Genomics and Cancer Medicine The Global Cancer Genomics Consortium: Interfacing Genomics and Cancer Medicine CANCER RESEARCH, 72, 15, 3720-3724 CANCER RESEARCH, 72, 15, 3720-3724 CANCER RESEARCH, 72, 15, 3720-3724 2012/08 英語 公開
M. Takada, M. Sugimoto, S. Ohno, K. Kuroi, N. Sato, H. Bando, N. Masuda, H. Iwata, M. Kondo, H. Sasano, L. W. C. Chow, T. Inamoto, Y. Naito, M. Tomita, M. Toi M. Takada, M. Sugimoto, S. Ohno, K. Kuroi, N. Sato, H. Bando, N. Masuda, H. Iwata, M. Kondo, H. Sasano, L. W. C. Chow, T. Inamoto, Y. Naito, M. Tomita, M. Toi M. Takada, M. Sugimoto, S. Ohno, K. Kuroi, N. Sato, H. Bando, N. Masuda, H. Iwata, M. Kondo, H. Sasano, L. W. C. Chow, T. Inamoto, Y. Naito, M. Tomita, M. Toi Predictions of the pathological response to neoadjuvant chemotherapy in patients with primary breast cancer using a data mining technique Predictions of the pathological response to neoadjuvant chemotherapy in patients with primary breast cancer using a data mining technique Predictions of the pathological response to neoadjuvant chemotherapy in patients with primary breast cancer using a data mining technique BREAST CANCER RESEARCH AND TREATMENT, 134, 2, 661-670 BREAST CANCER RESEARCH AND TREATMENT, 134, 2, 661-670 BREAST CANCER RESEARCH AND TREATMENT, 134, 2, 661-670 2012/07 英語 研究論文(学術雑誌) 公開
石黒 洋, 戸井雅和 石黒 洋, 戸井雅和 内分泌療法中の日本人乳癌患者において、薬物代謝酵素遺伝子多型が活性薬物血中濃度に及ぼす影響 内分泌療法中の日本人乳癌患者において、薬物代謝酵素遺伝子多型が活性薬物血中濃度に及ぼす影響 臨床薬理の進歩, 33, 9-15 臨床薬理の進歩, 33, 9-15 , 33, 9-15 2012/06 公開
Masahiro Takada, Masahiro Sugimoto, Yasuhiro Naito, Hyeong-Gon Moon, Wonshik Han, Dong-Young Noh, Masahide Kondo, Katsumasa Kuroi, Hironobu Sasano, Takashi Inamoto, Masaru Tomita, Masakazu Toi Masahiro Takada, Masahiro Sugimoto, Yasuhiro Naito, Hyeong-Gon Moon, Wonshik Han, Dong-Young Noh, Masahide Kondo, Katsumasa Kuroi, Hironobu Sasano, Takashi Inamoto, Masaru Tomita, Masakazu Toi Masahiro Takada, Masahiro Sugimoto, Yasuhiro Naito, Hyeong-Gon Moon, Wonshik Han, Dong-Young Noh, Masahide Kondo, Katsumasa Kuroi, Hironobu Sasano, Takashi Inamoto, Masaru Tomita, Masakazu Toi Prediction of axillary lymph node metastasis in primary breast cancer patients using a decision tree-based model Prediction of axillary lymph node metastasis in primary breast cancer patients using a decision tree-based model Prediction of axillary lymph node metastasis in primary breast cancer patients using a decision tree-based model BMC MEDICAL INFORMATICS AND DECISION MAKING, 12 BMC MEDICAL INFORMATICS AND DECISION MAKING, 12 BMC MEDICAL INFORMATICS AND DECISION MAKING, 12 2012/06 英語 研究論文(学術雑誌) 公開
M. Kondo, S.-L. Hoshi, H. Ishiguro, M. Toi M. Kondo, S.-L. Hoshi, H. Ishiguro, M. Toi Masahide Kondo, Shu-Ling Hoshi, Hiroshi Ishiguro, Masakazu Toi Economic evaluation of the 70-gene prognosis-signature (MammaPrint®) in hormone receptor-positive, lymph node-negative, human epidermal growth factor receptor type 2-negative early stage breast cancer in Japan Economic evaluation of the 70-gene prognosis-signature (MammaPrint®) in hormone receptor-positive, lymph node-negative, human epidermal growth factor receptor type 2-negative early stage breast cancer in Japan Economic evaluation of the 70-gene prognosis-signature (MammaPrint(A (R))) in hormone receptor-positive, lymph node-negative, human epidermal growth factor receptor type 2-negative early stage breast cancer in Japan Breast Cancer Research and Treatment, 133, 2, 759-768 Breast Cancer Research and Treatment, 133, 2, 759-768 BREAST CANCER RESEARCH AND TREATMENT, 133, 2, 759-768 2012/06 英語 研究論文(学術雑誌) 公開
C. Barrios, J. F. Forbes, W. Jonat, P. Conte, W. Gradishar, A. Buzdar, K. Gelmon, M. Gnant, J. Bonneterre, M. Toi, C. Hudis, J. F. R. Robertson C. Barrios, J. F. Forbes, W. Jonat, P. Conte, W. Gradishar, A. Buzdar, K. Gelmon, M. Gnant, J. Bonneterre, M. Toi, C. Hudis, J. F. R. Robertson C. Barrios, J. F. Forbes, W. Jonat, P. Conte, W. Gradishar, A. Buzdar, K. Gelmon, M. Gnant, J. Bonneterre, M. Toi, C. Hudis, J. F. R. Robertson The sequential use of endocrine treatment for advanced breast cancer: where are we? The sequential use of endocrine treatment for advanced breast cancer: where are we? The sequential use of endocrine treatment for advanced breast cancer: where are we? ANNALS OF ONCOLOGY, 23, 6, 1378-1386 ANNALS OF ONCOLOGY, 23, 6, 1378-1386 ANNALS OF ONCOLOGY, 23, 6, 1378-1386 2012/06 英語 公開
Yu Tang, Xiangtian Zeng, Fei He, Yonghui Liao, Niansong Qian, Masakazu Toi Yu Tang, Xiangtian Zeng, Fei He, Yonghui Liao, Niansong Qian, Masakazu Toi Yu Tang, Xiangtian Zeng, Fei He, Yonghui Liao, Niansong Qian, Masakazu Toi Caveolin-1 is related to invasion, survival, and poor prognosis in hepatocellular cancer Caveolin-1 is related to invasion, survival, and poor prognosis in hepatocellular cancer Caveolin-1 is related to invasion, survival, and poor prognosis in hepatocellular cancer MEDICAL ONCOLOGY, 29, 2, 977-984 MEDICAL ONCOLOGY, 29, 2, 977-984 MEDICAL ONCOLOGY, 29, 2, 977-984 2012/06 英語 研究論文(学術雑誌) 公開
鈴木 栄治, 佐藤 史顕, 鳥井 雅恵, 藤澤 憲良, 川島 雅央, 川口 展子, 高田 正泰, 辻 和香子, 竹内 恵, 上野 貴之, 杉江 知治, 戸井 雅和 鈴木 栄治, 佐藤 史顕, 鳥井 雅恵, 藤澤 憲良, 川島 雅央, 川口 展子, 高田 正泰, 辻 和香子, 竹内 恵, 上野 貴之, 杉江 知治, 戸井 雅和 Trastuzumabを介した抗体依存性細胞障害活性(ADCC)耐性乳癌細胞株の樹立 Trastuzumabを介した抗体依存性細胞障害活性(ADCC)耐性乳癌細胞株の樹立 日本乳癌学会総会プログラム抄録集, 20回, 255-255 日本乳癌学会総会プログラム抄録集, 20回, 255-255 , 20回, 255-255 2012/05 日本語 公開
杉江 知治, 戸井 雅和, 山内 智香子, 石黒 洋, 三上 芳喜, 岡村 隆仁, 加藤 大典, 山内 清明, 稲本 俊 杉江 知治, 戸井 雅和, 山内 智香子, 石黒 洋, 三上 芳喜, 岡村 隆仁, 加藤 大典, 山内 清明, 稲本 俊 【過渡期の家族性腫瘍診療、その現状と展望】 遺伝性・家族性乳がん診療のコンセンサス 多施設アンケート結果から 【過渡期の家族性腫瘍診療、その現状と展望】 遺伝性・家族性乳がん診療のコンセンサス 多施設アンケート結果から 家族性腫瘍 (1346-1052), 12, 2, 45-49 家族性腫瘍 (1346-1052), 12, 2, 45-49 , 12, 2, 45-49 2012/05 公開
Giampietro Gasparini, Francesco Torino, Takayuki Ueno, Stefano Cascinu, Teresa Troiani, Alberto Ballestrero, Rossana Berardi, Junichi Shishido, Akihiko Yoshizawa, Yukiko Mori, Satoshi Nagayama, Paola Morosini, Masakazu Toi Giampietro Gasparini, Francesco Torino, Takayuki Ueno, Stefano Cascinu, Teresa Troiani, Alberto Ballestrero, Rossana Berardi, Junichi Shishido, Akihiko Yoshizawa, Yukiko Mori, Satoshi Nagayama, Paola Morosini, Masakazu Toi Giampietro Gasparini, Francesco Torino, Takayuki Ueno, Stefano Cascinu, Teresa Troiani, Alberto Ballestrero, Rossana Berardi, Junichi Shishido, Akihiko Yoshizawa, Yukiko Mori, Satoshi Nagayama, Paola Morosini, Masakazu Toi A phase II study of neoadjuvant bevacizumab plus capecitabine and concomitant radiotherapy in patients with locally advanced rectal cancer A phase II study of neoadjuvant bevacizumab plus capecitabine and concomitant radiotherapy in patients with locally advanced rectal cancer A phase II study of neoadjuvant bevacizumab plus capecitabine and concomitant radiotherapy in patients with locally advanced rectal cancer ANGIOGENESIS, 15, 1, 141-150 ANGIOGENESIS, 15, 1, 141-150 ANGIOGENESIS, 15, 1, 141-150 2012/03 英語 研究論文(学術雑誌) 公開
Monica S. M. Chan, Lin Wang, Niramol Chanplakorn, Kentaro Tamaki, Takayuki Ueno, Masakazu Toi, Wings T. Y. Loo, Louis W. C. Chow, Takashi Suzuki, Hironobu Sasano Monica S. M. Chan, Lin Wang, Niramol Chanplakorn, Kentaro Tamaki, Takayuki Ueno, Masakazu Toi, Wings T. Y. Loo, Louis W. C. Chow, Takashi Suzuki, Hironobu Sasano Monica S. M. Chan, Lin Wang, Niramol Chanplakorn, Kentaro Tamaki, Takayuki Ueno, Masakazu Toi, Wings T. Y. Loo, Louis W. C. Chow, Takashi Suzuki, Hironobu Sasano Effects of estrogen depletion on angiogenesis in estrogen-receptor-positive breast carcinoma - an immunohistochemical study of vasohibin-1 and CD31 with correlation to pathobiological response of the patients in neoadjuvant aromatase inhibitor therapy Effects of estrogen depletion on angiogenesis in estrogen-receptor-positive breast carcinoma - an immunohistochemical study of vasohibin-1 and CD31 with correlation to pathobiological response of the patients in neoadjuvant aromatase inhibitor therapy Effects of estrogen depletion on angiogenesis in estrogen-receptor-positive breast carcinoma - an immunohistochemical study of vasohibin-1 and CD31 with correlation to pathobiological response of the patients in neoadjuvant aromatase inhibitor therapy EXPERT OPINION ON THERAPEUTIC TARGETS, 16, SUPPL. 1, S69-S78 EXPERT OPINION ON THERAPEUTIC TARGETS, 16, SUPPL. 1, S69-S78 EXPERT OPINION ON THERAPEUTIC TARGETS, 16, SUPPL. 1, S69-S78 2012/03 英語 研究論文(学術雑誌) 公開
Takayuki Ueno, Mitsuru Emi, Hidenori Sato, Noriko Ito, Mariko Muta, Katsumasa Kuroi, Masakazu Toi Takayuki Ueno, Mitsuru Emi, Hidenori Sato, Noriko Ito, Mariko Muta, Katsumasa Kuroi, Masakazu Toi Takayuki Ueno, Mitsuru Emi, Hidenori Sato, Noriko Ito, Mariko Muta, Katsumasa Kuroi, Masakazu Toi Genome-wide copy number analysis in primary breast cancer Genome-wide copy number analysis in primary breast cancer Genome-wide copy number analysis in primary breast cancer EXPERT OPINION ON THERAPEUTIC TARGETS, 16, SUPPL. 1, S31-S35 EXPERT OPINION ON THERAPEUTIC TARGETS, 16, SUPPL. 1, S31-S35 EXPERT OPINION ON THERAPEUTIC TARGETS, 16, SUPPL. 1, S31-S35 2012/03 英語 公開
冨田 勝 冨田 勝 Takada, M, Sugimoto, M, Naito, Y, Moon, H, Han, W, Noh, D, Kondo, M, Kuroi, K, Sasano, H, Inamoto, T, Tomita, M, Toi, M Utility of a Prediction Model for Axillary Lymph Node Metastasis in Patients with Primary Breast Cancer using A Decision-tree Algorithm Utility of a Prediction Model for Axillary Lymph Node Metastasis in Patients with Primary Breast Cancer using A Decision-tree Algorithm Utility of a Prediction Model for Axillary Lymph Node Metastasis in Patients with Primary Breast Cancer using A Decision-tree Algorithm ANNALS OF SURGICAL ONCOLOGY, 19, 1, S80-S80 ANNALS OF SURGICAL ONCOLOGY, 19, 1, S80-S80 ANNALS OF SURGICAL ONCOLOGY, 19, 1, S80-S80 2012/02 英語 研究論文(学術雑誌) 公開
Takehiro Ichikawa, Fumiaki Sato, Kazuya Terasawa, Soken Tsuchiya, Masakazu Toi, Gozoh Tsujimoto, Kazuharu Shimizu Takehiro Ichikawa, Fumiaki Sato, Kazuya Terasawa, Soken Tsuchiya, Masakazu Toi, Gozoh Tsujimoto, Kazuharu Shimizu Takehiro Ichikawa, Fumiaki Sato, Kazuya Terasawa, Soken Tsuchiya, Masakazu Toi, Gozoh Tsujimoto, Kazuharu Shimizu Trastuzumab Produces Therapeutic Actions by Upregulating miR-26a and miR-30b in Breast Cancer Cells Trastuzumab Produces Therapeutic Actions by Upregulating miR-26a and miR-30b in Breast Cancer Cells Trastuzumab Produces Therapeutic Actions by Upregulating miR-26a and miR-30b in Breast Cancer Cells PLOS ONE, 7, 2 PLOS ONE, 7, 2 PLOS ONE, 7, 2 2012/02 英語 研究論文(学術雑誌) 公開
Yan-Shun Ren, Nian-Song Qian, Yu Tang, Yong-Hui Liao, Yan-Ling Yang, Ke-Feng Dou, Masakazu Toi Yan-Shun Ren, Nian-Song Qian, Yu Tang, Yong-Hui Liao, Yan-Ling Yang, Ke-Feng Dou, Masakazu Toi Yan-Shun Ren, Nian-Song Qian, Yu Tang, Yong-Hui Liao, Yan-Ling Yang, Ke-Feng Dou, Masakazu Toi Sodium channel Nav1.6 is up-regulated in the dorsal root ganglia in a mouse model of type 2 diabetes Sodium channel Nav1.6 is up-regulated in the dorsal root ganglia in a mouse model of type 2 diabetes Sodium channel Nav1.6 is up-regulated in the dorsal root ganglia in a mouse model of type 2 diabetes BRAIN RESEARCH BULLETIN, 87, 2-3, 244-249 BRAIN RESEARCH BULLETIN, 87, 2-3, 244-249 BRAIN RESEARCH BULLETIN, 87, 2-3, 244-249 2012/02 英語 研究論文(学術雑誌) 公開
Masahiro Takada, Shigehira Saji, Norikazu Masuda, Katsumasa Kuroi, Nobuaki Sato, Hiroyuki Takei, Yutaka Yamamoto, Shinji Ohno, Hiroko Yamashita, Kazufumi Hisamatsu, Kenjiro Aogi, Hiroji Iwata, Takayuki Ueno, Hironobu Sasano, Masakazu Toi Masahiro Takada, Shigehira Saji, Norikazu Masuda, Katsumasa Kuroi, Nobuaki Sato, Hiroyuki Takei, Yutaka Yamamoto, Shinji Ohno, Hiroko Yamashita, Kazufumi Hisamatsu, Kenjiro Aogi, Hiroji Iwata, Takayuki Ueno, Hironobu Sasano, Masakazu Toi Masahiro Takada, Shigehira Saji, Norikazu Masuda, Katsumasa Kuroi, Nobuaki Sato, Hiroyuki Takei, Yutaka Yamamoto, Shinji Ohno, Hiroko Yamashita, Kazufumi Hisamatsu, Kenjiro Aogi, Hiroji Iwata, Takayuki Ueno, Hironobu Sasano, Masakazu Toi Relationship between body mass index and preoperative treatment response to aromatase inhibitor exemestane in postmenopausal patients with primary breast cancer Relationship between body mass index and preoperative treatment response to aromatase inhibitor exemestane in postmenopausal patients with primary breast cancer Relationship between body mass index and preoperative treatment response to aromatase inhibitor exemestane in postmenopausal patients with primary breast cancer BREAST, 21, 1, 40-45 BREAST, 21, 1, 40-45 BREAST, 21, 1, 40-45 2012/02 英語 研究論文(学術雑誌) 公開
冨田 勝 冨田 勝 Toi, M, Takada, M, Sugimoto, M, Naito, Y, Bando, H, Iwata, H, Kuroi, K, Masuda, N, Ohno, S, Sato, N, Kondo, M, Sasano, H, Inamoto, T, Tomita, M Development of a Prediction Model for Treatment Response to Neoadjuvant Chemotherapy in Patients with Primary Breast Cancer Using a Decision-tree Algorithm Development of a Prediction Model for Treatment Response to Neoadjuvant Chemotherapy in Patients with Primary Breast Cancer Using a Decision-tree Algorithm Development of a Prediction Model for Treatment Response to Neoadjuvant Chemotherapy in Patients with Primary Breast Cancer Using a Decision-tree Algorithm ANNALS OF SURGICAL ONCOLOGY, 19, 1, S69-S69 ANNALS OF SURGICAL ONCOLOGY, 19, 1, S69-S69 ANNALS OF SURGICAL ONCOLOGY, 19, 1, S69-S69 2012 英語 研究論文(学術雑誌) 公開
H. Ishiguro, S. Saji, M. Toi H. Ishiguro, S. Saji, M. Toi H. Ishiguro, S. Saji, M. Toi [Clinical pharmacology of targeted drug for breast cancer]. [Clinical pharmacology of targeted drug for breast cancer]. [Clinical pharmacology of targeted drug for breast cancer]. Nihon rinsho. Japanese journal of clinical medicine, 70 Suppl 8, 443-446 Nihon rinsho. Japanese journal of clinical medicine, 70 Suppl 8, 443-446 Nihon rinsho. Japanese journal of clinical medicine, 70 Suppl 8, 443-446 2012 英語 公開
H. Ishiguro, M. Toi H. Ishiguro, M. Toi H. Ishiguro, M. Toi How to dose cytotoxic chemotherapeutic drugs How to dose cytotoxic chemotherapeutic drugs How to dose cytotoxic chemotherapeutic drugs Current Topics in Pharmacology, 16, 1, 67-81 Current Topics in Pharmacology, 16, 1, 67-81 Current Topics in Pharmacology, 16, 1, 67-81 2012 英語 公開
H. Ishiguro, M. Toi H. Ishiguro, M. Toi H. Ishiguro, M. Toi Pharmacokinetics and pharmacogenomics of selective estrogen receptor modulators in breast cancer patients Pharmacokinetics and pharmacogenomics of selective estrogen receptor modulators in breast cancer patients Pharmacokinetics and pharmacogenomics of selective estrogen receptor modulators in breast cancer patients Current Topics in Pharmacology, 16, 1, 53-58 Current Topics in Pharmacology, 16, 1, 53-58 Current Topics in Pharmacology, 16, 1, 53-58 2012 英語 公開
E. Suzuki, M. Toi E. Suzuki, M. Toi E. Suzuki, M. Toi [Targeting therapy perspectives]. [Targeting therapy perspectives]. [Targeting therapy perspectives]. Nihon rinsho. Japanese journal of clinical medicine, 70 Suppl 7, 620-626 Nihon rinsho. Japanese journal of clinical medicine, 70 Suppl 7, 620-626 Nihon rinsho. Japanese journal of clinical medicine, 70 Suppl 7, 620-626 2012 英語 公開
Y. Mitsudo, M. Takada, M. Toi Y. Mitsudo, M. Takada, M. Toi Y. Mitsudo, M. Takada, M. Toi [Multidisciplinary treatment of chemotherapy and surgical therapy]. [Multidisciplinary treatment of chemotherapy and surgical therapy]. [Multidisciplinary treatment of chemotherapy and surgical therapy]. Nihon rinsho. Japanese journal of clinical medicine, 70 Suppl 7, 571-575 Nihon rinsho. Japanese journal of clinical medicine, 70 Suppl 7, 571-575 Nihon rinsho. Japanese journal of clinical medicine, 70 Suppl 7, 571-575 2012 英語 公開
T. Kitai, M. Toi T. Kitai, M. Toi T. Kitai, M. Toi [Photoacoustic mammography for the diagnosis of breast cancer]. [Photoacoustic mammography for the diagnosis of breast cancer]. [Photoacoustic mammography for the diagnosis of breast cancer]. Nihon rinsho. Japanese journal of clinical medicine, 70 Suppl 7, 326-330 Nihon rinsho. Japanese journal of clinical medicine, 70 Suppl 7, 326-330 Nihon rinsho. Japanese journal of clinical medicine, 70 Suppl 7, 326-330 2012 英語 公開
N. Masuda, M. Toi, K. Kuroi N. Masuda, M. Toi, K. Kuroi N. Masuda, M. Toi, K. Kuroi [Current activities and perspective of JBCRG (Japan Breast Cancer Research Group)]. [Current activities and perspective of JBCRG (Japan Breast Cancer Research Group)]. [Current activities and perspective of JBCRG (Japan Breast Cancer Research Group)]. Nihon rinsho. Japanese journal of clinical medicine, 70 Suppl 7, 763-772 Nihon rinsho. Japanese journal of clinical medicine, 70 Suppl 7, 763-772 Nihon rinsho. Japanese journal of clinical medicine, 70 Suppl 7, 763-772 2012 英語 公開
E. Fakhrejahani, M. Toi E. Fakhrejahani, M. Toi E. Fakhrejahani, M. Toi Tumor angiogenesis: Pericytes and maturation are not to be ignored Tumor angiogenesis: Pericytes and maturation are not to be ignored Tumor angiogenesis: Pericytes and maturation are not to be ignored Journal of Oncology Journal of Oncology Journal of Oncology 2012 英語 公開
西村 友美, 山城 大泰, 清水 華子, 光藤 悠子, 鳥井 雅恵, 辻 和香子, 上野 貴之, 竹内 恵, 杉江 知治, 金尾 昌太郎, 石黒 洋, 三上 芳喜, 戸井 雅和 西村 友美, 山城 大泰, 清水 華子, 光藤 悠子, 鳥井 雅恵, 辻 和香子, 上野 貴之, 竹内 恵, 杉江 知治, 金尾 昌太郎, 石黒 洋, 三上 芳喜, 戸井 雅和 術前高用量トレミフェン療法が著効した閉経後乳癌の1例 術前高用量トレミフェン療法が著効した閉経後乳癌の1例 乳癌の臨床, 26, 6, 711-716 乳癌の臨床, 26, 6, 711-716 , 26, 6, 711-716 2011/12 公開
M. Kanai, H. Ishiguro, Y. Mori, T. Kitano, T. Nishimura, S. Matsumoto, K. Yanagihara, T. Chiba, M. Toi M. Kanai, H. Ishiguro, Y. Mori, T. Kitano, T. Nishimura, S. Matsumoto, K. Yanagihara, T. Chiba, M. Toi M. Kanai, H. Ishiguro, Y. Mori, T. Kitano, T. Nishimura, S. Matsumoto, K. Yanagihara, T. Chiba, M. Toi Temporary blood pressure drop after bevacizumab administration is associated with clinical course of advanced colorectal cancer Temporary blood pressure drop after bevacizumab administration is associated with clinical course of advanced colorectal cancer Temporary blood pressure drop after bevacizumab administration is associated with clinical course of advanced colorectal cancer BRITISH JOURNAL OF CANCER, 105, 11, 1693-1696 BRITISH JOURNAL OF CANCER, 105, 11, 1693-1696 BRITISH JOURNAL OF CANCER, 105, 11, 1693-1696 2011/11 英語 研究論文(学術雑誌) 公開
Hyo Sook Han, Isildinha M. Reis, Wei Zhao, Katsumasa Kuroi, Masakazu Toi, Eiji Suzuki, Rachel Syme, Louis Chow, Adrian Y. S. Yip, Stefan Glueck Hyo Sook Han, Isildinha M. Reis, Wei Zhao, Katsumasa Kuroi, Masakazu Toi, Eiji Suzuki, Rachel Syme, Louis Chow, Adrian Y. S. Yip, Stefan Glueck Hyo Sook Han, Isildinha M. Reis, Wei Zhao, Katsumasa Kuroi, Masakazu Toi, Eiji Suzuki, Rachel Syme, Louis Chow, Adrian Y. S. Yip, Stefan Glueck Racial differences in acute toxicities of neoadjuvant or adjuvant chemotherapy in patients with early-stage breast cancer Racial differences in acute toxicities of neoadjuvant or adjuvant chemotherapy in patients with early-stage breast cancer Racial differences in acute toxicities of neoadjuvant or adjuvant chemotherapy in patients with early-stage breast cancer EUROPEAN JOURNAL OF CANCER, 47, 17, 2537-2545 EUROPEAN JOURNAL OF CANCER, 47, 17, 2537-2545 EUROPEAN JOURNAL OF CANCER, 47, 17, 2537-2545 2011/11 英語 研究論文(学術雑誌) 公開
K. Kawaguchi, H. Ishiguro, S. Morita, S. Nakamura, S. Ohno, N. Masuda, H. Iwata, K. Aogi, K. Kuroi, M. Toi K. Kawaguchi, H. Ishiguro, S. Morita, S. Nakamura, S. Ohno, N. Masuda, H. Iwata, K. Aogi, K. Kuroi, M. Toi K. Kawaguchi, H. Ishiguro, S. Morita, S. Nakamura, S. Ohno, N. Masuda, H. Iwata, K. Aogi, K. Kuroi, M. Toi Correlation between docetaxel-induced skin toxicity and the use of steroids and H-2 blockers: a multi-institution survey Correlation between docetaxel-induced skin toxicity and the use of steroids and H-2 blockers: a multi-institution survey Correlation between docetaxel-induced skin toxicity and the use of steroids and H-2 blockers: a multi-institution survey BREAST CANCER RESEARCH AND TREATMENT, 130, 2, 627-634 BREAST CANCER RESEARCH AND TREATMENT, 130, 2, 627-634 BREAST CANCER RESEARCH AND TREATMENT, 130, 2, 627-634 2011/11 英語 研究論文(学術雑誌) 公開
Masakazu Toi, Eric P. Winer, Takashi Inamoto, John R. Benson, John F. Forbes, Michihide Mitsumori, John F. R. Robertson, Hironobu Sasano, Gunter von Minckwitz, Akira Yamauchi, V. Suzanne Klimberg Masakazu Toi, Eric P. Winer, Takashi Inamoto, John R. Benson, John F. Forbes, Michihide Mitsumori, John F. R. Robertson, Hironobu Sasano, Gunter von Minckwitz, Akira Yamauchi, V. Suzanne Klimberg Masakazu Toi, Eric P. Winer, Takashi Inamoto, John R. Benson, John F. Forbes, Michihide Mitsumori, John F. R. Robertson, Hironobu Sasano, Gunter von Minckwitz, Akira Yamauchi, V. Suzanne Klimberg Identifying Gaps in the Locoregional Management of Early Breast Cancer: Highlights from the Kyoto Consensus Conference Identifying Gaps in the Locoregional Management of Early Breast Cancer: Highlights from the Kyoto Consensus Conference Identifying Gaps in the Locoregional Management of Early Breast Cancer: Highlights from the Kyoto Consensus Conference ANNALS OF SURGICAL ONCOLOGY, 18, 10, 2885-2892 ANNALS OF SURGICAL ONCOLOGY, 18, 10, 2885-2892 ANNALS OF SURGICAL ONCOLOGY, 18, 10, 2885-2892 2011/10 英語 研究論文(学術雑誌) 公開
Arwa M. Ali, Takayuki Ueno, Sunao Tanaka, Masahiro Takada, Hiroshi Ishiguro, Ashraf Z. Abdellah, Masakazu Toi Arwa M. Ali, Takayuki Ueno, Sunao Tanaka, Masahiro Takada, Hiroshi Ishiguro, Ashraf Z. Abdellah, Masakazu Toi Arwa M. Ali, Takayuki Ueno, Sunao Tanaka, Masahiro Takada, Hiroshi Ishiguro, Ashraf Z. Abdellah, Masakazu Toi Determining circulating endothelial cells using CellSearch system during preoperative systemic chemotherapy in breast cancer patients Determining circulating endothelial cells using CellSearch system during preoperative systemic chemotherapy in breast cancer patients Determining circulating endothelial cells using CellSearch system during preoperative systemic chemotherapy in breast cancer patients EUROPEAN JOURNAL OF CANCER, 47, 15, 2265-2272 EUROPEAN JOURNAL OF CANCER, 47, 15, 2265-2272 EUROPEAN JOURNAL OF CANCER, 47, 15, 2265-2272 2011/10 英語 研究論文(学術雑誌) 公開
Masakazu Toi, Eric P. Winer, Takashi Inamoto, John R. Benson, John F. Forbes, Michihide Mitsumori, John F. R. Robertson, Hironobu Sasano, Gunter von Minckwitz, Akira Yamauchi, V. Suzanne Klimberg Masakazu Toi, Eric P. Winer, Takashi Inamoto, John R. Benson, John F. Forbes, Michihide Mitsumori, John F. R. Robertson, Hironobu Sasano, Gunter von Minckwitz, Akira Yamauchi, V. Suzanne Klimberg Masakazu Toi, Eric P. Winer, Takashi Inamoto, John R. Benson, John F. Forbes, Michihide Mitsumori, John F. R. Robertson, Hironobu Sasano, Gunter von Minckwitz, Akira Yamauchi, V. Suzanne Klimberg Identifying Gaps in the Locoregional Management of Early Breast Cancer: Highlights from the Kyoto Consensus Conference Identifying Gaps in the Locoregional Management of Early Breast Cancer: Highlights from the Kyoto Consensus Conference Identifying Gaps in the Locoregional Management of Early Breast Cancer: Highlights from the Kyoto Consensus Conference ANNALS OF SURGICAL ONCOLOGY, 18, 10, 2885-2892 ANNALS OF SURGICAL ONCOLOGY, 18, 10, 2885-2892 ANNALS OF SURGICAL ONCOLOGY, 18, 10, 2885-2892 2011/10 英語 研究論文(学術雑誌) 公開
Niansong Qian, Takayuki Ueno, Nobuko Kawaguchi-Sakita, Masahiro Kawashima, Noriyuki Yoshida, Yoshiki Mikami, Tomoko Wakasa, Masayuki Shintaku, Shigeru Tsuyuki, Takashi Inamoto, Masakazu Toi Niansong Qian, Takayuki Ueno, Nobuko Kawaguchi-Sakita, Masahiro Kawashima, Noriyuki Yoshida, Yoshiki Mikami, Tomoko Wakasa, Masayuki Shintaku, Shigeru Tsuyuki, Takashi Inamoto, Masakazu Toi Niansong Qian, Takayuki Ueno, Nobuko Kawaguchi-Sakita, Masahiro Kawashima, Noriyuki Yoshida, Yoshiki Mikami, Tomoko Wakasa, Masayuki Shintaku, Shigeru Tsuyuki, Takashi Inamoto, Masakazu Toi Prognostic significance of tumor/stromal caveolin-1 expression in breast cancer patients Prognostic significance of tumor/stromal caveolin-1 expression in breast cancer patients Prognostic significance of tumor/stromal caveolin-1 expression in breast cancer patients CANCER SCIENCE, 102, 8, 1590-1596 CANCER SCIENCE, 102, 8, 1590-1596 CANCER SCIENCE, 102, 8, 1590-1596 2011/08 英語 研究論文(学術雑誌) 公開
石黒 洋, 戸井雅和 石黒 洋, 戸井雅和 【乳癌最前線】 腫瘍内科医の考える「乳がん薬物療法」 【乳癌最前線】 腫瘍内科医の考える「乳がん薬物療法」 クリニシアン, 58, 7, 803-808 クリニシアン, 58, 7, 803-808 , 58, 7, 803-808 2011/07 公開
Yu Tang, Yonghui Liao, Nobuko Kawaguchi-Sakita, Vikram Raut, Elham Fakhrejahani, Niansong Qian, Masakazu Toi Yu Tang, Yonghui Liao, Nobuko Kawaguchi-Sakita, Vikram Raut, Elham Fakhrejahani, Niansong Qian, Masakazu Toi Yu Tang, Yonghui Liao, Nobuko Kawaguchi-Sakita, Vikram Raut, Elham Fakhrejahani, Niansong Qian, Masakazu Toi Sinisan, a traditional Chinese medicine, attenuates experimental chronic pancreatitis induced by trinitrobenzene sulfonic acid in rats Sinisan, a traditional Chinese medicine, attenuates experimental chronic pancreatitis induced by trinitrobenzene sulfonic acid in rats Sinisan, a traditional Chinese medicine, attenuates experimental chronic pancreatitis induced by trinitrobenzene sulfonic acid in rats JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 18, 4, 551-558 JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 18, 4, 551-558 JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 18, 4, 551-558 2011/07 英語 研究論文(学術雑誌) 公開
Hiroji Iwata, Nobuaki Sato, Norikazu Masuda, Seigo Nakamura, Naohito Yamamoto, Katsumasa Kuroi, Masafumi Kurosumi, Hitoshi Tsuda, Futoshi Akiyama, Yasuo Ohashi, Masakazu Toi Hiroji Iwata, Nobuaki Sato, Norikazu Masuda, Seigo Nakamura, Naohito Yamamoto, Katsumasa Kuroi, Masafumi Kurosumi, Hitoshi Tsuda, Futoshi Akiyama, Yasuo Ohashi, Masakazu Toi Hiroji Iwata, Nobuaki Sato, Norikazu Masuda, Seigo Nakamura, Naohito Yamamoto, Katsumasa Kuroi, Masafumi Kurosumi, Hitoshi Tsuda, Futoshi Akiyama, Yasuo Ohashi, Masakazu Toi Docetaxel Followed by Fluorouracil/Epirubicin/Cyclophosphamide as Neoadjuvant Chemotherapy for Patients with Primary Breast Cancer Docetaxel Followed by Fluorouracil/Epirubicin/Cyclophosphamide as Neoadjuvant Chemotherapy for Patients with Primary Breast Cancer Docetaxel Followed by Fluorouracil/Epirubicin/Cyclophosphamide as Neoadjuvant Chemotherapy for Patients with Primary Breast Cancer JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 41, 7, 867-875 JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 41, 7, 867-875 JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 41, 7, 867-875 2011/07 英語 研究論文(学術雑誌) 公開
M. Kondo, S.-L. Hoshi, T. Yamanaka, H. Ishiguro, M. Toi M. Kondo, S.-L. Hoshi, T. Yamanaka, H. Ishiguro, M. Toi Masahide Kondo, Shu-Ling Hoshi, Takeharu Yamanaka, Hiroshi Ishiguro, Masakazu Toi Economic evaluation of the 21-gene signature (Oncotype DX <sup>®</sup>) in lymph node-negative/positive, hormone receptor-positive early-stage breast cancer based on Japanese validation study (JBCRG-TR03) Economic evaluation of the 21-gene signature (Oncotype DX <sup>®</sup>) in lymph node-negative/positive, hormone receptor-positive early-stage breast cancer based on Japanese validation study (JBCRG-TR03) Economic evaluation of the 21-gene signature (Oncotype DXA (R)) in lymph node-negative/positive, hormone receptor-positive early-stage breast cancer based on Japanese validation study (JBCRG-TR03) Breast Cancer Research and Treatment, 127, 3, 739-749 Breast Cancer Research and Treatment, 127, 3, 739-749 BREAST CANCER RESEARCH AND TREATMENT, 127, 3, 739-749 2011/06 英語 研究論文(学術雑誌) 公開
Louis W. C. Chow, Adrian Y. S. Yip, W. P. Chu, Wings T. Y. Loo, Masakazu Toi Louis W. C. Chow, Adrian Y. S. Yip, W. P. Chu, Wings T. Y. Loo, Masakazu Toi Louis W. C. Chow, Adrian Y. S. Yip, W. P. Chu, Wings T. Y. Loo, Masakazu Toi Bone metabolism and quality-of-life of postmenopausal women with invasive breast cancer receiving neoadjuvant hormonal therapy: Sub-analyses from celecoxib anti-aromatase neoadjuvant (CAAN) trial Bone metabolism and quality-of-life of postmenopausal women with invasive breast cancer receiving neoadjuvant hormonal therapy: Sub-analyses from celecoxib anti-aromatase neoadjuvant (CAAN) trial Bone metabolism and quality-of-life of postmenopausal women with invasive breast cancer receiving neoadjuvant hormonal therapy: Sub-analyses from celecoxib anti-aromatase neoadjuvant (CAAN) trial JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 125, 1-2, 112-119 JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 125, 1-2, 112-119 JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 125, 1-2, 112-119 2011/05 英語 研究論文(学術雑誌) 公開
Kenjiro Aogi, Masayuki Yoshida, Yoshiaki Sagara, Shunji Kamigaki, Minoru Okazaki, Jumpei Funai, Toshio Fujimoto, Masakazu Toi, Toshiaki Saeki, Shigemitsu Takashima Kenjiro Aogi, Masayuki Yoshida, Yoshiaki Sagara, Shunji Kamigaki, Minoru Okazaki, Jumpei Funai, Toshio Fujimoto, Masakazu Toi, Toshiaki Saeki, Shigemitsu Takashima Kenjiro Aogi, Masayuki Yoshida, Yoshiaki Sagara, Shunji Kamigaki, Minoru Okazaki, Jumpei Funai, Toshio Fujimoto, Masakazu Toi, Toshiaki Saeki, Shigemitsu Takashima The efficacy and safety of gemcitabine plus paclitaxel combination first-line therapy for Japanese patients with metastatic breast cancer including triple-negative phenotype The efficacy and safety of gemcitabine plus paclitaxel combination first-line therapy for Japanese patients with metastatic breast cancer including triple-negative phenotype The efficacy and safety of gemcitabine plus paclitaxel combination first-line therapy for Japanese patients with metastatic breast cancer including triple-negative phenotype CANCER CHEMOTHERAPY AND PHARMACOLOGY, 67, 5, 1007-1015 CANCER CHEMOTHERAPY AND PHARMACOLOGY, 67, 5, 1007-1015 CANCER CHEMOTHERAPY AND PHARMACOLOGY, 67, 5, 1007-1015 2011/05 英語 研究論文(学術雑誌) 公開
Yu Tang, Fei Xu, Kaishan Tao, Niansong Qian, Masakazu Toi Yu Tang, Fei Xu, Kaishan Tao, Niansong Qian, Masakazu Toi Yu Tang, Fei Xu, Kaishan Tao, Niansong Qian, Masakazu Toi Clinical Applications of Sentinel Lymph Node Biopsy in Ductal Carcinoma in situ of the Breast: A Dilemma Clinical Applications of Sentinel Lymph Node Biopsy in Ductal Carcinoma in situ of the Breast: A Dilemma Clinical Applications of Sentinel Lymph Node Biopsy in Ductal Carcinoma in situ of the Breast: A Dilemma TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 224, 1, 1-5 TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 224, 1, 1-5 TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 224, 1, 1-5 2011/05 英語 公開
Masakazu Toi, Shigehira Saji, Norikazu Masuda, Katsumasa Kuroi, Nobuaki Sato, Hiroyuki Takei, Yutaka Yamamoto, Shinji Ohno, Hiroko Yamashita, Kazufumi Hisamatsu, Kenjiro Aogi, Hiroji Iwata, Masahiro Takada, Takayuki Ueno, Shigetoyo Saji, Niramol Chanplakorn, Takashi Suzuki, Hironobu Sasano Masakazu Toi, Shigehira Saji, Norikazu Masuda, Katsumasa Kuroi, Nobuaki Sato, Hiroyuki Takei, Yutaka Yamamoto, Shinji Ohno, Hiroko Yamashita, Kazufumi Hisamatsu, Kenjiro Aogi, Hiroji Iwata, Masahiro Takada, Takayuki Ueno, Shigetoyo Saji, Niramol Chanplakorn, Takashi Suzuki, Hironobu Sasano Masakazu Toi, Shigehira Saji, Norikazu Masuda, Katsumasa Kuroi, Nobuaki Sato, Hiroyuki Takei, Yutaka Yamamoto, Shinji Ohno, Hiroko Yamashita, Kazufumi Hisamatsu, Kenjiro Aogi, Hiroji Iwata, Masahiro Takada, Takayuki Ueno, Shigetoyo Saji, Niramol Chanplakorn, Takashi Suzuki, Hironobu Sasano Ki67 index changes, pathological response and clinical benefits in primary breast cancer patients treated with 24 weeks of aromatase inhibition Ki67 index changes, pathological response and clinical benefits in primary breast cancer patients treated with 24 weeks of aromatase inhibition Ki67 index changes, pathological response and clinical benefits in primary breast cancer patients treated with 24 weeks of aromatase inhibition CANCER SCIENCE, 102, 4, 858-865 CANCER SCIENCE, 102, 4, 858-865 CANCER SCIENCE, 102, 4, 858-865 2011/04 英語 研究論文(学術雑誌) 公開
Michitaka Honda, Shigehira Saji, Shin-ichiro Horiguchi, Eiji Suzuki, Tomoyuki Aruga, Kazumi Horiguchi, Dai Kitagawa, Susumu Sekine, Nobuaki Funata, Masakazu Toi, Katsumasa Kuroi Michitaka Honda, Shigehira Saji, Shin-ichiro Horiguchi, Eiji Suzuki, Tomoyuki Aruga, Kazumi Horiguchi, Dai Kitagawa, Susumu Sekine, Nobuaki Funata, Masakazu Toi, Katsumasa Kuroi Michitaka Honda, Shigehira Saji, Shin-ichiro Horiguchi, Eiji Suzuki, Tomoyuki Aruga, Kazumi Horiguchi, Dai Kitagawa, Susumu Sekine, Nobuaki Funata, Masakazu Toi, Katsumasa Kuroi Clinicopathological Analysis of Ten Patients with Metaplastic Squamous Cell Carcinoma of the Breast Clinicopathological Analysis of Ten Patients with Metaplastic Squamous Cell Carcinoma of the Breast Clinicopathological Analysis of Ten Patients with Metaplastic Squamous Cell Carcinoma of the Breast SURGERY TODAY, 41, 3, 328-332 SURGERY TODAY, 41, 3, 328-332 SURGERY TODAY, 41, 3, 328-332 2011/03 英語 研究論文(学術雑誌) 公開
M. Iwasaki, Y. Tanaka, H. Kobayashi, K. Murata-Hirai, H. Miyabe, T. Sugie, M. Toi, N. Minato M. Iwasaki, Y. Tanaka, H. Kobayashi, K. Murata-Hirai, H. Miyabe, T. Sugie, M. Toi, N. Minato Masashi Iwasaki, Yoshimasa Tanaka, Hirohito Kobayashi, Kaoru Murata-Hirai, Hideto Miyabe, Tomoharu Sugie, Masakazu Toi, Nagahiro Minato Expression and function of PD-1 in human γδ T cells that recognize phosphoantigens Expression and function of PD-1 in human γδ T cells that recognize phosphoantigens Expression and function of PD-1 in human gamma delta T cells that recognize phosphoantigens European Journal of Immunology, 41, 2, 345-355 European Journal of Immunology, 41, 2, 345-355 EUROPEAN JOURNAL OF IMMUNOLOGY, 41, 2, 345-355 2011/02 英語 研究論文(学術雑誌) 公開
Iwasaki, M, Tanaka, Y, Kobayashi, H, Hirai K, Sugie, T, Toi, M, Minato, N Iwasaki, M, Tanaka, Y, Kobayashi, H, Hirai K, Sugie, T, Toi, M, Minato, N Iwasaki, M, Tanaka, Y, Kobayashi, H, Hirai K, Sugie, T, Toi, M, Minato, N Expression and function of PD-1 in human gd T cell responses to tumor cells. Eur. Expression and function of PD-1 in human gd T cell responses to tumor cells. Eur. Expression and function of PD-1 in human gd T cell responses to tumor cells. Eur. J. Immunol. 41(2):345-355. J. Immunol. 41(2):345-355. J. Immunol. 41(2):345-355. 2011 英語 公開
Masahiro Takada, Hiroshi Terunuma, Xuewen Deng, Md. Zahidunnabi Dewan, Shigehira Saji, Katsumasa Kuroi, Naoki Yamamoto, Masakazu Toi Masahiro Takada, Hiroshi Terunuma, Xuewen Deng, Md. Zahidunnabi Dewan, Shigehira Saji, Katsumasa Kuroi, Naoki Yamamoto, Masakazu Toi Masahiro Takada, Hiroshi Terunuma, Xuewen Deng, Md. Zahidunnabi Dewan, Shigehira Saji, Katsumasa Kuroi, Naoki Yamamoto, Masakazu Toi Refractory lung metastasis from breast cancer treated with multidisciplinary therapy including an immunological approach Refractory lung metastasis from breast cancer treated with multidisciplinary therapy including an immunological approach Refractory lung metastasis from breast cancer treated with multidisciplinary therapy including an immunological approach BREAST CANCER, 18, 1, 64-67 BREAST CANCER, 18, 1, 64-67 BREAST CANCER, 18, 1, 64-67 2011/01 英語 研究論文(学術雑誌) 公開
A. Tomotaki, S. Hirota, Y. Ohashi, A. Teramoto, M. Yokobori, M. Toi A. Tomotaki, S. Hirota, Y. Ohashi, A. Teramoto, M. Yokobori, M. Toi A. Tomotaki, S. Hirota, Y. Ohashi, A. Teramoto, M. Yokobori, M. Toi Participant proportion of population controls and matching for cases and controls: Lactic acid bacterium and breast cancer in the case-control study Participant proportion of population controls and matching for cases and controls: Lactic acid bacterium and breast cancer in the case-control study Participant proportion of population controls and matching for cases and controls: Lactic acid bacterium and breast cancer in the case-control study Japanese Pharmacology and Therapeutics, 39, SUPPL. 2, S211-SS221 Japanese Pharmacology and Therapeutics, 39, SUPPL. 2, S211-SS221 Japanese Pharmacology and Therapeutics, 39, SUPPL. 2, S211-SS221 2011 英語 公開
M. Takada, M. Toi M. Takada, M. Toi Surgery for breast cancer - From radical mastectomy to breast-conserving surgery Surgery for breast cancer - From radical mastectomy to breast-conserving surgery Japanese Journal of Cancer and Chemotherapy, 38, 2, 173-178 Japanese Journal of Cancer and Chemotherapy, 38, 2, 173-178 , 38, 2, 173-178 2011 日本語 公開
福谷和彦, 染田恭宏, 卓雅一, 浅尾恭史, 小林秀一, 八木隆行, 山川誠, 椎名 毅, 杉江知治, 戸井雅和 福谷和彦, 染田恭宏, 卓雅一, 浅尾恭史, 小林秀一, 八木隆行, 山川誠, 椎名 毅, 杉江知治, 戸井雅和 高深度イメージングを目指した両面照射型光音響イメージングシステムの評価 高深度イメージングを目指した両面照射型光音響イメージングシステムの評価 2011 BIOS(SPIE Photonic West) (2011.1.24) 2011 BIOS(SPIE Photonic West) (2011.1.24) 2011 日本語 公開
M. Toi, W. Yasui, H. Ito, E. Tahara M. Toi, W. Yasui, H. Ito, E. Tahara M. Toi, W. Yasui, H. Ito, E. Tahara Recent progress in carcinogenesis, progression and therapy of breast cancer: The 20th Hiroshima Cancer seminar-the 4th three universities\\' Consortium International Symposium, october 2010 Recent progress in carcinogenesis, progression and therapy of breast cancer: The 20th Hiroshima Cancer seminar-the 4th three universities\\' Consortium International Symposium, october 2010 Recent progress in carcinogenesis, progression and therapy of breast cancer: The 20th Hiroshima Cancer seminar-the 4th three universities\\' Consortium International Symposium, october 2010 Japanese Journal of Clinical Oncology, 41, 7, 924-930 Japanese Journal of Clinical Oncology, 41, 7, 924-930 Japanese Journal of Clinical Oncology, 41, 7, 924-930 2011 英語 公開
H. Takuwa, T. Ueno, H. Ishiguro, Y. Mikami, S. Kanao, M. Takada, T. Sugie, M. Toi H. Takuwa, T. Ueno, H. Ishiguro, Y. Mikami, S. Kanao, M. Takada, T. Sugie, M. Toi H. Takuwa, T. Ueno, H. Ishiguro, Y. Mikami, S. Kanao, M. Takada, T. Sugie, M. Toi A case of metaplastic breast cancer that showed a good response to platinum-based preoperative chemotherapy A case of metaplastic breast cancer that showed a good response to platinum-based preoperative chemotherapy A case of metaplastic breast cancer that showed a good response to platinum-based preoperative chemotherapy Breast Cancer, 1-4 Breast Cancer, 1-4 Breast Cancer, 1-4 2011 英語 公開
T. Sugie, K. A. Kassim, M. Takeuchi, T. Hashimoto, K. Yamagami, Y. Masai, M. Toi T. Sugie, K. A. Kassim, M. Takeuchi, T. Hashimoto, K. Yamagami, Y. Masai, M. Toi T. Sugie, K. A. Kassim, M. Takeuchi, T. Hashimoto, K. Yamagami, Y. Masai, M. Toi A Novel Method for Sentinel Lymph Node Biopsy by Indocyanine Green Fluorescence Technique in Breast Cancer A Novel Method for Sentinel Lymph Node Biopsy by Indocyanine Green Fluorescence Technique in Breast Cancer A Novel Method for Sentinel Lymph Node Biopsy by Indocyanine Green Fluorescence Technique in Breast Cancer CANCER RESEARCH, 70, 2, 713-720 CANCER RESEARCH, 70, 2, 713-720 CANCER RESEARCH, 70, 2, 713-720 2010/12 英語 公開
Youichi Kumagai, Masakazu Toi, Kenro Kawada, Tatsuyuki Kawano Youichi Kumagai, Masakazu Toi, Kenro Kawada, Tatsuyuki Kawano Youichi Kumagai, Masakazu Toi, Kenro Kawada, Tatsuyuki Kawano ANGIOGENESIS IN SUPERFICIAL ESOPHAGEAL SQUAMOUS CELL CARCINOMA: MAGNIFYING ENDOSCOPIC OBSERVATION AND MOLECULAR ANALYSIS ANGIOGENESIS IN SUPERFICIAL ESOPHAGEAL SQUAMOUS CELL CARCINOMA: MAGNIFYING ENDOSCOPIC OBSERVATION AND MOLECULAR ANALYSIS ANGIOGENESIS IN SUPERFICIAL ESOPHAGEAL SQUAMOUS CELL CARCINOMA: MAGNIFYING ENDOSCOPIC OBSERVATION AND MOLECULAR ANALYSIS DIGESTIVE ENDOSCOPY, 22, 4, 259-267 DIGESTIVE ENDOSCOPY, 22, 4, 259-267 DIGESTIVE ENDOSCOPY, 22, 4, 259-267 2010/10 英語 公開
Christopher C. P. Yiu, Niramol Chanplakorn, Monica S. M. Chan, Wings T. Y. Loo, Louis W. C. Chow, Masakazu Toi, Hironobu Sasano Christopher C. P. Yiu, Niramol Chanplakorn, Monica S. M. Chan, Wings T. Y. Loo, Louis W. C. Chow, Masakazu Toi, Hironobu Sasano Christopher C. P. Yiu, Niramol Chanplakorn, Monica S. M. Chan, Wings T. Y. Loo, Louis W. C. Chow, Masakazu Toi, Hironobu Sasano Down-regulation of Heat-shock Protein 70 (HSP-70) Correlated with Responsiveness to Neoadjuvant Aromatase Inhibitor Therapy in Breast Cancer Patients Down-regulation of Heat-shock Protein 70 (HSP-70) Correlated with Responsiveness to Neoadjuvant Aromatase Inhibitor Therapy in Breast Cancer Patients Down-regulation of Heat-shock Protein 70 (HSP-70) Correlated with Responsiveness to Neoadjuvant Aromatase Inhibitor Therapy in Breast Cancer Patients ANTICANCER RESEARCH, 30, 9, 3465-3472 ANTICANCER RESEARCH, 30, 9, 3465-3472 ANTICANCER RESEARCH, 30, 9, 3465-3472 2010/09 英語 研究論文(学術雑誌) 公開
Masakazu Toi, Yasuo Ohashi, Adeline Seow, Takuya Moriya, Gary Tse, Hironobu Sasano, Byeong Woo Park, Louis W. C. Chow, Adriano V. Laudico, Cheng Har Yip, Ei Ueno, Hiroshi Ishiguro, Hiroko Bando Masakazu Toi, Yasuo Ohashi, Adeline Seow, Takuya Moriya, Gary Tse, Hironobu Sasano, Byeong Woo Park, Louis W. C. Chow, Adriano V. Laudico, Cheng Har Yip, Ei Ueno, Hiroshi Ishiguro, Hiroko Bando Masakazu Toi, Yasuo Ohashi, Adeline Seow, Takuya Moriya, Gary Tse, Hironobu Sasano, Byeong Woo Park, Louis W. C. Chow, Adriano V. Laudico, Cheng Har Yip, Ei Ueno, Hiroshi Ishiguro, Hiroko Bando The Breast Cancer Working Group Presentation was Divided into Three Sections: The Epidemiology, Pathology and Treatment of Breast Cancer The Breast Cancer Working Group Presentation was Divided into Three Sections: The Epidemiology, Pathology and Treatment of Breast Cancer The Breast Cancer Working Group Presentation was Divided into Three Sections: The Epidemiology, Pathology and Treatment of Breast Cancer JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 40, SUPPL. 1, i13-i18 JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 40, SUPPL. 1, i13-i18 JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 40, SUPPL. 1, i13-i18 2010/09 英語 研究論文(学術雑誌) 公開
L. Chen, A. Endler, K. Uchida, S.-I. Horiguchi, Y. Morizane, O. Iijima, M. Toi, F. Shibasaki L. Chen, A. Endler, K. Uchida, S.-I. Horiguchi, Y. Morizane, O. Iijima, M. Toi, F. Shibasaki Li Chen, Alexander Endler, Kazuyo Uchida, Shin-ichiro Horiguchi, Yoshihito Morizane, Osamu Iijima, Masakazu Toi, Futoshi Shibasaki Int6/eIF3e silencing promotes functional blood vessel outgrowth and enhances wound healing by upregulating hypoxia-induced factor 2α expression Int6/eIF3e silencing promotes functional blood vessel outgrowth and enhances wound healing by upregulating hypoxia-induced factor 2α expression Int6/eIF3e Silencing Promotes Functional Blood Vessel Outgrowth and Enhances Wound Healing by Upregulating Hypoxia-Induced Factor 2 alpha Expression Circulation, 122, 9, 910-919 Circulation, 122, 9, 910-919 CIRCULATION, 122, 9, 910-919 2010/08 英語 研究論文(学術雑誌) 公開
Marion Procter, Thomas M. Suter, Evandro de Azambuja, Urania Dafni, Veerle van Dooren, Susanne Muehlbauer, Miguel Angel Climent, Ernst Rechberger, Walter Tsang-Wu Liu, Mazakasu Toi, R. Charles Coombes, David Dodwell, Olivia Pagani, Jorge Madrid, Marcia Hall, Shin-Cheh Chen, Christian Focan, Michael Muschol, Dirk J. van Veldhuisen, Martine J. Piccart-Gebhart Marion Procter, Thomas M. Suter, Evandro de Azambuja, Urania Dafni, Veerle van Dooren, Susanne Muehlbauer, Miguel Angel Climent, Ernst Rechberger, Walter Tsang-Wu Liu, Mazakasu Toi, R. Charles Coombes, David Dodwell, Olivia Pagani, Jorge Madrid, Marcia Hall, Shin-Cheh Chen, Christian Focan, Michael Muschol, Dirk J. van Veldhuisen, Martine J. Piccart-Gebhart Marion Procter, Thomas M. Suter, Evandro de Azambuja, Urania Dafni, Veerle van Dooren, Susanne Muehlbauer, Miguel Angel Climent, Ernst Rechberger, Walter Tsang-Wu Liu, Mazakasu Toi, R. Charles Coombes, David Dodwell, Olivia Pagani, Jorge Madrid, Marcia Hall, Shin-Cheh Chen, Christian Focan, Michael Muschol, Dirk J. van Veldhuisen, Martine J. Piccart-Gebhart Longer-Term Assessment of Trastuzumab-Related Cardiac Adverse Events in the Herceptin Adjuvant (HERA) Trial Longer-Term Assessment of Trastuzumab-Related Cardiac Adverse Events in the Herceptin Adjuvant (HERA) Trial Longer-Term Assessment of Trastuzumab-Related Cardiac Adverse Events in the Herceptin Adjuvant (HERA) Trial JOURNAL OF CLINICAL ONCOLOGY, 28, 21, 3422-3428 JOURNAL OF CLINICAL ONCOLOGY, 28, 21, 3422-3428 JOURNAL OF CLINICAL ONCOLOGY, 28, 21, 3422-3428 2010/07 英語 研究論文(学術雑誌) 公開
Masakazu Toi, Hiroji Iwata, Takeharu Yamanaka, Norikazu Masuda, Shinji Ohno, Seigo Nakamura, Takahiro Nakayama, Masahiro Kashiwaba, Shunji Kamigaki, Katsumasa Kuroi Masakazu Toi, Hiroji Iwata, Takeharu Yamanaka, Norikazu Masuda, Shinji Ohno, Seigo Nakamura, Takahiro Nakayama, Masahiro Kashiwaba, Shunji Kamigaki, Katsumasa Kuroi Masakazu Toi, Hiroji Iwata, Takeharu Yamanaka, Norikazu Masuda, Shinji Ohno, Seigo Nakamura, Takahiro Nakayama, Masahiro Kashiwaba, Shunji Kamigaki, Katsumasa Kuroi Clinical Significance of the 21-Gene Signature (Oncotype DX) in Hormone Receptor-Positive Early Stage Primary Breast Cancer in the Japanese Population Clinical Significance of the 21-Gene Signature (Oncotype DX) in Hormone Receptor-Positive Early Stage Primary Breast Cancer in the Japanese Population Clinical Significance of the 21-Gene Signature (Oncotype DX) in Hormone Receptor-Positive Early Stage Primary Breast Cancer in the Japanese Population CANCER, 116, 13, 3112-3118 CANCER, 116, 13, 3112-3118 CANCER, 116, 13, 3112-3118 2010/07 英語 研究論文(学術雑誌) 公開
Seigo Nakamura, Hiroshi Yagata, Shinji Ohno, Hiroshi Yamaguchi, Hiroji Iwata, Nobuyuki Tsunoda, Yoshinori Ito, Nahomi Tokudome, Masakazu Toi, Katsumasa Kuroi, Eiji Suzuki Seigo Nakamura, Hiroshi Yagata, Shinji Ohno, Hiroshi Yamaguchi, Hiroji Iwata, Nobuyuki Tsunoda, Yoshinori Ito, Nahomi Tokudome, Masakazu Toi, Katsumasa Kuroi, Eiji Suzuki Seigo Nakamura, Hiroshi Yagata, Shinji Ohno, Hiroshi Yamaguchi, Hiroji Iwata, Nobuyuki Tsunoda, Yoshinori Ito, Nahomi Tokudome, Masakazu Toi, Katsumasa Kuroi, Eiji Suzuki Multi-center study evaluating circulating tumor cells as a surrogate for response to treatment and overall survival in metastatic breast cancer Multi-center study evaluating circulating tumor cells as a surrogate for response to treatment and overall survival in metastatic breast cancer Multi-center study evaluating circulating tumor cells as a surrogate for response to treatment and overall survival in metastatic breast cancer BREAST CANCER, 17, 3, 199-204 BREAST CANCER, 17, 3, 199-204 BREAST CANCER, 17, 3, 199-204 2010/07 英語 研究論文(学術雑誌) 公開
Dai Kitagawa, Shigehira Saji, Shin-ichiro Horiguchi, Yu Satoh, Kazumi Horiguchi, Masakazu Toi, Nobuaki Funata, Katsumasa Kuroi Dai Kitagawa, Shigehira Saji, Shin-ichiro Horiguchi, Yu Satoh, Kazumi Horiguchi, Masakazu Toi, Nobuaki Funata, Katsumasa Kuroi Dai Kitagawa, Shigehira Saji, Shin-ichiro Horiguchi, Yu Satoh, Kazumi Horiguchi, Masakazu Toi, Nobuaki Funata, Katsumasa Kuroi Alternation of Estrogen Receptor and Progesterone Receptor Expression in Primary Breast Cancer Patients Treated with Neoadjuvant Chemotherapy Alternation of Estrogen Receptor and Progesterone Receptor Expression in Primary Breast Cancer Patients Treated with Neoadjuvant Chemotherapy Alternation of Estrogen Receptor and Progesterone Receptor Expression in Primary Breast Cancer Patients Treated with Neoadjuvant Chemotherapy BREAST JOURNAL, 16, 4, 435-436 BREAST JOURNAL, 16, 4, 435-436 BREAST JOURNAL, 16, 4, 435-436 2010/07 英語 公開
Morihiko Kimura, Takeshi Tominaga, Yuichi Takatsuka, Masakazu Toi, Rikiya Abe, Hiroki Koyama, Shigemitsu Takashima, Yasuo Nomura, Shigeto Miura, Izo Kimijima, Hideya Tashiro, Yasuo Ohashi Morihiko Kimura, Takeshi Tominaga, Yuichi Takatsuka, Masakazu Toi, Rikiya Abe, Hiroki Koyama, Shigemitsu Takashima, Yasuo Nomura, Shigeto Miura, Izo Kimijima, Hideya Tashiro, Yasuo Ohashi Morihiko Kimura, Takeshi Tominaga, Yuichi Takatsuka, Masakazu Toi, Rikiya Abe, Hiroki Koyama, Shigemitsu Takashima, Yasuo Nomura, Shigeto Miura, Izo Kimijima, Hideya Tashiro, Yasuo Ohashi Randomized trial of cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil with node-positive breast cancer in Japan Randomized trial of cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil with node-positive breast cancer in Japan Randomized trial of cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil with node-positive breast cancer in Japan BREAST CANCER, 17, 3, 190-198 BREAST CANCER, 17, 3, 190-198 BREAST CANCER, 17, 3, 190-198 2010/07 英語 研究論文(学術雑誌) 公開
Takuro Shimbo, Tsuguya Fukui, Chikashi Ishioka, Kohji Okamoto, Takahiro Okamoto, Shingo Kameoka, Atsushi Sato, Masakazu Toi, Kunihiko Matsui, Toshihiko Mayumi, Shigetoyo Saji, Masaru Miyazaki, Yuichi Takatsuka, Koichi Hirata Takuro Shimbo, Tsuguya Fukui, Chikashi Ishioka, Kohji Okamoto, Takahiro Okamoto, Shingo Kameoka, Atsushi Sato, Masakazu Toi, Kunihiko Matsui, Toshihiko Mayumi, Shigetoyo Saji, Masaru Miyazaki, Yuichi Takatsuka, Koichi Hirata Takuro Shimbo, Tsuguya Fukui, Chikashi Ishioka, Kohji Okamoto, Takahiro Okamoto, Shingo Kameoka, Atsushi Sato, Masakazu Toi, Kunihiko Matsui, Toshihiko Mayumi, Shigetoyo Saji, Masaru Miyazaki, Yuichi Takatsuka, Koichi Hirata Quality of guideline development assessed by the Evaluation Committee of the Japan Society of Clinical Oncology Quality of guideline development assessed by the Evaluation Committee of the Japan Society of Clinical Oncology Quality of guideline development assessed by the Evaluation Committee of the Japan Society of Clinical Oncology INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 15, 3, 227-233 INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 15, 3, 227-233 INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 15, 3, 227-233 2010/06 英語 研究論文(学術雑誌) 公開
Niramol Chanplakorn, Pongsthorn Chanplakorn, Takashi Suzuki, Katsuhiko Ono, Monica S. M. Chan, Yasuhiro Miki, Shigetoyo Saji, Takayuki Ueno, Masakazu Toi, Hironobu Sasano Niramol Chanplakorn, Pongsthorn Chanplakorn, Takashi Suzuki, Katsuhiko Ono, Monica S. M. Chan, Yasuhiro Miki, Shigetoyo Saji, Takayuki Ueno, Masakazu Toi, Hironobu Sasano Niramol Chanplakorn, Pongsthorn Chanplakorn, Takashi Suzuki, Katsuhiko Ono, Monica S. M. Chan, Yasuhiro Miki, Shigetoyo Saji, Takayuki Ueno, Masakazu Toi, Hironobu Sasano Increased estrogen sulfatase (STS) and 17 beta-hydroxysteroid dehydrogenase type 1(17 beta-HSD1) following neoadjuvant aromatase inhibitor therapy in breast cancer patients Increased estrogen sulfatase (STS) and 17 beta-hydroxysteroid dehydrogenase type 1(17 beta-HSD1) following neoadjuvant aromatase inhibitor therapy in breast cancer patients Increased estrogen sulfatase (STS) and 17 beta-hydroxysteroid dehydrogenase type 1(17 beta-HSD1) following neoadjuvant aromatase inhibitor therapy in breast cancer patients BREAST CANCER RESEARCH AND TREATMENT, 120, 3, 639-648 BREAST CANCER RESEARCH AND TREATMENT, 120, 3, 639-648 BREAST CANCER RESEARCH AND TREATMENT, 120, 3, 639-648 2010/04 英語 研究論文(学術雑誌) 公開
N. Chanplakorn, P. Chanplakorn, T. Suzuki, K. Ono, M.S.M. Chan, Y. Miki, S. Saji, T. Ueno, M. Toi, H. Sasano N. Chanplakorn, P. Chanplakorn, T. Suzuki, K. Ono, M.S.M. Chan, Y. Miki, S. Saji, T. Ueno, M. Toi, H. Sasano Niramol Chanplakorn, Pongsthorn Chanplakorn, Takashi Suzuki, Katsuhiko Ono, Monica S. M. Chan, Yasuhiro Miki, Shigetoyo Saji, Takayuki Ueno, Masakazu Toi, Hironobu Sasano Increased estrogen sulfatase (STS) and 17βhydroxysteroid dehydrogenase type l(17β-HSD1) following neoadjuvant aromatase inhibitor therapy in breast cancer patients Increased estrogen sulfatase (STS) and 17βhydroxysteroid dehydrogenase type l(17β-HSD1) following neoadjuvant aromatase inhibitor therapy in breast cancer patients Increased estrogen sulfatase (STS) and 17 beta-hydroxysteroid dehydrogenase type 1(17 beta-HSD1) following neoadjuvant aromatase inhibitor therapy in breast cancer patients Breast Cancer Research and Treatment, 120, 3, 639-648 Breast Cancer Research and Treatment, 120, 3, 639-648 BREAST CANCER RESEARCH AND TREATMENT, 120, 3, 639-648 2010/04 英語 研究論文(学術雑誌) 公開
Louis W. C. Chow, Masakazu Toi Louis W. C. Chow, Masakazu Toi Louis W. C. Chow, Masakazu Toi Combat against cancer with science and medicine Combat against cancer with science and medicine Combat against cancer with science and medicine EXPERT OPINION ON INVESTIGATIONAL DRUGS, 19, SUPPL. 1, S3-S4 EXPERT OPINION ON INVESTIGATIONAL DRUGS, 19, SUPPL. 1, S3-S4 EXPERT OPINION ON INVESTIGATIONAL DRUGS, 19, SUPPL. 1, S3-S4 2010/04 英語 公開
Hiroshi Ishiguro, Masahide Kondo, Shu-Ling Hoshi, Masahiro Takada, Seigo Nakamura, Satoshi Teramukai, Kazuhiro Yanagihara, Masakazu Toi Hiroshi Ishiguro, Masahide Kondo, Shu-Ling Hoshi, Masahiro Takada, Seigo Nakamura, Satoshi Teramukai, Kazuhiro Yanagihara, Masakazu Toi Hiroshi Ishiguro, Masahide Kondo, Shu-Ling Hoshi, Masahiro Takada, Seigo Nakamura, Satoshi Teramukai, Kazuhiro Yanagihara, Masakazu Toi Economic Evaluation of Intensive Chemotherapy With Prophylactic Granulocyte Colony-Stimulating Factor for Patients With High-Risk Early Breast Cancer in Japan Economic Evaluation of Intensive Chemotherapy With Prophylactic Granulocyte Colony-Stimulating Factor for Patients With High-Risk Early Breast Cancer in Japan Economic Evaluation of Intensive Chemotherapy With Prophylactic Granulocyte Colony-Stimulating Factor for Patients With High-Risk Early Breast Cancer in Japan CLINICAL THERAPEUTICS, 32, 2, 311-326 CLINICAL THERAPEUTICS, 32, 2, 311-326 CLINICAL THERAPEUTICS, 32, 2, 311-326 2010/02 英語 研究論文(学術雑誌) 公開
Masakazu Toi, Jeff Sperinde, Weidong Huang, Shigehira Saji, John Winslow, Xueguang Jin, Yuping Tan, Shinji Ohno, Seigo Nakamura, Hiroji Iwata, Norikazu Masuda, Kenjiro Aogi, Satoshi Morita, Christos Petropoulos, Michael Bates Masakazu Toi, Jeff Sperinde, Weidong Huang, Shigehira Saji, John Winslow, Xueguang Jin, Yuping Tan, Shinji Ohno, Seigo Nakamura, Hiroji Iwata, Norikazu Masuda, Kenjiro Aogi, Satoshi Morita, Christos Petropoulos, Michael Bates Masakazu Toi, Jeff Sperinde, Weidong Huang, Shigehira Saji, John Winslow, Xueguang Jin, Yuping Tan, Shinji Ohno, Seigo Nakamura, Hiroji Iwata, Norikazu Masuda, Kenjiro Aogi, Satoshi Morita, Christos Petropoulos, Michael Bates Differential survival following trastuzumab treatment based on quantitative HER2 expression and HER2 homodimers in a clinic-based cohort of patients with metastatic breast cancer Differential survival following trastuzumab treatment based on quantitative HER2 expression and HER2 homodimers in a clinic-based cohort of patients with metastatic breast cancer Differential survival following trastuzumab treatment based on quantitative HER2 expression and HER2 homodimers in a clinic-based cohort of patients with metastatic breast cancer BMC CANCER, 10 BMC CANCER, 10 BMC CANCER, 10 2010/02 英語 研究論文(学術雑誌) 公開
柏葉, 匡寛, 石黒, 洋, 大野, 真司, 川端, 英孝, 中村, 清吾, 坂東, 裕子, 増田, 慎三, 戸井, 雅和 柏葉, 匡寛, 石黒, 洋, 大野, 真司, 川端, 英孝, 中村, 清吾, 坂東, 裕子, 増田, 慎三, 戸井, 雅和 柏葉, 匡寛, 石黒, 洋, 大野, 真司, 川端, 英孝, 中村, 清吾, 坂東, 裕子, 増田, 慎三, 戸井, 雅和 臨床エビデンスからの視点によるTC療法の展開 臨床エビデンスからの視点によるTC療法の展開 臨床エビデンスからの視点によるTC療法の展開 CANCER BOARD 乳癌, 3, 1, 26-38 CANCER BOARD 乳癌, 3, 1, 26-38 CANCER BOARD 乳癌, 3, 1, 26-38 2010/01 日本語 研究論文(学術雑誌) 公開
M. Toi M. Toi M. Toi [Current organ topics: chemotherapy of breast cancer]. [Current organ topics: chemotherapy of breast cancer]. [Current organ topics: chemotherapy of breast cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 37, 13, 2844- Gan to kagaku ryoho. Cancer & chemotherapy, 37, 13, 2844- Gan to kagaku ryoho. Cancer & chemotherapy, 37, 13, 2844- 2010 英語 公開
W. Tsuji, H. Yamashiro, M. Toi W. Tsuji, H. Yamashiro, M. Toi W. Tsuji, H. Yamashiro, M. Toi [Basic fibroblast growth factor (FGF-2)]. [Basic fibroblast growth factor (FGF-2)]. [Basic fibroblast growth factor (FGF-2)]. Nippon rinsho. Japanese journal of clinical medicine, 68 Suppl 7, 118-120 Nippon rinsho. Japanese journal of clinical medicine, 68 Suppl 7, 118-120 Nippon rinsho. Japanese journal of clinical medicine, 68 Suppl 7, 118-120 2010 英語 公開
H. Yamashiro, M. Toi H. Yamashiro, M. Toi H. Yamashiro, M. Toi [Molecular targeted therapy for breast cancer treatment, challenge to cure]. [Molecular targeted therapy for breast cancer treatment, challenge to cure]. [Molecular targeted therapy for breast cancer treatment, challenge to cure]. Nippon rinsho. Japanese journal of clinical medicine, 68, 10, 1854-1858 Nippon rinsho. Japanese journal of clinical medicine, 68, 10, 1854-1858 Nippon rinsho. Japanese journal of clinical medicine, 68, 10, 1854-1858 2010 英語 公開
S.-I. Horiguchi, T. Hishima, Y. Hayashi, Y. Shiozawa, K. Horiguchi, K. Kuroi, M. Toi, N. Funata, Y. Eishi S.-I. Horiguchi, T. Hishima, Y. Hayashi, Y. Shiozawa, K. Horiguchi, K. Kuroi, M. Toi, N. Funata, Y. Eishi S.-I. Horiguchi, T. Hishima, Y. Hayashi, Y. Shiozawa, K. Horiguchi, K. Kuroi, M. Toi, N. Funata, Y. Eishi HER-2/neu cytoplasmic staining is correlated with neuroendocrine differentiation in breast carcinoma HER-2/neu cytoplasmic staining is correlated with neuroendocrine differentiation in breast carcinoma HER-2/neu cytoplasmic staining is correlated with neuroendocrine differentiation in breast carcinoma Journal of Medical and Dental Sciences, 57, 2, 155-163 Journal of Medical and Dental Sciences, 57, 2, 155-163 Journal of Medical and Dental Sciences, 57, 2, 155-163 2010 英語 公開
K. Horiguchi, M. Toi, S.-I. Horiguchi, M. Sugimoto, Y. Naito, Y. Hayashi, T. Ueno, S. Ohno, N. Funata, K. Kuroi, M. Tomita, Y. Eishi K. Horiguchi, M. Toi, S.-I. Horiguchi, M. Sugimoto, Y. Naito, Y. Hayashi, T. Ueno, S. Ohno, N. Funata, K. Kuroi, M. Tomita, Y. Eishi K. Horiguchi, M. Toi, S.-I. Horiguchi, M. Sugimoto, Y. Naito, Y. Hayashi, T. Ueno, S. Ohno, N. Funata, K. Kuroi, M. Tomita, Y. Eishi Predictive value of CD24 and CD44 for neoadjuvant chemotherapy response and prognosis in primary breast cancer patients Predictive value of CD24 and CD44 for neoadjuvant chemotherapy response and prognosis in primary breast cancer patients Predictive value of CD24 and CD44 for neoadjuvant chemotherapy response and prognosis in primary breast cancer patients Journal of Medical and Dental Sciences, 57, 2, 165-175 Journal of Medical and Dental Sciences, 57, 2, 165-175 Journal of Medical and Dental Sciences, 57, 2, 165-175 2010 英語 公開
Y. Matsumura, H. Yamashiro, M. Toi Y. Matsumura, H. Yamashiro, M. Toi Trastuzumab for cancer treatment: Present role and future perspective Trastuzumab for cancer treatment: Present role and future perspective Biotherapy, 24, 2, 178-182 Biotherapy, 24, 2, 178-182 , 24, 2, 178-182 2010 日本語 公開
Yu Kimura, Wakako Tsuji, Hiroyasu Yamashiro, Masakazu Toi, Takashi Inamoto, Yasuhiko Tabata Yu Kimura, Wakako Tsuji, Hiroyasu Yamashiro, Masakazu Toi, Takashi Inamoto, Yasuhiko Tabata Yu Kimura, Wakako Tsuji, Hiroyasu Yamashiro, Masakazu Toi, Takashi Inamoto, Yasuhiko Tabata In situ adipogenesis in fat tissue augmented by collagen scaffold with gelatin microspheres containing basic fibroblast growth factor In situ adipogenesis in fat tissue augmented by collagen scaffold with gelatin microspheres containing basic fibroblast growth factor In situ adipogenesis in fat tissue augmented by collagen scaffold with gelatin microspheres containing basic fibroblast growth factor JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE, 4, 1, 55-61 JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE, 4, 1, 55-61 JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE, 4, 1, 55-61 2010/01 英語 研究論文(学術雑誌) 公開
M. Toi, H. Iwata, Y. Fujiwara, Y. Ito, S. Nakamura, Y. Tokuda, T. Taguchi, Y. Rai, K. Aogi, T. Arai, J. Watanabe, T. Wakamatsu, K. Katsura, C. E. Ellis, R. C. Gagnon, K. E. Allen, Y. Sasaki, S. Takashima M. Toi, H. Iwata, Y. Fujiwara, Y. Ito, S. Nakamura, Y. Tokuda, T. Taguchi, Y. Rai, K. Aogi, T. Arai, J. Watanabe, T. Wakamatsu, K. Katsura, C. E. Ellis, R. C. Gagnon, K. E. Allen, Y. Sasaki, S. Takashima M. Toi, H. Iwata, Y. Fujiwara, Y. Ito, S. Nakamura, Y. Tokuda, T. Taguchi, Y. Rai, K. Aogi, T. Arai, J. Watanabe, T. Wakamatsu, K. Katsura, C. E. Ellis, R. C. Gagnon, K. E. Allen, Y. Sasaki, S. Takashima Lapatinib monotherapy in patients with relapsed, advanced, or metastatic breast cancer: efficacy, safety, and biomarker results from Japanese patients phase II studies Lapatinib monotherapy in patients with relapsed, advanced, or metastatic breast cancer: efficacy, safety, and biomarker results from Japanese patients phase II studies Lapatinib monotherapy in patients with relapsed, advanced, or metastatic breast cancer: efficacy, safety, and biomarker results from Japanese patients phase II studies BRITISH JOURNAL OF CANCER, 101, 10, 1676-1682 BRITISH JOURNAL OF CANCER, 101, 10, 1676-1682 BRITISH JOURNAL OF CANCER, 101, 10, 1676-1682 2009/11 英語 研究論文(学術雑誌) 公開
Md. Zahidunnabi Dewan, Masahiro Takada, Hiroshi Terunuma, Xuewen Deng, Sunjida Ahmed, Naoki Yamamoto, Masakazu Toi Md. Zahidunnabi Dewan, Masahiro Takada, Hiroshi Terunuma, Xuewen Deng, Sunjida Ahmed, Naoki Yamamoto, Masakazu Toi Md. Zahidunnabi Dewan, Masahiro Takada, Hiroshi Terunuma, Xuewen Deng, Sunjida Ahmed, Naoki Yamamoto, Masakazu Toi Natural killer activity of peripheral-blood mononuclear cells in breast cancer patients Natural killer activity of peripheral-blood mononuclear cells in breast cancer patients Natural killer activity of peripheral-blood mononuclear cells in breast cancer patients BIOMEDICINE & PHARMACOTHERAPY, 63, 9, 703-706 BIOMEDICINE & PHARMACOTHERAPY, 63, 9, 703-706 BIOMEDICINE & PHARMACOTHERAPY, 63, 9, 703-706 2009/11 英語 研究論文(学術雑誌) 公開
Masahide Kondo, Shu-Ling Hoshi, Masakazu Toi Masahide Kondo, Shu-Ling Hoshi, Masakazu Toi Masahide Kondo, Shu-Ling Hoshi, Masakazu Toi Budget Impact Analysis of Chemoprevention of Breast Cancer with Tamoxifen and Raloxifene among High-risk Women in Japan Budget Impact Analysis of Chemoprevention of Breast Cancer with Tamoxifen and Raloxifene among High-risk Women in Japan Budget Impact Analysis of Chemoprevention of Breast Cancer with Tamoxifen and Raloxifene among High-risk Women in Japan JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 39, 11, 767-770 JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 39, 11, 767-770 JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 39, 11, 767-770 2009/11 英語 研究論文(学術雑誌) 公開
A. M. Ali, M. Toi, T. Ueno A. M. Ali, M. Toi, T. Ueno A. M. Ali, M. Toi, T. Ueno Anti-Angiogenic Cancer Therapy Updates Anti-Angiogenic Cancer Therapy Updates Anti-Angiogenic Cancer Therapy Updates CURRENT MOLECULAR MEDICINE, 9, 8, 954-966 CURRENT MOLECULAR MEDICINE, 9, 8, 954-966 CURRENT MOLECULAR MEDICINE, 9, 8, 954-966 2009/11 英語 公開
Shinzaburo Noguchi, Masakazu Toi Shinzaburo Noguchi, Masakazu Toi Shinzaburo Noguchi, Masakazu Toi From standardization to personalization in breast cancer treatment From standardization to personalization in breast cancer treatment From standardization to personalization in breast cancer treatment BREAST CANCER, 16, 4, 241-242 BREAST CANCER, 16, 4, 241-242 BREAST CANCER, 16, 4, 241-242 2009/10 英語 公開
Tomoyuki Aruga, Eiji Suzuki, Shigehira Saji, Shin-Ichirou Horiguchi, Kazumi Horiguchi, Susumu Sekine, Dai Kitagawa, Nobuaki Funata, Masakazu Toi, Kenichi Sugihara, Katsumasa Kuroi Tomoyuki Aruga, Eiji Suzuki, Shigehira Saji, Shin-Ichirou Horiguchi, Kazumi Horiguchi, Susumu Sekine, Dai Kitagawa, Nobuaki Funata, Masakazu Toi, Kenichi Sugihara, Katsumasa Kuroi Tomoyuki Aruga, Eiji Suzuki, Shigehira Saji, Shin-Ichirou Horiguchi, Kazumi Horiguchi, Susumu Sekine, Dai Kitagawa, Nobuaki Funata, Masakazu Toi, Kenichi Sugihara, Katsumasa Kuroi A low number of tumor-infiltrating FOXP3-positive cells during primary systemic chemotherapy correlates with favorable anti-tumor response in patients with breast cancer A low number of tumor-infiltrating FOXP3-positive cells during primary systemic chemotherapy correlates with favorable anti-tumor response in patients with breast cancer A low number of tumor-infiltrating FOXP3-positive cells during primary systemic chemotherapy correlates with favorable anti-tumor response in patients with breast cancer ONCOLOGY REPORTS, 22, 2, 273-278 ONCOLOGY REPORTS, 22, 2, 273-278 ONCOLOGY REPORTS, 22, 2, 273-278 2009/08 英語 研究論文(学術雑誌) 公開
Masakazu Toi, Hiroyasu Yamashiro, Wakako Tsuji Masakazu Toi, Hiroyasu Yamashiro, Wakako Tsuji Masakazu Toi, Hiroyasu Yamashiro, Wakako Tsuji Risk reduction of distant metastasis in hormone-sensitive postmenopausal breast cancer Risk reduction of distant metastasis in hormone-sensitive postmenopausal breast cancer Risk reduction of distant metastasis in hormone-sensitive postmenopausal breast cancer BREAST CANCER, 16, 3, 207-218 BREAST CANCER, 16, 3, 207-218 BREAST CANCER, 16, 3, 207-218 2009/07 英語 公開
F. Chen, T. Fujinaga, K. Sato, M. Sonobe, T. Shoji, H. Sakai, R. Miyahara, T. Bando, K. Okubo, T. Hirata, M. Toi, H. Date F. Chen, T. Fujinaga, K. Sato, M. Sonobe, T. Shoji, H. Sakai, R. Miyahara, T. Bando, K. Okubo, T. Hirata, M. Toi, H. Date F. Chen, T. Fujinaga, K. Sato, M. Sonobe, T. Shoji, H. Sakai, R. Miyahara, T. Bando, K. Okubo, T. Hirata, M. Toi, H. Date Clinical features of surgical resection for pulmonary metastasis from breast cancer Clinical features of surgical resection for pulmonary metastasis from breast cancer Clinical features of surgical resection for pulmonary metastasis from breast cancer EJSO, 35, 4, 393-397 EJSO, 35, 4, 393-397 EJSO, 35, 4, 393-397 2009/04 英語 研究論文(学術雑誌) 公開
M. Kondo, S-L Hoshi, M. Toi M. Kondo, S-L Hoshi, M. Toi M. Kondo, S-L Hoshi, M. Toi Economic evaluation of chemoprevention of breast cancer with tamoxifen and raloxifene among high-risk women in Japan Economic evaluation of chemoprevention of breast cancer with tamoxifen and raloxifene among high-risk women in Japan Economic evaluation of chemoprevention of breast cancer with tamoxifen and raloxifene among high-risk women in Japan BRITISH JOURNAL OF CANCER, 100, 2, 281-290 BRITISH JOURNAL OF CANCER, 100, 2, 281-290 BRITISH JOURNAL OF CANCER, 100, 2, 281-290 2009/01 英語 研究論文(学術雑誌) 公開
Wakako Tsuji, Takashi Inamoto, Hiroyasu Yamashiro, Takayuki Ueno, Hironori Kato, Yu Kimura, Yasuhiko Tabata, Masakazu Toi Wakako Tsuji, Takashi Inamoto, Hiroyasu Yamashiro, Takayuki Ueno, Hironori Kato, Yu Kimura, Yasuhiko Tabata, Masakazu Toi Wakako Tsuji, Takashi Inamoto, Hiroyasu Yamashiro, Takayuki Ueno, Hironori Kato, Yu Kimura, Yasuhiko Tabata, Masakazu Toi Adipogenesis Induced by Human Adipose Tissue-Derived Stem Cells Adipogenesis Induced by Human Adipose Tissue-Derived Stem Cells Adipogenesis Induced by Human Adipose Tissue-Derived Stem Cells TISSUE ENGINEERING PART A, 15, 1, 83-93 TISSUE ENGINEERING PART A, 15, 1, 83-93 TISSUE ENGINEERING PART A, 15, 1, 83-93 2009/01 英語 研究論文(学術雑誌) 公開
Kimura Y, Tsuji W, Yamashiro H, Toi M, Inamoto T, Tabata Y Kimura Y, Tsuji W, Yamashiro H, Toi M, Inamoto T, Tabata Y Kimura Y, Tsuji W, Yamashiro H, Toi M, Inamoto T, Tabata Y In Situ adipose tissue regeneration augmented by collagen scaffold combined with gelatin microspheres containing basic fibroblast growth factor. In Situ adipose tissue regeneration augmented by collagen scaffold combined with gelatin microspheres containing basic fibroblast growth factor. In Situ adipose tissue regeneration augmented by collagen scaffold combined with gelatin microspheres containing basic fibroblast growth factor. The 2nd World Congress of the Tissue Engineering and Regenerative Medicine International Society (TERMIS-WC2009) (2009.08.31-09. 03 Seoul, Korea) The 2nd World Congress of the Tissue Engineering and Regenerative Medicine International Society (TERMIS-WC2009) (2009.08.31-09. 03 Seoul, Korea) The 2nd World Congress of the Tissue Engineering and Regenerative Medicine International Society (TERMIS-WC2009) (2009.08.31-09. 03 Seoul, Korea) 2009 英語 公開
H. Ishiguro, I. Yano, M. Toi H. Ishiguro, I. Yano, M. Toi H. Ishiguro, I. Yano, M. Toi Pharmacogenomic considerations in breast cancer management Pharmacogenomic considerations in breast cancer management Pharmacogenomic considerations in breast cancer management Frontiers in Drug Design and Discovery, 4, 1, 122-134 Frontiers in Drug Design and Discovery, 4, 1, 122-134 Frontiers in Drug Design and Discovery, 4, 1, 122-134 2009 英語 公開
H. Ishiguro, I. Yano, M. Toi H. Ishiguro, I. Yano, M. Toi H. Ishiguro, I. Yano, M. Toi Important drug interactions for clinical oncologists Important drug interactions for clinical oncologists Important drug interactions for clinical oncologists Frontiers in Drug Design and Discovery, 4, 1, 97-121 Frontiers in Drug Design and Discovery, 4, 1, 97-121 Frontiers in Drug Design and Discovery, 4, 1, 97-121 2009 英語 公開
T. Ueno, M. Toi T. Ueno, M. Toi T. Ueno, M. Toi Biomarker Biomarker Biomarker Japanese Journal of Cancer and Chemotherapy, 36, 1, 15-20 Japanese Journal of Cancer and Chemotherapy, 36, 1, 15-20 Japanese Journal of Cancer and Chemotherapy, 36, 1, 15-20 2009 英語 公開
H. Yamashiro, M. Toi H. Yamashiro, M. Toi Anti-HER2 antibody and small-molecule tyrosine kinase inhibitor therapy targeting EGFR signal pathway Anti-HER2 antibody and small-molecule tyrosine kinase inhibitor therapy targeting EGFR signal pathway Japanese Journal of Cancer and Chemotherapy, 36, 7, 1067-1071 Japanese Journal of Cancer and Chemotherapy, 36, 7, 1067-1071 , 36, 7, 1067-1071 2009 日本語 公開
M. Toi, H. Sasano, M.J. Ellis M. Toi, H. Sasano, M.J. Ellis Future prospects of neoadjuvant endocrine therapy in postmenopausal breast cancer Future prospects of neoadjuvant endocrine therapy in postmenopausal breast cancer Japanese Journal of Cancer and Chemotherapy, 36, 6, 1035-1042 Japanese Journal of Cancer and Chemotherapy, 36, 6, 1035-1042 , 36, 6, 1035-1042 2009 日本語 公開
T. Sugie, Y. Tanaka, M. Toi T. Sugie, Y. Tanaka, M. Toi T. Sugie, Y. Tanaka, M. Toi New development in breast cancer therapy. III. Zoledronic acid and anti-tumor immunity in breast cancer New development in breast cancer therapy. III. Zoledronic acid and anti-tumor immunity in breast cancer New development in breast cancer therapy. III. Zoledronic acid and anti-tumor immunity in breast cancer Gan to kagaku ryoho. Cancer & chemotherapy, 36, 13, 2555-2559 Gan to kagaku ryoho. Cancer & chemotherapy, 36, 13, 2555-2559 Gan to kagaku ryoho. Cancer & chemotherapy, 36, 13, 2555-2559 2009 英語 公開
Mariko Muta, Tomonori Yanagawa, Yoshimichi Sai, Shigehira Saji, Eiji Suzuki, Tomoyuki Aruga, Katsumasa Kuroi, Gaku Matsumoto, Masakazu Toi, Emi Nakashima Mariko Muta, Tomonori Yanagawa, Yoshimichi Sai, Shigehira Saji, Eiji Suzuki, Tomoyuki Aruga, Katsumasa Kuroi, Gaku Matsumoto, Masakazu Toi, Emi Nakashima Mariko Muta, Tomonori Yanagawa, Yoshimichi Sai, Shigehira Saji, Eiji Suzuki, Tomoyuki Aruga, Katsumasa Kuroi, Gaku Matsumoto, Masakazu Toi, Emi Nakashima Effect of Low-Dose Paclitaxel and Docetaxel on Endothelial Progenitor Cells Effect of Low-Dose Paclitaxel and Docetaxel on Endothelial Progenitor Cells Effect of Low-Dose Paclitaxel and Docetaxel on Endothelial Progenitor Cells ONCOLOGY, 77, 3-4, 182-191 ONCOLOGY, 77, 3-4, 182-191 ONCOLOGY, 77, 3-4, 182-191 2009 英語 研究論文(学術雑誌) 公開
芳林 哲史, 石黒 洋, 戸井 雅和 芳林 哲史, 石黒 洋, 戸井 雅和 【補助化学療法】 乳がんに対する補助薬物療法 【補助化学療法】 乳がんに対する補助薬物療法 腫瘍内科, 2, 6, 500-509 腫瘍内科, 2, 6, 500-509 , 2, 6, 500-509 2008/12 公開
Takayoshi Kiba, Takashi Inamoto, Tsutomu Nishimura, Masaya Ueno, Kazuhiro Yanagihara, Satoshi Teramukai, Hironori Kato, Masakazu Toi, Masanori Fukushima Takayoshi Kiba, Takashi Inamoto, Tsutomu Nishimura, Masaya Ueno, Kazuhiro Yanagihara, Satoshi Teramukai, Hironori Kato, Masakazu Toi, Masanori Fukushima Takayoshi Kiba, Takashi Inamoto, Tsutomu Nishimura, Masaya Ueno, Kazuhiro Yanagihara, Satoshi Teramukai, Hironori Kato, Masakazu Toi, Masanori Fukushima The reversal of recurrence hazard rate between ER positive and negative breast cancer patients with axillary lymph node dissection (pathological stage I-III) 3 years after surgery The reversal of recurrence hazard rate between ER positive and negative breast cancer patients with axillary lymph node dissection (pathological stage I-III) 3 years after surgery The reversal of recurrence hazard rate between ER positive and negative breast cancer patients with axillary lymph node dissection (pathological stage I-III) 3 years after surgery BMC CANCER, 8 BMC CANCER, 8 BMC CANCER, 8 2008/11 英語 研究論文(学術雑誌) 公開
Masahide Kondo, Shu Ling Hoshi, Hiroshi Ishiguro, Hiroshi Yoshibayashi, Masakazu Toi Masahide Kondo, Shu Ling Hoshi, Hiroshi Ishiguro, Hiroshi Yoshibayashi, Masakazu Toi Masahide Kondo, Shu Ling Hoshi, Hiroshi Ishiguro, Hiroshi Yoshibayashi, Masakazu Toi Economic evaluation of 21-gene reverse transcriptase-polymerase chain reaction assay in lymph-node-negative, estrogen-receptor-positive, early-stage breast cancer in Japan Economic evaluation of 21-gene reverse transcriptase-polymerase chain reaction assay in lymph-node-negative, estrogen-receptor-positive, early-stage breast cancer in Japan Economic evaluation of 21-gene reverse transcriptase-polymerase chain reaction assay in lymph-node-negative, estrogen-receptor-positive, early-stage breast cancer in Japan BREAST CANCER RESEARCH AND TREATMENT, 112, 1, 175-187 BREAST CANCER RESEARCH AND TREATMENT, 112, 1, 175-187 BREAST CANCER RESEARCH AND TREATMENT, 112, 1, 175-187 2008/11 英語 研究論文(学術雑誌) 公開
N. Honma, S. Saji, R. Kurabayashi, J. Aida, T. Arai, R. Horii, F. Akiyama, T. Iwase, N. Harada, M. Younes, M. Toi, K. Takubo, G. Sakamoto N. Honma, S. Saji, R. Kurabayashi, J. Aida, T. Arai, R. Horii, F. Akiyama, T. Iwase, N. Harada, M. Younes, M. Toi, K. Takubo, G. Sakamoto Naoko Honma, Shigehira Saji, Rie Kurabayashi, Junko Aida, Tomio Arai, Rie Horii, Futoshi Akiyama, Takuji Iwase, Nobuhiro Harada, Mamoun Younes, Masakazu Toi, Kaiyo Takubo, Goi Sakamoto Oestrogen receptor-β1 but not oestrogen receptor-βcx is of prognostic value in apocrine carcinoma of the breast Oestrogen receptor-β1 but not oestrogen receptor-βcx is of prognostic value in apocrine carcinoma of the breast Oestrogen receptor-beta 1 but not oestrogen receptor-beta cx is of prognostic value in apocrine carcinoma of the breast APMIS, 116, 10, 923-930 APMIS, 116, 10, 923-930 APMIS, 116, 10, 923-930 2008/10 英語 研究論文(学術雑誌) 公開
Nahomi Tokudome, Yoshinori Ito, Kiyohiko Hatake, Masakazu Toi, Muneaki Sano, Hiroji Iwata, Yasuyuki Sato, Toshiaki Saeki, Kenjiro Aogi, Shigemitsu Takashima Nahomi Tokudome, Yoshinori Ito, Kiyohiko Hatake, Masakazu Toi, Muneaki Sano, Hiroji Iwata, Yasuyuki Sato, Toshiaki Saeki, Kenjiro Aogi, Shigemitsu Takashima Nahomi Tokudome, Yoshinori Ito, Kiyohiko Hatake, Masakazu Toi, Muneaki Sano, Hiroji Iwata, Yasuyuki Sato, Toshiaki Saeki, Kenjiro Aogi, Shigemitsu Takashima Trastuzumab and vinorelbine as first-line therapy for HER2-overexpressing metastatic breast cancer: multicenter phase II and pharmacokinetic study in Japan Trastuzumab and vinorelbine as first-line therapy for HER2-overexpressing metastatic breast cancer: multicenter phase II and pharmacokinetic study in Japan Trastuzumab and vinorelbine as first-line therapy for HER2-overexpressing metastatic breast cancer: multicenter phase II and pharmacokinetic study in Japan ANTI-CANCER DRUGS, 19, 7, 753-759 ANTI-CANCER DRUGS, 19, 7, 753-759 ANTI-CANCER DRUGS, 19, 7, 753-759 2008/08 英語 研究論文(学術雑誌) 公開
Masakazu Toi, Seigo Nakamura, Katsumasa Kuroi, Hiroji Iwata, Shinji Ohno, Norikazu Masuda, Mikihiro Kusama, Kosuke Yamazaki, Kazuhumi Hisamatsu, Yasuyuki Sato, Masahiro Kashiwaba, Hiroshi Kaise, Masafumi Kurosumi, Hitoshi Tsuda, Futoshi Akiyama, Yasuo Ohashi, Yuichi Takatsuka Masakazu Toi, Seigo Nakamura, Katsumasa Kuroi, Hiroji Iwata, Shinji Ohno, Norikazu Masuda, Mikihiro Kusama, Kosuke Yamazaki, Kazuhumi Hisamatsu, Yasuyuki Sato, Masahiro Kashiwaba, Hiroshi Kaise, Masafumi Kurosumi, Hitoshi Tsuda, Futoshi Akiyama, Yasuo Ohashi, Yuichi Takatsuka Masakazu Toi, Seigo Nakamura, Katsumasa Kuroi, Hiroji Iwata, Shinji Ohno, Norikazu Masuda, Mikihiro Kusama, Kosuke Yamazaki, Kazuhumi Hisamatsu, Yasuyuki Sato, Masahiro Kashiwaba, Hiroshi Kaise, Masafumi Kurosumi, Hitoshi Tsuda, Futoshi Akiyama, Yasuo Ohashi, Yuichi Takatsuka Phase II study of preoperative sequential FEC and docetaxel predicts of pathological response and disease free survival Phase II study of preoperative sequential FEC and docetaxel predicts of pathological response and disease free survival Phase II study of preoperative sequential FEC and docetaxel predicts of pathological response and disease free survival BREAST CANCER RESEARCH AND TREATMENT, 110, 3, 531-539 BREAST CANCER RESEARCH AND TREATMENT, 110, 3, 531-539 BREAST CANCER RESEARCH AND TREATMENT, 110, 3, 531-539 2008/08 英語 研究論文(学術雑誌) 公開
Louis Wing-Cheong Chow, Adrian Yun-San Yip, Wings Tjing-Yung Loo, Chi-Kei Lam, Masakazu Toi Louis Wing-Cheong Chow, Adrian Yun-San Yip, Wings Tjing-Yung Loo, Chi-Kei Lam, Masakazu Toi Louis Wing-Cheong Chow, Adrian Yun-San Yip, Wings Tjing-Yung Loo, Chi-Kei Lam, Masakazu Toi Celecoxib anti-aromatase neoadjuvant (CAAN) trial for locally advanced breast cancer Celecoxib anti-aromatase neoadjuvant (CAAN) trial for locally advanced breast cancer Celecoxib anti-aromatase neoadjuvant (CAAN) trial for locally advanced breast cancer JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 111, 1-2, 13-17 JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 111, 1-2, 13-17 JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 111, 1-2, 13-17 2008/07 英語 研究論文(学術雑誌) 公開
Hiroshi Yagata, Seigo Nakamura, Masakazu Toi, Hiroko Bando, Shinji Ohno, Akemi Kataoka Hiroshi Yagata, Seigo Nakamura, Masakazu Toi, Hiroko Bando, Shinji Ohno, Akemi Kataoka Hiroshi Yagata, Seigo Nakamura, Masakazu Toi, Hiroko Bando, Shinji Ohno, Akemi Kataoka Evaluation of circulating tumor cells in patients with breast cancer: multi-institutional clinical trial in Japan Evaluation of circulating tumor cells in patients with breast cancer: multi-institutional clinical trial in Japan Evaluation of circulating tumor cells in patients with breast cancer: multi-institutional clinical trial in Japan INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 13, 3, 252-256 INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 13, 3, 252-256 INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 13, 3, 252-256 2008/06 英語 研究論文(学術雑誌) 公開
H. Ishiguro, T. Kitano, H. Yoshibayashi, M. Toi, T. Ueno, H. Yasuda, K. Yanagihara, C. L. Garbo, M. Fukushima H. Ishiguro, T. Kitano, H. Yoshibayashi, M. Toi, T. Ueno, H. Yasuda, K. Yanagihara, C. L. Garbo, M. Fukushima H. Ishiguro, T. Kitano, H. Yoshibayashi, M. Toi, T. Ueno, H. Yasuda, K. Yanagihara, C. L. Garbo, M. Fukushima Prolonged neutropenia after dose-dense chemotherapy with pegfilgrastim Prolonged neutropenia after dose-dense chemotherapy with pegfilgrastim Prolonged neutropenia after dose-dense chemotherapy with pegfilgrastim ANNALS OF ONCOLOGY, 19, 5, 1019- ANNALS OF ONCOLOGY, 19, 5, 1019- ANNALS OF ONCOLOGY, 19, 5, 1019- 2008/05 英語 公開
山城 大泰, 石黒 洋, 戸井 雅和 山城 大泰, 石黒 洋, 戸井 雅和 【妊娠中に発見された悪性腫瘍の取り扱い】 妊娠中に発見される乳癌 【妊娠中に発見された悪性腫瘍の取り扱い】 妊娠中に発見される乳癌 産婦人科の実際, 57, 4, 669-675 産婦人科の実際, 57, 4, 669-675 , 57, 4, 669-675 2008/04 公開
Louis Wing-Cheong Chow, Adrian Yun-San Yip, Wings Tjing-Yung Loo, Masakazu Toi Louis Wing-Cheong Chow, Adrian Yun-San Yip, Wings Tjing-Yung Loo, Masakazu Toi Louis Wing-Cheong Chow, Adrian Yun-San Yip, Wings Tjing-Yung Loo, Masakazu Toi Evaluation of neoadjuvant inhibition of aromatase activity and signal transduction in breast cancer Evaluation of neoadjuvant inhibition of aromatase activity and signal transduction in breast cancer Evaluation of neoadjuvant inhibition of aromatase activity and signal transduction in breast cancer CANCER LETTERS, 262, 2, 232-238 CANCER LETTERS, 262, 2, 232-238 CANCER LETTERS, 262, 2, 232-238 2008/04 英語 研究論文(学術雑誌) 公開
Takayuki Ueno, Goran Elmberger, Timothy E. Weaver, Masakazu Toi, Stig Linder Takayuki Ueno, Goran Elmberger, Timothy E. Weaver, Masakazu Toi, Stig Linder Takayuki Ueno, Goran Elmberger, Timothy E. Weaver, Masakazu Toi, Stig Linder The aspartic protease napsin A suppresses tumor growth independent of its catalytic activity The aspartic protease napsin A suppresses tumor growth independent of its catalytic activity The aspartic protease napsin A suppresses tumor growth independent of its catalytic activity LABORATORY INVESTIGATION, 88, 3, 256-263 LABORATORY INVESTIGATION, 88, 3, 256-263 LABORATORY INVESTIGATION, 88, 3, 256-263 2008/03 英語 研究論文(学術雑誌) 公開
Hiroyasu Yamashiro, Masakazu Toi Hiroyasu Yamashiro, Masakazu Toi Hiroyasu Yamashiro, Masakazu Toi Update of evidence in chemotherapy for breast cancer Update of evidence in chemotherapy for breast cancer Update of evidence in chemotherapy for breast cancer INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 13, 1, 3-7 INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 13, 1, 3-7 INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 13, 1, 3-7 2008/02 英語 公開
M. Takada, H. Ishiguro, M. Toi M. Takada, H. Ishiguro, M. Toi M. Takada, H. Ishiguro, M. Toi Treatment for breast cancer and endocrine neoplasm Treatment for breast cancer and endocrine neoplasm Treatment for breast cancer and endocrine neoplasm Gan to kagaku ryoho. Cancer & chemotherapy, 35, 13, 2344-2350 Gan to kagaku ryoho. Cancer & chemotherapy, 35, 13, 2344-2350 Gan to kagaku ryoho. Cancer & chemotherapy, 35, 13, 2344-2350 2008 英語 公開
H. Yoshibayashi, H. Ishiguro, M. Takada, M. Takeuchi, H. Yamashiro, T. Ueno, H. Kato, K. Yoshikawa, S. Kanao, C. Yamauchi, Y. Mikami, M. Toi H. Yoshibayashi, H. Ishiguro, M. Takada, M. Takeuchi, H. Yamashiro, T. Ueno, H. Kato, K. Yoshikawa, S. Kanao, C. Yamauchi, Y. Mikami, M. Toi A case of primary breast cancer who responded remarkably to the neoadjuvant chemotherapy with the combination of docetaxel and cyclophosphamide A case of primary breast cancer who responded remarkably to the neoadjuvant chemotherapy with the combination of docetaxel and cyclophosphamide Gan to kagaku ryoho. Cancer & chemotherapy, 35, 6, 987-990 Gan to kagaku ryoho. Cancer & chemotherapy, 35, 6, 987-990 , 35, 6, 987-990 2008 日本語 公開
M. Toi M. Toi M. Toi Novel targeting therapy concept for breast cancer treatment Novel targeting therapy concept for breast cancer treatment Novel targeting therapy concept for breast cancer treatment Folia Pharmacologica Japonica, 132, 3, 177-179 Folia Pharmacologica Japonica, 132, 3, 177-179 Folia Pharmacologica Japonica, 132, 3, 177-179 2008 英語 公開
Shinzaburo Noguchi, Masakazu Toi Shinzaburo Noguchi, Masakazu Toi Shinzaburo Noguchi, Masakazu Toi Molecular target therapy: basics and clinical application Molecular target therapy: basics and clinical application Molecular target therapy: basics and clinical application BREAST CANCER, 15, 1, 47-48 BREAST CANCER, 15, 1, 47-48 BREAST CANCER, 15, 1, 47-48 2008/01 英語 研究論文(学術雑誌) 公開
Masakazu Toi Masakazu Toi Masakazu Toi Long-term outcomes of aromatase inhibition for breast cancer Long-term outcomes of aromatase inhibition for breast cancer Long-term outcomes of aromatase inhibition for breast cancer LANCET ONCOLOGY, 9, 1, 8-10 LANCET ONCOLOGY, 9, 1, 8-10 LANCET ONCOLOGY, 9, 1, 8-10 2008/01 英語 公開
Masakazu Toi, Tadashi Ikeda, Futoshi Akiyama, Masafumi Kurosumi, Hitoshi Tsuda, Goi Sakamoto, Osahiko Abe Masakazu Toi, Tadashi Ikeda, Futoshi Akiyama, Masafumi Kurosumi, Hitoshi Tsuda, Goi Sakamoto, Osahiko Abe Masakazu Toi, Tadashi Ikeda, Futoshi Akiyama, Masafumi Kurosumi, Hitoshi Tsuda, Goi Sakamoto, Osahiko Abe Predictive implications of nucleoside metabolizing enzymes in premenopausal women with node-positive primary breast cancer who were randomly assigned to receive tamoxifen alone or tamoxifen plus tegafur-uracil as adjuvant therapy Predictive implications of nucleoside metabolizing enzymes in premenopausal women with node-positive primary breast cancer who were randomly assigned to receive tamoxifen alone or tamoxifen plus tegafur-uracil as adjuvant therapy Predictive implications of nucleoside metabolizing enzymes in premenopausal women with node-positive primary breast cancer who were randomly assigned to receive tamoxifen alone or tamoxifen plus tegafur-uracil as adjuvant therapy INTERNATIONAL JOURNAL OF ONCOLOGY, 31, 4, 899-906 INTERNATIONAL JOURNAL OF ONCOLOGY, 31, 4, 899-906 INTERNATIONAL JOURNAL OF ONCOLOGY, 31, 4, 899-906 2007/10 英語 研究論文(学術雑誌) 公開
Md. Zahidunnabi Dewan, Hiroshi Terunuma, Masahiro Takada, Yuetsu Tanaka, Hiroyuki Abe, Tetsutaro Sata, Masakazu Toi, Naoki Yamamoto Md. Zahidunnabi Dewan, Hiroshi Terunuma, Masahiro Takada, Yuetsu Tanaka, Hiroyuki Abe, Tetsutaro Sata, Masakazu Toi, Naoki Yamamoto Md. Zahidunnabi Dewan, Hiroshi Terunuma, Masahiro Takada, Yuetsu Tanaka, Hiroyuki Abe, Tetsutaro Sata, Masakazu Toi, Naoki Yamamoto Role of natural killer cells in hormone-independent rapid tumor formation and spontaneous metastasis of breast cancer cells in vivo Role of natural killer cells in hormone-independent rapid tumor formation and spontaneous metastasis of breast cancer cells in vivo Role of natural killer cells in hormone-independent rapid tumor formation and spontaneous metastasis of breast cancer cells in vivo BREAST CANCER RESEARCH AND TREATMENT, 104, 3, 267-275 BREAST CANCER RESEARCH AND TREATMENT, 104, 3, 267-275 BREAST CANCER RESEARCH AND TREATMENT, 104, 3, 267-275 2007/09 英語 研究論文(学術雑誌) 公開
Maria Hagg Olofsson, Takayuki Ueno, Yang Pan, Ren Xu, Feng Cai, Heiko van der Kuip, Thomas E. Muerdter, Maike Sonnenberg, Walter E. Aulitzk, Stephan Schwarz, Elina Andersson, Maria C. Shoshan, Aleksandra Mandic Havelka, Masakozu Toi, Stig Linder Maria Hagg Olofsson, Takayuki Ueno, Yang Pan, Ren Xu, Feng Cai, Heiko van der Kuip, Thomas E. Muerdter, Maike Sonnenberg, Walter E. Aulitzk, Stephan Schwarz, Elina Andersson, Maria C. Shoshan, Aleksandra Mandic Havelka, Masakozu Toi, Stig Linder Maria Hagg Olofsson, Takayuki Ueno, Yang Pan, Ren Xu, Feng Cai, Heiko van der Kuip, Thomas E. Muerdter, Maike Sonnenberg, Walter E. Aulitzk, Stephan Schwarz, Elina Andersson, Maria C. Shoshan, Aleksandra Mandic Havelka, Masakozu Toi, Stig Linder Cytokeratin-18 is a useful serum biomarker for early determination of response of breast carcinomas to chemotherapy Cytokeratin-18 is a useful serum biomarker for early determination of response of breast carcinomas to chemotherapy Cytokeratin-18 is a useful serum biomarker for early determination of response of breast carcinomas to chemotherapy CLINICAL CANCER RESEARCH, 13, 11, 3198-3206 CLINICAL CANCER RESEARCH, 13, 11, 3198-3206 CLINICAL CANCER RESEARCH, 13, 11, 3198-3206 2007/06 英語 研究論文(学術雑誌) 公開
Eiji Suzuki, Masakazu Toi Eiji Suzuki, Masakazu Toi Eiji Suzuki, Masakazu Toi Improving the efficacy of trastuzumab in breast cancer Improving the efficacy of trastuzumab in breast cancer Improving the efficacy of trastuzumab in breast cancer CANCER SCIENCE, 98, 6, 767-771 CANCER SCIENCE, 98, 6, 767-771 CANCER SCIENCE, 98, 6, 767-771 2007/06 英語 公開
Eiji Suzuki, Rinpei Niwa, Shigehira Saji, Mariko Muta, Makiko Hirose, Shigeru Iida, Yukimasa Shiotsu, Mitsuo Satoh, Kenya Shitara, Masahide Kondo, Masakazu Toi Eiji Suzuki, Rinpei Niwa, Shigehira Saji, Mariko Muta, Makiko Hirose, Shigeru Iida, Yukimasa Shiotsu, Mitsuo Satoh, Kenya Shitara, Masahide Kondo, Masakazu Toi Eiji Suzuki, Rinpei Niwa, Shigehira Saji, Mariko Muta, Makiko Hirose, Shigeru Iida, Yukimasa Shiotsu, Mitsuo Satoh, Kenya Shitara, Masahide Kondo, Masakazu Toi A nonfucosylated anti-HER2 antibody augments antibody-dependent cellular cytotoxicity in breast cancer patients A nonfucosylated anti-HER2 antibody augments antibody-dependent cellular cytotoxicity in breast cancer patients A nonfucosylated anti-HER2 antibody augments antibody-dependent cellular cytotoxicity in breast cancer patients CLINICAL CANCER RESEARCH, 13, 6, 1875-1882 CLINICAL CANCER RESEARCH, 13, 6, 1875-1882 CLINICAL CANCER RESEARCH, 13, 6, 1875-1882 2007/03 英語 研究論文(学術雑誌) 公開
Tatsuro Yamaguchi, Hiroko Bando, Takeo Mori, Keiichi Takahashi, Hiroshi Matsumoto, Michiya Yasutome, Herbert A. Weich, Masakazu Toi Tatsuro Yamaguchi, Hiroko Bando, Takeo Mori, Keiichi Takahashi, Hiroshi Matsumoto, Michiya Yasutome, Herbert A. Weich, Masakazu Toi Tatsuro Yamaguchi, Hiroko Bando, Takeo Mori, Keiichi Takahashi, Hiroshi Matsumoto, Michiya Yasutome, Herbert A. Weich, Masakazu Toi Overexpression of soluble vascular endothelial growth factor receptor 1 in colorectal cancer: Association with progression and prognosis Overexpression of soluble vascular endothelial growth factor receptor 1 in colorectal cancer: Association with progression and prognosis Overexpression of soluble vascular endothelial growth factor receptor 1 in colorectal cancer: Association with progression and prognosis CANCER SCIENCE, 98, 3, 405-410 CANCER SCIENCE, 98, 3, 405-410 CANCER SCIENCE, 98, 3, 405-410 2007/03 英語 研究論文(学術雑誌) 公開
Toshiaki Saeki, Tadashi Nomizu, Masakazu Toi, Yoshinori Ito, Shinzaburo Noguchi, Tadashi Kobayashi, Taro Asaga, Hironobu Minami, Naohito Yamamoto, Kenjiro Aogi, Tadashi Ikeda, Yasuo Ohashi, Wakao Sato, Takashi Tsuruo Toshiaki Saeki, Tadashi Nomizu, Masakazu Toi, Yoshinori Ito, Shinzaburo Noguchi, Tadashi Kobayashi, Taro Asaga, Hironobu Minami, Naohito Yamamoto, Kenjiro Aogi, Tadashi Ikeda, Yasuo Ohashi, Wakao Sato, Takashi Tsuruo Toshiaki Saeki, Tadashi Nomizu, Masakazu Toi, Yoshinori Ito, Shinzaburo Noguchi, Tadashi Kobayashi, Taro Asaga, Hironobu Minami, Naohito Yamamoto, Kenjiro Aogi, Tadashi Ikeda, Yasuo Ohashi, Wakao Sato, Takashi Tsuruo Dofequidar fumarate (MS-209) in combination with cyclophosphamide, doxorubicin, and fluorouracil for patients with advanced or recurrent breast cancer Dofequidar fumarate (MS-209) in combination with cyclophosphamide, doxorubicin, and fluorouracil for patients with advanced or recurrent breast cancer Dofequidar fumarate (MS-209) in combination with cyclophosphamide, doxorubicin, and fluorouracil for patients with advanced or recurrent breast cancer JOURNAL OF CLINICAL ONCOLOGY, 25, 4, 411-417 JOURNAL OF CLINICAL ONCOLOGY, 25, 4, 411-417 JOURNAL OF CLINICAL ONCOLOGY, 25, 4, 411-417 2007/02 英語 研究論文(学術雑誌) 公開
Tsutomu Oikawa, Chizuko Onozawa, Sachi Kuranuki, Yasuhiro Igarashi, Mayumi Sato, Hiromi Ashino, Mariko Shimamura, Masakazu Toi, Shinichi Kurakata Tsutomu Oikawa, Chizuko Onozawa, Sachi Kuranuki, Yasuhiro Igarashi, Mayumi Sato, Hiromi Ashino, Mariko Shimamura, Masakazu Toi, Shinichi Kurakata Tsutomu Oikawa, Chizuko Onozawa, Sachi Kuranuki, Yasuhiro Igarashi, Mayumi Sato, Hiromi Ashino, Mariko Shimamura, Masakazu Toi, Shinichi Kurakata Dipalmitoylation of radicicol results in improved efficacy against tumor growth and angiogenesis in vivo Dipalmitoylation of radicicol results in improved efficacy against tumor growth and angiogenesis in vivo Dipalmitoylation of radicicol results in improved efficacy against tumor growth and angiogenesis in vivo CANCER SCIENCE, 98, 2, 219-225 CANCER SCIENCE, 98, 2, 219-225 CANCER SCIENCE, 98, 2, 219-225 2007/02 英語 研究論文(学術雑誌) 公開
Shigehira Saji, Masakazu Toi, Satoshi Morita, Hiroji Iwata, Yoshinori Ito, Shinji Ohno, Tadashi Kobayashi, Yasuo Hozumi, Junichi Sakamoto Shigehira Saji, Masakazu Toi, Satoshi Morita, Hiroji Iwata, Yoshinori Ito, Shinji Ohno, Tadashi Kobayashi, Yasuo Hozumi, Junichi Sakamoto Shigehira Saji, Masakazu Toi, Satoshi Morita, Hiroji Iwata, Yoshinori Ito, Shinji Ohno, Tadashi Kobayashi, Yasuo Hozumi, Junichi Sakamoto Dose-finding phase I and pharmacokinetic study of capecitabine (xeloda) in combination with epirubicin and cyclophosphamide (CEX) in patients with inoperable or metastatic breast cancer Dose-finding phase I and pharmacokinetic study of capecitabine (xeloda) in combination with epirubicin and cyclophosphamide (CEX) in patients with inoperable or metastatic breast cancer Dose-finding phase I and pharmacokinetic study of capecitabine (xeloda) in combination with epirubicin and cyclophosphamide (CEX) in patients with inoperable or metastatic breast cancer ONCOLOGY, 72, 5-6, 330-337 ONCOLOGY, 72, 5-6, 330-337 ONCOLOGY, 72, 5-6, 330-337 2007 英語 研究論文(学術雑誌) 公開
M. Takada, M. Toi M. Takada, M. Toi Primary systemic chemotherapy for breast cancer Primary systemic chemotherapy for breast cancer Gan to kagaku ryoho. Cancer & chemotherapy, 34, 11, 1730-1734 Gan to kagaku ryoho. Cancer & chemotherapy, 34, 11, 1730-1734 , 34, 11, 1730-1734 2007 日本語 公開
N. Masuda, M. Toi, Y. Takatsuka, S. Nakamura, H. Iwata, S. Ohno, K. Kuroi, M. Kusama, K. Hisamatsu, K. Yamazaki, S. Eisei, Y. Sato, H. Kaise, M. Kashiwaba, H. Iwase, M. Kurosumi, H. Tsuda, F. Akiyama N. Masuda, M. Toi, Y. Takatsuka, S. Nakamura, H. Iwata, S. Ohno, K. Kuroi, M. Kusama, K. Hisamatsu, K. Yamazaki, S. Eisei, Y. Sato, H. Kaise, M. Kashiwaba, H. Iwase, M. Kurosumi, H. Tsuda, F. Akiyama N. Masuda, M. Toi, Y. Takatsuka, S. Nakamura, H. Iwata, S. Ohno, K. Kuroi, M. Kusama, K. Hisamatsu, K. Yamazaki, S. Eisei, Y. Sato, H. Kaise, M. Kashiwaba, H. Iwase, M. Kurosumi, H. Tsuda, F. Akiyama Results of survey conducted on perioperative chemotherapy and supportive care in primary breast cancer (JBCRG01) Results of survey conducted on perioperative chemotherapy and supportive care in primary breast cancer (JBCRG01) Results of survey conducted on perioperative chemotherapy and supportive care in primary breast cancer (JBCRG01) Gan to kagaku ryoho. Cancer & chemotherapy, 34, 10, 1609-1615 Gan to kagaku ryoho. Cancer & chemotherapy, 34, 10, 1609-1615 Gan to kagaku ryoho. Cancer & chemotherapy, 34, 10, 1609-1615 2007 英語 公開
Satoshi Morita, Masakazu Toi, Shigehira Saji, Hiroji Iwata, Shinji Ohno, Yoshinori Ito, Tadashi Kobayashi, Yasuo Hozumi, Junichi Sakamoto Satoshi Morita, Masakazu Toi, Shigehira Saji, Hiroji Iwata, Shinji Ohno, Yoshinori Ito, Tadashi Kobayashi, Yasuo Hozumi, Junichi Sakamoto Satoshi Morita, Masakazu Toi, Shigehira Saji, Hiroji Iwata, Shinji Ohno, Yoshinori Ito, Tadashi Kobayashi, Yasuo Hozumi, Junichi Sakamoto Practical application of the continual reassessment method to a phase I dose-finding trial in advanced breast cancer Practical application of the continual reassessment method to a phase I dose-finding trial in advanced breast cancer Practical application of the continual reassessment method to a phase I dose-finding trial in advanced breast cancer DRUG INFORMATION JOURNAL, 41, 6, 691-700 DRUG INFORMATION JOURNAL, 41, 6, 691-700 DRUG INFORMATION JOURNAL, 41, 6, 691-700 2007 英語 研究論文(学術雑誌) 公開
Gottfried E. Konecny Gottfried E. Konecny Gottfried E. Konecny Lapatinib - Viewpoint Lapatinib - Viewpoint Lapatinib - Viewpoint DRUGS, 67, 14, 2109-2110 DRUGS, 67, 14, 2109-2110 DRUGS, 67, 14, 2109-2110 2007 英語 公開
H. Yamashiro, M. Toi H. Yamashiro, M. Toi Herceptin (trastuzumab) Herceptin (trastuzumab) Gan to kagaku ryoho. Cancer & chemotherapy, 34, 8, 1173-1176 Gan to kagaku ryoho. Cancer & chemotherapy, 34, 8, 1173-1176 , 34, 8, 1173-1176 2007 日本語 公開
D. Kitagawa, M. Toi D. Kitagawa, M. Toi D. Kitagawa, M. Toi Current status and the perspective of treatment strategy for the patients with advanced or recurrent breast cancer Current status and the perspective of treatment strategy for the patients with advanced or recurrent breast cancer Current status and the perspective of treatment strategy for the patients with advanced or recurrent breast cancer Nippon rinsho. Japanese journal of clinical medicine, 65 Suppl 6, 396-401 Nippon rinsho. Japanese journal of clinical medicine, 65 Suppl 6, 396-401 Nippon rinsho. Japanese journal of clinical medicine, 65 Suppl 6, 396-401 2007 英語 公開
Masakazu Toi Masakazu Toi Masakazu Toi What does DNA methylation surrogate? What does DNA methylation surrogate? What does DNA methylation surrogate? DIGESTION, 75, 1, 53-53 DIGESTION, 75, 1, 53-53 DIGESTION, 75, 1, 53-53 2007 英語 公開
Md. Zahidunnabi Dewan, Hiroshi Terunuma, Masakazu Toi, Yuetsu Tanaka, Harutaka Katano, Xuewen Deng, Hiroyuki Abe, Tadashi Nakasone, Naoki Mori, Tetsutaro Sata, Naoki Yamamoto Md. Zahidunnabi Dewan, Hiroshi Terunuma, Masakazu Toi, Yuetsu Tanaka, Harutaka Katano, Xuewen Deng, Hiroyuki Abe, Tadashi Nakasone, Naoki Mori, Tetsutaro Sata, Naoki Yamamoto Md. Zahidunnabi Dewan, Hiroshi Terunuma, Masakazu Toi, Yuetsu Tanaka, Harutaka Katano, Xuewen Deng, Hiroyuki Abe, Tadashi Nakasone, Naoki Mori, Tetsutaro Sata, Naoki Yamamoto Potential role of natural killer cells in controlling growth and infiltration of AIDS-associated primary effusion lymphoma cells Potential role of natural killer cells in controlling growth and infiltration of AIDS-associated primary effusion lymphoma cells Potential role of natural killer cells in controlling growth and infiltration of AIDS-associated primary effusion lymphoma cells CANCER SCIENCE, 97, 12, 1381-1387 CANCER SCIENCE, 97, 12, 1381-1387 CANCER SCIENCE, 97, 12, 1381-1387 2006/12 英語 研究論文(学術雑誌) 公開
Yukihiro Asami, Hideaki Kakeya, Gen Okada, Masakazu Toi, Hiroyuki Osada Yukihiro Asami, Hideaki Kakeya, Gen Okada, Masakazu Toi, Hiroyuki Osada Yukihiro Asami, Hideaki Kakeya, Gen Okada, Masakazu Toi, Hiroyuki Osada RK-95113, a new angiogenesis inhibitor produced by Aspergillus fumigatus RK-95113, a new angiogenesis inhibitor produced by Aspergillus fumigatus RK-95113, a new angiogenesis inhibitor produced by Aspergillus fumigatus JOURNAL OF ANTIBIOTICS, 59, 11, 724-728 JOURNAL OF ANTIBIOTICS, 59, 11, 724-728 JOURNAL OF ANTIBIOTICS, 59, 11, 724-728 2006/11 英語 研究論文(学術雑誌) 公開
T. Ueno, L.W.C. Chow, M. Toi T. Ueno, L.W.C. Chow, M. Toi T. Ueno, L. W. C. Chow, M. Toi Increases in circulating VEGF levels during COX-2 inhibitor treatment in breast cancer patients Increases in circulating VEGF levels during COX-2 inhibitor treatment in breast cancer patients Increases in circulating VEGF levels during COX-2 inhibitor treatment in breast cancer patients Biomedicine and Pharmacotherapy, 60, 6, 277-279 Biomedicine and Pharmacotherapy, 60, 6, 277-279 BIOMEDICINE & PHARMACOTHERAPY, 60, 6, 277-279 2006/07 英語 研究論文(学術雑誌) 公開
M.Z. Dewan, S. Ahmed, Y. Iwasaki, K. Ohba, M. Toi, N. Yamamoto M.Z. Dewan, S. Ahmed, Y. Iwasaki, K. Ohba, M. Toi, N. Yamamoto M. Z. Dewan, S. Ahmed, Y. Iwasaki, K. Ohba, M. Toi, N. Yamamoto Stromal cell-derived factor-1 and CXCR4 receptor interaction in tumor growth and metastasis of breast cancer Stromal cell-derived factor-1 and CXCR4 receptor interaction in tumor growth and metastasis of breast cancer Stromal cell-derived factor-1 and CXCR4 receptor interaction in tumor growth and metastasis of breast cancer Biomedicine and Pharmacotherapy, 60, 6, 273-276 Biomedicine and Pharmacotherapy, 60, 6, 273-276 BIOMEDICINE & PHARMACOTHERAPY, 60, 6, 273-276 2006/07 英語 公開
H Bando, HA Weich, S Horiguchi, N Funata, T Ogawa, M Toi H Bando, HA Weich, S Horiguchi, N Funata, T Ogawa, M Toi H Bando, HA Weich, S Horiguchi, N Funata, T Ogawa, M Toi The association between vascular endothelial growth factor-C, its corresponding receptor, VEGFR-3, and prognosis in primary breast cancer: A study with 193 cases The association between vascular endothelial growth factor-C, its corresponding receptor, VEGFR-3, and prognosis in primary breast cancer: A study with 193 cases The association between vascular endothelial growth factor-C, its corresponding receptor, VEGFR-3, and prognosis in primary breast cancer: A study with 193 cases ONCOLOGY REPORTS, 15, 3, 653-659 ONCOLOGY REPORTS, 15, 3, 653-659 ONCOLOGY REPORTS, 15, 3, 653-659 2006/03 英語 研究論文(学術雑誌) 公開
Masahide Kondo, Masakazu Toi Masahide Kondo, Masakazu Toi Masahide Kondo, Masakazu Toi Cost-effective treatment options in first-line therapy for advanced breast cancer in Japan Cost-effective treatment options in first-line therapy for advanced breast cancer in Japan Cost-effective treatment options in first-line therapy for advanced breast cancer in Japan EXPERT REVIEW OF ANTICANCER THERAPY, 6, 2, 197-204 EXPERT REVIEW OF ANTICANCER THERAPY, 6, 2, 197-204 EXPERT REVIEW OF ANTICANCER THERAPY, 6, 2, 197-204 2006/02 英語 公開
M. Toi, Y. Iino M. Toi, Y. Iino M. Toi, Y. Iino Who benefits from hormone therapy? Who benefits from hormone therapy? Who benefits from hormone therapy? Breast cancer (Tokyo, Japan), 13, 2, 117-122 Breast cancer (Tokyo, Japan), 13, 2, 117-122 Breast cancer (Tokyo, Japan), 13, 2, 117-122 2006 英語 公開
E. Suzuki, M. Toi E. Suzuki, M. Toi E. Suzuki, M. Toi Neoadjuvant Chemotherapy in breast cancer Neoadjuvant Chemotherapy in breast cancer Neoadjuvant Chemotherapy in breast cancer Nippon rinsho. Japanese journal of clinical medicine, 64, 3, 536-539 Nippon rinsho. Japanese journal of clinical medicine, 64, 3, 536-539 Nippon rinsho. Japanese journal of clinical medicine, 64, 3, 536-539 2006 英語 公開
K. Kuroi, M. Toi, H. Tsuda, M. Kurosumi, F. Akiyama K. Kuroi, M. Toi, H. Tsuda, M. Kurosumi, F. Akiyama K. Kuroi, M. Toi, H. Tsuda, M. Kurosumi, F. Akiyama Issues in the assessment of the pathologic effect of primary systemic therapy for breast cancer. Issues in the assessment of the pathologic effect of primary systemic therapy for breast cancer. Issues in the assessment of the pathologic effect of primary systemic therapy for breast cancer. Breast cancer (Tokyo, Japan), 13, 1, 38-48 Breast cancer (Tokyo, Japan), 13, 1, 38-48 Breast cancer (Tokyo, Japan), 13, 1, 38-48 2006 英語 公開
T. Saeki, T. Kimura, M. Toi, T. Taguchi T. Saeki, T. Kimura, M. Toi, T. Taguchi T. Saeki, T. Kimura, M. Toi, T. Taguchi A pilot phase II study of capecitabine in advanced or recurrent breast cancer. A pilot phase II study of capecitabine in advanced or recurrent breast cancer. A pilot phase II study of capecitabine in advanced or recurrent breast cancer. Breast cancer (Tokyo, Japan), 13, 1, 49-57 Breast cancer (Tokyo, Japan), 13, 1, 49-57 Breast cancer (Tokyo, Japan), 13, 1, 49-57 2006 英語 公開
T. Suzuki, M. Toi, S. Saji, K. Horiguchi, T. Aruga, E. Suzuki, S. Horiguchi, N. Funata, K. Karasawa, N. Kamata T. Suzuki, M. Toi, S. Saji, K. Horiguchi, T. Aruga, E. Suzuki, S. Horiguchi, N. Funata, K. Karasawa, N. Kamata T. Suzuki, M. Toi, S. Saji, K. Horiguchi, T. Aruga, E. Suzuki, S. Horiguchi, N. Funata, K. Karasawa, N. Kamata Early breast cancer Early breast cancer Early breast cancer International Journal of Clinical Oncology, 11, 2, 108-119 International Journal of Clinical Oncology, 11, 2, 108-119 International Journal of Clinical Oncology, 11, 2, 108-119 2006 英語 公開
M Muta, G Matsumoto, E Nakashima, M Toi M Muta, G Matsumoto, E Nakashima, M Toi M Muta, G Matsumoto, E Nakashima, M Toi Mechanical analysis of tumor growth regression by the cyclooxygenase-2 inhibitor, DFU, in a Walker256 rat tumor model: Importance of monocyte chemoattractant protein-1 modulation Mechanical analysis of tumor growth regression by the cyclooxygenase-2 inhibitor, DFU, in a Walker256 rat tumor model: Importance of monocyte chemoattractant protein-1 modulation Mechanical analysis of tumor growth regression by the cyclooxygenase-2 inhibitor, DFU, in a Walker256 rat tumor model: Importance of monocyte chemoattractant protein-1 modulation CLINICAL CANCER RESEARCH, 12, 1, 264-272 CLINICAL CANCER RESEARCH, 12, 1, 264-272 CLINICAL CANCER RESEARCH, 12, 1, 264-272 2006/01 英語 研究論文(学術雑誌) 公開
MZ Dewan, J Uchihara, K Terashima, M Honda, T Sata, M Ito, N Fujii, K Uozumi, K Tsukasaki, M Tomonaga, Y Kubuki, A Okayama, M Toi, N Mori, N Yamamoto MZ Dewan, J Uchihara, K Terashima, M Honda, T Sata, M Ito, N Fujii, K Uozumi, K Tsukasaki, M Tomonaga, Y Kubuki, A Okayama, M Toi, N Mori, N Yamamoto MZ Dewan, J Uchihara, K Terashima, M Honda, T Sata, M Ito, N Fujii, K Uozumi, K Tsukasaki, M Tomonaga, Y Kubuki, A Okayama, M Toi, N Mori, N Yamamoto Efficient intervention of growth and infiltration of primary adult T-cell leukemia cells by an HIV protease inhibitor, ritonavir Efficient intervention of growth and infiltration of primary adult T-cell leukemia cells by an HIV protease inhibitor, ritonavir Efficient intervention of growth and infiltration of primary adult T-cell leukemia cells by an HIV protease inhibitor, ritonavir BLOOD, 107, 2, 716-724 BLOOD, 107, 2, 716-724 BLOOD, 107, 2, 716-724 2006/01 英語 研究論文(学術雑誌) 公開
G. Matsumoto, M. Muta, K. Umezawa, T. Suzuki, K. Misumi, K. Tsuruta, A. Okamoto, M. Toi G. Matsumoto, M. Muta, K. Umezawa, T. Suzuki, K. Misumi, K. Tsuruta, A. Okamoto, M. Toi G Matsumoto, M Muta, K Umezawa, T Suzuki, K Misumi, K Tsuruta, A Okamoto, M Toi Enhancement of the caspase-independent apoptotic sensitivity of pancreatic cancer cells by DHMEQ, an NF-κB inhibitor Enhancement of the caspase-independent apoptotic sensitivity of pancreatic cancer cells by DHMEQ, an NF-κB inhibitor Enhancement of the caspase-independent apoptotic sensitivity of pancreatic cancer cells by DHMEQ, an NF-kappa B inhibitor International Journal of Oncology, 27, 5, 1247-1255 International Journal of Oncology, 27, 5, 1247-1255 INTERNATIONAL JOURNAL OF ONCOLOGY, 27, 5, 1247-1255 2005/11 英語 研究論文(学術雑誌) 公開
M Toi, K Horiguchi, H Bando, S Shigehira, LWC Chow M Toi, K Horiguchi, H Bando, S Shigehira, LWC Chow M Toi, K Horiguchi, H Bando, S Shigehira, LWC Chow Trastuzumab: updates and future issues Trastuzumab: updates and future issues Trastuzumab: updates and future issues CANCER CHEMOTHERAPY AND PHARMACOLOGY, 56, SUPPL. 7, S94-S99 CANCER CHEMOTHERAPY AND PHARMACOLOGY, 56, SUPPL. 7, S94-S99 CANCER CHEMOTHERAPY AND PHARMACOLOGY, 56, SUPPL. 7, S94-S99 2005/11 英語 研究論文(学術雑誌) 公開
S. Saji, M. Hirose, M. Toi S. Saji, M. Hirose, M. Toi S Saji, M Hirose, M Toi Clinical significance of estrogen receptor β in breast cancer Clinical significance of estrogen receptor β in breast cancer Clinical significance of estrogen receptor beta in breast cancer Cancer Chemotherapy and Pharmacology, 56, SUPPL. 7, S21-S26 Cancer Chemotherapy and Pharmacology, 56, SUPPL. 7, S21-S26 CANCER CHEMOTHERAPY AND PHARMACOLOGY, 56, SUPPL. 7, S21-S26 2005/11 英語 研究論文(学術雑誌) 公開
G Gasparini, R Longo, M Toi, N Ferrara G Gasparini, R Longo, M Toi, N Ferrara G Gasparini, R Longo, M Toi, N Ferrara Angiogenic inhibitors: a new therapeutic strategy in oncology Angiogenic inhibitors: a new therapeutic strategy in oncology Angiogenic inhibitors: a new therapeutic strategy in oncology NATURE CLINICAL PRACTICE ONCOLOGY, 2, 11, 562-577 NATURE CLINICAL PRACTICE ONCOLOGY, 2, 11, 562-577 NATURE CLINICAL PRACTICE ONCOLOGY, 2, 11, 562-577 2005/11 英語 公開
LWC Chow, WTY Loo, M Toi LWC Chow, WTY Loo, M Toi LWC Chow, WTY Loo, M Toi Current directions for COX-2 inhibition in breast cancer Current directions for COX-2 inhibition in breast cancer Current directions for COX-2 inhibition in breast cancer BIOMEDICINE & PHARMACOTHERAPY, 59, SUPPL. 2, S281-S284 BIOMEDICINE & PHARMACOTHERAPY, 59, SUPPL. 2, S281-S284 BIOMEDICINE & PHARMACOTHERAPY, 59, SUPPL. 2, S281-S284 2005/10 英語 研究論文(学術雑誌) 公開
M Toi, H Bando, HA Weich M Toi, H Bando, HA Weich M Toi, H Bando, HA Weich Vascular endothelial growth factor and its relationships with endogenous inhibitors in a breast cancer microenvironment manipulated by hormonal therapy: a hypothetical consideration Vascular endothelial growth factor and its relationships with endogenous inhibitors in a breast cancer microenvironment manipulated by hormonal therapy: a hypothetical consideration Vascular endothelial growth factor and its relationships with endogenous inhibitors in a breast cancer microenvironment manipulated by hormonal therapy: a hypothetical consideration BIOMEDICINE & PHARMACOTHERAPY, 59, SUPPL. 2, S344-S347 BIOMEDICINE & PHARMACOTHERAPY, 59, SUPPL. 2, S344-S347 BIOMEDICINE & PHARMACOTHERAPY, 59, SUPPL. 2, S344-S347 2005/10 英語 研究論文(学術雑誌) 公開
LWC Chow, M Toi LWC Chow, M Toi LWC Chow, M Toi Translational research in oncology comes timely Translational research in oncology comes timely Translational research in oncology comes timely BIOMEDICINE & PHARMACOTHERAPY, 59, SUPPL. 2, S263-S263 BIOMEDICINE & PHARMACOTHERAPY, 59, SUPPL. 2, S263-S263 BIOMEDICINE & PHARMACOTHERAPY, 59, SUPPL. 2, S263-S263 2005/10 英語 公開
K Kuroi, M Toi, H Tsuda, M Kurosumi, F Akiyama K Kuroi, M Toi, H Tsuda, M Kurosumi, F Akiyama K Kuroi, M Toi, H Tsuda, M Kurosumi, F Akiyama Unargued issues on the pathological assessment of response in primary systemic therapy for breast cancer Unargued issues on the pathological assessment of response in primary systemic therapy for breast cancer Unargued issues on the pathological assessment of response in primary systemic therapy for breast cancer BIOMEDICINE & PHARMACOTHERAPY, 59, SUPPL. 2, S387-S392 BIOMEDICINE & PHARMACOTHERAPY, 59, SUPPL. 2, S387-S392 BIOMEDICINE & PHARMACOTHERAPY, 59, SUPPL. 2, S387-S392 2005/10 英語 研究論文(学術雑誌) 公開
LWC Chow, CWL Cheng, JLN Wong, M Toi LWC Chow, CWL Cheng, JLN Wong, M Toi LWC Chow, CWL Cheng, JLN Wong, M Toi Serum lipid profiles in patients receiving endocrine treatment for breast cancer - the results from the Celecoxib Anti-Aromatase Neoadjuvant (CAAN) Trial Serum lipid profiles in patients receiving endocrine treatment for breast cancer - the results from the Celecoxib Anti-Aromatase Neoadjuvant (CAAN) Trial Serum lipid profiles in patients receiving endocrine treatment for breast cancer - the results from the Celecoxib Anti-Aromatase Neoadjuvant (CAAN) Trial BIOMEDICINE & PHARMACOTHERAPY, 59, SUPPL. 2, S302-S305 BIOMEDICINE & PHARMACOTHERAPY, 59, SUPPL. 2, S302-S305 BIOMEDICINE & PHARMACOTHERAPY, 59, SUPPL. 2, S302-S305 2005/10 英語 研究論文(学術雑誌) 公開
T Ueno, M Toi, S Linder T Ueno, M Toi, S Linder T Ueno, M Toi, S Linder Detection of epithelial cell death in the body by cytokeratin 18 measurement Detection of epithelial cell death in the body by cytokeratin 18 measurement Detection of epithelial cell death in the body by cytokeratin 18 measurement BIOMEDICINE & PHARMACOTHERAPY, 59, SUPPL. 2, S359-S362 BIOMEDICINE & PHARMACOTHERAPY, 59, SUPPL. 2, S359-S362 BIOMEDICINE & PHARMACOTHERAPY, 59, SUPPL. 2, S359-S362 2005/10 英語 研究論文(学術雑誌) 公開
LWC Chow, WTY Loo, CCY Wai, ELH Lui, L Zhu, M Toi LWC Chow, WTY Loo, CCY Wai, ELH Lui, L Zhu, M Toi LWC Chow, WTY Loo, CCY Wai, ELH Lui, L Zhu, M Toi Study of COX-2, Ki67, and p53 expression to predict effectiveness of 5-flurouracil, epirubicin and cyclophosphamide with celecoxib treatment in breast cancer patients Study of COX-2, Ki67, and p53 expression to predict effectiveness of 5-flurouracil, epirubicin and cyclophosphamide with celecoxib treatment in breast cancer patients Study of COX-2, Ki67, and p53 expression to predict effectiveness of 5-flurouracil, epirubicin and cyclophosphamide with celecoxib treatment in breast cancer patients BIOMEDICINE & PHARMACOTHERAPY, 59, SUPPL. 2, S298-S301 BIOMEDICINE & PHARMACOTHERAPY, 59, SUPPL. 2, S298-S301 BIOMEDICINE & PHARMACOTHERAPY, 59, SUPPL. 2, S298-S301 2005/10 英語 研究論文(学術雑誌) 公開
MZ Dewan, H Terunuma, S Ahmed, K Ohba, M Takada, Y Tanaka, M Toi, N Yamamoto MZ Dewan, H Terunuma, S Ahmed, K Ohba, M Takada, Y Tanaka, M Toi, N Yamamoto MZ Dewan, H Terunuma, S Ahmed, K Ohba, M Takada, Y Tanaka, M Toi, N Yamamoto Natural killer cells in breast cancer cell growth and metastasis in SCID mice Natural killer cells in breast cancer cell growth and metastasis in SCID mice Natural killer cells in breast cancer cell growth and metastasis in SCID mice BIOMEDICINE & PHARMACOTHERAPY, 59, SUPPL. 2, S375-S379 BIOMEDICINE & PHARMACOTHERAPY, 59, SUPPL. 2, S375-S379 BIOMEDICINE & PHARMACOTHERAPY, 59, SUPPL. 2, S375-S379 2005/10 英語 研究論文(学術雑誌) 公開
S Ohno, M Toi, K Kuroi, S Nakamura, H Iwata, M Kusama, N Masuda, K Yamazaki, K Hisamatsu, Y Sato, Y Takatsuka, E Shin, H Kaise, M Kurozumi, H Tsuda, F Akiyama S Ohno, M Toi, K Kuroi, S Nakamura, H Iwata, M Kusama, N Masuda, K Yamazaki, K Hisamatsu, Y Sato, Y Takatsuka, E Shin, H Kaise, M Kurozumi, H Tsuda, F Akiyama S Ohno, M Toi, K Kuroi, S Nakamura, H Iwata, M Kusama, N Masuda, K Yamazaki, K Hisamatsu, Y Sato, Y Takatsuka, E Shin, H Kaise, M Kurozumi, H Tsuda, F Akiyama Update results of FEC followed by docetaxel neoadjuvant trials for primary breast cancer Update results of FEC followed by docetaxel neoadjuvant trials for primary breast cancer Update results of FEC followed by docetaxel neoadjuvant trials for primary breast cancer BIOMEDICINE & PHARMACOTHERAPY, 59, SUPPL. 2, S323-S324 BIOMEDICINE & PHARMACOTHERAPY, 59, SUPPL. 2, S323-S324 BIOMEDICINE & PHARMACOTHERAPY, 59, SUPPL. 2, S323-S324 2005/10 英語 研究論文(学術雑誌) 公開
M Toi, T Saeki, K Aogi, M Sano, K Hatake, T Asaga, Y Tokuda, S Mitsuyama, M Kimura, T Kobayashi, M Tamura, T Tabei, E Shin, R Nishimura, S Ohno, S Takashima M Toi, T Saeki, K Aogi, M Sano, K Hatake, T Asaga, Y Tokuda, S Mitsuyama, M Kimura, T Kobayashi, M Tamura, T Tabei, E Shin, R Nishimura, S Ohno, S Takashima M Toi, T Saeki, K Aogi, M Sano, K Hatake, T Asaga, Y Tokuda, S Mitsuyama, M Kimura, T Kobayashi, M Tamura, T Tabei, E Shin, R Nishimura, S Ohno, S Takashima Late phase II clinical study of vinorelbine monotherapy in advanced or recurrent breast cancer previously treated with anthracyclines and taxanes Late phase II clinical study of vinorelbine monotherapy in advanced or recurrent breast cancer previously treated with anthracyclines and taxanes Late phase II clinical study of vinorelbine monotherapy in advanced or recurrent breast cancer previously treated with anthracyclines and taxanes JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 35, 6, 310-315 JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 35, 6, 310-315 JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 35, 6, 310-315 2005/06 英語 研究論文(学術雑誌) 公開
S Saji, M Kawakami, S Hayashi, N Yoshida, M Hirose, SI Horiguchi, A Itoh, N Funata, SL Schreiber, M Yoshida, M Toi S Saji, M Kawakami, S Hayashi, N Yoshida, M Hirose, SI Horiguchi, A Itoh, N Funata, SL Schreiber, M Yoshida, M Toi S Saji, M Kawakami, S Hayashi, N Yoshida, M Hirose, SI Horiguchi, A Itoh, N Funata, SL Schreiber, M Yoshida, M Toi Significance of HDAC6 regulation via estrogen signaling for cell motility and prognosis in estrogen receptor-positive breast cancer Significance of HDAC6 regulation via estrogen signaling for cell motility and prognosis in estrogen receptor-positive breast cancer Significance of HDAC6 regulation via estrogen signaling for cell motility and prognosis in estrogen receptor-positive breast cancer ONCOGENE, 24, 28, 4531-4539 ONCOGENE, 24, 28, 4531-4539 ONCOGENE, 24, 28, 4531-4539 2005/06 英語 研究論文(学術雑誌) 公開
K Hiramatsu, K Takahashi, T Yamaguchi, H Matsumoto, H Miyamoto, S Tanaka, C Tanaka, Y Tamamori, M Imajo, M Kawaguchi, M Toi, T Mori, M Kawakita K Hiramatsu, K Takahashi, T Yamaguchi, H Matsumoto, H Miyamoto, S Tanaka, C Tanaka, Y Tamamori, M Imajo, M Kawaguchi, M Toi, T Mori, M Kawakita K Hiramatsu, K Takahashi, T Yamaguchi, H Matsumoto, H Miyamoto, S Tanaka, C Tanaka, Y Tamamori, M Imajo, M Kawaguchi, M Toi, T Mori, M Kawakita N-1,N-12-diacetylspermine as a sensitive and specific novel marker for early- and late-stage colorectal and breast cancers N-1,N-12-diacetylspermine as a sensitive and specific novel marker for early- and late-stage colorectal and breast cancers N-1,N-12-diacetylspermine as a sensitive and specific novel marker for early- and late-stage colorectal and breast cancers CLINICAL CANCER RESEARCH, 11, 8, 2986-2990 CLINICAL CANCER RESEARCH, 11, 8, 2986-2990 CLINICAL CANCER RESEARCH, 11, 8, 2986-2990 2005/04 英語 研究論文(学術雑誌) 公開
C. Nakanishi, M. Toi C. Nakanishi, M. Toi C Nakanishi, M Toi Nuclear factor-κB inhibitors as sensitizers to anticancer drugs Nuclear factor-κB inhibitors as sensitizers to anticancer drugs Nuclear factor-kappa B inhibitors as sensitizers to anticancer drugs Nature Reviews Cancer, 5, 4, 297-309 Nature Reviews Cancer, 5, 4, 297-309 NATURE REVIEWS CANCER, 5, 4, 297-309 2005/04 英語 公開
M Yasuno, T Mori, M Koike, K Takahashi, M Toi, T Takizawa, S Shimizu, T Yamaguchi, H Matsumoto M Yasuno, T Mori, M Koike, K Takahashi, M Toi, T Takizawa, S Shimizu, T Yamaguchi, H Matsumoto M Yasuno, T Mori, M Koike, K Takahashi, M Toi, T Takizawa, S Shimizu, T Yamaguchi, H Matsumoto Importance of thymidine phosphorylase expression in tumor stroma as a prognostic factor in patients with advanced colorectal carcinoma Importance of thymidine phosphorylase expression in tumor stroma as a prognostic factor in patients with advanced colorectal carcinoma Importance of thymidine phosphorylase expression in tumor stroma as a prognostic factor in patients with advanced colorectal carcinoma ONCOLOGY REPORTS, 13, 3, 405-412 ONCOLOGY REPORTS, 13, 3, 405-412 ONCOLOGY REPORTS, 13, 3, 405-412 2005/03 英語 研究論文(学術雑誌) 公開
M Toi, MA Rahman, H Bando, LWC Chow M Toi, MA Rahman, H Bando, LWC Chow M Toi, MA Rahman, H Bando, LWC Chow Thymidine phosphorylase (platelet-derived endothelial-cell growth factor) in cancer biology and treatment Thymidine phosphorylase (platelet-derived endothelial-cell growth factor) in cancer biology and treatment Thymidine phosphorylase (platelet-derived endothelial-cell growth factor) in cancer biology and treatment LANCET ONCOLOGY, 6, 3, 158-166 LANCET ONCOLOGY, 6, 3, 158-166 LANCET ONCOLOGY, 6, 3, 158-166 2005/03 英語 公開
G. Matsumoto, J.-I. Namekawa, M. Muta, T. Nakamura, H. Bando, K. Tohyama, M. Toi, K. Umezawa G. Matsumoto, J.-I. Namekawa, M. Muta, T. Nakamura, H. Bando, K. Tohyama, M. Toi, K. Umezawa G Matsumoto, J Namekawa, M Muta, T Nakamura, H Bando, K Tohyama, M Toi, K Umezawa Targeting of nuclear factor κB pathways by dehydroxymethylepoxyquinomicin, a novel inhibitor of breast carcinomas: Antitumor and antiangiogenic potential in vivo Targeting of nuclear factor κB pathways by dehydroxymethylepoxyquinomicin, a novel inhibitor of breast carcinomas: Antitumor and antiangiogenic potential in vivo Targeting of nuclear factor kappa B pathways by dehydroxymethylepoxyquinomicin, a novel inhibitor of breast carcinomas: Antitumor and antiangiogenic potential in vivo Clinical Cancer Research, 11, 3, 1287-1293 Clinical Cancer Research, 11, 3, 1287-1293 CLINICAL CANCER RESEARCH, 11, 3, 1287-1293 2005/02 英語 研究論文(学術雑誌) 公開
H Bando, HA Weich, M Brokelmann, S Horiguchi, N Funata, T Ogawa, M Toi H Bando, HA Weich, M Brokelmann, S Horiguchi, N Funata, T Ogawa, M Toi H Bando, HA Weich, M Brokelmann, S Horiguchi, N Funata, T Ogawa, M Toi Association between intratumoral free and total VEGF, soluble VEGFR-1, VEGFR-2 and prognosis in breast cancer Association between intratumoral free and total VEGF, soluble VEGFR-1, VEGFR-2 and prognosis in breast cancer Association between intratumoral free and total VEGF, soluble VEGFR-1, VEGFR-2 and prognosis in breast cancer BRITISH JOURNAL OF CANCER, 92, 3, 553-561 BRITISH JOURNAL OF CANCER, 92, 3, 553-561 BRITISH JOURNAL OF CANCER, 92, 3, 553-561 2005/02 英語 研究論文(学術雑誌) 公開
LWC Chow, M Toi LWC Chow, M Toi LWC Chow, M Toi Celecoxib anti-aromatase neoadjuvant (CAAN) Trial for locally advanced breast cancer Celecoxib anti-aromatase neoadjuvant (CAAN) Trial for locally advanced breast cancer Celecoxib anti-aromatase neoadjuvant (CAAN) Trial for locally advanced breast cancer BREAST CANCER RESEARCH AND TREATMENT, 94, 1-2, S240-S240 BREAST CANCER RESEARCH AND TREATMENT, 94, 1-2, S240-S240 BREAST CANCER RESEARCH AND TREATMENT, 94, 1-2, S240-S240 2005 英語 公開
H. Bando, M. Toi H. Bando, M. Toi H. Bando, M. Toi VEGF (vascular endothelial growth factor) VEGF (vascular endothelial growth factor) VEGF (vascular endothelial growth factor) Nippon rinsho. Japanese journal of clinical medicine., 63 Suppl 8, 99-102 Nippon rinsho. Japanese journal of clinical medicine., 63 Suppl 8, 99-102 Nippon rinsho. Japanese journal of clinical medicine., 63 Suppl 8, 99-102 2005 英語 公開
I. Okubo, M. Kondo, M. Toi, T. Ochiai, S. Miki I. Okubo, M. Kondo, M. Toi, T. Ochiai, S. Miki I. Okubo, M. Kondo, M. Toi, T. Ochiai, S. Miki Cost-effectiveness of letrozole versus tamoxifen as first-line hormonal therapy in treating postmenopausal women with advanced breast cancer in Japan. Cost-effectiveness of letrozole versus tamoxifen as first-line hormonal therapy in treating postmenopausal women with advanced breast cancer in Japan. Cost-effectiveness of letrozole versus tamoxifen as first-line hormonal therapy in treating postmenopausal women with advanced breast cancer in Japan. Gan to kagaku ryoho. Cancer & chemotherapy, 32, 3, 351-363 Gan to kagaku ryoho. Cancer & chemotherapy, 32, 3, 351-363 Gan to kagaku ryoho. Cancer & chemotherapy, 32, 3, 351-363 2005 英語 公開
K.S. Albain, J. de, la, Garza Salazar, T. Pienkowski, M. Aapro, J. Bergh, M. Caleffi, R. Coleman, W. Eiermann, F. Içli, M. Pegram, M. Piccart, R. Snyder, M. Toi, G.N. Hortobagyi K.S. Albain, J. de, la, Garza Salazar, T. Pienkowski, M. Aapro, J. Bergh, M. Caleffi, R. Coleman, W. Eiermann, F. Içli, M. Pegram, M. Piccart, R. Snyder, M. Toi, G.N. Hortobagyi K.S. Albain, J. de, la, Garza Salazar, T. Pienkowski, M. Aapro, J. Bergh, M. Caleffi, R. Coleman, W. Eiermann, F. Içli, M. Pegram, M. Piccart, R. Snyder, M. Toi, G.N. Hortobagyi Reducing the global breast cancer burden: The importance of patterns of care research Reducing the global breast cancer burden: The importance of patterns of care research Reducing the global breast cancer burden: The importance of patterns of care research Clinical Breast Cancer, 6, 5, 412-420 Clinical Breast Cancer, 6, 5, 412-420 Clinical Breast Cancer, 6, 5, 412-420 2005 英語 公開
H. Iwata, S. Nakamura, M. Toi, E. Shin, N. Masuda, S. Ohno, Y. Takatsuka, K. Hisamatsu, K. Yamazaki, M. Kusama, H. Kaise, Y. Sato, K. Kuroi, F. Akiyama, H. Tsuda, M. Kurosumi H. Iwata, S. Nakamura, M. Toi, E. Shin, N. Masuda, S. Ohno, Y. Takatsuka, K. Hisamatsu, K. Yamazaki, M. Kusama, H. Kaise, Y. Sato, K. Kuroi, F. Akiyama, H. Tsuda, M. Kurosumi H. Iwata, S. Nakamura, M. Toi, E. Shin, N. Masuda, S. Ohno, Y. Takatsuka, K. Hisamatsu, K. Yamazaki, M. Kusama, H. Kaise, Y. Sato, K. Kuroi, F. Akiyama, H. Tsuda, M. Kurosumi Interim analysis of a phase II trial of cyclophosphamide, epirubicin and 5-fluorouracil (CEF) followed by docetaxel as preoperative chemotherapy for early stage Breast carcinoma Interim analysis of a phase II trial of cyclophosphamide, epirubicin and 5-fluorouracil (CEF) followed by docetaxel as preoperative chemotherapy for early stage Breast carcinoma Interim analysis of a phase II trial of cyclophosphamide, epirubicin and 5-fluorouracil (CEF) followed by docetaxel as preoperative chemotherapy for early stage Breast carcinoma Breast Cancer, 12, 2, 99-103 Breast Cancer, 12, 2, 99-103 Breast Cancer, 12, 2, 99-103 2005 英語 公開
M. Toi, Y. Takebayashi, L.W. Chow M. Toi, Y. Takebayashi, L.W. Chow M. Toi, Y. Takebayashi, L.W. Chow Translational research in breast cancer Translational research in breast cancer Translational research in breast cancer Breast Cancer, 12, 2, 86-90 Breast Cancer, 12, 2, 86-90 Breast Cancer, 12, 2, 86-90 2005 英語 公開
T. Saeki, S. Takashima, M. Terashima, A. Satoh, M. Toi, A. Osaki, T. Toge, S. Ohno, N. Nomura, Y. Fukuyama, W. Koizumi, T. Taguchi T. Saeki, S. Takashima, M. Terashima, A. Satoh, M. Toi, A. Osaki, T. Toge, S. Ohno, N. Nomura, Y. Fukuyama, W. Koizumi, T. Taguchi T. Saeki, S. Takashima, M. Terashima, A. Satoh, M. Toi, A. Osaki, T. Toge, S. Ohno, N. Nomura, Y. Fukuyama, W. Koizumi, T. Taguchi A Japanese phase I study of continuous oral capecitabine in patients with malignant solid tumors A Japanese phase I study of continuous oral capecitabine in patients with malignant solid tumors A Japanese phase I study of continuous oral capecitabine in patients with malignant solid tumors International Journal of Clinical Oncology, 10, 1, 51-57 International Journal of Clinical Oncology, 10, 1, 51-57 International Journal of Clinical Oncology, 10, 1, 51-57 2005 英語 公開
M Toi, H Bando, LWC Chow M Toi, H Bando, LWC Chow M Toi, H Bando, LWC Chow Novel insights in clinical trials with preoperative systemic therapy for primary breast cancer Novel insights in clinical trials with preoperative systemic therapy for primary breast cancer Novel insights in clinical trials with preoperative systemic therapy for primary breast cancer BIOMEDICINE & PHARMACOTHERAPY, 58, 9, 531-535 BIOMEDICINE & PHARMACOTHERAPY, 58, 9, 531-535 BIOMEDICINE & PHARMACOTHERAPY, 58, 9, 531-535 2004/11 英語 研究論文(学術雑誌) 公開
M Kuwano, Y Oda, H Izumi, SJ Yang, T Uchiumi, Y Iwamoto, M Toi, T Fujii, H Yamana, H Kinoshita, T Kamura, M Tsuneyoshi, K Yasumoto, K Kohno M Kuwano, Y Oda, H Izumi, SJ Yang, T Uchiumi, Y Iwamoto, M Toi, T Fujii, H Yamana, H Kinoshita, T Kamura, M Tsuneyoshi, K Yasumoto, K Kohno M Kuwano, Y Oda, H Izumi, SJ Yang, T Uchiumi, Y Iwamoto, M Toi, T Fujii, H Yamana, H Kinoshita, T Kamura, M Tsuneyoshi, K Yasumoto, K Kohno The role of nuclear Y-box binding protein 1 as a global marker in drug resistance The role of nuclear Y-box binding protein 1 as a global marker in drug resistance The role of nuclear Y-box binding protein 1 as a global marker in drug resistance MOLECULAR CANCER THERAPEUTICS, 3, 11, 1485-1492 MOLECULAR CANCER THERAPEUTICS, 3, 11, 1485-1492 MOLECULAR CANCER THERAPEUTICS, 3, 11, 1485-1492 2004/11 英語 公開
T Tominaga, M Kimura, T Asaga, M Yoshida, H Awane, H Koyama, Y Takatsuka, S Mitsuyama, T Ikeda, M Ogita, H Aoyama, M Sano, R Abe, T Nish, T Wada, M Danno, M Toi, S Takashima T Tominaga, M Kimura, T Asaga, M Yoshida, H Awane, H Koyama, Y Takatsuka, S Mitsuyama, T Ikeda, M Ogita, H Aoyama, M Sano, R Abe, T Nish, T Wada, M Danno, M Toi, S Takashima T Tominaga, M Kimura, T Asaga, M Yoshida, H Awane, H Koyama, Y Takatsuka, S Mitsuyama, T Ikeda, M Ogita, H Aoyama, M Sano, R Abe, T Nish, T Wada, M Danno, M Toi, S Takashima 1-hexylcarbamoyl-5-fluorouracil plus cyclophosphamide plus tamoxifen versus CMF plus tamoxifen in women with lymph node-positive breast cancer after primary surgery: A randomized controlled trial 1-hexylcarbamoyl-5-fluorouracil plus cyclophosphamide plus tamoxifen versus CMF plus tamoxifen in women with lymph node-positive breast cancer after primary surgery: A randomized controlled trial 1-hexylcarbamoyl-5-fluorouracil plus cyclophosphamide plus tamoxifen versus CMF plus tamoxifen in women with lymph node-positive breast cancer after primary surgery: A randomized controlled trial ONCOLOGY REPORTS, 12, 4, 797-803 ONCOLOGY REPORTS, 12, 4, 797-803 ONCOLOGY REPORTS, 12, 4, 797-803 2004/10 英語 研究論文(学術雑誌) 公開
M Takada, A Kataoka, M Toi, H Bando, K Toyama, S Horiguchi, T Ueno, S Linder, S Saji, Y Hayashi, N Funata, J Kinoshita, S Murakami, S Ohono M Takada, A Kataoka, M Toi, H Bando, K Toyama, S Horiguchi, T Ueno, S Linder, S Saji, Y Hayashi, N Funata, J Kinoshita, S Murakami, S Ohono M Takada, A Kataoka, M Toi, H Bando, K Toyama, S Horiguchi, T Ueno, S Linder, S Saji, Y Hayashi, N Funata, J Kinoshita, S Murakami, S Ohono A close association between alteration in growth kinetics by neoadjuvant chemotherapy and survival outcome in primary breast cancer A close association between alteration in growth kinetics by neoadjuvant chemotherapy and survival outcome in primary breast cancer A close association between alteration in growth kinetics by neoadjuvant chemotherapy and survival outcome in primary breast cancer INTERNATIONAL JOURNAL OF ONCOLOGY, 25, 2, 397-405 INTERNATIONAL JOURNAL OF ONCOLOGY, 25, 2, 397-405 INTERNATIONAL JOURNAL OF ONCOLOGY, 25, 2, 397-405 2004/08 英語 研究論文(学術雑誌) 公開
G Matsumoto, MA Rahman, M Muta, T Nakamura, H Bando, S Saji, K Tsuruta, A Okamoto, M Toi G Matsumoto, MA Rahman, M Muta, T Nakamura, H Bando, S Saji, K Tsuruta, A Okamoto, M Toi G Matsumoto, MA Rahman, M Muta, T Nakamura, H Bando, S Saji, K Tsuruta, A Okamoto, M Toi DFU, a selective COX-2 inhibitor, suppresses MCF-7 xenograft tumor growth in mice DFU, a selective COX-2 inhibitor, suppresses MCF-7 xenograft tumor growth in mice DFU, a selective COX-2 inhibitor, suppresses MCF-7 xenograft tumor growth in mice ONCOLOGY REPORTS, 12, 2, 281-285 ONCOLOGY REPORTS, 12, 2, 281-285 ONCOLOGY REPORTS, 12, 2, 281-285 2004/08 英語 研究論文(学術雑誌) 公開
Y Asami, H Kakeya, R Onose, YH Chang, M Toi, H Osada Y Asami, H Kakeya, R Onose, YH Chang, M Toi, H Osada Y Asami, H Kakeya, R Onose, YH Chang, M Toi, H Osada RK-805, an endothelial-cell-growth inhibitor produced by Neosartorya sp., and a docking model with methionine aminopeptidase-2 RK-805, an endothelial-cell-growth inhibitor produced by Neosartorya sp., and a docking model with methionine aminopeptidase-2 RK-805, an endothelial-cell-growth inhibitor produced by Neosartorya sp., and a docking model with methionine aminopeptidase-2 TETRAHEDRON, 60, 33, 7085-7091 TETRAHEDRON, 60, 33, 7085-7091 TETRAHEDRON, 60, 33, 7085-7091 2004/08 英語 研究論文(学術雑誌) 公開
H Bando, M Brokelmann, M Toi, K Alitalo, JP Sleeman, B Sipos, HJ Grone, HA Weich H Bando, M Brokelmann, M Toi, K Alitalo, JP Sleeman, B Sipos, HJ Grone, HA Weich H Bando, M Brokelmann, M Toi, K Alitalo, JP Sleeman, B Sipos, HJ Grone, HA Weich Immunodetection and quantification of vascular endothelial growth factor receptor-3 in human malignant tumor tissues Immunodetection and quantification of vascular endothelial growth factor receptor-3 in human malignant tumor tissues Immunodetection and quantification of vascular endothelial growth factor receptor-3 in human malignant tumor tissues INTERNATIONAL JOURNAL OF CANCER, 111, 2, 184-191 INTERNATIONAL JOURNAL OF CANCER, 111, 2, 184-191 INTERNATIONAL JOURNAL OF CANCER, 111, 2, 184-191 2004/08 英語 研究論文(学術雑誌) 公開
L Zhu, LWC Chow, WTY Loo, XY Guan, M Toi L Zhu, LWC Chow, WTY Loo, XY Guan, M Toi L Zhu, LWC Chow, WTY Loo, XY Guan, M Toi Her2/neu expression predicts the response to antiaromatase neoadjuvant therapy in primary breast cancer: Subgroup analysis from celecoxib antiaromatase neoadjuvant trial Her2/neu expression predicts the response to antiaromatase neoadjuvant therapy in primary breast cancer: Subgroup analysis from celecoxib antiaromatase neoadjuvant trial Her2/neu expression predicts the response to antiaromatase neoadjuvant therapy in primary breast cancer: Subgroup analysis from celecoxib antiaromatase neoadjuvant trial CLINICAL CANCER RESEARCH, 10, 14, 4639-4644 CLINICAL CANCER RESEARCH, 10, 14, 4639-4644 CLINICAL CANCER RESEARCH, 10, 14, 4639-4644 2004/07 英語 研究論文(学術雑誌) 公開
M Toi, H Bando, S Horiguchi, M Takada, A Kataoka, T Ueno, S Saji, M Muta, N Funata, S Ohno M Toi, H Bando, S Horiguchi, M Takada, A Kataoka, T Ueno, S Saji, M Muta, N Funata, S Ohno M Toi, H Bando, S Horiguchi, M Takada, A Kataoka, T Ueno, S Saji, M Muta, N Funata, S Ohno Modulation of thymidine phosphorylase by neoadjuvant chemotherapy in primary breast cancer Modulation of thymidine phosphorylase by neoadjuvant chemotherapy in primary breast cancer Modulation of thymidine phosphorylase by neoadjuvant chemotherapy in primary breast cancer BRITISH JOURNAL OF CANCER, 90, 12, 2338-2343 BRITISH JOURNAL OF CANCER, 90, 12, 2338-2343 BRITISH JOURNAL OF CANCER, 90, 12, 2338-2343 2004/06 英語 研究論文(学術雑誌) 公開
H Nakayama, H Enzan, E Miyazaki, N Kuroda, M Toi, M Hiroi, W Yasui H Nakayama, H Enzan, E Miyazaki, N Kuroda, M Toi, M Hiroi, W Yasui H Nakayama, H Enzan, E Miyazaki, N Kuroda, M Toi, M Hiroi, W Yasui Lack of vascular adventitial fibroblastic cells in tumour stroma of intestinal-type and solid-type gastric carcinomas Lack of vascular adventitial fibroblastic cells in tumour stroma of intestinal-type and solid-type gastric carcinomas Lack of vascular adventitial fibroblastic cells in tumour stroma of intestinal-type and solid-type gastric carcinomas JOURNAL OF CLINICAL PATHOLOGY, 57, 2, 183-185 JOURNAL OF CLINICAL PATHOLOGY, 57, 2, 183-185 JOURNAL OF CLINICAL PATHOLOGY, 57, 2, 183-185 2004/02 英語 研究論文(学術雑誌) 公開
S Morita, M Toi, T Kobayashi, Y Ito, Y Hozumi, S Ohno, H Iwata, J Sakamoto S Morita, M Toi, T Kobayashi, Y Ito, Y Hozumi, S Ohno, H Iwata, J Sakamoto S Morita, M Toi, T Kobayashi, Y Ito, Y Hozumi, S Ohno, H Iwata, J Sakamoto Application of a continual reassessment method to a phase I clinical trial of capecitabine in combination with cyclophosphamide and epirubicin (CEX) for inoperable or recurrent breast cancer Application of a continual reassessment method to a phase I clinical trial of capecitabine in combination with cyclophosphamide and epirubicin (CEX) for inoperable or recurrent breast cancer Application of a continual reassessment method to a phase I clinical trial of capecitabine in combination with cyclophosphamide and epirubicin (CEX) for inoperable or recurrent breast cancer JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 34, 2, 104-106 JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 34, 2, 104-106 JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 34, 2, 104-106 2004/02 英語 研究論文(学術雑誌) 公開
HA Weich, H Bando, M Brokelmann, P Baumann, M Toi, B Barleon, K Alitalo, B Sipos, J Sleeman HA Weich, H Bando, M Brokelmann, P Baumann, M Toi, B Barleon, K Alitalo, B Sipos, J Sleeman HA Weich, H Bando, M Brokelmann, P Baumann, M Toi, B Barleon, K Alitalo, B Sipos, J Sleeman Quantification of vascular endothelial growth factor-C (VEGF-C) by a novel ELISA Quantification of vascular endothelial growth factor-C (VEGF-C) by a novel ELISA Quantification of vascular endothelial growth factor-C (VEGF-C) by a novel ELISA JOURNAL OF IMMUNOLOGICAL METHODS, 285, 2, 145-155 JOURNAL OF IMMUNOLOGICAL METHODS, 285, 2, 145-155 JOURNAL OF IMMUNOLOGICAL METHODS, 285, 2, 145-155 2004/02 英語 研究論文(学術雑誌) 公開
H. Yamashiro, K. Toyama, H. Bando, S. Saji, M. Toi H. Yamashiro, K. Toyama, H. Bando, S. Saji, M. Toi H. Yamashiro, K. Toyama, H. Bando, S. Saji, M. Toi Trastuzumab treatment for breast cancer Trastuzumab treatment for breast cancer Trastuzumab treatment for breast cancer Nippon rinsho. Japanese journal of clinical medicine, 62, 7, 1305-1311 Nippon rinsho. Japanese journal of clinical medicine, 62, 7, 1305-1311 Nippon rinsho. Japanese journal of clinical medicine, 62, 7, 1305-1311 2004 英語 公開
M. Kawakita, K. Hiramatsu, M. Sugimoto, K. Takahashi, M. Toi M. Kawakita, K. Hiramatsu, M. Sugimoto, K. Takahashi, M. Toi M. Kawakita, K. Hiramatsu, M. Sugimoto, K. Takahashi, M. Toi Clinical usefulness of urinary diacetylpolyamines as novel tumor markers Clinical usefulness of urinary diacetylpolyamines as novel tumor markers Clinical usefulness of urinary diacetylpolyamines as novel tumor markers Rinsho byori. The Japanese journal of clinical pathology, 52, 4, 321-327 Rinsho byori. The Japanese journal of clinical pathology, 52, 4, 321-327 Rinsho byori. The Japanese journal of clinical pathology, 52, 4, 321-327 2004 英語 公開
M. Kawakami, S. Saji, M. Toi M. Kawakami, S. Saji, M. Toi M. Kawakami, S. Saji, M. Toi Controversies in endocrine therapy for breast cancer Controversies in endocrine therapy for breast cancer Controversies in endocrine therapy for breast cancer Gan to kagaku ryoho. Cancer & chemotherapy, 31, 2, 181-187 Gan to kagaku ryoho. Cancer & chemotherapy, 31, 2, 181-187 Gan to kagaku ryoho. Cancer & chemotherapy, 31, 2, 181-187 2004 英語 公開
S. Saji, M. Hirose, M. Toi S. Saji, M. Hirose, M. Toi S. Saji, M. Hirose, M. Toi Novel sensitizing agents: Potential contribution of COX-2 inhibitor for endocrine therapy of breast cancer Novel sensitizing agents: Potential contribution of COX-2 inhibitor for endocrine therapy of breast cancer Novel sensitizing agents: Potential contribution of COX-2 inhibitor for endocrine therapy of breast cancer Breast Cancer, 11, 2, 129-133 Breast Cancer, 11, 2, 129-133 Breast Cancer, 11, 2, 129-133 2004 英語 公開
M. Toi, M. Takada, H. Bando, K. Toyama, H. Yamashiro, S. Horiguchi, S. Saji M. Toi, M. Takada, H. Bando, K. Toyama, H. Yamashiro, S. Horiguchi, S. Saji M. Toi, M. Takada, H. Bando, K. Toyama, H. Yamashiro, S. Horiguchi, S. Saji Current status of antibody therapy for breast cancer Current status of antibody therapy for breast cancer Current status of antibody therapy for breast cancer Breast Cancer, 11, 1, 10-14 Breast Cancer, 11, 1, 10-14 Breast Cancer, 11, 1, 10-14 2004 英語 公開
C Nakanishi, T Yamaguchi, T Iijima, S Saji, M Toi, T Mori, M Miyaki C Nakanishi, T Yamaguchi, T Iijima, S Saji, M Toi, T Mori, M Miyaki C Nakanishi, T Yamaguchi, T Iijima, S Saji, M Toi, T Mori, M Miyaki Germline mutation of the LKB1/STK11 gene with loss of the normal allele in an aggressive breast cancer of Peutz-Jeghers syndrome Germline mutation of the LKB1/STK11 gene with loss of the normal allele in an aggressive breast cancer of Peutz-Jeghers syndrome Germline mutation of the LKB1/STK11 gene with loss of the normal allele in an aggressive breast cancer of Peutz-Jeghers syndrome ONCOLOGY, 67, 5-6, 476-479 ONCOLOGY, 67, 5-6, 476-479 ONCOLOGY, 67, 5-6, 476-479 2004 英語 研究論文(学術雑誌) 公開
MA Rahman, M Toi MA Rahman, M Toi MA Rahman, M Toi Anti-angiogenic therapy in breast cancer Anti-angiogenic therapy in breast cancer Anti-angiogenic therapy in breast cancer BIOMEDICINE & PHARMACOTHERAPY, 57, 10, 463-470 BIOMEDICINE & PHARMACOTHERAPY, 57, 10, 463-470 BIOMEDICINE & PHARMACOTHERAPY, 57, 10, 463-470 2003/12 英語 研究論文(学術雑誌) 公開
M Muta, G Matsumoto, K Hiruma, E Nakashima, M Toi M Muta, G Matsumoto, K Hiruma, E Nakashima, M Toi M Muta, G Matsumoto, K Hiruma, E Nakashima, M Toi Study of cancer gene therapy using IL-12-secreting endothelial progenitor cells in a rat solid tumor model Study of cancer gene therapy using IL-12-secreting endothelial progenitor cells in a rat solid tumor model Study of cancer gene therapy using IL-12-secreting endothelial progenitor cells in a rat solid tumor model ONCOLOGY REPORTS, 10, 6, 1765-1769 ONCOLOGY REPORTS, 10, 6, 1765-1769 ONCOLOGY REPORTS, 10, 6, 1765-1769 2003/11 英語 研究論文(学術雑誌) 公開
H Bando, M Toi, K Kitada, M Koike H Bando, M Toi, K Kitada, M Koike H Bando, M Toi, K Kitada, M Koike Genes commonly upregulated by hypoxia in human breast cancer cells MCF-7 and MDA-MB-231 Genes commonly upregulated by hypoxia in human breast cancer cells MCF-7 and MDA-MB-231 Genes commonly upregulated by hypoxia in human breast cancer cells MCF-7 and MDA-MB-231 BIOMEDICINE & PHARMACOTHERAPY, 57, 8, 333-340 BIOMEDICINE & PHARMACOTHERAPY, 57, 8, 333-340 BIOMEDICINE & PHARMACOTHERAPY, 57, 8, 333-340 2003/10 英語 研究論文(学術雑誌) 公開
K Kuroi, H Bando, S Saji, M Toi K Kuroi, H Bando, S Saji, M Toi K Kuroi, H Bando, S Saji, M Toi Protracted administration of weekly docetaxel in metastatic breast cancer Protracted administration of weekly docetaxel in metastatic breast cancer Protracted administration of weekly docetaxel in metastatic breast cancer ONCOLOGY REPORTS, 10, 5, 1479-1484 ONCOLOGY REPORTS, 10, 5, 1479-1484 ONCOLOGY REPORTS, 10, 5, 1479-1484 2003/09 英語 研究論文(学術雑誌) 公開
G Matsumoto, S Nagai, M Muta, K Tsuruta, A Okamoto, M Toi G Matsumoto, S Nagai, M Muta, K Tsuruta, A Okamoto, M Toi G Matsumoto, S Nagai, M Muta, K Tsuruta, A Okamoto, M Toi Survival benefit of KRN7000 immune therapy in combination with TNP470 in hamster liver metastasis model of pancreatic cancer Survival benefit of KRN7000 immune therapy in combination with TNP470 in hamster liver metastasis model of pancreatic cancer Survival benefit of KRN7000 immune therapy in combination with TNP470 in hamster liver metastasis model of pancreatic cancer ONCOLOGY REPORTS, 10, 5, 1201-1206 ONCOLOGY REPORTS, 10, 5, 1201-1206 ONCOLOGY REPORTS, 10, 5, 1201-1206 2003/09 英語 研究論文(学術雑誌) 公開
M Muta, G Matsumoto, K Hiruma, S Saji, E Nakashima, M Toi M Muta, G Matsumoto, K Hiruma, S Saji, E Nakashima, M Toi M Muta, G Matsumoto, K Hiruma, S Saji, E Nakashima, M Toi Impact of vasculogenesis on solid tumor growth in a rat model Impact of vasculogenesis on solid tumor growth in a rat model Impact of vasculogenesis on solid tumor growth in a rat model ONCOLOGY REPORTS, 10, 5, 1213-1218 ONCOLOGY REPORTS, 10, 5, 1213-1218 ONCOLOGY REPORTS, 10, 5, 1213-1218 2003/09 英語 研究論文(学術雑誌) 公開
LWC Chow, JLN Wong, M Toi LWC Chow, JLN Wong, M Toi LWC Chow, JLN Wong, M Toi Celecoxib anti-aromatase neoadjuvant (CAAN) trial for locally advanced breast cancer: preliminary report Celecoxib anti-aromatase neoadjuvant (CAAN) trial for locally advanced breast cancer: preliminary report Celecoxib anti-aromatase neoadjuvant (CAAN) trial for locally advanced breast cancer: preliminary report JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 86, 3-5, 443-447 JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 86, 3-5, 443-447 JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 86, 3-5, 443-447 2003/09 英語 研究論文(学術雑誌) 公開
Y Yamamoto, JI Yamashita, M Toi, M Muta, S Nagai, N Hanai, A Furuya, Y Osawa, S Saji, M Ogawa Y Yamamoto, JI Yamashita, M Toi, M Muta, S Nagai, N Hanai, A Furuya, Y Osawa, S Saji, M Ogawa Y Yamamoto, JI Yamashita, M Toi, M Muta, S Nagai, N Hanai, A Furuya, Y Osawa, S Saji, M Ogawa Immunohistochemical analysis of estrone sulfatase and aromatase in human breast cancer tissues Immunohistochemical analysis of estrone sulfatase and aromatase in human breast cancer tissues Immunohistochemical analysis of estrone sulfatase and aromatase in human breast cancer tissues ONCOLOGY REPORTS, 10, 4, 791-796 ONCOLOGY REPORTS, 10, 4, 791-796 ONCOLOGY REPORTS, 10, 4, 791-796 2003/07 英語 研究論文(学術雑誌) 公開
K Biven, H Erdal, M Hagg, T Ueno, R Zhou, M Lynch, B Rowley, J Wood, C Zhang, M Toi, MC Shoshan, S Linder K Biven, H Erdal, M Hagg, T Ueno, R Zhou, M Lynch, B Rowley, J Wood, C Zhang, M Toi, MC Shoshan, S Linder K Biven, H Erdal, M Hagg, T Ueno, R Zhou, M Lynch, B Rowley, J Wood, C Zhang, M Toi, MC Shoshan, S Linder A novel assay for discovery and characterization of pro-apoptotic drugs and for monitoring apoptosis in patient sera A novel assay for discovery and characterization of pro-apoptotic drugs and for monitoring apoptosis in patient sera A novel assay for discovery and characterization of pro-apoptotic drugs and for monitoring apoptosis in patient sera APOPTOSIS, 8, 3, 263-268 APOPTOSIS, 8, 3, 263-268 APOPTOSIS, 8, 3, 263-268 2003/05 英語 研究論文(学術雑誌) 公開
T Ueno, M Toi, K Biven, H Bando, T Ogawa, S Linder T Ueno, M Toi, K Biven, H Bando, T Ogawa, S Linder T Ueno, M Toi, K Biven, H Bando, T Ogawa, S Linder Measurement of an apoptotic product in the sera of breast cancer patients Measurement of an apoptotic product in the sera of breast cancer patients Measurement of an apoptotic product in the sera of breast cancer patients EUROPEAN JOURNAL OF CANCER, 39, 6, 769-774 EUROPEAN JOURNAL OF CANCER, 39, 6, 769-774 EUROPEAN JOURNAL OF CANCER, 39, 6, 769-774 2003/04 英語 研究論文(学術雑誌) 公開
T Tominaga, H Koyama, T Toge, S Miura, K Sugimachi, S Yamaguchi, K Hirata, Y Monden, Y Nomura, M Toi, Kimijima, I, S Noguchi, H Sonoo, K Asaishi, T Ikeda, T Morimoto, J Ota, Y Ohashi, O Abe T Tominaga, H Koyama, T Toge, S Miura, K Sugimachi, S Yamaguchi, K Hirata, Y Monden, Y Nomura, M Toi, Kimijima, I, S Noguchi, H Sonoo, K Asaishi, T Ikeda, T Morimoto, J Ota, Y Ohashi, O Abe T Tominaga, H Koyama, T Toge, S Miura, K Sugimachi, S Yamaguchi, K Hirata, Y Monden, Y Nomura, M Toi, Kimijima, I, S Noguchi, H Sonoo, K Asaishi, T Ikeda, T Morimoto, J Ota, Y Ohashi, O Abe Randomized controlled trial comparing oral doxifluridine plus oral cyclophosphamide with doxifluridine alone in women with node-positive breast cancer after primary surgery Randomized controlled trial comparing oral doxifluridine plus oral cyclophosphamide with doxifluridine alone in women with node-positive breast cancer after primary surgery Randomized controlled trial comparing oral doxifluridine plus oral cyclophosphamide with doxifluridine alone in women with node-positive breast cancer after primary surgery JOURNAL OF CLINICAL ONCOLOGY, 21, 6, 991-998 JOURNAL OF CLINICAL ONCOLOGY, 21, 6, 991-998 JOURNAL OF CLINICAL ONCOLOGY, 21, 6, 991-998 2003/03 英語 研究論文(学術雑誌) 公開
H Saji, M Toi, S Saji, M Koike, K Kohno, M Kuwano H Saji, M Toi, S Saji, M Koike, K Kohno, M Kuwano H Saji, M Toi, S Saji, M Koike, K Kohno, M Kuwano Nuclear expression of YB-1 protein correlates with P-glycoprotein expression in human breast carcinoma Nuclear expression of YB-1 protein correlates with P-glycoprotein expression in human breast carcinoma Nuclear expression of YB-1 protein correlates with P-glycoprotein expression in human breast carcinoma CANCER LETTERS, 190, 2, 191-197 CANCER LETTERS, 190, 2, 191-197 CANCER LETTERS, 190, 2, 191-197 2003/02 英語 研究論文(学術雑誌) 公開
O Ogura, A Kanzaki, H Bando, T Ogura, M Toi, Y Takebayashi O Ogura, A Kanzaki, H Bando, T Ogura, M Toi, Y Takebayashi O Ogura, A Kanzaki, H Bando, T Ogura, M Toi, Y Takebayashi Expression of thymidylate synthase and thymidine phosphorylase in human breast carcinoma: implication for method to detect expression of these molecules in clinic Expression of thymidylate synthase and thymidine phosphorylase in human breast carcinoma: implication for method to detect expression of these molecules in clinic Expression of thymidylate synthase and thymidine phosphorylase in human breast carcinoma: implication for method to detect expression of these molecules in clinic CANCER LETTERS, 190, 1, 97-104 CANCER LETTERS, 190, 1, 97-104 CANCER LETTERS, 190, 1, 97-104 2003/02 英語 研究論文(学術雑誌) 公開
K. Kuroi, M. Toi K. Kuroi, M. Toi K. Kuroi, M. Toi Male breast cancer Male breast cancer Male breast cancer Gan to kagaku ryoho. Cancer & chemotherapy, 30, 5, 599-605 Gan to kagaku ryoho. Cancer & chemotherapy, 30, 5, 599-605 Gan to kagaku ryoho. Cancer & chemotherapy, 30, 5, 599-605 2003 英語 公開
M. Toi, H. Bando, S. Saji M. Toi, H. Bando, S. Saji M. Toi, H. Bando, S. Saji Decision tree and paradigms of primary breast cancer: Changes elicited by preoperative therapy Decision tree and paradigms of primary breast cancer: Changes elicited by preoperative therapy Decision tree and paradigms of primary breast cancer: Changes elicited by preoperative therapy Medical Science Monitor, 9, 5, RA90-RA95 Medical Science Monitor, 9, 5, RA90-RA95 Medical Science Monitor, 9, 5, RA90-RA95 2003 英語 公開
M. Toi, H. Bando, C. Ramachandran, S.J. Melnick, A. Imai, R.S. Fife, R.E. Carr, T. Oikawa, E.P. Lansky M. Toi, H. Bando, C. Ramachandran, S.J. Melnick, A. Imai, R.S. Fife, R.E. Carr, T. Oikawa, E.P. Lansky M. Toi, H. Bando, C. Ramachandran, S.J. Melnick, A. Imai, R.S. Fife, R.E. Carr, T. Oikawa, E.P. Lansky Preliminary studies on the anti-angiogenic potential of pomegranate fractions in vitro and in vivo Preliminary studies on the anti-angiogenic potential of pomegranate fractions in vitro and in vivo Preliminary studies on the anti-angiogenic potential of pomegranate fractions in vitro and in vivo Angiogenesis, 6, 2, 121-128 Angiogenesis, 6, 2, 121-128 Angiogenesis, 6, 2, 121-128 2003 英語 公開
K. Kuroi, H. Bando, S. Saji, M. Toi K. Kuroi, H. Bando, S. Saji, M. Toi K. Kuroi, H. Bando, S. Saji, M. Toi Weekly schedule of docetaxel in breast cancer: Evaluation of response and toxicity Weekly schedule of docetaxel in breast cancer: Evaluation of response and toxicity Weekly schedule of docetaxel in breast cancer: Evaluation of response and toxicity Breast Cancer, 10, 1, 10-14 Breast Cancer, 10, 1, 10-14 Breast Cancer, 10, 1, 10-14 2003 英語 公開
T Tominaga, Adachi, I, Y Sasaki, T Tabei, T Ikeda, Y Takatsuka, M Toi, T Suwa, Y Ohashi T Tominaga, Adachi, I, Y Sasaki, T Tabei, T Ikeda, Y Takatsuka, M Toi, T Suwa, Y Ohashi T Tominaga, Adachi, I, Y Sasaki, T Tabei, T Ikeda, Y Takatsuka, M Toi, T Suwa, Y Ohashi Double-blind randomised trial comparing the non-steroidal aromatase inhibitors letrozole and fadrozole in postmenopausal women with advanced breast cancer Double-blind randomised trial comparing the non-steroidal aromatase inhibitors letrozole and fadrozole in postmenopausal women with advanced breast cancer Double-blind randomised trial comparing the non-steroidal aromatase inhibitors letrozole and fadrozole in postmenopausal women with advanced breast cancer ANNALS OF ONCOLOGY, 14, 1, 62-70 ANNALS OF ONCOLOGY, 14, 1, 62-70 ANNALS OF ONCOLOGY, 14, 1, 62-70 2003/01 英語 研究論文(学術雑誌) 公開
K Tsuruta, A Okamoto, M Toi, H Saji, T Takahashi K Tsuruta, A Okamoto, M Toi, H Saji, T Takahashi K Tsuruta, A Okamoto, M Toi, H Saji, T Takahashi Impact of selective Glisson transection on survival of hepatocellular carcinoma Impact of selective Glisson transection on survival of hepatocellular carcinoma Impact of selective Glisson transection on survival of hepatocellular carcinoma HEPATO-GASTROENTEROLOGY, 49, 48, 1607-1610 HEPATO-GASTROENTEROLOGY, 49, 48, 1607-1610 HEPATO-GASTROENTEROLOGY, 49, 48, 1607-1610 2002/11 英語 研究論文(学術雑誌) 公開
Y Kumagai, M Toi, H Inoue Y Kumagai, M Toi, H Inoue Y Kumagai, M Toi, H Inoue Dynamism of tumour vasculature in the early phase of cancer progression: outcomes from oesophageal cancer research Dynamism of tumour vasculature in the early phase of cancer progression: outcomes from oesophageal cancer research Dynamism of tumour vasculature in the early phase of cancer progression: outcomes from oesophageal cancer research LANCET ONCOLOGY, 3, 10, 604-610 LANCET ONCOLOGY, 3, 10, 604-610 LANCET ONCOLOGY, 3, 10, 604-610 2002/10 英語 公開
S. Saji, Y. Omoto, C. Shimizu, M. Warner, Y. Hayashi, S.-I. Horiguchi, T. Watanabe, S.-I. Hayashi, J.-Å. Gustafsson, M. Toi S. Saji, Y. Omoto, C. Shimizu, M. Warner, Y. Hayashi, S.-I. Horiguchi, T. Watanabe, S.-I. Hayashi, J.-Å. Gustafsson, M. Toi S Saji, Y Omoto, C Shimizu, M Warner, Y Hayashi, S Horiguchi, T Watanabe, S Hayashi, JA Gustafsson, M Toi Expression of estrogen receptor (ER) βcx protein in ERα-positive breast cancer: Specific correlation with progesterone receptor Expression of estrogen receptor (ER) βcx protein in ERα-positive breast cancer: Specific correlation with progesterone receptor Expression of estrogen receptor (ER) beta cx protein in ER alpha-positive breast cancer: Specific correlation with progesterone receptor Cancer Research, 62, 17, 4849-4853 Cancer Research, 62, 17, 4849-4853 CANCER RESEARCH, 62, 17, 4849-4853 2002/09 英語 研究論文(学術雑誌) 公開
G Asai, N Yamamoto, M Toi, E Shin, K Nishiyama, T Sekine, Y Nomura, S Takashima, M Kimura, T Tominaga G Asai, N Yamamoto, M Toi, E Shin, K Nishiyama, T Sekine, Y Nomura, S Takashima, M Kimura, T Tominaga G Asai, N Yamamoto, M Toi, E Shin, K Nishiyama, T Sekine, Y Nomura, S Takashima, M Kimura, T Tominaga Pharmacokinetic and pharmacodynamic study of IST-622, a novel synthetic derivative of chartreusin, by oral administration in a phase II study of patients with breast cancer Pharmacokinetic and pharmacodynamic study of IST-622, a novel synthetic derivative of chartreusin, by oral administration in a phase II study of patients with breast cancer Pharmacokinetic and pharmacodynamic study of IST-622, a novel synthetic derivative of chartreusin, by oral administration in a phase II study of patients with breast cancer CANCER CHEMOTHERAPY AND PHARMACOLOGY, 49, 6, 468-472 CANCER CHEMOTHERAPY AND PHARMACOLOGY, 49, 6, 468-472 CANCER CHEMOTHERAPY AND PHARMACOLOGY, 49, 6, 468-472 2002/06 英語 研究論文(学術雑誌) 公開
H Bando, G Matsumoto, M Bando, M Muta, T Ogawa, N Funata, J Nishihira, M Koike, M Toi H Bando, G Matsumoto, M Bando, M Muta, T Ogawa, N Funata, J Nishihira, M Koike, M Toi H Bando, G Matsumoto, M Bando, M Muta, T Ogawa, N Funata, J Nishihira, M Koike, M Toi Expression of macrophage migration inhibitory factor in human breast cancer: Association with nodal spread Expression of macrophage migration inhibitory factor in human breast cancer: Association with nodal spread Expression of macrophage migration inhibitory factor in human breast cancer: Association with nodal spread JAPANESE JOURNAL OF CANCER RESEARCH, 93, 4, 389-396 JAPANESE JOURNAL OF CANCER RESEARCH, 93, 4, 389-396 JAPANESE JOURNAL OF CANCER RESEARCH, 93, 4, 389-396 2002/04 英語 研究論文(学術雑誌) 公開
T Tominaga, M Toi, O Abe, Y Ohashi, J Uchino, H Hayasaka, R Abe, M Izuo, K Enomoto, H Watanabe, M Yoshida, T Taguchi, H Koyama, T Senoo, T Toge, Y Monden, T Hattori, Y Nomura, K Sugimachi, K Hirata, H Nakazato, S Miura, T Morimoto, K Asaishi, Kimijima, I, J Ota, H Sonoo, S Yamaguchi T Tominaga, M Toi, O Abe, Y Ohashi, J Uchino, H Hayasaka, R Abe, M Izuo, K Enomoto, H Watanabe, M Yoshida, T Taguchi, H Koyama, T Senoo, T Toge, Y Monden, T Hattori, Y Nomura, K Sugimachi, K Hirata, H Nakazato, S Miura, T Morimoto, K Asaishi, Kimijima, I, J Ota, H Sonoo, S Yamaguchi T Tominaga, M Toi, O Abe, Y Ohashi, J Uchino, H Hayasaka, R Abe, M Izuo, K Enomoto, H Watanabe, M Yoshida, T Taguchi, H Koyama, T Senoo, T Toge, Y Monden, T Hattori, Y Nomura, K Sugimachi, K Hirata, H Nakazato, S Miura, T Morimoto, K Asaishi, Kimijima, I, J Ota, H Sonoo, S Yamaguchi The effect of adjuvant 5 '-deoxy-5-fluorouridine in early stage breast cancer patients: Results from a multicenter randomized controlled trial The effect of adjuvant 5 '-deoxy-5-fluorouridine in early stage breast cancer patients: Results from a multicenter randomized controlled trial The effect of adjuvant 5 '-deoxy-5-fluorouridine in early stage breast cancer patients: Results from a multicenter randomized controlled trial INTERNATIONAL JOURNAL OF ONCOLOGY, 20, 3, 517-525 INTERNATIONAL JOURNAL OF ONCOLOGY, 20, 3, 517-525 INTERNATIONAL JOURNAL OF ONCOLOGY, 20, 3, 517-525 2002/03 英語 研究論文(学術雑誌) 公開
M Toi, H Bando, T Ogawa, M Muta, C Hornig, HA Weich M Toi, H Bando, T Ogawa, M Muta, C Hornig, HA Weich M Toi, H Bando, T Ogawa, M Muta, C Hornig, HA Weich Significance of vascular endothelial growth factor (VEGF)/soluble VEGF receptor-1 relationship in breast cancer Significance of vascular endothelial growth factor (VEGF)/soluble VEGF receptor-1 relationship in breast cancer Significance of vascular endothelial growth factor (VEGF)/soluble VEGF receptor-1 relationship in breast cancer INTERNATIONAL JOURNAL OF CANCER, 98, 1, 14-18 INTERNATIONAL JOURNAL OF CANCER, 98, 1, 14-18 INTERNATIONAL JOURNAL OF CANCER, 98, 1, 14-18 2002/03 英語 研究論文(学術雑誌) 公開
A Kanzaki, Y Takebayashi, H Bando, JF Eliason, S Watanabe, H Miyashita, M Fukumoto, M Toi, T Uchida A Kanzaki, Y Takebayashi, H Bando, JF Eliason, S Watanabe, H Miyashita, M Fukumoto, M Toi, T Uchida A Kanzaki, Y Takebayashi, H Bando, JF Eliason, S Watanabe, H Miyashita, M Fukumoto, M Toi, T Uchida Expression of uridine and thymidine phosphorylase genes in human breast carcinoma Expression of uridine and thymidine phosphorylase genes in human breast carcinoma Expression of uridine and thymidine phosphorylase genes in human breast carcinoma INTERNATIONAL JOURNAL OF CANCER, 97, 5, 631-635 INTERNATIONAL JOURNAL OF CANCER, 97, 5, 631-635 INTERNATIONAL JOURNAL OF CANCER, 97, 5, 631-635 2002/02 英語 研究論文(学術雑誌) 公開
C. Nakanishi, M. Toi, S. Saji, H. Bando C. Nakanishi, M. Toi, S. Saji, H. Bando C. Nakanishi, M. Toi, S. Saji, H. Bando Current indications for mastectomy in patients with breast cancer Current indications for mastectomy in patients with breast cancer Current indications for mastectomy in patients with breast cancer Nippon Geka Gakkai zasshi, 103, 11, 821-824 Nippon Geka Gakkai zasshi, 103, 11, 821-824 Nippon Geka Gakkai zasshi, 103, 11, 821-824 2002 英語 公開
T. Watanabe, M. Sano, M. Toi, T. Saeki, K. Kanda, S. Miura, H. Inaji, H. Sono, H. Saeki, R. Nishimura, Y. Fujita T. Watanabe, M. Sano, M. Toi, T. Saeki, K. Kanda, S. Miura, H. Inaji, H. Sono, H. Saeki, R. Nishimura, Y. Fujita T. Watanabe, M. Sano, M. Toi, T. Saeki, K. Kanda, S. Miura, H. Inaji, H. Sono, H. Saeki, R. Nishimura, Y. Fujita Late phase II study of exemestane in postmenopausal patients with breast cancer resistant to anti-estrogenic agents Late phase II study of exemestane in postmenopausal patients with breast cancer resistant to anti-estrogenic agents Late phase II study of exemestane in postmenopausal patients with breast cancer resistant to anti-estrogenic agents Japanese Journal of Cancer and Chemotherapy, 29, 7, 1211-1221 Japanese Journal of Cancer and Chemotherapy, 29, 7, 1211-1221 Japanese Journal of Cancer and Chemotherapy, 29, 7, 1211-1221 2002 英語 公開
T. Tominaga, M. Toi, Y. Ohashi T. Tominaga, M. Toi, Y. Ohashi T. Tominaga, M. Toi, Y. Ohashi Erratum: Prognostic and predictive value of thymidine phosphorylase activity in early-stage breast cancer patients (Clinical Breast Cancer (2002) vol. 3 (55-64)) Erratum: Prognostic and predictive value of thymidine phosphorylase activity in early-stage breast cancer patients (Clinical Breast Cancer (2002) vol. 3 (55-64)) Erratum: Prognostic and predictive value of thymidine phosphorylase activity in early-stage breast cancer patients (Clinical Breast Cancer (2002) vol. 3 (55-64)) Clinical Breast Cancer, 3, 2, 159- Clinical Breast Cancer, 3, 2, 159- Clinical Breast Cancer, 3, 2, 159- 2002 英語 公開
M. Toi M. Toi M. Toi Proinflammation in human tumor microenvironment: Its status and implication [1] Proinflammation in human tumor microenvironment: Its status and implication [1] Proinflammation in human tumor microenvironment: Its status and implication [1] Medical Science Monitor, 8, 7, LE25-LE26 Medical Science Monitor, 8, 7, LE25-LE26 Medical Science Monitor, 8, 7, LE25-LE26 2002 英語 公開
A Kanzaki, M Toi, N Neamati, H Miyashita, M Oubu, K Nakayama, H Bando, K Ogawa, M Mutoh, S Mori, K Terada, T Sugiyama, M Fukumoto, Y Takebayashi A Kanzaki, M Toi, N Neamati, H Miyashita, M Oubu, K Nakayama, H Bando, K Ogawa, M Mutoh, S Mori, K Terada, T Sugiyama, M Fukumoto, Y Takebayashi A Kanzaki, M Toi, N Neamati, H Miyashita, M Oubu, K Nakayama, H Bando, K Ogawa, M Mutoh, S Mori, K Terada, T Sugiyama, M Fukumoto, Y Takebayashi Copper-transporting P-type adenosine triphosphatase (ATP7B) is expressed in human breast carcinoma Copper-transporting P-type adenosine triphosphatase (ATP7B) is expressed in human breast carcinoma Copper-transporting P-type adenosine triphosphatase (ATP7B) is expressed in human breast carcinoma JAPANESE JOURNAL OF CANCER RESEARCH, 93, 1, 70-77 JAPANESE JOURNAL OF CANCER RESEARCH, 93, 1, 70-77 JAPANESE JOURNAL OF CANCER RESEARCH, 93, 1, 70-77 2002/01 英語 研究論文(学術雑誌) 公開
S. Saji, M. Toi S. Saji, M. Toi S. Saji, M. Toi Aromatase inhibitors and other novel agents in breast cancer treatment Aromatase inhibitors and other novel agents in breast cancer treatment Aromatase inhibitors and other novel agents in breast cancer treatment Expert Opinion on Emerging Drugs, 7, 2, 303-319 Expert Opinion on Emerging Drugs, 7, 2, 303-319 Expert Opinion on Emerging Drugs, 7, 2, 303-319 2002 英語 公開
S. Saji, Y. Omoto, C. Shimizu, S.-I. Horiguchi, T. Watanabe, N. Funata, S.-I. Hayashi, J.-A. Gustafsson, M. Toi S. Saji, Y. Omoto, C. Shimizu, S.-I. Horiguchi, T. Watanabe, N. Funata, S.-I. Hayashi, J.-A. Gustafsson, M. Toi S. Saji, Y. Omoto, C. Shimizu, S.-I. Horiguchi, T. Watanabe, N. Funata, S.-I. Hayashi, J.-A. Gustafsson, M. Toi Clinical impact of assay of estrogen receptorβcx in breast cancer Clinical impact of assay of estrogen receptorβcx in breast cancer Clinical impact of assay of estrogen receptorβcx in breast cancer Breast Cancer, 9, 4, 303-307 Breast Cancer, 9, 4, 303-307 Breast Cancer, 9, 4, 303-307 2002 英語 公開
N Kuroda, LM Guo, M Toi, K Naruse, E Miyazaki, Y Hayashi, C Yoshikawa, S Ashida, T Shuin, H Enzan N Kuroda, LM Guo, M Toi, K Naruse, E Miyazaki, Y Hayashi, C Yoshikawa, S Ashida, T Shuin, H Enzan N Kuroda, LM Guo, M Toi, K Naruse, E Miyazaki, Y Hayashi, C Yoshikawa, S Ashida, T Shuin, H Enzan Paxillin: Application of immunohistochemistry to the diagnosis of chromophobe renal cell carcinoma and oncocytoma Paxillin: Application of immunohistochemistry to the diagnosis of chromophobe renal cell carcinoma and oncocytoma Paxillin: Application of immunohistochemistry to the diagnosis of chromophobe renal cell carcinoma and oncocytoma APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 9, 4, 315-318 APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 9, 4, 315-318 APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 9, 4, 315-318 2001/12 英語 研究論文(学術雑誌) 公開
M Shitashige, M Toi, T Yano, M Shibata, Y Matsuo, F Shibasaki M Shitashige, M Toi, T Yano, M Shibata, Y Matsuo, F Shibasaki M Shitashige, M Toi, T Yano, M Shibata, Y Matsuo, F Shibasaki Dissociation of Bax from a Bcl-2/Bax heterodimer triggered by phosphorylation of serine 70 of Bcl-2 Dissociation of Bax from a Bcl-2/Bax heterodimer triggered by phosphorylation of serine 70 of Bcl-2 Dissociation of Bax from a Bcl-2/Bax heterodimer triggered by phosphorylation of serine 70 of Bcl-2 JOURNAL OF BIOCHEMISTRY, 130, 6, 741-748 JOURNAL OF BIOCHEMISTRY, 130, 6, 741-748 JOURNAL OF BIOCHEMISTRY, 130, 6, 741-748 2001/12 英語 研究論文(学術雑誌) 公開
M Toi, T Matsumoto, H Bando M Toi, T Matsumoto, H Bando M Toi, T Matsumoto, H Bando Vascular endothelial growth factor: its prognostic, predictive, and therapeutic implications Vascular endothelial growth factor: its prognostic, predictive, and therapeutic implications Vascular endothelial growth factor: its prognostic, predictive, and therapeutic implications LANCET ONCOLOGY, 2, 11, 667-673 LANCET ONCOLOGY, 2, 11, 667-673 LANCET ONCOLOGY, 2, 11, 667-673 2001/11 英語 公開
K Nakayama, A Kanzaki, Y Takebayashi, M Toi, H Bando, T Nabei, K Miyazaki, M Fukumoto K Nakayama, A Kanzaki, Y Takebayashi, M Toi, H Bando, T Nabei, K Miyazaki, M Fukumoto K Nakayama, A Kanzaki, Y Takebayashi, M Toi, H Bando, T Nabei, K Miyazaki, M Fukumoto Different features of angiogenesis between ovarian and breast carcinoma Different features of angiogenesis between ovarian and breast carcinoma Different features of angiogenesis between ovarian and breast carcinoma CANCER LETTERS, 170, 2, 161-167 CANCER LETTERS, 170, 2, 161-167 CANCER LETTERS, 170, 2, 161-167 2001/09 英語 研究論文(学術雑誌) 公開
H Saji, M Koike, T Yamori, S Saji, M Seiki, K Matsushima, M Toi H Saji, M Koike, T Yamori, S Saji, M Seiki, K Matsushima, M Toi H Saji, M Koike, T Yamori, S Saji, M Seiki, K Matsushima, M Toi Significant correlation of monocyte chemoattractant protein-1 expression with neovascularization and progression of breast carcinoma Significant correlation of monocyte chemoattractant protein-1 expression with neovascularization and progression of breast carcinoma Significant correlation of monocyte chemoattractant protein-1 expression with neovascularization and progression of breast carcinoma CANCER, 92, 5, 1085-1091 CANCER, 92, 5, 1085-1091 CANCER, 92, 5, 1085-1091 2001/09 英語 研究論文(学術雑誌) 公開
K Kuroi, C Tanaka, M Toi K Kuroi, C Tanaka, M Toi K Kuroi, C Tanaka, M Toi Clinical significance of plasma nucleosome levels in cancer patients Clinical significance of plasma nucleosome levels in cancer patients Clinical significance of plasma nucleosome levels in cancer patients INTERNATIONAL JOURNAL OF ONCOLOGY, 19, 1, 143-148 INTERNATIONAL JOURNAL OF ONCOLOGY, 19, 1, 143-148 INTERNATIONAL JOURNAL OF ONCOLOGY, 19, 1, 143-148 2001/07 英語 研究論文(学術雑誌) 公開
A. Mandic, K. Viktorsson, M. Molin, G. Akusjärvi, H. Eguchi, S.-I. Hayashi, M. Toi, J. Hansson, S. Linder, M.C. Shoshan A. Mandic, K. Viktorsson, M. Molin, G. Akusjärvi, H. Eguchi, S.-I. Hayashi, M. Toi, J. Hansson, S. Linder, M.C. Shoshan A Mandic, K Viktorsson, M Molin, G Akusjarvi, H Eguchi, SI Hayashi, M Toi, J Hansson, S Linder, MC Shoshan Cisplatin induces the proapoptotic conformation of Bak in a ΔMEKK1-dependent manner Cisplatin induces the proapoptotic conformation of Bak in a ΔMEKK1-dependent manner Cisplatin induces the proapoptotic conformation of Bak in a Delta MEKK1-dependent manner Molecular and Cellular Biology, 21, 11, 3684-3691 Molecular and Cellular Biology, 21, 11, 3684-3691 MOLECULAR AND CELLULAR BIOLOGY, 21, 11, 3684-3691 2001/06 英語 研究論文(学術雑誌) 公開
O Ohno, Y Shima, Y Ikeda, SI Kondo, K Kato, M Toi, K Umezawa O Ohno, Y Shima, Y Ikeda, SI Kondo, K Kato, M Toi, K Umezawa O Ohno, Y Shima, Y Ikeda, SI Kondo, K Kato, M Toi, K Umezawa Selective growth inhibition by sangivamycin of human umbilical vein endothelial cells Selective growth inhibition by sangivamycin of human umbilical vein endothelial cells Selective growth inhibition by sangivamycin of human umbilical vein endothelial cells INTERNATIONAL JOURNAL OF ONCOLOGY, 18, 5, 1009-1015 INTERNATIONAL JOURNAL OF ONCOLOGY, 18, 5, 1009-1015 INTERNATIONAL JOURNAL OF ONCOLOGY, 18, 5, 1009-1015 2001/05 英語 研究論文(学術雑誌) 公開
A Kanzaki, M Toi, K Nakayama, H Bando, M Mutoh, T Uchida, M Fukumoto, Y Takebayashi A Kanzaki, M Toi, K Nakayama, H Bando, M Mutoh, T Uchida, M Fukumoto, Y Takebayashi A Kanzaki, M Toi, K Nakayama, H Bando, M Mutoh, T Uchida, M Fukumoto, Y Takebayashi Expression of multidrug resistance-related transporters in human breast carcinoma Expression of multidrug resistance-related transporters in human breast carcinoma Expression of multidrug resistance-related transporters in human breast carcinoma JAPANESE JOURNAL OF CANCER RESEARCH, 92, 4, 452-458 JAPANESE JOURNAL OF CANCER RESEARCH, 92, 4, 452-458 JAPANESE JOURNAL OF CANCER RESEARCH, 92, 4, 452-458 2001/04 英語 研究論文(学術雑誌) 公開
K Kuroi, C Tanaka, M Toi K Kuroi, C Tanaka, M Toi K Kuroi, C Tanaka, M Toi Circulating levels of endostatin in cancer patients Circulating levels of endostatin in cancer patients Circulating levels of endostatin in cancer patients ONCOLOGY REPORTS, 8, 2, 405-409 ONCOLOGY REPORTS, 8, 2, 405-409 ONCOLOGY REPORTS, 8, 2, 405-409 2001/03 英語 研究論文(学術雑誌) 公開
N Tsuneyoshi, K Fukudome, S Horiguchi, XF Ye, M Matsuzaki, M Toi, K Suzuki, M Kimoto N Tsuneyoshi, K Fukudome, S Horiguchi, XF Ye, M Matsuzaki, M Toi, K Suzuki, M Kimoto N Tsuneyoshi, K Fukudome, S Horiguchi, XF Ye, M Matsuzaki, M Toi, K Suzuki, M Kimoto Expression and anticoagulant function of the endothelial cell protein C receptor (EPCR) in cancer cell lines Expression and anticoagulant function of the endothelial cell protein C receptor (EPCR) in cancer cell lines Expression and anticoagulant function of the endothelial cell protein C receptor (EPCR) in cancer cell lines THROMBOSIS AND HAEMOSTASIS, 85, 2, 356-361 THROMBOSIS AND HAEMOSTASIS, 85, 2, 356-361 THROMBOSIS AND HAEMOSTASIS, 85, 2, 356-361 2001/02 英語 研究論文(学術雑誌) 公開
S Saji, N Okumura, H Eguchi, S Nakashima, A Suzuki, M Toi, Y Nozawa, S Saji, S Hayashi S Saji, N Okumura, H Eguchi, S Nakashima, A Suzuki, M Toi, Y Nozawa, S Saji, S Hayashi S Saji, N Okumura, H Eguchi, S Nakashima, A Suzuki, M Toi, Y Nozawa, S Saji, S Hayashi MDM2 enhances the function of estrogen receptor alpha in human breast cancer cells MDM2 enhances the function of estrogen receptor alpha in human breast cancer cells MDM2 enhances the function of estrogen receptor alpha in human breast cancer cells BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 281, 1, 259-265 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 281, 1, 259-265 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 281, 1, 259-265 2001/02 英語 研究論文(学術雑誌) 公開
H. Kodama, I. To, J. Ishiwata, Y. Shinohara, N. Katayanagi, K. Kubota, T. Murakami, K. Kuroi, K. Hayashi, M. Toi H. Kodama, I. To, J. Ishiwata, Y. Shinohara, N. Katayanagi, K. Kubota, T. Murakami, K. Kuroi, K. Hayashi, M. Toi H. Kodama, I. To, J. Ishiwata, Y. Shinohara, N. Katayanagi, K. Kubota, T. Murakami, K. Kuroi, K. Hayashi, M. Toi MEN2A incidentally detected by high level of CEA and family history MEN2A incidentally detected by high level of CEA and family history MEN2A incidentally detected by high level of CEA and family history [Zasshi] Journal. Nihon Naika Gakkai, 90, 4, 683-686 [Zasshi] Journal. Nihon Naika Gakkai, 90, 4, 683-686 [Zasshi] Journal. Nihon Naika Gakkai, 90, 4, 683-686 2001 英語 公開
M. Toi, Y. Bando, S. Saji, T. Matsumoto M. Toi, Y. Bando, S. Saji, T. Matsumoto M. Toi, Y. Bando, S. Saji, T. Matsumoto Tumor angiogenesis and hypoxia Tumor angiogenesis and hypoxia Tumor angiogenesis and hypoxia Biotherapy, 15, 6, 663-668 Biotherapy, 15, 6, 663-668 Biotherapy, 15, 6, 663-668 2001 英語 公開
K. Kuroi, H. Bando, S. Nagai, C. Tanaka, K. Hayashi, M. Toi K. Kuroi, H. Bando, S. Nagai, C. Tanaka, K. Hayashi, M. Toi K. Kuroi, H. Bando, S. Nagai, C. Tanaka, K. Hayashi, M. Toi Efficacy of weekly docetaxel therapy for advanced or recurrent breast cancer Efficacy of weekly docetaxel therapy for advanced or recurrent breast cancer Efficacy of weekly docetaxel therapy for advanced or recurrent breast cancer Japanese Journal of Cancer and Chemotherapy, 28, 6, 797-802 Japanese Journal of Cancer and Chemotherapy, 28, 6, 797-802 Japanese Journal of Cancer and Chemotherapy, 28, 6, 797-802 2001 英語 公開
G. Matsumoto, S. Nagai, M. Toi, S. Ishiyama, K. Kuroi, K. Turuta, A. Okamoto, T. Takahashi G. Matsumoto, S. Nagai, M. Toi, S. Ishiyama, K. Kuroi, K. Turuta, A. Okamoto, T. Takahashi G. Matsumoto, S. Nagai, M. Toi, S. Ishiyama, K. Kuroi, K. Turuta, A. Okamoto, T. Takahashi KRN7000 inhibit hepatic metastasis of pancreatic cancer KRN7000 inhibit hepatic metastasis of pancreatic cancer KRN7000 inhibit hepatic metastasis of pancreatic cancer Nippon Geka Gakkai zasshi, 102, 5, 421- Nippon Geka Gakkai zasshi, 102, 5, 421- Nippon Geka Gakkai zasshi, 102, 5, 421- 2001 英語 公開
K Kuroi, M Toi K Kuroi, M Toi K Kuroi, M Toi Circulating angiogenesis regulators in cancer patients Circulating angiogenesis regulators in cancer patients Circulating angiogenesis regulators in cancer patients INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 16, 1, 5-26 INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 16, 1, 5-26 INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 16, 1, 5-26 2001/01 英語 公開
S. Umemura, G. Sakamoto, H. Sasano, H. Tsuda, F. Akiyama, M. Kurosumi, Y. Tokuda, T. Watanabe, M. Toi, T. Hasegawa, R. Yoshiyuki Osamura S. Umemura, G. Sakamoto, H. Sasano, H. Tsuda, F. Akiyama, M. Kurosumi, Y. Tokuda, T. Watanabe, M. Toi, T. Hasegawa, R. Yoshiyuki Osamura S. Umemura, G. Sakamoto, H. Sasano, H. Tsuda, F. Akiyama, M. Kurosumi, Y. Tokuda, T. Watanabe, M. Toi, T. Hasegawa, R. Yoshiyuki Osamura Evaluation of HER2 status: For the treatment of metastatic breast cancers by humanized anti-HER2 monoclonal antibody (trastuzumab) (pathological committee for optimal use of trastuzumab) Evaluation of HER2 status: For the treatment of metastatic breast cancers by humanized anti-HER2 monoclonal antibody (trastuzumab) (pathological committee for optimal use of trastuzumab) Evaluation of HER2 status: For the treatment of metastatic breast cancers by humanized anti-HER2 monoclonal antibody (trastuzumab) (pathological committee for optimal use of trastuzumab) Breast Cancer, 8, 4, 316-320 Breast Cancer, 8, 4, 316-320 Breast Cancer, 8, 4, 316-320 2001 英語 公開
M. Toi, H. Bando, S. Saji M. Toi, H. Bando, S. Saji M. Toi, H. Bando, S. Saji Aromatase and aromatase inhibitors Aromatase and aromatase inhibitors Aromatase and aromatase inhibitors Breast Cancer, 8, 4, 329-332 Breast Cancer, 8, 4, 329-332 Breast Cancer, 8, 4, 329-332 2001 英語 公開
G Gasparini, M Toi, E Biganzoli, R Dittadi, M Fanelli, A Morabito, P Boracchi, M Gion G Gasparini, M Toi, E Biganzoli, R Dittadi, M Fanelli, A Morabito, P Boracchi, M Gion G Gasparini, M Toi, E Biganzoli, R Dittadi, M Fanelli, A Morabito, P Boracchi, M Gion Thrombospondin-l and-2 in node-negative breast cancer: Correlation with angiogenic factors, p53, cathepsin D, hormone receptors and prognosis Thrombospondin-l and-2 in node-negative breast cancer: Correlation with angiogenic factors, p53, cathepsin D, hormone receptors and prognosis Thrombospondin-l and-2 in node-negative breast cancer: Correlation with angiogenic factors, p53, cathepsin D, hormone receptors and prognosis ONCOLOGY, 60, 1, 72-80 ONCOLOGY, 60, 1, 72-80 ONCOLOGY, 60, 1, 72-80 2001 英語 研究論文(学術雑誌) 公開
K Hattori, M Muta, M Toi, H Iizasa, M Shinsei, T Terasaki, M Obinata, M Ueda, E Nakashima K Hattori, M Muta, M Toi, H Iizasa, M Shinsei, T Terasaki, M Obinata, M Ueda, E Nakashima K Hattori, M Muta, M Toi, H Iizasa, M Shinsei, T Terasaki, M Obinata, M Ueda, E Nakashima Establishment of bone marrow-derived endothelial cell lines from ts-SV40 T-antigen gene transgenic rats Establishment of bone marrow-derived endothelial cell lines from ts-SV40 T-antigen gene transgenic rats Establishment of bone marrow-derived endothelial cell lines from ts-SV40 T-antigen gene transgenic rats PHARMACEUTICAL RESEARCH, 18, 1, 9-15 PHARMACEUTICAL RESEARCH, 18, 1, 9-15 PHARMACEUTICAL RESEARCH, 18, 1, 9-15 2001/01 英語 研究論文(学術雑誌) 公開
M. Miyaki, T. Iijima, K. Hosono, R. Ishii, M. Yasuno, T. Mori, M. Toi, T. Hishima, N. Shitara, K. Tamura, J. Utsunomiya, N. Kobayashi, T. Kuroki, T. Iwama M. Miyaki, T. Iijima, K. Hosono, R. Ishii, M. Yasuno, T. Mori, M. Toi, T. Hishima, N. Shitara, K. Tamura, J. Utsunomiya, N. Kobayashi, T. Kuroki, T. Iwama M Miyaki, T Iijima, K Hosono, R Ishii, M Yasuno, T Mori, M Toi, T Hishima, N Shitara, K Tamura, J Utsunomiya, N Kobayashi, T Kuroki, T Iwama Somatic mutations of LKB1 and β-catenin genes in gastrointestinal polyps from patients with Peutz-Jeghers syndrome Somatic mutations of LKB1 and β-catenin genes in gastrointestinal polyps from patients with Peutz-Jeghers syndrome Somatic mutations of LKB1 and beta-catenin genes in gastrointestinal polyps from patients with Peutz-Jeghers syndrome Cancer Research, 60, 22, 6311-6313 Cancer Research, 60, 22, 6311-6313 CANCER RESEARCH, 60, 22, 6311-6313 2000/11 英語 研究論文(学術雑誌) 公開
M Seki, M Toi, K Kobayashi, K Shitara, K Umezawa, BK Seon, M Kan, JS Rhim M Seki, M Toi, K Kobayashi, K Shitara, K Umezawa, BK Seon, M Kan, JS Rhim M Seki, M Toi, K Kobayashi, K Shitara, K Umezawa, BK Seon, M Kan, JS Rhim Differential behavior of VEGF receptor expression and response to TNP-470 in two immortalized human endothelial cell lines Differential behavior of VEGF receptor expression and response to TNP-470 in two immortalized human endothelial cell lines Differential behavior of VEGF receptor expression and response to TNP-470 in two immortalized human endothelial cell lines INTERNATIONAL JOURNAL OF ONCOLOGY, 17, 3, 525-533 INTERNATIONAL JOURNAL OF ONCOLOGY, 17, 3, 525-533 INTERNATIONAL JOURNAL OF ONCOLOGY, 17, 3, 525-533 2000/09 英語 研究論文(学術雑誌) 公開
M Tozaki, M Toi, Y Miyamoto, K Fukuda M Tozaki, M Toi, Y Miyamoto, K Fukuda M Tozaki, M Toi, Y Miyamoto, K Fukuda Power Doppler sonography of breast masses: Correlation of Doppler spectral parameters with tumor angiogenesis and histologic growth pattern Power Doppler sonography of breast masses: Correlation of Doppler spectral parameters with tumor angiogenesis and histologic growth pattern Power Doppler sonography of breast masses: Correlation of Doppler spectral parameters with tumor angiogenesis and histologic growth pattern JOURNAL OF ULTRASOUND IN MEDICINE, 19, 9, 593-600 JOURNAL OF ULTRASOUND IN MEDICINE, 19, 9, 593-600 JOURNAL OF ULTRASOUND IN MEDICINE, 19, 9, 593-600 2000/09 英語 研究論文(学術雑誌) 公開
T Ueno, M Toi, H Saji, M Muta, H Bando, K Kuroi, M Koike, H Inadera, K Matsushima T Ueno, M Toi, H Saji, M Muta, H Bando, K Kuroi, M Koike, H Inadera, K Matsushima T Ueno, M Toi, H Saji, M Muta, H Bando, K Kuroi, M Koike, H Inadera, K Matsushima Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer CLINICAL CANCER RESEARCH, 6, 8, 3282-3289 CLINICAL CANCER RESEARCH, 6, 8, 3282-3289 CLINICAL CANCER RESEARCH, 6, 8, 3282-3289 2000/08 英語 研究論文(学術雑誌) 公開
K Mori, M Hasegawa, M Nishida, H Toma, M Fukuda, T Kubota, N Nagasue, H Yamana, KHY Chung, T Ikeda, K Takasaki, M Oka, M Kameyama, M Toi, H Fujii, M Kitamura, M Murai, H Sasaki, S Ozono, H Makuuchi, Y Shimada, Y Onishi, S Aoyagi, K Mizutani, M Ogawa, A Nakao, H Kinoshita, T Tono, H Imamoto, Y Nakashima, T Manabe K Mori, M Hasegawa, M Nishida, H Toma, M Fukuda, T Kubota, N Nagasue, H Yamana, KHY Chung, T Ikeda, K Takasaki, M Oka, M Kameyama, M Toi, H Fujii, M Kitamura, M Murai, H Sasaki, S Ozono, H Makuuchi, Y Shimada, Y Onishi, S Aoyagi, K Mizutani, M Ogawa, A Nakao, H Kinoshita, T Tono, H Imamoto, Y Nakashima, T Manabe K Mori, M Hasegawa, M Nishida, H Toma, M Fukuda, T Kubota, N Nagasue, H Yamana, KHY Chung, T Ikeda, K Takasaki, M Oka, M Kameyama, M Toi, H Fujii, M Kitamura, M Murai, H Sasaki, S Ozono, H Makuuchi, Y Shimada, Y Onishi, S Aoyagi, K Mizutani, M Ogawa, A Nakao, H Kinoshita, T Tono, H Imamoto, Y Nakashima, T Manabe Expression levels of thymidine phosphorylase and dihydropyrimidine dehydrogenase in various human tumor tissues Expression levels of thymidine phosphorylase and dihydropyrimidine dehydrogenase in various human tumor tissues Expression levels of thymidine phosphorylase and dihydropyrimidine dehydrogenase in various human tumor tissues INTERNATIONAL JOURNAL OF ONCOLOGY, 17, 1, 33-38 INTERNATIONAL JOURNAL OF ONCOLOGY, 17, 1, 33-38 INTERNATIONAL JOURNAL OF ONCOLOGY, 17, 1, 33-38 2000/07 英語 研究論文(学術雑誌) 公開
T Ueno, M Toi, M Koike, S Nakamura, T Tominaga T Ueno, M Toi, M Koike, S Nakamura, T Tominaga T Ueno, M Toi, M Koike, S Nakamura, T Tominaga Tissue factor expression in breast cancer tissues: its correlation with prognosis and plasma concentration Tissue factor expression in breast cancer tissues: its correlation with prognosis and plasma concentration Tissue factor expression in breast cancer tissues: its correlation with prognosis and plasma concentration BRITISH JOURNAL OF CANCER, 83, 2, 164-170 BRITISH JOURNAL OF CANCER, 83, 2, 164-170 BRITISH JOURNAL OF CANCER, 83, 2, 164-170 2000/07 英語 研究論文(学術雑誌) 公開
H Eguchi, K Suga, H Saji, M Toi, K Nakachi, SI Hayashi H Eguchi, K Suga, H Saji, M Toi, K Nakachi, SI Hayashi H Eguchi, K Suga, H Saji, M Toi, K Nakachi, SI Hayashi Different expression patterns of Bcl-2 family genes in breast cancer by estrogen receptor status with special reference to pro-apoptotic Bak gene Different expression patterns of Bcl-2 family genes in breast cancer by estrogen receptor status with special reference to pro-apoptotic Bak gene Different expression patterns of Bcl-2 family genes in breast cancer by estrogen receptor status with special reference to pro-apoptotic Bak gene CELL DEATH AND DIFFERENTIATION, 7, 5, 439-446 CELL DEATH AND DIFFERENTIATION, 7, 5, 439-446 CELL DEATH AND DIFFERENTIATION, 7, 5, 439-446 2000/05 英語 研究論文(学術雑誌) 公開
H Bando, M Toi H Bando, M Toi H Bando, M Toi Tumor angiogenesis, macrophages, and cytokines Tumor angiogenesis, macrophages, and cytokines Tumor angiogenesis, macrophages, and cytokines ANGIOGENESIS: FROM THE MOLECULAR TO INTEGRATIVE PHARMACOLOGY, 476, 267-284 ANGIOGENESIS: FROM THE MOLECULAR TO INTEGRATIVE PHARMACOLOGY, 476, 267-284 ANGIOGENESIS: FROM THE MOLECULAR TO INTEGRATIVE PHARMACOLOGY, 476, 267-284 2000 英語 研究論文(学術雑誌) 公開
M. Toi, G. Matsumoto M. Toi, G. Matsumoto M. Toi, G. Matsumoto Isolated tumor cells and micrometastasis--clinical behavior and therapeutic implications Isolated tumor cells and micrometastasis--clinical behavior and therapeutic implications Isolated tumor cells and micrometastasis--clinical behavior and therapeutic implications Japanese Journal of Cancer and Chemotherapy, 27, 9, 1315-1336 Japanese Journal of Cancer and Chemotherapy, 27, 9, 1315-1336 Japanese Journal of Cancer and Chemotherapy, 27, 9, 1315-1336 2000 英語 公開
M. Toi, G. Matsumoto, H. Bando, K. Kuroi M. Toi, G. Matsumoto, H. Bando, K. Kuroi M. Toi, G. Matsumoto, H. Bando, K. Kuroi Antiangiogenesis therapy and hormone therapy--their resemblance and applications of prognostic and predictive factors Antiangiogenesis therapy and hormone therapy--their resemblance and applications of prognostic and predictive factors Antiangiogenesis therapy and hormone therapy--their resemblance and applications of prognostic and predictive factors Japanese Journal of Cancer and Chemotherapy, 27, 8, 1212-1216 Japanese Journal of Cancer and Chemotherapy, 27, 8, 1212-1216 Japanese Journal of Cancer and Chemotherapy, 27, 8, 1212-1216 2000 英語 公開
K. Kuroi, M. Toi K. Kuroi, M. Toi K. Kuroi, M. Toi Angiogenesis as a prognostic factor of breast cancers Angiogenesis as a prognostic factor of breast cancers Angiogenesis as a prognostic factor of breast cancers Nippon rinsho. Japanese journal of clinical medicine, 58 Suppl, 435-441 Nippon rinsho. Japanese journal of clinical medicine, 58 Suppl, 435-441 Nippon rinsho. Japanese journal of clinical medicine, 58 Suppl, 435-441 2000 英語 公開
C. Tanaka, M. Toi C. Tanaka, M. Toi C. Tanaka, M. Toi Capecitabine for treatment of advanced breast cancers Capecitabine for treatment of advanced breast cancers Capecitabine for treatment of advanced breast cancers Nippon rinsho. Japanese journal of clinical medicine, 58 Suppl, 279-283 Nippon rinsho. Japanese journal of clinical medicine, 58 Suppl, 279-283 Nippon rinsho. Japanese journal of clinical medicine, 58 Suppl, 279-283 2000 英語 公開
M. Toi, H. Bando, K. Kuroi M. Toi, H. Bando, K. Kuroi M. Toi, H. Bando, K. Kuroi The predictive value of angiogenesis for adjuvant therapy in breast cancer The predictive value of angiogenesis for adjuvant therapy in breast cancer The predictive value of angiogenesis for adjuvant therapy in breast cancer Breast Cancer, 7, 4, 311-314 Breast Cancer, 7, 4, 311-314 Breast Cancer, 7, 4, 311-314 2000 英語 公開
S. Nagai, M. Toi S. Nagai, M. Toi S. Nagai, M. Toi Interleukin-4 and breast cancer Interleukin-4 and breast cancer Interleukin-4 and breast cancer Breast Cancer, 7, 3, 181-186 Breast Cancer, 7, 3, 181-186 Breast Cancer, 7, 3, 181-186 2000 英語 公開
J Kurebayashi, H Sonoo, H Inaji, R Nishimura, Y Iino, M Toi, S Kobayashi, T Saeki J Kurebayashi, H Sonoo, H Inaji, R Nishimura, Y Iino, M Toi, S Kobayashi, T Saeki J Kurebayashi, H Sonoo, H Inaji, R Nishimura, Y Iino, M Toi, S Kobayashi, T Saeki Endocrine therapies for patients with recurrent breast cancer: Predictive factors for responses to first- and second-line endocrine therapies Endocrine therapies for patients with recurrent breast cancer: Predictive factors for responses to first- and second-line endocrine therapies Endocrine therapies for patients with recurrent breast cancer: Predictive factors for responses to first- and second-line endocrine therapies ONCOLOGY, 59, SUPPL. 1, 31-37 ONCOLOGY, 59, SUPPL. 1, 31-37 ONCOLOGY, 59, SUPPL. 1, 31-37 2000 英語 研究論文(学術雑誌) 公開
M Toi, M Gion, H Saji, M Asano, R Dittadi, S Gilberti, N Locopo, G Gasparini M Toi, M Gion, H Saji, M Asano, R Dittadi, S Gilberti, N Locopo, G Gasparini M Toi, M Gion, H Saji, M Asano, R Dittadi, S Gilberti, N Locopo, G Gasparini Endogenous interleukin-12: Relationship with angiogenic factors, hormone receptors and nodal status in human breast carcinoma Endogenous interleukin-12: Relationship with angiogenic factors, hormone receptors and nodal status in human breast carcinoma Endogenous interleukin-12: Relationship with angiogenic factors, hormone receptors and nodal status in human breast carcinoma INTERNATIONAL JOURNAL OF ONCOLOGY, 15, 6, 1169-1175 INTERNATIONAL JOURNAL OF ONCOLOGY, 15, 6, 1169-1175 INTERNATIONAL JOURNAL OF ONCOLOGY, 15, 6, 1169-1175 1999/12 英語 研究論文(学術雑誌) 公開
T Ueno, M Toi, T Tominaga T Ueno, M Toi, T Tominaga T Ueno, M Toi, T Tominaga Circulating soluble Fas concentration in breast cancer patients Circulating soluble Fas concentration in breast cancer patients Circulating soluble Fas concentration in breast cancer patients CLINICAL CANCER RESEARCH, 5, 11, 3529-3533 CLINICAL CANCER RESEARCH, 5, 11, 3529-3533 CLINICAL CANCER RESEARCH, 5, 11, 3529-3533 1999/11 英語 研究論文(学術雑誌) 公開
SI Kumeda, A Deguchi, M Toi, S Omura, K Umezawa SI Kumeda, A Deguchi, M Toi, S Omura, K Umezawa SI Kumeda, A Deguchi, M Toi, S Omura, K Umezawa Induction of G1 arrest and selective growth inhibition by lactacystin in human umbilical vein endothelial cells Induction of G1 arrest and selective growth inhibition by lactacystin in human umbilical vein endothelial cells Induction of G1 arrest and selective growth inhibition by lactacystin in human umbilical vein endothelial cells ANTICANCER RESEARCH, 19, 5B, 3961-3968 ANTICANCER RESEARCH, 19, 5B, 3961-3968 ANTICANCER RESEARCH, 19, 5B, 3961-3968 1999/09 英語 研究論文(学術雑誌) 公開
S Ishigaki, M Toi, T Ueno, H Matsumoto, M Muta, M Koike, M Seiki S Ishigaki, M Toi, T Ueno, H Matsumoto, M Muta, M Koike, M Seiki S Ishigaki, M Toi, T Ueno, H Matsumoto, M Muta, M Koike, M Seiki Significance of membrane type 1 matrix metalloproteinase expression in breast cancer Significance of membrane type 1 matrix metalloproteinase expression in breast cancer Significance of membrane type 1 matrix metalloproteinase expression in breast cancer JAPANESE JOURNAL OF CANCER RESEARCH, 90, 5, 516-522 JAPANESE JOURNAL OF CANCER RESEARCH, 90, 5, 516-522 JAPANESE JOURNAL OF CANCER RESEARCH, 90, 5, 516-522 1999/05 英語 研究論文(学術雑誌) 公開
M Toi, T Ueno, H Matsumoto, H Saji, N Funata, M Koike, T Tominaga M Toi, T Ueno, H Matsumoto, H Saji, N Funata, M Koike, T Tominaga M Toi, T Ueno, H Matsumoto, H Saji, N Funata, M Koike, T Tominaga Significance of thymidine phosphorylase as a marker of protumor monocytes in breast cancer Significance of thymidine phosphorylase as a marker of protumor monocytes in breast cancer Significance of thymidine phosphorylase as a marker of protumor monocytes in breast cancer CLINICAL CANCER RESEARCH, 5, 5, 1131-1137 CLINICAL CANCER RESEARCH, 5, 5, 1131-1137 CLINICAL CANCER RESEARCH, 5, 5, 1131-1137 1999/05 英語 研究論文(学術雑誌) 公開
G Gasparini, M Toi, R Miceli, PB Vermeulen, R Dittadi, E Biganzoli, A Morabito, M Fanelli, C Gatti, H Suzuki, T Tominaga, LY Dirix, M Gion G Gasparini, M Toi, R Miceli, PB Vermeulen, R Dittadi, E Biganzoli, A Morabito, M Fanelli, C Gatti, H Suzuki, T Tominaga, LY Dirix, M Gion G Gasparini, M Toi, R Miceli, PB Vermeulen, R Dittadi, E Biganzoli, A Morabito, M Fanelli, C Gatti, H Suzuki, T Tominaga, LY Dirix, M Gion Clinical relevance of vascular endothelial growth factor and thymidine phosphorylase in patients with node-positive breast cancer treated with either adjuvant chemotherapy or hormone therapy Clinical relevance of vascular endothelial growth factor and thymidine phosphorylase in patients with node-positive breast cancer treated with either adjuvant chemotherapy or hormone therapy Clinical relevance of vascular endothelial growth factor and thymidine phosphorylase in patients with node-positive breast cancer treated with either adjuvant chemotherapy or hormone therapy CANCER JOURNAL FROM SCIENTIFIC AMERICAN, 5, 2, 101-111 CANCER JOURNAL FROM SCIENTIFIC AMERICAN, 5, 2, 101-111 CANCER JOURNAL FROM SCIENTIFIC AMERICAN, 5, 2, 101-111 1999/03 英語 研究論文(学術雑誌) 公開
S Saji, S Nakashima, S Hayashi, M Toi, S Saji, Y Nozawa S Saji, S Nakashima, S Hayashi, M Toi, S Saji, Y Nozawa S Saji, S Nakashima, S Hayashi, M Toi, S Saji, Y Nozawa Overexpression of MDM2 in MCF-7 promotes both growth advantage and p53 accumulation in response to estradiol Overexpression of MDM2 in MCF-7 promotes both growth advantage and p53 accumulation in response to estradiol Overexpression of MDM2 in MCF-7 promotes both growth advantage and p53 accumulation in response to estradiol JAPANESE JOURNAL OF CANCER RESEARCH, 90, 2, 210-218 JAPANESE JOURNAL OF CANCER RESEARCH, 90, 2, 210-218 JAPANESE JOURNAL OF CANCER RESEARCH, 90, 2, 210-218 1999/02 英語 研究論文(学術雑誌) 公開
S. Nagai, M. Toi, K. Kuroi, K. Hayashi, T. Tominaga S. Nagai, M. Toi, K. Kuroi, K. Hayashi, T. Tominaga S. Nagai, M. Toi, K. Kuroi, K. Hayashi, T. Tominaga Docetaxel as a single agent in cases of advanced/recurrent breast cancer previously treated with anthracycline Docetaxel as a single agent in cases of advanced/recurrent breast cancer previously treated with anthracycline Docetaxel as a single agent in cases of advanced/recurrent breast cancer previously treated with anthracycline Gan to kagaku ryoho. Cancer & chemotherapy, 26, 13, 2037-2042 Gan to kagaku ryoho. Cancer & chemotherapy, 26, 13, 2037-2042 Gan to kagaku ryoho. Cancer & chemotherapy, 26, 13, 2037-2042 1999 英語 公開
M. Toi, H. Saji M. Toi, H. Saji M. Toi, H. Saji Thymidine phosphorylase targeting treatment Thymidine phosphorylase targeting treatment Thymidine phosphorylase targeting treatment Biotherapy, 13, 2, 166-172 Biotherapy, 13, 2, 166-172 Biotherapy, 13, 2, 166-172 1999 英語 公開
M. Toi, M. Seki M. Toi, M. Seki M. Toi, M. Seki Assessment of angiogenesis inhibitors using cultured endothelial cells Assessment of angiogenesis inhibitors using cultured endothelial cells Assessment of angiogenesis inhibitors using cultured endothelial cells Biotherapy, 13, 6, 675-678 Biotherapy, 13, 6, 675-678 Biotherapy, 13, 6, 675-678 1999 英語 公開
H. Sonoo, J. Kurebayashi, Y. Lino, H. Inaji, T. Watanabe, M. Toi, S. Kobayashi, B. Sato, M. Yoshimoto H. Sonoo, J. Kurebayashi, Y. Lino, H. Inaji, T. Watanabe, M. Toi, S. Kobayashi, B. Sato, M. Yoshimoto H. Sonoo, J. Kurebayashi, Y. Lino, H. Inaji, T. Watanabe, M. Toi, S. Kobayashi, B. Sato, M. Yoshimoto Current status and controversial issues concerning endocrine therapy for patients with recurrent breast cancer in Japan Current status and controversial issues concerning endocrine therapy for patients with recurrent breast cancer in Japan Current status and controversial issues concerning endocrine therapy for patients with recurrent breast cancer in Japan Breast Cancer, 6, 4, 344-350 Breast Cancer, 6, 4, 344-350 Breast Cancer, 6, 4, 344-350 1999 英語 公開
K. Kuroi, C. Tanaka, M. Toi K. Kuroi, C. Tanaka, M. Toi K. Kuroi, C. Tanaka, M. Toi Plasma nucleosome levels in node-negative breast cancer patients Plasma nucleosome levels in node-negative breast cancer patients Plasma nucleosome levels in node-negative breast cancer patients Breast Cancer, 6, 4, 361-364 Breast Cancer, 6, 4, 361-364 Breast Cancer, 6, 4, 361-364 1999 英語 公開
M Kitamura, M Toi, K Arai, Y Iwasaki, H Suzuki, K Matsuo M Kitamura, M Toi, K Arai, Y Iwasaki, H Suzuki, K Matsuo M Kitamura, M Toi, K Arai, Y Iwasaki, H Suzuki, K Matsuo Concentrations of vascular endothelial growth factor in the sera of gastric cancer patients Concentrations of vascular endothelial growth factor in the sera of gastric cancer patients Concentrations of vascular endothelial growth factor in the sera of gastric cancer patients ONCOLOGY REPORTS, 5, 6, 1419-1424 ONCOLOGY REPORTS, 5, 6, 1419-1424 ONCOLOGY REPORTS, 5, 6, 1419-1424 1998/11 英語 研究論文(学術雑誌) 公開
T Ueno, M Toi, T Taniguchi, T Tominaga T Ueno, M Toi, T Taniguchi, T Tominaga T Ueno, M Toi, T Taniguchi, T Tominaga Serum hepatocyte growth factor levels in breast cancer patients with distant metastases Serum hepatocyte growth factor levels in breast cancer patients with distant metastases Serum hepatocyte growth factor levels in breast cancer patients with distant metastases CANCER JOURNAL, 11, 3, 147-152 CANCER JOURNAL, 11, 3, 147-152 CANCER JOURNAL, 11, 3, 147-152 1998/05 英語 研究論文(学術雑誌) 公開
T Kurizaki, M Toi, T Tominaga T Kurizaki, M Toi, T Tominaga T Kurizaki, M Toi, T Tominaga Relationship between matrix metalloproteinase expression and tumor angiogenesis in human breast carcinoma Relationship between matrix metalloproteinase expression and tumor angiogenesis in human breast carcinoma Relationship between matrix metalloproteinase expression and tumor angiogenesis in human breast carcinoma ONCOLOGY REPORTS, 5, 3, 673-677 ONCOLOGY REPORTS, 5, 3, 673-677 ONCOLOGY REPORTS, 5, 3, 673-677 1998/05 英語 研究論文(学術雑誌) 公開
G Gasparini, M Toi, P Verderio, G Ranieri, S Dante, E Bonoldi, P Boracchi, M Fanelli, T Tominaga G Gasparini, M Toi, P Verderio, G Ranieri, S Dante, E Bonoldi, P Boracchi, M Fanelli, T Tominaga G Gasparini, M Toi, P Verderio, G Ranieri, S Dante, E Bonoldi, P Boracchi, M Fanelli, T Tominaga Prognostic significance of p53, angiogenesis, and other conventional features in operable breast cancer: subanalysis in node-positive and node-negative patients Prognostic significance of p53, angiogenesis, and other conventional features in operable breast cancer: subanalysis in node-positive and node-negative patients Prognostic significance of p53, angiogenesis, and other conventional features in operable breast cancer: subanalysis in node-positive and node-negative patients INTERNATIONAL JOURNAL OF ONCOLOGY, 12, 5, 1117-1125 INTERNATIONAL JOURNAL OF ONCOLOGY, 12, 5, 1117-1125 INTERNATIONAL JOURNAL OF ONCOLOGY, 12, 5, 1117-1125 1998/05 英語 研究論文(学術雑誌) 公開
M Toi, T Taniguchi, T Ueno, M Asano, N Funata, K Sekiguchi, H Iwanari, T Tominaga M Toi, T Taniguchi, T Ueno, M Asano, N Funata, K Sekiguchi, H Iwanari, T Tominaga M Toi, T Taniguchi, T Ueno, M Asano, N Funata, K Sekiguchi, H Iwanari, T Tominaga Significance of circulating hepatocyte growth factor level as a prognostic indicator in primary breast cancer Significance of circulating hepatocyte growth factor level as a prognostic indicator in primary breast cancer Significance of circulating hepatocyte growth factor level as a prognostic indicator in primary breast cancer CLINICAL CANCER RESEARCH, 4, 3, 659-664 CLINICAL CANCER RESEARCH, 4, 3, 659-664 CLINICAL CANCER RESEARCH, 4, 3, 659-664 1998/03 英語 研究論文(学術雑誌) 公開
A Suzuki, M Toi, Y Yamamoto, S Saji, M Muta, T Tominaga A Suzuki, M Toi, Y Yamamoto, S Saji, M Muta, T Tominaga A Suzuki, M Toi, Y Yamamoto, S Saji, M Muta, T Tominaga Role of MDM2 overexpression in doxorubicin resistance of breast carcinoma Role of MDM2 overexpression in doxorubicin resistance of breast carcinoma Role of MDM2 overexpression in doxorubicin resistance of breast carcinoma JAPANESE JOURNAL OF CANCER RESEARCH, 89, 2, 221-227 JAPANESE JOURNAL OF CANCER RESEARCH, 89, 2, 221-227 JAPANESE JOURNAL OF CANCER RESEARCH, 89, 2, 221-227 1998/02 英語 研究論文(学術雑誌) 公開
M. Toi M. Toi M. Toi Antiangiogenic therapy Antiangiogenic therapy Antiangiogenic therapy Gan to kagaku ryoho. Cancer & chemotherapy, 25, 13, 2003-2009 Gan to kagaku ryoho. Cancer & chemotherapy, 25, 13, 2003-2009 Gan to kagaku ryoho. Cancer & chemotherapy, 25, 13, 2003-2009 1998 英語 公開
Y. Lino, M. Toi Y. Lino, M. Toi Y. Lino, M. Toi Chemoendocrine therapy: Basic science and clinical aspects Chemoendocrine therapy: Basic science and clinical aspects Chemoendocrine therapy: Basic science and clinical aspects Breast Cancer, 5, 4, 344-346 Breast Cancer, 5, 4, 344-346 Breast Cancer, 5, 4, 344-346 1998 英語 公開
S. Umemura, K. Komaki, S. Noguchi, E. Shiba, M. Toi, I. Kimijima, H. Itoh, Y.R. Osamura S. Umemura, K. Komaki, S. Noguchi, E. Shiba, M. Toi, I. Kimijima, H. Itoh, Y.R. Osamura S. Umemura, K. Komaki, S. Noguchi, E. Shiba, M. Toi, I. Kimijima, H. Itoh, Y.R. Osamura Prognostic factors for node-negative breast cancers: Results of a study program by the Japanese breast cancer society Prognostic factors for node-negative breast cancers: Results of a study program by the Japanese breast cancer society Prognostic factors for node-negative breast cancers: Results of a study program by the Japanese breast cancer society Breast Cancer, 5, 3, 243-249 Breast Cancer, 5, 3, 243-249 Breast Cancer, 5, 3, 243-249 1998 英語 公開
M Toi, S Ishigaki, T Tominaga M Toi, S Ishigaki, T Tominaga M Toi, S Ishigaki, T Tominaga Metalloproteinases and tissue inhibitors of metalloproteinases Metalloproteinases and tissue inhibitors of metalloproteinases Metalloproteinases and tissue inhibitors of metalloproteinases BREAST CANCER RESEARCH AND TREATMENT, 52, 1-3, 113-124 BREAST CANCER RESEARCH AND TREATMENT, 52, 1-3, 113-124 BREAST CANCER RESEARCH AND TREATMENT, 52, 1-3, 113-124 1998 英語 研究論文(学術雑誌) 公開
T Narita, N Kimura, C Mitsuoka, M Toi, M Sato, N Matsuura, K Matsumoto, T Nakamura, R Kannagi T Narita, N Kimura, C Mitsuoka, M Toi, M Sato, N Matsuura, K Matsumoto, T Nakamura, R Kannagi T Narita, N Kimura, C Mitsuoka, M Toi, M Sato, N Matsuura, K Matsumoto, T Nakamura, R Kannagi Biological and clinical significance of hepatocyte growth factor in breast cancer Biological and clinical significance of hepatocyte growth factor in breast cancer Biological and clinical significance of hepatocyte growth factor in breast cancer INTERNATIONAL JOURNAL OF ONCOLOGY, 11, 6, 1305-1310 INTERNATIONAL JOURNAL OF ONCOLOGY, 11, 6, 1305-1310 INTERNATIONAL JOURNAL OF ONCOLOGY, 11, 6, 1305-1310 1997/12 英語 研究論文(学術雑誌) 公開
T Narita, C Mitsuoka, N Kimura, M Toi, T Nakashio, K Sekiguchi, H Iwanari, R Kannagi T Narita, C Mitsuoka, N Kimura, M Toi, T Nakashio, K Sekiguchi, H Iwanari, R Kannagi T Narita, C Mitsuoka, N Kimura, M Toi, T Nakashio, K Sekiguchi, H Iwanari, R Kannagi Increased concentration of hepatocyte growth factor in the sera of patients with gastrointestinal cancer Increased concentration of hepatocyte growth factor in the sera of patients with gastrointestinal cancer Increased concentration of hepatocyte growth factor in the sera of patients with gastrointestinal cancer ONCOLOGY REPORTS, 4, 6, 1239-1241 ONCOLOGY REPORTS, 4, 6, 1239-1241 ONCOLOGY REPORTS, 4, 6, 1239-1241 1997/11 英語 研究論文(学術雑誌) 公開
S Saji, M Toi, Y Yamamoto, T Tominaga S Saji, M Toi, Y Yamamoto, T Tominaga S Saji, M Toi, Y Yamamoto, T Tominaga The increase of apoptosis and the decrease of proliferation by angiogenesis inhibitor in rat mammary tumors The increase of apoptosis and the decrease of proliferation by angiogenesis inhibitor in rat mammary tumors The increase of apoptosis and the decrease of proliferation by angiogenesis inhibitor in rat mammary tumors ONCOLOGY REPORTS, 4, 1, 111-114 ONCOLOGY REPORTS, 4, 1, 111-114 ONCOLOGY REPORTS, 4, 1, 111-114 1997/01 英語 研究論文(学術雑誌) 公開
K Tsuruta, M Toi, M Kondo, A Okamoto K Tsuruta, M Toi, M Kondo, A Okamoto K Tsuruta, M Toi, M Kondo, A Okamoto Removal of primary tumor might alter the growth rate of metastatic tumor in hepatocellular carcinoma Removal of primary tumor might alter the growth rate of metastatic tumor in hepatocellular carcinoma Removal of primary tumor might alter the growth rate of metastatic tumor in hepatocellular carcinoma CANCER JOURNAL, 10, 1, 53-55 CANCER JOURNAL, 10, 1, 53-55 CANCER JOURNAL, 10, 1, 53-55 1997/01 英語 研究論文(学術雑誌) 公開
N. Nagaya, M. Toi, S. Sunahara, F. Kurimoto, T. Tominaga N. Nagaya, M. Toi, S. Sunahara, F. Kurimoto, T. Tominaga N. Nagaya, M. Toi, S. Sunahara, F. Kurimoto, T. Tominaga Determination of intratumoral estrone (E<sub>1</sub>) and estradiol (E<sub>2</sub>) in primary breast cancer tissues by sensitive HPLC-RIA Determination of intratumoral estrone (E<sub>1</sub>) and estradiol (E<sub>2</sub>) in primary breast cancer tissues by sensitive HPLC-RIA Determination of intratumoral estrone (E<sub>1</sub>) and estradiol (E<sub>2</sub>) in primary breast cancer tissues by sensitive HPLC-RIA Japanese Journal of Cancer and Chemotherapy, 24, 3, 329-336 Japanese Journal of Cancer and Chemotherapy, 24, 3, 329-336 Japanese Journal of Cancer and Chemotherapy, 24, 3, 329-336 1997 英語 公開
K. Abe, K. Suzuki, N. Kamata, Y. Yokoyama, T. Ushimi, T. Masumoto, M. Koike, M. Toi K. Abe, K. Suzuki, N. Kamata, Y. Yokoyama, T. Ushimi, T. Masumoto, M. Koike, M. Toi K. Abe, K. Suzuki, N. Kamata, Y. Yokoyama, T. Ushimi, T. Masumoto, M. Koike, M. Toi Case report ; pulmonary thromboembolism due to medroxyprogesterone acetate Case report ; pulmonary thromboembolism due to medroxyprogesterone acetate Case report ; pulmonary thromboembolism due to medroxyprogesterone acetate Japanese Journal of Clinical Radiology, 42, 6, 719-722 Japanese Journal of Clinical Radiology, 42, 6, 719-722 Japanese Journal of Clinical Radiology, 42, 6, 719-722 1997 英語 公開
M. Toi, S. Saji, T. Tominaga M. Toi, S. Saji, T. Tominaga M. Toi, S. Saji, T. Tominaga Novel target of biotherapy: Angiogenesis Novel target of biotherapy: Angiogenesis Novel target of biotherapy: Angiogenesis Biotherapy, 11, 6, 738-742 Biotherapy, 11, 6, 738-742 Biotherapy, 11, 6, 738-742 1997 英語 公開
M. Toi, M. Gion, E. Biganzoli, R. Dittadi, P. Boracchi, R. Miceli, S. Meli, K. Mori, T. Tominaga, G. Gasparini M. Toi, M. Gion, E. Biganzoli, R. Dittadi, P. Boracchi, R. Miceli, S. Meli, K. Mori, T. Tominaga, G. Gasparini M. Toi, M. Gion, E. Biganzoli, R. Dittadi, P. Boracchi, R. Miceli, S. Meli, K. Mori, T. Tominaga, G. Gasparini Co-determination of the angiogenic factors thymidine phosphorylase and vascular endothelial growth factor in node-negative breast cancer: Prognostic implications Co-determination of the angiogenic factors thymidine phosphorylase and vascular endothelial growth factor in node-negative breast cancer: Prognostic implications Co-determination of the angiogenic factors thymidine phosphorylase and vascular endothelial growth factor in node-negative breast cancer: Prognostic implications Angiogenesis, 1, 1, 71-83 Angiogenesis, 1, 1, 71-83 Angiogenesis, 1, 1, 71-83 1997 英語 公開
M Toi, S Tanaka, M Bando, K Hayashi, T Tominaga M Toi, S Tanaka, M Bando, K Hayashi, T Tominaga M Toi, S Tanaka, M Bando, K Hayashi, T Tominaga Outcome of surgical resection for chest wall recurrence in breast cancer patients Outcome of surgical resection for chest wall recurrence in breast cancer patients Outcome of surgical resection for chest wall recurrence in breast cancer patients JOURNAL OF SURGICAL ONCOLOGY, 64, 1, 23-26 JOURNAL OF SURGICAL ONCOLOGY, 64, 1, 23-26 JOURNAL OF SURGICAL ONCOLOGY, 64, 1, 23-26 1997/01 英語 研究論文(学術雑誌) 公開
T Taniguchi, M Kitamura, K Arai, Y Iwasaki, Y Yamamoto, A Igari, M Toi T Taniguchi, M Kitamura, K Arai, Y Iwasaki, Y Yamamoto, A Igari, M Toi T Taniguchi, M Kitamura, K Arai, Y Iwasaki, Y Yamamoto, A Igari, M Toi Increase in the circulating level of hepatocyte growth factor in gastric cancer patients Increase in the circulating level of hepatocyte growth factor in gastric cancer patients Increase in the circulating level of hepatocyte growth factor in gastric cancer patients BRITISH JOURNAL OF CANCER, 75, 5, 673-677 BRITISH JOURNAL OF CANCER, 75, 5, 673-677 BRITISH JOURNAL OF CANCER, 75, 5, 673-677 1997 英語 研究論文(学術雑誌) 公開
G Gasparini, M Toi, M Gion, P Verderio, R Dittadi, M Hanatani, Matsubara, I, O Vinante, E Bonoldi, P Boracchi, C Gatti, H Suzuki, T Tominaga G Gasparini, M Toi, M Gion, P Verderio, R Dittadi, M Hanatani, Matsubara, I, O Vinante, E Bonoldi, P Boracchi, C Gatti, H Suzuki, T Tominaga G Gasparini, M Toi, M Gion, P Verderio, R Dittadi, M Hanatani, Matsubara, I, O Vinante, E Bonoldi, P Boracchi, C Gatti, H Suzuki, T Tominaga Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma JOURNAL OF THE NATIONAL CANCER INSTITUTE, 89, 2, 139-147 JOURNAL OF THE NATIONAL CANCER INSTITUTE, 89, 2, 139-147 JOURNAL OF THE NATIONAL CANCER INSTITUTE, 89, 2, 139-147 1997/01 英語 研究論文(学術雑誌) 公開
M. Toi, S. Saji, A. Suzuki, Y. Yamamoto, T. Tominaga M. Toi, S. Saji, A. Suzuki, Y. Yamamoto, T. Tominaga M. Toi, S. Saji, A. Suzuki, Y. Yamamoto, T. Tominaga MDM2 in breast cancer MDM2 in breast cancer MDM2 in breast cancer Breast Cancer, 4, 4, 264-268 Breast Cancer, 4, 4, 264-268 Breast Cancer, 4, 4, 264-268 1997 英語 公開
PB Vermeulen, G Gasparini, SB Fox, M Toi, L Martin, P McCulloch, F Pezzella, G Viale, N Weidner, AL Harris, LY Dirix PB Vermeulen, G Gasparini, SB Fox, M Toi, L Martin, P McCulloch, F Pezzella, G Viale, N Weidner, AL Harris, LY Dirix PB Vermeulen, G Gasparini, SB Fox, M Toi, L Martin, P McCulloch, F Pezzella, G Viale, N Weidner, AL Harris, LY Dirix Quantification of angiogenesis in solid human tumours: An international consensus on the methodology and criteria of evaluation Quantification of angiogenesis in solid human tumours: An international consensus on the methodology and criteria of evaluation Quantification of angiogenesis in solid human tumours: An international consensus on the methodology and criteria of evaluation EUROPEAN JOURNAL OF CANCER, 32A, 14, 2474-2484 EUROPEAN JOURNAL OF CANCER, 32A, 14, 2474-2484 EUROPEAN JOURNAL OF CANCER, 32A, 14, 2474-2484 1996/12 英語 研究論文(学術雑誌) 公開
M Toi, T Taniguchi, Y Yamamoto, T Kurisaki, H Suzuki, T Tominaga M Toi, T Taniguchi, Y Yamamoto, T Kurisaki, H Suzuki, T Tominaga M Toi, T Taniguchi, Y Yamamoto, T Kurisaki, H Suzuki, T Tominaga Clinical significance of the determination of angiogenic factors Clinical significance of the determination of angiogenic factors Clinical significance of the determination of angiogenic factors EUROPEAN JOURNAL OF CANCER, 32A, 14, 2513-2519 EUROPEAN JOURNAL OF CANCER, 32A, 14, 2513-2519 EUROPEAN JOURNAL OF CANCER, 32A, 14, 2513-2519 1996/12 英語 研究論文(学術雑誌) 公開
K Inada, T Tominaga, M Toi, Y Yamamoto, M Abe, J Yamashita, M Ogawa K Inada, T Tominaga, M Toi, Y Yamamoto, M Abe, J Yamashita, M Ogawa K Inada, T Tominaga, M Toi, Y Yamamoto, M Abe, J Yamashita, M Ogawa Protective effect of leuprolide acetate on 7,12-dimethylbenz(a)anthracene (DMBA)-induced mammary carcinogenesis in rats Protective effect of leuprolide acetate on 7,12-dimethylbenz(a)anthracene (DMBA)-induced mammary carcinogenesis in rats Protective effect of leuprolide acetate on 7,12-dimethylbenz(a)anthracene (DMBA)-induced mammary carcinogenesis in rats EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 22, 6, 583-587 EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 22, 6, 583-587 EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 22, 6, 583-587 1996/12 英語 研究論文(学術雑誌) 公開
Y Yamamoto, M Toi, T Tominaga Y Yamamoto, M Toi, T Tominaga Y Yamamoto, M Toi, T Tominaga Prediction of the effect of 5'-deoxy-5-fluorouridine by the status of angiogenic enzyme thymidine phosphorylase expression in recurrent breast cancer patients Prediction of the effect of 5'-deoxy-5-fluorouridine by the status of angiogenic enzyme thymidine phosphorylase expression in recurrent breast cancer patients Prediction of the effect of 5'-deoxy-5-fluorouridine by the status of angiogenic enzyme thymidine phosphorylase expression in recurrent breast cancer patients ONCOLOGY REPORTS, 3, 5, 863-865 ONCOLOGY REPORTS, 3, 5, 863-865 ONCOLOGY REPORTS, 3, 5, 863-865 1996/09 英語 研究論文(学術雑誌) 公開
K Inada, M Toi, Y Yamamoto, A Suzuki, T Kurisaki, H Suzuki, T Tominaga K Inada, M Toi, Y Yamamoto, A Suzuki, T Kurisaki, H Suzuki, T Tominaga K Inada, M Toi, Y Yamamoto, A Suzuki, T Kurisaki, H Suzuki, T Tominaga Immunocytochemical analysis of MDM2 protein expression and its relevance to tumor angiogenesis in primary breast cancer Immunocytochemical analysis of MDM2 protein expression and its relevance to tumor angiogenesis in primary breast cancer Immunocytochemical analysis of MDM2 protein expression and its relevance to tumor angiogenesis in primary breast cancer ONCOLOGY REPORTS, 3, 4, 667-671 ONCOLOGY REPORTS, 3, 4, 667-671 ONCOLOGY REPORTS, 3, 4, 667-671 1996/07 英語 研究論文(学術雑誌) 公開
Y Yamamoto, M Toi, S Kondo, T Matsumoto, H Suzuki, M Kitamura, K Tsuruta, T Taniguchi, A Okamoto, T Mori, M Yoshida, T Ikeda, T Tominaga Y Yamamoto, M Toi, S Kondo, T Matsumoto, H Suzuki, M Kitamura, K Tsuruta, T Taniguchi, A Okamoto, T Mori, M Yoshida, T Ikeda, T Tominaga Y Yamamoto, M Toi, S Kondo, T Matsumoto, H Suzuki, M Kitamura, K Tsuruta, T Taniguchi, A Okamoto, T Mori, M Yoshida, T Ikeda, T Tominaga Concentrations of vascular endothelial growth factor in the sera of normal controls and cancer patients Concentrations of vascular endothelial growth factor in the sera of normal controls and cancer patients Concentrations of vascular endothelial growth factor in the sera of normal controls and cancer patients CLINICAL CANCER RESEARCH, 2, 5, 821-826 CLINICAL CANCER RESEARCH, 2, 5, 821-826 CLINICAL CANCER RESEARCH, 2, 5, 821-826 1996/05 英語 研究論文(学術雑誌) 公開
M Toi, S Kondo, H Suzuki, Y Yamamoto, K Inada, T Imazawa, T Taniguchi, T Tominaga M Toi, S Kondo, H Suzuki, Y Yamamoto, K Inada, T Imazawa, T Taniguchi, T Tominaga M Toi, S Kondo, H Suzuki, Y Yamamoto, K Inada, T Imazawa, T Taniguchi, T Tominaga Quantitative analysis of vascular endothelial growth factor in primary breast cancer Quantitative analysis of vascular endothelial growth factor in primary breast cancer Quantitative analysis of vascular endothelial growth factor in primary breast cancer CANCER, 77, 6, 1101-1106 CANCER, 77, 6, 1101-1106 CANCER, 77, 6, 1101-1106 1996/03 英語 研究論文(学術雑誌) 公開
M Kitamura, K Arai, Y Iwasaki, M Toi M Kitamura, K Arai, Y Iwasaki, M Toi M Kitamura, K Arai, Y Iwasaki, M Toi Antitumor effect of the angiogenesis inhibitor TNP-470 and its combination effect with 5-FU and PSK in colon 26 tumors Antitumor effect of the angiogenesis inhibitor TNP-470 and its combination effect with 5-FU and PSK in colon 26 tumors Antitumor effect of the angiogenesis inhibitor TNP-470 and its combination effect with 5-FU and PSK in colon 26 tumors ONCOLOGY REPORTS, 3, 1, 151-153 ONCOLOGY REPORTS, 3, 1, 151-153 ONCOLOGY REPORTS, 3, 1, 151-153 1996/01 英語 研究論文(学術雑誌) 公開
M. Toi, Y. Yamamoto, T. Taniguchi, S. Saji, K. Hayashi, T. Tominaga M. Toi, Y. Yamamoto, T. Taniguchi, S. Saji, K. Hayashi, T. Tominaga M. Toi, Y. Yamamoto, T. Taniguchi, S. Saji, K. Hayashi, T. Tominaga Regulation of endothelial growth factor expressions in breast cancer. Regulation of endothelial growth factor expressions in breast cancer. Regulation of endothelial growth factor expressions in breast cancer. Gan to kagaku ryoho. Cancer & chemotherapy, 23 Suppl 1, 75-79 Gan to kagaku ryoho. Cancer & chemotherapy, 23 Suppl 1, 75-79 Gan to kagaku ryoho. Cancer & chemotherapy, 23 Suppl 1, 75-79 1996 英語 公開
S. Saji, M. Toi, T. Tominaga S. Saji, M. Toi, T. Tominaga S. Saji, M. Toi, T. Tominaga The importance of tumor angiogenesis as a prognostic indicator in primary breast cancer The importance of tumor angiogenesis as a prognostic indicator in primary breast cancer The importance of tumor angiogenesis as a prognostic indicator in primary breast cancer Nippon Geka Gakkai zasshi, 97, 5, 368-374 Nippon Geka Gakkai zasshi, 97, 5, 368-374 Nippon Geka Gakkai zasshi, 97, 5, 368-374 1996 英語 公開
M. Toi, T. Tominaga M. Toi, T. Tominaga M. Toi, T. Tominaga Breast cancer angiogenesis Breast cancer angiogenesis Breast cancer angiogenesis Japanese Journal of Cancer and Chemotherapy, 23, 6, 659-666 Japanese Journal of Cancer and Chemotherapy, 23, 6, 659-666 Japanese Journal of Cancer and Chemotherapy, 23, 6, 659-666 1996 英語 公開
T. Tominaga, M. Toi, Y. Yamamoto T. Tominaga, M. Toi, Y. Yamamoto T. Tominaga, M. Toi, Y. Yamamoto Tumor angiogenesis as a key prognostic factor in breast cancer Tumor angiogenesis as a key prognostic factor in breast cancer Tumor angiogenesis as a key prognostic factor in breast cancer Biotherapy, 10, 7, 958-962 Biotherapy, 10, 7, 958-962 Biotherapy, 10, 7, 958-962 1996 英語 公開
K Umezawa, T Taniguchi, M Toi, T Ohse, N Tsutsumi, T Yamamoto, T Koyano, M Ishizuka K Umezawa, T Taniguchi, M Toi, T Ohse, N Tsutsumi, T Yamamoto, T Koyano, M Ishizuka K Umezawa, T Taniguchi, M Toi, T Ohse, N Tsutsumi, T Yamamoto, T Koyano, M Ishizuka Growth inhibition of K-ras-expressing tumours by a new vinca alkaloid, conophylline, in nude mice Growth inhibition of K-ras-expressing tumours by a new vinca alkaloid, conophylline, in nude mice Growth inhibition of K-ras-expressing tumours by a new vinca alkaloid, conophylline, in nude mice DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH, 22, 2, 35-40 DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH, 22, 2, 35-40 DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH, 22, 2, 35-40 1996 英語 研究論文(学術雑誌) 公開
M Toi M Toi M Toi Endothelial growth factors: A target for antiangiogenesis Endothelial growth factors: A target for antiangiogenesis Endothelial growth factors: A target for antiangiogenesis CANCER JOURNAL, 8, 6, 315-319 CANCER JOURNAL, 8, 6, 315-319 CANCER JOURNAL, 8, 6, 315-319 1995/11 英語 公開
T Taniguchi, M Toi, K Inada, T Imazawa, Y Yamamoto, T Tominaga T Taniguchi, M Toi, K Inada, T Imazawa, Y Yamamoto, T Tominaga T Taniguchi, M Toi, K Inada, T Imazawa, Y Yamamoto, T Tominaga Serum concentrations of hepatocyte growth factor in breast cancer patients Serum concentrations of hepatocyte growth factor in breast cancer patients Serum concentrations of hepatocyte growth factor in breast cancer patients CLINICAL CANCER RESEARCH, 1, 9, 1031-1034 CLINICAL CANCER RESEARCH, 1, 9, 1031-1034 CLINICAL CANCER RESEARCH, 1, 9, 1031-1034 1995/09 英語 研究論文(学術雑誌) 公開
M Toi, K Inada, S Hoshina, H Suzuki, S Kondo, T Tominaga M Toi, K Inada, S Hoshina, H Suzuki, S Kondo, T Tominaga M Toi, K Inada, S Hoshina, H Suzuki, S Kondo, T Tominaga Vascular endothelial growth factor and platelet-derived endothelial cell growth factor are frequently coexpressed in highly vascularized human breast cancer Vascular endothelial growth factor and platelet-derived endothelial cell growth factor are frequently coexpressed in highly vascularized human breast cancer Vascular endothelial growth factor and platelet-derived endothelial cell growth factor are frequently coexpressed in highly vascularized human breast cancer CLINICAL CANCER RESEARCH, 1, 9, 961-964 CLINICAL CANCER RESEARCH, 1, 9, 961-964 CLINICAL CANCER RESEARCH, 1, 9, 961-964 1995/09 英語 研究論文(学術雑誌) 公開
Y YAMAMOTO, M TOI, R YAMADA, T TOMINAGA Y YAMAMOTO, M TOI, R YAMADA, T TOMINAGA Y YAMAMOTO, M TOI, R YAMADA, T TOMINAGA COMBINATION EFFECT OF AN ANGIOGENESIS INHIBITOR AGM-1470 WITH 5'-DEOXY-5-FLUOROURIDINE, AND WITH HORMONAL DRUGS IN DMBA-INDUCED RAT MAMMARY-TUMORS COMBINATION EFFECT OF AN ANGIOGENESIS INHIBITOR AGM-1470 WITH 5'-DEOXY-5-FLUOROURIDINE, AND WITH HORMONAL DRUGS IN DMBA-INDUCED RAT MAMMARY-TUMORS COMBINATION EFFECT OF AN ANGIOGENESIS INHIBITOR AGM-1470 WITH 5'-DEOXY-5-FLUOROURIDINE, AND WITH HORMONAL DRUGS IN DMBA-INDUCED RAT MAMMARY-TUMORS ONCOLOGY REPORTS, 2, 5, 793-796 ONCOLOGY REPORTS, 2, 5, 793-796 ONCOLOGY REPORTS, 2, 5, 793-796 1995/09 英語 研究論文(学術雑誌) 公開
M TOI, S HOSHINA, T TANIGUCHI, Y YAMAMOTO, H ISHITSUKA, T TOMINAGA M TOI, S HOSHINA, T TANIGUCHI, Y YAMAMOTO, H ISHITSUKA, T TOMINAGA M TOI, S HOSHINA, T TANIGUCHI, Y YAMAMOTO, H ISHITSUKA, T TOMINAGA EXPRESSION OF PLATELET-DERIVED ENDOTHELIAL-CELL GROWTH-FACTOR THYMIDINE PHOSPHORYLASE IN HUMAN BREAST-CANCER EXPRESSION OF PLATELET-DERIVED ENDOTHELIAL-CELL GROWTH-FACTOR THYMIDINE PHOSPHORYLASE IN HUMAN BREAST-CANCER EXPRESSION OF PLATELET-DERIVED ENDOTHELIAL-CELL GROWTH-FACTOR THYMIDINE PHOSPHORYLASE IN HUMAN BREAST-CANCER INTERNATIONAL JOURNAL OF CANCER, 64, 2, 79-82 INTERNATIONAL JOURNAL OF CANCER, 64, 2, 79-82 INTERNATIONAL JOURNAL OF CANCER, 64, 2, 79-82 1995/04 英語 研究論文(学術雑誌) 公開
M. Toi, T. Taniguchi, K. Hayashi, T. Tominaga M. Toi, T. Taniguchi, K. Hayashi, T. Tominaga M. Toi, T. Taniguchi, K. Hayashi, T. Tominaga The effect of combination treatment consisted of 5\\'-deoxy-5-fluorouridine and medroxyprogesterone acetate for recurrent breast cancer patients The effect of combination treatment consisted of 5\\'-deoxy-5-fluorouridine and medroxyprogesterone acetate for recurrent breast cancer patients The effect of combination treatment consisted of 5\\'-deoxy-5-fluorouridine and medroxyprogesterone acetate for recurrent breast cancer patients Japanese Journal of Cancer and Chemotherapy, 22, 6, 799-804 Japanese Journal of Cancer and Chemotherapy, 22, 6, 799-804 Japanese Journal of Cancer and Chemotherapy, 22, 6, 799-804 1995 英語 公開
M TOI, K INADA, H SUZUKI, T TOMINAGA M TOI, K INADA, H SUZUKI, T TOMINAGA M TOI, K INADA, H SUZUKI, T TOMINAGA TUMOR ANGIOGENESIS IN BREAST-CANCER - ITS IMPORTANCE AS A PROGNOSTIC INDICATOR AND THE ASSOCIATION WITH VASCULAR ENDOTHELIAL GROWTH-FACTOR EXPRESSION TUMOR ANGIOGENESIS IN BREAST-CANCER - ITS IMPORTANCE AS A PROGNOSTIC INDICATOR AND THE ASSOCIATION WITH VASCULAR ENDOTHELIAL GROWTH-FACTOR EXPRESSION TUMOR ANGIOGENESIS IN BREAST-CANCER - ITS IMPORTANCE AS A PROGNOSTIC INDICATOR AND THE ASSOCIATION WITH VASCULAR ENDOTHELIAL GROWTH-FACTOR EXPRESSION BREAST CANCER RESEARCH AND TREATMENT, 36, 2, 193-204 BREAST CANCER RESEARCH AND TREATMENT, 36, 2, 193-204 BREAST CANCER RESEARCH AND TREATMENT, 36, 2, 193-204 1995 英語 研究論文(学術雑誌) 公開
T TANIGUCHI, M TOI, T TOMINAGA T TANIGUCHI, M TOI, T TOMINAGA T TANIGUCHI, M TOI, T TOMINAGA INCREASE IN THE CIRCULATING LEVEL OF HEPATOCYTE GROWTH-FACTOR IN BREAST-CANCER PATIENTS WITH DISTANT METASTASES INCREASE IN THE CIRCULATING LEVEL OF HEPATOCYTE GROWTH-FACTOR IN BREAST-CANCER PATIENTS WITH DISTANT METASTASES INCREASE IN THE CIRCULATING LEVEL OF HEPATOCYTE GROWTH-FACTOR IN BREAST-CANCER PATIENTS WITH DISTANT METASTASES ONCOLOGY REPORTS, 1, 6, 1199-1201 ONCOLOGY REPORTS, 1, 6, 1199-1201 ONCOLOGY REPORTS, 1, 6, 1199-1201 1994/11 英語 研究論文(学術雑誌) 公開
M TOI, S HOSHINA, T TAKAYANAGI, T TOMINAGA M TOI, S HOSHINA, T TAKAYANAGI, T TOMINAGA M TOI, S HOSHINA, T TAKAYANAGI, T TOMINAGA ASSOCIATION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR EXPRESSION WITH TUMOR ANGIOGENESIS AND WITH EARLY RELAPSE IN PRIMARY BREAST-CANCER ASSOCIATION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR EXPRESSION WITH TUMOR ANGIOGENESIS AND WITH EARLY RELAPSE IN PRIMARY BREAST-CANCER ASSOCIATION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR EXPRESSION WITH TUMOR ANGIOGENESIS AND WITH EARLY RELAPSE IN PRIMARY BREAST-CANCER JAPANESE JOURNAL OF CANCER RESEARCH, 85, 10, 1045-1049 JAPANESE JOURNAL OF CANCER RESEARCH, 85, 10, 1045-1049 JAPANESE JOURNAL OF CANCER RESEARCH, 85, 10, 1045-1049 1994/10 英語 研究論文(学術雑誌) 公開
T TANIGUCHI, M TOI, T TOMINAGA T TANIGUCHI, M TOI, T TOMINAGA T TANIGUCHI, M TOI, T TOMINAGA RAPID INDUCTION OF HEPATOCYTE GROWTH-FACTOR BY HEPARIN RAPID INDUCTION OF HEPATOCYTE GROWTH-FACTOR BY HEPARIN RAPID INDUCTION OF HEPATOCYTE GROWTH-FACTOR BY HEPARIN LANCET, 344, 8920, 470-470 LANCET, 344, 8920, 470-470 LANCET, 344, 8920, 470-470 1994/08 英語 公開
M TOI, T TAKAYANAGI, R SOUMA, T TOMINAGA M TOI, T TAKAYANAGI, R SOUMA, T TOMINAGA M TOI, T TAKAYANAGI, R SOUMA, T TOMINAGA INHIBITION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR INDUCED CELL-GROWTH BY AN ANGIOGENESIS INHIBITOR AGM-1470 IN CAPILLARY ENDOTHELIAL-CELLS INHIBITION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR INDUCED CELL-GROWTH BY AN ANGIOGENESIS INHIBITOR AGM-1470 IN CAPILLARY ENDOTHELIAL-CELLS INHIBITION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR INDUCED CELL-GROWTH BY AN ANGIOGENESIS INHIBITOR AGM-1470 IN CAPILLARY ENDOTHELIAL-CELLS ONCOLOGY REPORTS, 1, 2, 423-426 ONCOLOGY REPORTS, 1, 2, 423-426 ONCOLOGY REPORTS, 1, 2, 423-426 1994/03 英語 研究論文(学術雑誌) 公開
M KITAMURA, K TAKAHASHI, T TOMINAGA, M TOI M KITAMURA, K TAKAHASHI, T TOMINAGA, M TOI M KITAMURA, K TAKAHASHI, T TOMINAGA, M TOI PREVENTIVE EFFECT OF WHOLE PEPTIDOGLYCAN (WPG) ON THE OCCURRENCE OF RAT MAMMARY-TUMORS INDUCED BY 7,12-DIMETHYLBENZ(A)ANTHRACENE (DMBA) PREVENTIVE EFFECT OF WHOLE PEPTIDOGLYCAN (WPG) ON THE OCCURRENCE OF RAT MAMMARY-TUMORS INDUCED BY 7,12-DIMETHYLBENZ(A)ANTHRACENE (DMBA) PREVENTIVE EFFECT OF WHOLE PEPTIDOGLYCAN (WPG) ON THE OCCURRENCE OF RAT MAMMARY-TUMORS INDUCED BY 7,12-DIMETHYLBENZ(A)ANTHRACENE (DMBA) ONCOLOGY REPORTS, 1, 2, 309-312 ONCOLOGY REPORTS, 1, 2, 309-312 ONCOLOGY REPORTS, 1, 2, 309-312 1994/03 英語 研究論文(学術雑誌) 公開
M. Toi, S. Hoshina, Y. Yamamoto, T. Ishii, K. Hayashi, T. Tominaga M. Toi, S. Hoshina, Y. Yamamoto, T. Ishii, K. Hayashi, T. Tominaga M. Toi, S. Hoshina, Y. Yamamoto, T. Ishii, K. Hayashi, T. Tominaga Tumor angiogenesis in breast cancer: significance of vessel density as a prognostic indicator Tumor angiogenesis in breast cancer: significance of vessel density as a prognostic indicator Tumor angiogenesis in breast cancer: significance of vessel density as a prognostic indicator Japanese Journal of Cancer and Chemotherapy, 21 Suppl 2, 178-182 Japanese Journal of Cancer and Chemotherapy, 21 Suppl 2, 178-182 Japanese Journal of Cancer and Chemotherapy, 21 Suppl 2, 178-182 1994 英語 公開
K. Inada, M. Toi, T. Imazawa, S. Hoshina, K. Hayashi, T. Tominaga K. Inada, M. Toi, T. Imazawa, S. Hoshina, K. Hayashi, T. Tominaga K. Inada, M. Toi, T. Imazawa, S. Hoshina, K. Hayashi, T. Tominaga Significance of overexpression of p53 protein in human breast cancer Significance of overexpression of p53 protein in human breast cancer Significance of overexpression of p53 protein in human breast cancer Japanese Journal of Cancer and Chemotherapy, 21, 6, 817-821 Japanese Journal of Cancer and Chemotherapy, 21, 6, 817-821 Japanese Journal of Cancer and Chemotherapy, 21, 6, 817-821 1994 英語 公開
M. Toi, K. Hayashi, T. Tominaga M. Toi, K. Hayashi, T. Tominaga M. Toi, K. Hayashi, T. Tominaga Feasibility of adjuvant high-dose CAF (cyclophosphamide, adriamycin, 5-FU) therapy for primary breast cancer patients Feasibility of adjuvant high-dose CAF (cyclophosphamide, adriamycin, 5-FU) therapy for primary breast cancer patients Feasibility of adjuvant high-dose CAF (cyclophosphamide, adriamycin, 5-FU) therapy for primary breast cancer patients Japanese Journal of Cancer and Chemotherapy, 21, 12, 2057-2060 Japanese Journal of Cancer and Chemotherapy, 21, 12, 2057-2060 Japanese Journal of Cancer and Chemotherapy, 21, 12, 2057-2060 1994 英語 公開
M TOI, T TOMINAGA, A OSAKI, T TOGE M TOI, T TOMINAGA, A OSAKI, T TOGE M TOI, T TOMINAGA, A OSAKI, T TOGE ROLE OF EPIDERMAL GROWTH-FACTOR RECEPTOR EXPRESSION IN PRIMARY BREAST-CANCER - RESULTS OF A BIOCHEMICAL-STUDY AND AN IMMUNOCYTOCHEMICAL STUDY ROLE OF EPIDERMAL GROWTH-FACTOR RECEPTOR EXPRESSION IN PRIMARY BREAST-CANCER - RESULTS OF A BIOCHEMICAL-STUDY AND AN IMMUNOCYTOCHEMICAL STUDY ROLE OF EPIDERMAL GROWTH-FACTOR RECEPTOR EXPRESSION IN PRIMARY BREAST-CANCER - RESULTS OF A BIOCHEMICAL-STUDY AND AN IMMUNOCYTOCHEMICAL STUDY BREAST CANCER RESEARCH AND TREATMENT, 29, 1, 51-58 BREAST CANCER RESEARCH AND TREATMENT, 29, 1, 51-58 BREAST CANCER RESEARCH AND TREATMENT, 29, 1, 51-58 1994 英語 研究論文(学術雑誌) 公開
M TOI, AL HARRIS, R BICKNELL M TOI, AL HARRIS, R BICKNELL M TOI, AL HARRIS, R BICKNELL CDNA TRANSFECTION FOLLOWED BY THE ISOLATION OF A MCF-7 BREAST CELL-LINE RESISTANT TO TAMOXIFEN IN-VITRO AND IN-VIVO CDNA TRANSFECTION FOLLOWED BY THE ISOLATION OF A MCF-7 BREAST CELL-LINE RESISTANT TO TAMOXIFEN IN-VITRO AND IN-VIVO CDNA TRANSFECTION FOLLOWED BY THE ISOLATION OF A MCF-7 BREAST CELL-LINE RESISTANT TO TAMOXIFEN IN-VITRO AND IN-VIVO BRITISH JOURNAL OF CANCER, 68, 6, 1088-1096 BRITISH JOURNAL OF CANCER, 68, 6, 1088-1096 BRITISH JOURNAL OF CANCER, 68, 6, 1088-1096 1993/12 英語 研究論文(学術雑誌) 公開
T TOMINAGA, M TOI, T SHIRASAKA T TOMINAGA, M TOI, T SHIRASAKA T TOMINAGA, M TOI, T SHIRASAKA ENHANCED INHIBITION OF THYMIDYLATE SYNTHASE BY 5-FLUOROURACIL AND [6S]LEUCOVORIN COMBINATION THERAPY FOR BREAST-CANCER ENHANCED INHIBITION OF THYMIDYLATE SYNTHASE BY 5-FLUOROURACIL AND [6S]LEUCOVORIN COMBINATION THERAPY FOR BREAST-CANCER ENHANCED INHIBITION OF THYMIDYLATE SYNTHASE BY 5-FLUOROURACIL AND [6S]LEUCOVORIN COMBINATION THERAPY FOR BREAST-CANCER ANTICANCER RESEARCH, 13, 6B, 2425-2427 ANTICANCER RESEARCH, 13, 6B, 2425-2427 ANTICANCER RESEARCH, 13, 6B, 2425-2427 1993/11 英語 研究論文(学術雑誌) 公開
M TOI, Y YAMAMOTO, T IMAZAWA, T TAKAYANAGI, K AKUTSU, T TOMINAGA M TOI, Y YAMAMOTO, T IMAZAWA, T TAKAYANAGI, K AKUTSU, T TOMINAGA M TOI, Y YAMAMOTO, T IMAZAWA, T TAKAYANAGI, K AKUTSU, T TOMINAGA ANTITUMOR EFFECT OF THE ANGIOGENESIS INHIBITOR AGM-1470 AND ITS COMBINATION EFFECT WITH TAMOXIFEN IN DMBA INDUCED MAMMARY-TUMORS IN RATS ANTITUMOR EFFECT OF THE ANGIOGENESIS INHIBITOR AGM-1470 AND ITS COMBINATION EFFECT WITH TAMOXIFEN IN DMBA INDUCED MAMMARY-TUMORS IN RATS ANTITUMOR EFFECT OF THE ANGIOGENESIS INHIBITOR AGM-1470 AND ITS COMBINATION EFFECT WITH TAMOXIFEN IN DMBA INDUCED MAMMARY-TUMORS IN RATS INTERNATIONAL JOURNAL OF ONCOLOGY, 3, 3, 525-528 INTERNATIONAL JOURNAL OF ONCOLOGY, 3, 3, 525-528 INTERNATIONAL JOURNAL OF ONCOLOGY, 3, 3, 525-528 1993/09 英語 研究論文(学術雑誌) 公開
M TOI, J KASHITANI, T TOMINAGA M TOI, J KASHITANI, T TOMINAGA M TOI, J KASHITANI, T TOMINAGA TUMOR ANGIOGENESIS IS AN INDEPENDENT PROGNOSTIC INDICATOR IN PRIMARY BREAST-CARCINOMA TUMOR ANGIOGENESIS IS AN INDEPENDENT PROGNOSTIC INDICATOR IN PRIMARY BREAST-CARCINOMA TUMOR ANGIOGENESIS IS AN INDEPENDENT PROGNOSTIC INDICATOR IN PRIMARY BREAST-CARCINOMA INTERNATIONAL JOURNAL OF CANCER, 55, 3, 371-374 INTERNATIONAL JOURNAL OF CANCER, 55, 3, 371-374 INTERNATIONAL JOURNAL OF CANCER, 55, 3, 371-374 1993/09 英語 研究論文(学術雑誌) 公開
T OIKAWA, H ITO, H ASHINO, M TOI, T TOMINAGA, MORITA, I, S MUROTA T OIKAWA, H ITO, H ASHINO, M TOI, T TOMINAGA, MORITA, I, S MUROTA T OIKAWA, H ITO, H ASHINO, M TOI, T TOMINAGA, MORITA, I, S MUROTA RADICICOL, A MICROBIAL CELL-DIFFERENTIATION MODULATOR, INHIBITS IN-VIVO ANGIOGENESIS RADICICOL, A MICROBIAL CELL-DIFFERENTIATION MODULATOR, INHIBITS IN-VIVO ANGIOGENESIS RADICICOL, A MICROBIAL CELL-DIFFERENTIATION MODULATOR, INHIBITS IN-VIVO ANGIOGENESIS EUROPEAN JOURNAL OF PHARMACOLOGY, 241, 2-3, 221-227 EUROPEAN JOURNAL OF PHARMACOLOGY, 241, 2-3, 221-227 EUROPEAN JOURNAL OF PHARMACOLOGY, 241, 2-3, 221-227 1993/09 英語 研究論文(学術雑誌) 公開
K KUROI, A OSAKI, H YAMADA, M TOI, T TOGE, Y TAKIMOTO, A KURAMOTO, K ARIHIRO, K INAI K KUROI, A OSAKI, H YAMADA, M TOI, T TOGE, Y TAKIMOTO, A KURAMOTO, K ARIHIRO, K INAI K KUROI, A OSAKI, H YAMADA, M TOI, T TOGE, Y TAKIMOTO, A KURAMOTO, K ARIHIRO, K INAI PRIMARY SQUAMOUS-CELL CARCINOMA OF THE BREAST AFTER CURED HODGKINS-DISEASE PRIMARY SQUAMOUS-CELL CARCINOMA OF THE BREAST AFTER CURED HODGKINS-DISEASE PRIMARY SQUAMOUS-CELL CARCINOMA OF THE BREAST AFTER CURED HODGKINS-DISEASE SURGERY TODAY-THE JAPANESE JOURNAL OF SURGERY, 23, 1, 81-84 SURGERY TODAY-THE JAPANESE JOURNAL OF SURGERY, 23, 1, 81-84 SURGERY TODAY-THE JAPANESE JOURNAL OF SURGERY, 23, 1, 81-84 1993 英語 研究論文(学術雑誌) 公開
M TOI, T HATTORI, M AKAGI, K INOKUCHI, K ORITA, K SUGIMACHI, K DOHI, Y NOMURA, Y MONDEN, Y HAMADA, T MORIMOTO, N OGAWA M TOI, T HATTORI, M AKAGI, K INOKUCHI, K ORITA, K SUGIMACHI, K DOHI, Y NOMURA, Y MONDEN, Y HAMADA, T MORIMOTO, N OGAWA M TOI, T HATTORI, M AKAGI, K INOKUCHI, K ORITA, K SUGIMACHI, K DOHI, Y NOMURA, Y MONDEN, Y HAMADA, T MORIMOTO, N OGAWA RANDOMIZED ADJUVANT TRIAL TO EVALUATE THE ADDITION OF TAMOXIFEN AND PSK TO CHEMOTHERAPY IN PATIENTS WITH PRIMARY BREAST-CANCER - 5-YEAR RESULTS FROM THE NISHI-NIPPON GROUP OF THE ADJUVANT CHEMOENDOCRINE THERAPY FOR BREAST-CANCER ORGANIZATION RANDOMIZED ADJUVANT TRIAL TO EVALUATE THE ADDITION OF TAMOXIFEN AND PSK TO CHEMOTHERAPY IN PATIENTS WITH PRIMARY BREAST-CANCER - 5-YEAR RESULTS FROM THE NISHI-NIPPON GROUP OF THE ADJUVANT CHEMOENDOCRINE THERAPY FOR BREAST-CANCER ORGANIZATION RANDOMIZED ADJUVANT TRIAL TO EVALUATE THE ADDITION OF TAMOXIFEN AND PSK TO CHEMOTHERAPY IN PATIENTS WITH PRIMARY BREAST-CANCER - 5-YEAR RESULTS FROM THE NISHI-NIPPON GROUP OF THE ADJUVANT CHEMOENDOCRINE THERAPY FOR BREAST-CANCER ORGANIZATION CANCER, 70, 10, 2475-2483 CANCER, 70, 10, 2475-2483 CANCER, 70, 10, 2475-2483 1992/11 英語 研究論文(学術雑誌) 公開
A OSAKI, M TOI, H YAMADA, H KAWAMI, K KUROI, T TOGE A OSAKI, M TOI, H YAMADA, H KAWAMI, K KUROI, T TOGE A OSAKI, M TOI, H YAMADA, H KAWAMI, K KUROI, T TOGE PROGNOSTIC-SIGNIFICANCE OF COEXPRESSION OF C-ERBB-2 ONCOPROTEIN AND EPIDERMAL GROWTH-FACTOR RECEPTOR IN BREAST-CANCER PATIENTS PROGNOSTIC-SIGNIFICANCE OF COEXPRESSION OF C-ERBB-2 ONCOPROTEIN AND EPIDERMAL GROWTH-FACTOR RECEPTOR IN BREAST-CANCER PATIENTS PROGNOSTIC-SIGNIFICANCE OF COEXPRESSION OF C-ERBB-2 ONCOPROTEIN AND EPIDERMAL GROWTH-FACTOR RECEPTOR IN BREAST-CANCER PATIENTS AMERICAN JOURNAL OF SURGERY, 164, 4, 323-326 AMERICAN JOURNAL OF SURGERY, 164, 4, 323-326 AMERICAN JOURNAL OF SURGERY, 164, 4, 323-326 1992/10 英語 研究論文(学術雑誌) 公開
M TOI, R BICKNELL, AL HARRIS M TOI, R BICKNELL, AL HARRIS M TOI, R BICKNELL, AL HARRIS INHIBITION OF COLON AND BREAST-CARCINOMA CELL-GROWTH BY INTERLEUKIN-4 INHIBITION OF COLON AND BREAST-CARCINOMA CELL-GROWTH BY INTERLEUKIN-4 INHIBITION OF COLON AND BREAST-CARCINOMA CELL-GROWTH BY INTERLEUKIN-4 CANCER RESEARCH, 52, 2, 275-279 CANCER RESEARCH, 52, 2, 275-279 CANCER RESEARCH, 52, 2, 275-279 1992/01 英語 研究論文(学術雑誌) 公開
H MUKAIDA, M TOI, T HIRAI, Y YAMASHITA, T TOGE H MUKAIDA, M TOI, T HIRAI, Y YAMASHITA, T TOGE H MUKAIDA, M TOI, T HIRAI, Y YAMASHITA, T TOGE CLINICAL-SIGNIFICANCE OF THE EXPRESSION OF EPIDERMAL GROWTH-FACTOR AND ITS RECEPTOR IN ESOPHAGEAL CANCER CLINICAL-SIGNIFICANCE OF THE EXPRESSION OF EPIDERMAL GROWTH-FACTOR AND ITS RECEPTOR IN ESOPHAGEAL CANCER CLINICAL-SIGNIFICANCE OF THE EXPRESSION OF EPIDERMAL GROWTH-FACTOR AND ITS RECEPTOR IN ESOPHAGEAL CANCER CANCER, 68, 1, 142-148 CANCER, 68, 1, 142-148 CANCER, 68, 1, 142-148 1991/07 英語 研究論文(学術雑誌) 公開
M TOI, AL HARRIS, R BICKNELL M TOI, AL HARRIS, R BICKNELL M TOI, AL HARRIS, R BICKNELL INTERLEUKIN-4 IS A POTENT MITOGEN FOR CAPILLARY ENDOTHELIUM INTERLEUKIN-4 IS A POTENT MITOGEN FOR CAPILLARY ENDOTHELIUM INTERLEUKIN-4 IS A POTENT MITOGEN FOR CAPILLARY ENDOTHELIUM BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 174, 3, 1287-1293 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 174, 3, 1287-1293 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 174, 3, 1287-1293 1991/02 英語 研究論文(学術雑誌) 公開
K. Umezaza, M. Toi K. Umezaza, M. Toi K. Umezaza, M. Toi Inhibitors of growth factor functions, possible antineoplastic agents Inhibitors of growth factor functions, possible antineoplastic agents Inhibitors of growth factor functions, possible antineoplastic agents Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme, 36, 7, 1429-1435 Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme, 36, 7, 1429-1435 Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme, 36, 7, 1429-1435 1991 英語 公開
K. Yoshinaka, M. Yagi, S. Ohtagaki, M. Toi, T. Toge K. Yoshinaka, M. Yagi, S. Ohtagaki, M. Toi, T. Toge K. Yoshinaka, M. Yagi, S. Ohtagaki, M. Toi, T. Toge 5\\'-deoxy-5-fluorouridine (5\\'-DFUR), mitomycin C (MMC), etoposide and medroxy progesterone acetate (MPA) in a previously treated patient with advanced breast cancer 5\\'-deoxy-5-fluorouridine (5\\'-DFUR), mitomycin C (MMC), etoposide and medroxy progesterone acetate (MPA) in a previously treated patient with advanced breast cancer 5\\'-deoxy-5-fluorouridine (5\\'-DFUR), mitomycin C (MMC), etoposide and medroxy progesterone acetate (MPA) in a previously treated patient with advanced breast cancer Japanese Journal of Cancer and Chemotherapy, 18, 1, 115-118 Japanese Journal of Cancer and Chemotherapy, 18, 1, 115-118 Japanese Journal of Cancer and Chemotherapy, 18, 1, 115-118 1991 英語 公開
M TOI, A OSAKI, H YAMADA, T TOGE M TOI, A OSAKI, H YAMADA, T TOGE M TOI, A OSAKI, H YAMADA, T TOGE EPIDERMAL GROWTH-FACTOR RECEPTOR EXPRESSION AS A PROGNOSTIC INDICATOR IN BREAST-CANCER EPIDERMAL GROWTH-FACTOR RECEPTOR EXPRESSION AS A PROGNOSTIC INDICATOR IN BREAST-CANCER EPIDERMAL GROWTH-FACTOR RECEPTOR EXPRESSION AS A PROGNOSTIC INDICATOR IN BREAST-CANCER EUROPEAN JOURNAL OF CANCER, 27, 8, 977-980 EUROPEAN JOURNAL OF CANCER, 27, 8, 977-980 EUROPEAN JOURNAL OF CANCER, 27, 8, 977-980 1991 英語 研究論文(学術雑誌) 公開
M TOI, T NAKAMURA, H MUKAIDA, T WADA, A OSAKI, H YAMADA, T TOGE, M NIIMOTO, T HATTORI M TOI, T NAKAMURA, H MUKAIDA, T WADA, A OSAKI, H YAMADA, T TOGE, M NIIMOTO, T HATTORI M TOI, T NAKAMURA, H MUKAIDA, T WADA, A OSAKI, H YAMADA, T TOGE, M NIIMOTO, T HATTORI RELATIONSHIP BETWEEN EPIDERMAL GROWTH-FACTOR RECEPTOR STATUS AND VARIOUS PROGNOSTIC FACTORS IN HUMAN BREAST-CANCER RELATIONSHIP BETWEEN EPIDERMAL GROWTH-FACTOR RECEPTOR STATUS AND VARIOUS PROGNOSTIC FACTORS IN HUMAN BREAST-CANCER RELATIONSHIP BETWEEN EPIDERMAL GROWTH-FACTOR RECEPTOR STATUS AND VARIOUS PROGNOSTIC FACTORS IN HUMAN BREAST-CANCER CANCER, 65, 9, 1980-1984 CANCER, 65, 9, 1980-1984 CANCER, 65, 9, 1980-1984 1990/05 英語 研究論文(学術雑誌) 公開
M TOI, T WADA, H YAMADA, A OHSAKI, A YAMAMOTO, T NAKAMURA, M NIIMOTO, T HATTORI M TOI, T WADA, H YAMADA, A OHSAKI, A YAMAMOTO, T NAKAMURA, M NIIMOTO, T HATTORI M TOI, T WADA, H YAMADA, A OHSAKI, A YAMAMOTO, T NAKAMURA, M NIIMOTO, T HATTORI GROWTH FRACTIONS OF BREAST-CANCER IN RELATION TO EPIDERMAL GROWTH-FACTOR RECEPTOR AND ESTROGEN-RECEPTOR GROWTH FRACTIONS OF BREAST-CANCER IN RELATION TO EPIDERMAL GROWTH-FACTOR RECEPTOR AND ESTROGEN-RECEPTOR GROWTH FRACTIONS OF BREAST-CANCER IN RELATION TO EPIDERMAL GROWTH-FACTOR RECEPTOR AND ESTROGEN-RECEPTOR JAPANESE JOURNAL OF SURGERY, 20, 3, 327-330 JAPANESE JOURNAL OF SURGERY, 20, 3, 327-330 JAPANESE JOURNAL OF SURGERY, 20, 3, 327-330 1990/05 英語 研究論文(学術雑誌) 公開
H MUKAIDA, T YAMAMOTO, T HIRAI, M TOI, T NAKAMURA, T WADA, Y YAMASHITA, K KAWANO, M NIIMOTO H MUKAIDA, T YAMAMOTO, T HIRAI, M TOI, T NAKAMURA, T WADA, Y YAMASHITA, K KAWANO, M NIIMOTO H MUKAIDA, T YAMAMOTO, T HIRAI, M TOI, T NAKAMURA, T WADA, Y YAMASHITA, K KAWANO, M NIIMOTO EXPRESSION OF HUMAN EPIDERMAL GROWTH-FACTOR AND ITS RECEPTOR IN ESOPHAGEAL CANCER EXPRESSION OF HUMAN EPIDERMAL GROWTH-FACTOR AND ITS RECEPTOR IN ESOPHAGEAL CANCER EXPRESSION OF HUMAN EPIDERMAL GROWTH-FACTOR AND ITS RECEPTOR IN ESOPHAGEAL CANCER JAPANESE JOURNAL OF SURGERY, 20, 3, 275-282 JAPANESE JOURNAL OF SURGERY, 20, 3, 275-282 JAPANESE JOURNAL OF SURGERY, 20, 3, 275-282 1990/05 英語 研究論文(学術雑誌) 公開
M NIIMOTO, T SAEKI, M TOI, M NISHIYAMA, T HIRAI, E YANAGAWA, T HATTORI M NIIMOTO, T SAEKI, M TOI, M NISHIYAMA, T HIRAI, E YANAGAWA, T HATTORI M NIIMOTO, T SAEKI, M TOI, M NISHIYAMA, T HIRAI, E YANAGAWA, T HATTORI PROSPECTIVE RANDOMIZED CONTROLLED-STUDY ON BESTATIN IN RESECTABLE GASTRIC-CANCER - 3RD REPORT PROSPECTIVE RANDOMIZED CONTROLLED-STUDY ON BESTATIN IN RESECTABLE GASTRIC-CANCER - 3RD REPORT PROSPECTIVE RANDOMIZED CONTROLLED-STUDY ON BESTATIN IN RESECTABLE GASTRIC-CANCER - 3RD REPORT JAPANESE JOURNAL OF SURGERY, 20, 2, 186-191 JAPANESE JOURNAL OF SURGERY, 20, 2, 186-191 JAPANESE JOURNAL OF SURGERY, 20, 2, 186-191 1990/03 英語 研究論文(学術雑誌) 公開
E. Miyahara, M. Toi, T. Wada, H. Yamada, A. Osaki, E. Yanagawa, T. Toge E. Miyahara, M. Toi, T. Wada, H. Yamada, A. Osaki, E. Yanagawa, T. Toge E. Miyahara, M. Toi, T. Wada, H. Yamada, A. Osaki, E. Yanagawa, T. Toge The expression of NCC-ST-439, a tumor marker, in human breast cancer patients The expression of NCC-ST-439, a tumor marker, in human breast cancer patients The expression of NCC-ST-439, a tumor marker, in human breast cancer patients Gan no rinsho. Japan journal of cancer clinics, 36, 11, 2023-2026 Gan no rinsho. Japan journal of cancer clinics, 36, 11, 2023-2026 Gan no rinsho. Japan journal of cancer clinics, 36, 11, 2023-2026 1990 英語 公開
S SUEHIRO, Y HAMADA, M TOI, T NAKAMURA, M NIIMOTO, T HATTORI S SUEHIRO, Y HAMADA, M TOI, T NAKAMURA, M NIIMOTO, T HATTORI S SUEHIRO, Y HAMADA, M TOI, T NAKAMURA, M NIIMOTO, T HATTORI NUCLEAR-DNA CONTENT IN BREAST-CARCINOMA WITH SPECIAL REFERENCE TO THE PARAMETERS OF MALIGNANT POTENTIALITY NUCLEAR-DNA CONTENT IN BREAST-CARCINOMA WITH SPECIAL REFERENCE TO THE PARAMETERS OF MALIGNANT POTENTIALITY NUCLEAR-DNA CONTENT IN BREAST-CARCINOMA WITH SPECIAL REFERENCE TO THE PARAMETERS OF MALIGNANT POTENTIALITY JAPANESE JOURNAL OF SURGERY, 20, 1, 115-118 JAPANESE JOURNAL OF SURGERY, 20, 1, 115-118 JAPANESE JOURNAL OF SURGERY, 20, 1, 115-118 1990/01 英語 公開
M TOI, H MUKAIDA, T WADA, N HIRABAYASHI, T TOGE, T HORI, K UMEZAWA M TOI, H MUKAIDA, T WADA, N HIRABAYASHI, T TOGE, T HORI, K UMEZAWA M TOI, H MUKAIDA, T WADA, N HIRABAYASHI, T TOGE, T HORI, K UMEZAWA ANTINEOPLASTIC EFFECT OF ERBSTATIN ON HUMAN MAMMARY AND ESOPHAGEAL TUMORS IN ATHYMIC NUDE-MICE ANTINEOPLASTIC EFFECT OF ERBSTATIN ON HUMAN MAMMARY AND ESOPHAGEAL TUMORS IN ATHYMIC NUDE-MICE ANTINEOPLASTIC EFFECT OF ERBSTATIN ON HUMAN MAMMARY AND ESOPHAGEAL TUMORS IN ATHYMIC NUDE-MICE EUROPEAN JOURNAL OF CANCER, 26, 6, 722-724 EUROPEAN JOURNAL OF CANCER, 26, 6, 722-724 EUROPEAN JOURNAL OF CANCER, 26, 6, 722-724 1990 英語 研究論文(学術雑誌) 公開
M TOI, T NAKAMURA, T WADA, A YAMAMOTO, T TOGE, M NIIMOTO, T HATTORI M TOI, T NAKAMURA, T WADA, A YAMAMOTO, T TOGE, M NIIMOTO, T HATTORI M TOI, T NAKAMURA, T WADA, A YAMAMOTO, T TOGE, M NIIMOTO, T HATTORI THE DISCREPANCY BETWEEN IMMUNOCYTOCHEMICAL AND BIOCHEMICAL ASSAY OF ESTROGEN-RECEPTOR IN BREAST-CANCER PATIENTS TREATED BY ENDOCRINE THERAPY THE DISCREPANCY BETWEEN IMMUNOCYTOCHEMICAL AND BIOCHEMICAL ASSAY OF ESTROGEN-RECEPTOR IN BREAST-CANCER PATIENTS TREATED BY ENDOCRINE THERAPY THE DISCREPANCY BETWEEN IMMUNOCYTOCHEMICAL AND BIOCHEMICAL ASSAY OF ESTROGEN-RECEPTOR IN BREAST-CANCER PATIENTS TREATED BY ENDOCRINE THERAPY JAPANESE JOURNAL OF SURGERY, 19, 6, 768-772 JAPANESE JOURNAL OF SURGERY, 19, 6, 768-772 JAPANESE JOURNAL OF SURGERY, 19, 6, 768-772 1989/11 英語 研究論文(学術雑誌) 公開
M TOI, T NAKAMURA, T WADA, A YAMAMOTO, T TOGE, M NIIMOTO, T HATTORI M TOI, T NAKAMURA, T WADA, A YAMAMOTO, T TOGE, M NIIMOTO, T HATTORI M TOI, T NAKAMURA, T WADA, A YAMAMOTO, T TOGE, M NIIMOTO, T HATTORI THE ACCEPTABLE DELAY BETWEEN BIOPSY AND RADICAL-MASTECTOMY IN BREAST-CANCER PATIENTS THE ACCEPTABLE DELAY BETWEEN BIOPSY AND RADICAL-MASTECTOMY IN BREAST-CANCER PATIENTS THE ACCEPTABLE DELAY BETWEEN BIOPSY AND RADICAL-MASTECTOMY IN BREAST-CANCER PATIENTS JAPANESE JOURNAL OF SURGERY, 19, 6, 679-683 JAPANESE JOURNAL OF SURGERY, 19, 6, 679-683 JAPANESE JOURNAL OF SURGERY, 19, 6, 679-683 1989/11 英語 研究論文(学術雑誌) 公開
S SUEHIRO, K INAI, S TOKUOKA, Y HAMADA, M TOI, M NIIMOTO, T HATTORI S SUEHIRO, K INAI, S TOKUOKA, Y HAMADA, M TOI, M NIIMOTO, T HATTORI S SUEHIRO, K INAI, S TOKUOKA, Y HAMADA, M TOI, M NIIMOTO, T HATTORI INVOLVEMENT OF THE NIPPLE IN EARLY CARCINOMA OF THE BREAST INVOLVEMENT OF THE NIPPLE IN EARLY CARCINOMA OF THE BREAST INVOLVEMENT OF THE NIPPLE IN EARLY CARCINOMA OF THE BREAST SURGERY GYNECOLOGY & OBSTETRICS, 168, 3, 244-248 SURGERY GYNECOLOGY & OBSTETRICS, 168, 3, 244-248 SURGERY GYNECOLOGY & OBSTETRICS, 168, 3, 244-248 1989/03 英語 研究論文(学術雑誌) 公開
M TOI, Y HAMADA, T NAKAMURA, H MUKAIDA, S SUEHIRO, T WADA, T TOGE, M NIIMOTO, T HATTORI M TOI, Y HAMADA, T NAKAMURA, H MUKAIDA, S SUEHIRO, T WADA, T TOGE, M NIIMOTO, T HATTORI M TOI, Y HAMADA, T NAKAMURA, H MUKAIDA, S SUEHIRO, T WADA, T TOGE, M NIIMOTO, T HATTORI IMMUNOCYTOCHEMICAL AND BIOCHEMICAL-ANALYSIS OF EPIDERMAL GROWTH-FACTOR RECEPTOR EXPRESSION IN HUMAN-BREAST CANCER TISSUES - RELATIONSHIP TO ESTROGEN-RECEPTOR AND LYMPHATIC INVASION IMMUNOCYTOCHEMICAL AND BIOCHEMICAL-ANALYSIS OF EPIDERMAL GROWTH-FACTOR RECEPTOR EXPRESSION IN HUMAN-BREAST CANCER TISSUES - RELATIONSHIP TO ESTROGEN-RECEPTOR AND LYMPHATIC INVASION IMMUNOCYTOCHEMICAL AND BIOCHEMICAL-ANALYSIS OF EPIDERMAL GROWTH-FACTOR RECEPTOR EXPRESSION IN HUMAN-BREAST CANCER TISSUES - RELATIONSHIP TO ESTROGEN-RECEPTOR AND LYMPHATIC INVASION INTERNATIONAL JOURNAL OF CANCER, 43, 2, 220-225 INTERNATIONAL JOURNAL OF CANCER, 43, 2, 220-225 INTERNATIONAL JOURNAL OF CANCER, 43, 2, 220-225 1989/02 英語 研究論文(学術雑誌) 公開
T. Saeki, K. Jinushi, R. Kim, M. Toi, K. Saeki, K. Yoshinaka, E. Yanagawa, M. Niimoto, T. Hattori T. Saeki, K. Jinushi, R. Kim, M. Toi, K. Saeki, K. Yoshinaka, E. Yanagawa, M. Niimoto, T. Hattori T. Saeki, K. Jinushi, R. Kim, M. Toi, K. Saeki, K. Yoshinaka, E. Yanagawa, M. Niimoto, T. Hattori Combination chemotherapy of CPM-MTX-5-FU for non-resectable and recurrent cancer patients Combination chemotherapy of CPM-MTX-5-FU for non-resectable and recurrent cancer patients Combination chemotherapy of CPM-MTX-5-FU for non-resectable and recurrent cancer patients Japanese Journal of Cancer and Chemotherapy, 16, 4 I, 827-831 Japanese Journal of Cancer and Chemotherapy, 16, 4 I, 827-831 Japanese Journal of Cancer and Chemotherapy, 16, 4 I, 827-831 1989 英語 公開
M TOI, Y HAMADA, Y SETO, M TANIMOTO, T NAKAMURA, T TOGE, M NIIMOTO, T HATTORI M TOI, Y HAMADA, Y SETO, M TANIMOTO, T NAKAMURA, T TOGE, M NIIMOTO, T HATTORI M TOI, Y HAMADA, Y SETO, M TANIMOTO, T NAKAMURA, T TOGE, M NIIMOTO, T HATTORI IMMUNOCYTOCHEMICAL STUDY ON THE VARIATION IN ESTROGEN-RECEPTORS OF PRIMARY AND NODAL METASTASES OF BREAST-CANCER IMMUNOCYTOCHEMICAL STUDY ON THE VARIATION IN ESTROGEN-RECEPTORS OF PRIMARY AND NODAL METASTASES OF BREAST-CANCER IMMUNOCYTOCHEMICAL STUDY ON THE VARIATION IN ESTROGEN-RECEPTORS OF PRIMARY AND NODAL METASTASES OF BREAST-CANCER JAPANESE JOURNAL OF SURGERY, 18, 2, 228-231 JAPANESE JOURNAL OF SURGERY, 18, 2, 228-231 JAPANESE JOURNAL OF SURGERY, 18, 2, 228-231 1988/03 英語 公開
M. Toi M. Toi M. Toi Comparative study on estrogen receptor, epidermal growth factor and epidermal growth factor receptor using immunocytochemical and biochemical assays in breast cancer Comparative study on estrogen receptor, epidermal growth factor and epidermal growth factor receptor using immunocytochemical and biochemical assays in breast cancer Comparative study on estrogen receptor, epidermal growth factor and epidermal growth factor receptor using immunocytochemical and biochemical assays in breast cancer Nippon Geka Gakkai zasshi, 89, 5, 725-736 Nippon Geka Gakkai zasshi, 89, 5, 725-736 Nippon Geka Gakkai zasshi, 89, 5, 725-736 1988 英語 公開
Y. Nomura, H. Tashiro, K. Hisamatsu, M. Toi Y. Nomura, H. Tashiro, K. Hisamatsu, M. Toi Y. Nomura, H. Tashiro, K. Hisamatsu, M. Toi Effects of high-dose medroxyprogesterone acetate for advanced breast cancer with special reference to prior endocrine therapy and hormone receptors Effects of high-dose medroxyprogesterone acetate for advanced breast cancer with special reference to prior endocrine therapy and hormone receptors Effects of high-dose medroxyprogesterone acetate for advanced breast cancer with special reference to prior endocrine therapy and hormone receptors Japanese Journal of Cancer and Chemotherapy, 15, 3, 513-518 Japanese Journal of Cancer and Chemotherapy, 15, 3, 513-518 Japanese Journal of Cancer and Chemotherapy, 15, 3, 513-518 1988 英語 公開
K. Hisamatsu, T. Toge, E. Yanagawa, Y. Hamada, Y. Seto, H. Yamada, M. Toi, T. Hattori K. Hisamatsu, T. Toge, E. Yanagawa, Y. Hamada, Y. Seto, H. Yamada, M. Toi, T. Hattori K. Hisamatsu, T. Toge, E. Yanagawa, Y. Hamada, Y. Seto, H. Yamada, M. Toi, T. Hattori Immune reactivities of lymphocytes from peripheral blood, regional lymph nodes and tumor-infiltrating lymphocytes in breast cancer patients Immune reactivities of lymphocytes from peripheral blood, regional lymph nodes and tumor-infiltrating lymphocytes in breast cancer patients Immune reactivities of lymphocytes from peripheral blood, regional lymph nodes and tumor-infiltrating lymphocytes in breast cancer patients Japanese Journal of Cancer and Chemotherapy, 13, 8, 2555-2561 Japanese Journal of Cancer and Chemotherapy, 13, 8, 2555-2561 Japanese Journal of Cancer and Chemotherapy, 13, 8, 2555-2561 1986 英語 公開
M. Toi, Y. Hamada, Y. Seto, K. Hisamatsu, S. Suehiro, T. Toge, M. Niimoto, T. Hattori M. Toi, Y. Hamada, Y. Seto, K. Hisamatsu, S. Suehiro, T. Toge, M. Niimoto, T. Hattori M. Toi, Y. Hamada, Y. Seto, K. Hisamatsu, S. Suehiro, T. Toge, M. Niimoto, T. Hattori Comparative study of estrogen receptor assays between immunocytochemical assay using monoclonal antibody and the dextran- coated charcoal method Comparative study of estrogen receptor assays between immunocytochemical assay using monoclonal antibody and the dextran- coated charcoal method Comparative study of estrogen receptor assays between immunocytochemical assay using monoclonal antibody and the dextran- coated charcoal method Gan to kagaku ryoho. Cancer & chemotherapy, 13, 10, 3056-3062 Gan to kagaku ryoho. Cancer & chemotherapy, 13, 10, 3056-3062 Gan to kagaku ryoho. Cancer & chemotherapy, 13, 10, 3056-3062 1986 英語 公開
M. Toi, T. Shiramizu, T. Yonemura, T. Ezaki, N. Oka, T. Yoshida, H. Tsurumaru M. Toi, T. Shiramizu, T. Yonemura, T. Ezaki, N. Oka, T. Yoshida, H. Tsurumaru M. Toi, T. Shiramizu, T. Yonemura, T. Ezaki, N. Oka, T. Yoshida, H. Tsurumaru Intraperitoneal cisplatin in peritoneal carcinomatosis patients Intraperitoneal cisplatin in peritoneal carcinomatosis patients Intraperitoneal cisplatin in peritoneal carcinomatosis patients Gan no rinsho. Japan journal of cancer clinics, 31, 5, 522-526 Gan no rinsho. Japan journal of cancer clinics, 31, 5, 522-526 Gan no rinsho. Japan journal of cancer clinics, 31, 5, 522-526 1985 英語 公開
M. Toi, K. Matsuki, K. Nakagami, M. Hirono, M. Niimoto, T. Hattori M. Toi, K. Matsuki, K. Nakagami, M. Hirono, M. Niimoto, T. Hattori M. Toi, K. Matsuki, K. Nakagami, M. Hirono, M. Niimoto, T. Hattori A case of minute carcinoma associated with an atypical epithelial lesion of the stomach and histopathological analysis A case of minute carcinoma associated with an atypical epithelial lesion of the stomach and histopathological analysis A case of minute carcinoma associated with an atypical epithelial lesion of the stomach and histopathological analysis Gan no rinsho. Japan journal of cancer clinics, 30, 5, 519-523 Gan no rinsho. Japan journal of cancer clinics, 30, 5, 519-523 Gan no rinsho. Japan journal of cancer clinics, 30, 5, 519-523 1984 英語 公開
Masahiro Takada, Hiroshi Ishiguro, Shigenori Nagai, Shoichiro Ohtani, Hidetaka Kawabata, Yasuhiro Yanagita, Yasuo Hozumi, Chikako Shimizu, Shintaro Takao, Nobuaki Sato, Yoshimasa Kosaka, Yasuaki Sagara, Hiroji Iwata, Shinji Ohno, Katsumasa Kuroi, Norikazu Masuda, Hiroyasu Yamashiro, Masahiro Sugimoto, Masahide Kondo, Yasuhiro Naito, Hironobu Sasano, Takashi Inamoto, Satoshi Morita, Masakazu Toi Masahiro Takada, Hiroshi Ishiguro, Shigenori Nagai, Shoichiro Ohtani, Hidetaka Kawabata, Yasuhiro Yanagita, Yasuo Hozumi, Chikako Shimizu, Shintaro Takao, Nobuaki Sato, Yoshimasa Kosaka, Yasuaki Sagara, Hiroji Iwata, Shinji Ohno, Katsumasa Kuroi, Norikazu Masuda, Hiroyasu Yamashiro, Masahiro Sugimoto, Masahide Kondo, Yasuhiro Naito, Hironobu Sasano, Takashi Inamoto, Satoshi Morita, Masakazu Toi Masahiro Takada, Hiroshi Ishiguro, Shigenori Nagai, Shoichiro Ohtani, Hidetaka Kawabata, Yasuhiro Yanagita, Yasuo Hozumi, Chikako Shimizu, Shintaro Takao, Nobuaki Sato, Yoshimasa Kosaka, Yasuaki Sagara, Hiroji Iwata, Shinji Ohno, Katsumasa Kuroi, Norikazu Masuda, Hiroyasu Yamashiro, Masahiro Sugimoto, Masahide Kondo, Yasuhiro Naito, Hironobu Sasano, Takashi Inamoto, Satoshi Morita, Masakazu Toi Predictive factors for pathologic complete response and disease-free survival after neoadjuvant chemotherapy with trastuzumab: a multicenter retrospective observational study in patients with HER2-positive primary breast cancer (JBCRG-C03 study) Predictive factors for pathologic complete response and disease-free survival after neoadjuvant chemotherapy with trastuzumab: a multicenter retrospective observational study in patients with HER2-positive primary breast cancer (JBCRG-C03 study) Predictive factors for pathologic complete response and disease-free survival after neoadjuvant chemotherapy with trastuzumab: a multicenter retrospective observational study in patients with HER2-positive primary breast cancer (JBCRG-C03 study) San Antonio Breast Cancer Symposium 2013 San Antonio Breast Cancer Symposium 2013 San Antonio Breast Cancer Symposium 2013 英語 公開
戸井 雅和 戸井 雅和 Matsumoto Y, Asao Y, Yoshikawa A, Sekiguchi H, Takada M, Furu M, Saito S, Kataoka M, Abe H, Yagi T, Togashi K, Toi M Label-free photoacoustic imaging of human palmar vessels: a structural morphological analysis. Label-free photoacoustic imaging of human palmar vessels: a structural morphological analysis. Label-free photoacoustic imaging of human palmar vessels: a structural morphological analysis. Sci Rep, 15;8(1), 786 Sci Rep, 15;8(1), 786 Sci Rep, 15;8(1), 786 公開
戸井 雅和 戸井 雅和 TOI Masakazu SALL4 - KHDRBS3 network enhances stemness by modulating CD44 splicing in basal-like breast cancer. SALL4 - KHDRBS3 network enhances stemness by modulating CD44 splicing in basal-like breast cancer. SALL4 - KHDRBS3 network enhances stemness by modulating CD44 splicing in basal-like breast cancer. Cancer Med, Feb;7(2), 454-462 Cancer Med, Feb;7(2), 454-462 Cancer Med, Feb;7(2), 454-462 公開
戸井 雅和 戸井 雅和 TOI Masakazu 5-Chloro-2,4-dihydroxypyridine, CDHP, prevents lung metastasis of basal-like breast cancer cells by reducing nascent adhesion formation. 5-Chloro-2,4-dihydroxypyridine, CDHP, prevents lung metastasis of basal-like breast cancer cells by reducing nascent adhesion formation. 5-Chloro-2,4-dihydroxypyridine, CDHP, prevents lung metastasis of basal-like breast cancer cells by reducing nascent adhesion formation. Cancer Med, 7(2), 463-470 Cancer Med, 7(2), 463-470 Cancer Med, 7(2), 463-470 公開
戸井 雅和 戸井 雅和 Miyake KK, Nakamoto Y, Saji S, Sugie T, Kurihara K, Kanao S, Ikeda DM, Toi M, Togashi K Impact of physiological hormonal fluctuations on 18F-fluorodeoxyglucose uptake in breast cancer. Impact of physiological hormonal fluctuations on 18F-fluorodeoxyglucose uptake in breast cancer. Impact of physiological hormonal fluctuations on 18F-fluorodeoxyglucose uptake in breast cancer. Breast Cancer Res Treat, 169(3), 437-446 Breast Cancer Res Treat, 169(3), 437-446 , 169(3), 437-446 公開
戸井 雅和 戸井 雅和 TOI Masakazu Efficacy and safety of everolimus in combination with trastuzumab and paclitaxel in Asian patients with HER2+ advanced breast cancer in BOLERO-1. Efficacy and safety of everolimus in combination with trastuzumab and paclitaxel in Asian patients with HER2+ advanced breast cancer in BOLERO-1. Toi M, Shao Z, Hurvitz S, Tseng LM, Zhang Q, Shen K, Liu D, Feng J, Xu B, Wang X, Lee KS, Ng TY, Ridolfi A, Noel-Baron F, Ringeisen F, Jiang Z. Breast Cancer Res, 19(1), 2017 Apr 11;19(1):47. doi: 10. Breast Cancer Res, 19(1), 2017 Apr 11;19(1):47. doi: 10. Breast Cancer Res, 19(1), 2017 Apr 11;19(1):47. doi: 10. 公開
戸井 雅和 戸井 雅和 Ueno T, Saji S, Sugimoto M, Masuda N, Kuroi K, Sato N, Takei H, Yamamoto Y, Ohno S, Yamashita H, Hisamatsu K, Aogi K, Iwata H, Imoto S, Sasano H, Toi M Clinical significance of the expression of autophagy-associated marker, beclin 1, in breast cancer patients who received neoadjuvant endocrine therapy. Clinical significance of the expression of autophagy-associated marker, beclin 1, in breast cancer patients who received neoadjuvant endocrine therapy. Clinical significance of the expression of autophagy-associated marker, beclin 1, in breast cancer patients who received neoadjuvant endocrine therapy. BMC Cancer, 16;16, 230-doi: 10 BMC Cancer, 16;16, 230-doi: 10 BMC Cancer, 16;16, 230-doi: 10 公開
戸井 雅和 戸井 雅和 André F, Hurvitz S, Fasolo A, Tseng LM, Jerusalem G, Wilks S, O'Regan R, Isaacs C, Toi M, Burris H, He W, Robinson D, Riester M, Taran T, Chen D, Slamon D Molecular Alterations and Everolimus Efficacy in Human Epidermal Growth Factor Receptor 2-Overexpressing Metastatic Breast Cancers: Combined Exploratory Biomarker Analysis From BOLERO-1 and BOLERO-3. Molecular Alterations and Everolimus Efficacy in Human Epidermal Growth Factor Receptor 2-Overexpressing Metastatic Breast Cancers: Combined Exploratory Biomarker Analysis From BOLERO-1 and BOLERO-3. Molecular Alterations and Everolimus Efficacy in Human Epidermal Growth Factor Receptor 2-Overexpressing Metastatic Breast Cancers: Combined Exploratory Biomarker Analysis From BOLERO-1 and BOLERO-3. J Clin Oncol, 20;34, 18, 2115-2124 J Clin Oncol, 20;34, 18, 2115-2124 J Clin Oncol, 20;34, 18, 2115-2124 公開
戸井 雅和 戸井 雅和 Asao Y, Hashizume Y, Suita T, Nagae KI, Fukutani K, Sudo Y, Matsushita T, Kobayashi S, Tokiwa M, Yamaga I, Fakhrejahani E, Torii M, Kawashima M, Takada M, Kanao S, Kataoka M, Shiina T, Toi M Photoacoustic mammography capable of simultaneously acquiring photoacoustic and ultrasound images. Photoacoustic mammography capable of simultaneously acquiring photoacoustic and ultrasound images. Photoacoustic mammography capable of simultaneously acquiring photoacoustic and ultrasound images. J Biomed Opt, 1;21, 11, :116009. J Biomed Opt, 1;21, 11, :116009. J Biomed Opt, 1;21, 11, :116009. 公開
Cameron D, Brown J, Dent R, Jackisch C, Mackey J, Pivot X, Steger GG, Suter TM, Toi M, Parmar M, Laeufle R, Im YH, Romieu G, Harvey V, Lipatov O, Pienkowski T, Cottu P, Chan A, Im SA, Hall PS, Bubuteishvili-Pacaud L, Henschel V, Deurloo RJ, Pallaud C, Bell R Cameron D, Brown J, Dent R, Jackisch C, Mackey J, Pivot X, Steger GG, Suter TM, Toi M, Parmar M, Laeufle R, Im YH, Romieu G, Harvey V, Lipatov O, Pienkowski T, Cottu P, Chan A, Im SA, Hall PS, Bubuteishvili-Pacaud L, Henschel V, Deurloo RJ, Pallaud C, Bell R Cameron D, Brown J, Dent R, Jackisch C, Mackey J, Pivot X, Steger GG, Suter TM, Toi M, Parmar M, Laeufle R, Im YH, Romieu G, Harvey V, Lipatov O, Pienkowski T, Cottu P, Chan A, Im SA, Hall PS, Bubuteishvili-Pacaud L, Henschel V, Deurloo RJ, Pallaud C, Bell R Adjuvant bevacizumab- containing therapy in triple-negative breast cancer (BEATRICE): primary results of a randomised, phase 3 trial Adjuvant bevacizumab- containing therapy in triple-negative breast cancer (BEATRICE): primary results of a randomised, phase 3 trial Adjuvant bevacizumab- containing therapy in triple-negative breast cancer (BEATRICE): primary results of a randomised, phase 3 trial Lancet Oncol. 2013 Lancet Oncol. 2013 Lancet Oncol. 2013 英語 公開
Suzuki R, Saji S, Toi M Suzuki R, Saji S, Toi M Suzuki R, Saji S, Toi M Impact of body mass index on breast cancer in accordance with the life-stage of women. Impact of body mass index on breast cancer in accordance with the life-stage of women. Impact of body mass index on breast cancer in accordance with the life-stage of women. Front Oncol. 2012;2:123 Front Oncol. 2012;2:123 Front Oncol. 2012;2:123 英語 公開

  • <<
  • >>
  • 表示
タイトル言語:
Misc
著者 著者(日本語) 著者(英語) タイトル タイトル(日本語) タイトル(英語) 書誌情報等 書誌情報等(日本語) 書誌情報等(英語) 出版年月 査読の有無 記述言語 掲載種別 公開
小味由里絵, 川口展子, 片岡裕貴, 石黒洋, 戸井雅和 小味由里絵, 川口展子, 片岡裕貴, 石黒洋, 戸井雅和 アンスラサイクリン系レジメンにおける経口デキサメタゾンと 口腔粘膜炎発症との関連の検討 アンスラサイクリン系レジメンにおける経口デキサメタゾンと 口腔粘膜炎発症との関連の検討 第27回日本乳癌学会総会プログラム抄録集 DP-1-27-3 第27回日本乳癌学会総会プログラム抄録集 DP-1-27-3 2019/07 日本語 研究発表要旨(全国大会、その他学術会議) 公開
飯間 麻美, 片岡 正子, 本田 茉也, 大野 文美, 太田 理恵, 大橋 茜, 三宅 可奈江, 戸井 雅和, 富樫 かおり 飯間 麻美, 片岡 正子, 本田 茉也, 大野 文美, 太田 理恵, 大橋 茜, 三宅 可奈江, 戸井 雅和, 富樫 かおり 乳腺腫瘍良悪性鑑別における異なる拡散時間を用いたADC値の有用性 乳腺腫瘍良悪性鑑別における異なる拡散時間を用いたADC値の有用性 日本乳癌学会総会プログラム抄録集, 27回, 431-431 日本乳癌学会総会プログラム抄録集, 27回, 431-431 , 27回, 431-431 2019/07 日本語 公開
大橋 茜, 片岡 正子, 飯間 麻美, 金尾 昌太郎, 本田 茉也, 大野 文美, 三宅 可奈江, 太田 理恵, 戸井 雅和, 富樫 かおり 大橋 茜, 片岡 正子, 飯間 麻美, 金尾 昌太郎, 本田 茉也, 大野 文美, 三宅 可奈江, 太田 理恵, 戸井 雅和, 富樫 かおり 高速撮像法(KWIC撮像)におけるダイナミック造影超早期Maximum Slope(MS)の診断能 WI、ADC値との比較 高速撮像法(KWIC撮像)におけるダイナミック造影超早期Maximum Slope(MS)の診断能 WI、ADC値との比較 日本乳癌学会総会プログラム抄録集, 27回, 431-431 日本乳癌学会総会プログラム抄録集, 27回, 431-431 , 27回, 431-431 2019/07 日本語 公開
本田 茉也, 片岡 正子, 尾仲 桜子, 宮川 哲, 川瀬 貫互, 金尾 昌太郎, 大西 奈都子, 三宅 可奈江, 片岡 竜貴, 桜井 孝規, 飯間 麻美, 大橋 茜, 大野 文美, 太田 理恵, 鈴木 栄治, 高田 正泰, 河口 浩介, 鳥井 雅恵, 戸井 雅和, 富樫 かおり 本田 茉也, 片岡 正子, 尾仲 桜子, 宮川 哲, 川瀬 貫互, 金尾 昌太郎, 大西 奈都子, 三宅 可奈江, 片岡 竜貴, 桜井 孝規, 飯間 麻美, 大橋 茜, 大野 文美, 太田 理恵, 鈴木 栄治, 高田 正泰, 河口 浩介, 鳥井 雅恵, 戸井 雅和, 富樫 かおり 乳房MRIカテゴリー4のサブカテゴリー導入による乳房病変の層別化 乳房MRIカテゴリー4のサブカテゴリー導入による乳房病変の層別化 日本乳癌学会総会プログラム抄録集, 27回, 470-470 日本乳癌学会総会プログラム抄録集, 27回, 470-470 , 27回, 470-470 2019/07 日本語 公開
大野 文美, 片岡 正子, 飯間 麻美, 本田 茉也, 三宅 可奈江, 大橋 茜, 太田 理恵, 片岡 竜貴, 桜井 孝規, 鈴木 栄治, 戸井 雅和, 富樫 かおり 大野 文美, 片岡 正子, 飯間 麻美, 本田 茉也, 三宅 可奈江, 大橋 茜, 太田 理恵, 片岡 竜貴, 桜井 孝規, 鈴木 栄治, 戸井 雅和, 富樫 かおり 高分解能拡散強調画像による乳癌病変の評価 病理所見との比較検討 高分解能拡散強調画像による乳癌病変の評価 病理所見との比較検討 日本乳癌学会総会プログラム抄録集, 27回, 471-471 日本乳癌学会総会プログラム抄録集, 27回, 471-471 , 27回, 471-471 2019/07 日本語 公開
片岡 正子, 鳥井 雅恵, 石守 崇好, 中本 裕士, 高田 正泰, 金尾 昌太郎, 阪口 怜奈, 三宅 可奈江, 本田 茉也, 太田 理恵, 飯間 麻美, 片岡 竜貴, 桜井 孝規, 磯田 裕義, 戸井 雅和, 富樫 かおり 片岡 正子, 鳥井 雅恵, 石守 崇好, 中本 裕士, 高田 正泰, 金尾 昌太郎, 阪口 怜奈, 三宅 可奈江, 本田 茉也, 太田 理恵, 飯間 麻美, 片岡 竜貴, 桜井 孝規, 磯田 裕義, 戸井 雅和, 富樫 かおり 乳房専用PETの集積に対する造影MRI所見 乳房専用PETの集積に対する造影MRI所見 日本乳癌学会総会プログラム抄録集, 27回, 509-509 日本乳癌学会総会プログラム抄録集, 27回, 509-509 , 27回, 509-509 2019/07 日本語 公開
太田 理恵, 片岡 正子, 金尾 昌太郎, 本田 茉也, 飯間 麻美, 大野 文美, 大橋 茜, 三宅 可奈江, 桜井 孝規, 片岡 竜貴, 高田 正泰, 鈴木 栄治, 戸井 雅和, 富樫 かおり 太田 理恵, 片岡 正子, 金尾 昌太郎, 本田 茉也, 飯間 麻美, 大野 文美, 大橋 茜, 三宅 可奈江, 桜井 孝規, 片岡 竜貴, 高田 正泰, 鈴木 栄治, 戸井 雅和, 富樫 かおり 術前薬物療法後の乳房MRI pCR診断におけるDWI所見の有用性 術前薬物療法後の乳房MRI pCR診断におけるDWI所見の有用性 日本乳癌学会総会プログラム抄録集, 27回, 621-621 日本乳癌学会総会プログラム抄録集, 27回, 621-621 , 27回, 621-621 2019/07 日本語 公開
松本 純明, 関口 博之, 浅尾 恭史, 高田 正泰, 片岡 正子, 櫻井 孝規, 八木 隆行, 椎名 毅, 富樫 かおり, 戸井 雅和 松本 純明, 関口 博之, 浅尾 恭史, 高田 正泰, 片岡 正子, 櫻井 孝規, 八木 隆行, 椎名 毅, 富樫 かおり, 戸井 雅和 【乳癌の診断から治療の最新アップデート2019】乳がん診療における光超音波イメージング 【乳癌の診断から治療の最新アップデート2019】乳がん診療における光超音波イメージング Rad Fan, 17, 7, 13-21 Rad Fan, 17, 7, 13-21 , 17, 7, 13-21 2019/06 日本語 公開
片岡正子, 河合真喜子, 本田茉也, 太田理恵, 飯間麻美, 大野文美, 大橋茜, 金尾昌太郎, 戸井雅和, 富樫かおり 片岡正子, 河合真喜子, 本田茉也, 太田理恵, 飯間麻美, 大野文美, 大橋茜, 金尾昌太郎, 戸井雅和, 富樫かおり 片岡正子, 河合真喜子, 本田茉也, 太田理恵, 飯間麻美, 大野文美, 大橋茜, 金尾昌太郎, 戸井雅和, 富樫かおり MRI検出DCISの画像所見 非MRI検出DCISとの比較 MRI検出DCISの画像所見 非MRI検出DCISとの比較 MRI検出DCISの画像所見 非MRI検出DCISとの比較 DCIS研究会(Web), 10th, 10 (WEB ONLY) DCIS研究会(Web), 10th, 10 (WEB ONLY) DCIS研究会(Web), 10th, 10 (WEB ONLY) 2019 日本語 公開
川口 展子, 杉本 昌弘, 西風 隆司, 関谷 禎規, 児嶋 浩一, 戸井 雅和 川口 展子, 杉本 昌弘, 西風 隆司, 関谷 禎規, 児嶋 浩一, 戸井 雅和 川口 展子, 杉本 昌弘, 西風 隆司, 関谷 禎規, 児嶋 浩一, 戸井 雅和 MALDI-MSによる血清IgGN型糖鎖修飾プロファイリングを用いた乳がんの診断予測 MALDI-MSによる血清IgGN型糖鎖修飾プロファイリングを用いた乳がんの診断予測 MALDI-MSによる血清IgGN型糖鎖修飾プロファイリングを用いた乳がんの診断予測 日本癌治療学会学術集会抄録集, 56回, O39-1 日本癌治療学会学術集会抄録集, 56回, O39-1 日本癌治療学会学術集会抄録集, 56回, O39-1 2018/10 英語 公開
川口 展子, 露木 茂, 仙田 典子, 戸井 雅和, 山神 和彦, 奥野 敏隆, 芳林 浩史, 諏訪 裕文, 木川 雄一, 山城 大泰, 高原 祥子, 岡村 隆仁, 杉江 智治, 華井 明子, 石黒 洋 川口 展子, 露木 茂, 仙田 典子, 戸井 雅和, 山神 和彦, 奥野 敏隆, 芳林 浩史, 諏訪 裕文, 木川 雄一, 山城 大泰, 高原 祥子, 岡村 隆仁, 杉江 智治, 華井 明子, 石黒 洋 圧迫療法の化学療法起因性末梢神経障害予防効果検討の多施設共同ランダム化比較試験 圧迫療法の化学療法起因性末梢神経障害予防効果検討の多施設共同ランダム化比較試験 日本癌治療学会学術集会抄録集 日本癌治療学会学術集会抄録集 2018/10 日本語 研究発表要旨(全国大会、その他学術会議) 公開
M. Kawashima, T. Nishimura, Y. Kawata, E. Suzuki, M. Toi M. Kawashima, T. Nishimura, Y. Kawata, E. Suzuki, M. Toi M. Kawashima, T. Nishimura, Y. Kawata, E. Suzuki, M. Toi High-resolution imaging mass spectrometry identified the missing link between fatty acid remodeling of phosphatidylinositols and the activity of PD1-related immune checkpoint pathway High-resolution imaging mass spectrometry identified the missing link between fatty acid remodeling of phosphatidylinositols and the activity of PD1-related immune checkpoint pathway High-resolution imaging mass spectrometry identified the missing link between fatty acid remodeling of phosphatidylinositols and the activity of PD1-related immune checkpoint pathway Translational Immunometabolism Translational Immunometabolism Translational Immunometabolism 2018/06 英語 研究発表要旨(国際会議) 公開
高田 正泰, 竹内 恵, 鈴木 栄治, 佐藤 史顕, 松本 純明, 鳥井 雅恵, 川口 展子, 西野 裕人, 瀬尾 智, 波多野 悦朗, 戸井 雅和 高田 正泰, 竹内 恵, 鈴木 栄治, 佐藤 史顕, 松本 純明, 鳥井 雅恵, 川口 展子, 西野 裕人, 瀬尾 智, 波多野 悦朗, 戸井 雅和 高田 正泰, 竹内 恵, 鈴木 栄治, 佐藤 史顕, 松本 純明, 鳥井 雅恵, 川口 展子, 西野 裕人, 瀬尾 智, 波多野 悦朗, 戸井 雅和 センチネルリンパ節生検の今後に向けた取り組み 蛍光色素法センチネルリンパ節生検におけるプロジェクションマッピングを用いたリアルタイムナビゲーション センチネルリンパ節生検の今後に向けた取り組み 蛍光色素法センチネルリンパ節生検におけるプロジェクションマッピングを用いたリアルタイムナビゲーション センチネルリンパ節生検の今後に向けた取り組み 蛍光色素法センチネルリンパ節生検におけるプロジェクションマッピングを用いたリアルタイムナビゲーション 日本乳癌学会総会プログラム抄録集, 26回, 317-317 日本乳癌学会総会プログラム抄録集, 26回, 317-317 日本乳癌学会総会プログラム抄録集, 26回, 317-317 2018/05 日本語 公開
服部 正也, 相良 安昭, 高田 正泰, 大井 恭代, 黒住 昌史, 大谷 彰一郎, 井上 賢一, 高尾 信太郎, 佐藤 信昭, 山下 年成, 小坂 愉賢, 黒住 献, 森田 智視, 岩田 広治, 戸井 雅和 服部 正也, 相良 安昭, 高田 正泰, 大井 恭代, 黒住 昌史, 大谷 彰一郎, 井上 賢一, 高尾 信太郎, 佐藤 信昭, 山下 年成, 小坂 愉賢, 黒住 献, 森田 智視, 岩田 広治, 戸井 雅和 服部 正也, 相良 安昭, 高田 正泰, 大井 恭代, 黒住 昌史, 大谷 彰一郎, 井上 賢一, 高尾 信太郎, 佐藤 信昭, 山下 年成, 小坂 愉賢, 黒住 献, 森田 智視, 岩田 広治, 戸井 雅和 HER2陽性原発性乳癌の治療最適化 ER陰性HER2陽性乳癌におけるbasal markerの有用性に関する研究 HER2陽性原発性乳癌の治療最適化 ER陰性HER2陽性乳癌におけるbasal markerの有用性に関する研究 HER2陽性原発性乳癌の治療最適化 ER陰性HER2陽性乳癌におけるbasal markerの有用性に関する研究 日本乳癌学会総会プログラム抄録集, 26回, 273-273 日本乳癌学会総会プログラム抄録集, 26回, 273-273 日本乳癌学会総会プログラム抄録集, 26回, 273-273 2018/05 日本語 公開
唐 宇飛, 山本 豊, 山城 大泰, 近藤 直人, 中村 力也, 柏葉 匡寛, 高橋 將人, 津川 浩一郎, 石川 孝, 中山 貴寛, 大谷 彰一郎, 高野 利実, 藤澤 知巳, 遠山 竜也, 川口 英俊, 増野 浩二郎, 谷野 裕一, 森田 智視, 戸井 雅和, 大野 真司 唐 宇飛, 山本 豊, 山城 大泰, 近藤 直人, 中村 力也, 柏葉 匡寛, 高橋 將人, 津川 浩一郎, 石川 孝, 中山 貴寛, 大谷 彰一郎, 高野 利実, 藤澤 知巳, 遠山 竜也, 川口 英俊, 増野 浩二郎, 谷野 裕一, 森田 智視, 戸井 雅和, 大野 真司 唐 宇飛, 山本 豊, 山城 大泰, 近藤 直人, 中村 力也, 柏葉 匡寛, 高橋 將人, 津川 浩一郎, 石川 孝, 中山 貴寛, 大谷 彰一郎, 高野 利実, 藤澤 知巳, 遠山 竜也, 川口 英俊, 増野 浩二郎, 谷野 裕一, 森田 智視, 戸井 雅和, 大野 真司 ER陽性HER2陰性再発・進行乳癌の治療戦略 HER2陰性進行・再発乳癌に対するベバシズマブとパクリタキセル併用療法の前向き観察研究(JBCRG-C05試験) ER陽性HER2陰性再発・進行乳癌の治療戦略 HER2陰性進行・再発乳癌に対するベバシズマブとパクリタキセル併用療法の前向き観察研究(JBCRG-C05試験) ER陽性HER2陰性再発・進行乳癌の治療戦略 HER2陰性進行・再発乳癌に対するベバシズマブとパクリタキセル併用療法の前向き観察研究(JBCRG-C05試験) 日本乳癌学会総会プログラム抄録集, 26回, 276-276 日本乳癌学会総会プログラム抄録集, 26回, 276-276 日本乳癌学会総会プログラム抄録集, 26回, 276-276 2018/05 日本語 公開
川島 雅央, 常盤 麻里子, 西村 友美, 川田 有希子, 片岡 竜樹, 桜井 孝規, 祝迫 惠子, 鈴木 栄治, 戸井 雅和 川島 雅央, 常盤 麻里子, 西村 友美, 川田 有希子, 片岡 竜樹, 桜井 孝規, 祝迫 惠子, 鈴木 栄治, 戸井 雅和 川島 雅央, 常盤 麻里子, 西村 友美, 川田 有希子, 片岡 竜樹, 桜井 孝規, 祝迫 惠子, 鈴木 栄治, 戸井 雅和 新規バイオマーカーの臨床応用、予後予測因子・治療効果予測因子 脂質代謝物は乳癌の新しいバイオマーカーとなるか? 高解像度質量顕微鏡の解析から見えてきた事 新規バイオマーカーの臨床応用、予後予測因子・治療効果予測因子 脂質代謝物は乳癌の新しいバイオマーカーとなるか? 高解像度質量顕微鏡の解析から見えてきた事 新規バイオマーカーの臨床応用、予後予測因子・治療効果予測因子 脂質代謝物は乳癌の新しいバイオマーカーとなるか? 高解像度質量顕微鏡の解析から見えてきた事 日本乳癌学会総会プログラム抄録集, 26回, 303-303 日本乳癌学会総会プログラム抄録集, 26回, 303-303 日本乳癌学会総会プログラム抄録集, 26回, 303-303 2018/05 日本語 公開
杉本 昌弘, 高田 正泰, 増田 慎三, 岩田 広治, 黒井 克昌, 山城 大泰, 大野 真司, 石黒 洋, 稲本 俊, 戸井 雅和 杉本 昌弘, 高田 正泰, 増田 慎三, 岩田 広治, 黒井 克昌, 山城 大泰, 大野 真司, 石黒 洋, 稲本 俊, 戸井 雅和 HER2陽性原発性乳癌の治療最適化 Trastuzumabを含む術前化学療法を施行されたHER2陽性原発性乳癌の予後予測数理モデルの開発 HER2陽性原発性乳癌の治療最適化 Trastuzumabを含む術前化学療法を施行されたHER2陽性原発性乳癌の予後予測数理モデルの開発 第26回日本乳癌学会総会プログラム抄録集, 274 第26回日本乳癌学会総会プログラム抄録集, 274 , 274 2018/05 日本語 研究発表要旨(全国大会、その他学術会議) 公開
清水 華子, 石黒 洋, 高田 正泰, 山口 絢音, 鳥井 雅恵, 鈴木 栄治, 竹内 恵, 佐藤 史顕, 戸井 雅和 清水 華子, 石黒 洋, 高田 正泰, 山口 絢音, 鳥井 雅恵, 鈴木 栄治, 竹内 恵, 佐藤 史顕, 戸井 雅和 トリプルネガティブ乳がんにおけるシスプラチンを含む術前化学療法の治療効果と予後、その予測因子の探索 トリプルネガティブ乳がんにおけるシスプラチンを含む術前化学療法の治療効果と予後、その予測因子の探索 第26回日本乳癌学会総会プログラム抄録集, 462 第26回日本乳癌学会総会プログラム抄録集, 462 , 462 2018/05 日本語 研究発表要旨(全国大会、その他学術会議) 公開
小味 由里絵, 川口 展子, 松本 純明, 川島 雅央, 鳥井 雅恵, 高田 正泰, 鈴木 栄治, 竹内 恵, 佐藤 史顕, 石黒 洋, 戸井 雅和 小味 由里絵, 川口 展子, 松本 純明, 川島 雅央, 鳥井 雅恵, 高田 正泰, 鈴木 栄治, 竹内 恵, 佐藤 史顕, 石黒 洋, 戸井 雅和 アンスラサイクリン系薬剤に伴う口腔粘膜炎の口腔内冷却による予防の取り組み アンスラサイクリン系薬剤に伴う口腔粘膜炎の口腔内冷却による予防の取り組み 第26回日本乳癌学会総会プログラム抄録集, 463 第26回日本乳癌学会総会プログラム抄録集, 463 , 463 2018/05 日本語 研究発表要旨(全国大会、その他学術会議) 公開
大野 文美, 片岡 正子, 飯間 麻美, 本田 茉也, 阪口 怜奈, 鈴木 瑞恵, 三宅 可奈江, 片岡 竜貴, 桜井 孝規, 戸井 雅和, 富樫 かおり 大野 文美, 片岡 正子, 飯間 麻美, 本田 茉也, 阪口 怜奈, 鈴木 瑞恵, 三宅 可奈江, 片岡 竜貴, 桜井 孝規, 戸井 雅和, 富樫 かおり 高分解能拡散強調画像による腫瘤性病変および非腫瘍性病変の治療前評価 高分解能拡散強調画像による腫瘤性病変および非腫瘍性病変の治療前評価 日本乳癌学会総会プログラム抄録集, 26回, 383-383 日本乳癌学会総会プログラム抄録集, 26回, 383-383 , 26回, 383-383 2018/05 日本語 公開
片岡 正子, 金尾 昌太郎, 大西 奈都子, 河合 真喜子, 阪口 怜奈, 大橋 茜, 飯間 麻美, 大野 文美, 三宅 可奈江, 本田 茉也, 片岡 竜貴, 桜井 孝規, 戸井 雅和, 富樫 かおり 片岡 正子, 金尾 昌太郎, 大西 奈都子, 河合 真喜子, 阪口 怜奈, 大橋 茜, 飯間 麻美, 大野 文美, 三宅 可奈江, 本田 茉也, 片岡 竜貴, 桜井 孝規, 戸井 雅和, 富樫 かおり MRI BI-RADS 4サブカテゴリー分類の試み MRI BI-RADS 4サブカテゴリー分類の試み 日本乳癌学会総会プログラム抄録集, 26回, 384-384 日本乳癌学会総会プログラム抄録集, 26回, 384-384 , 26回, 384-384 2018/05 日本語 公開
鳥井 雅恵, 片岡 正子, 高田 正泰, 石守 崇好, 中本 裕士, 三宅 可奈江, 片岡 竜貴, 桜井 孝規, 磯田 裕義, 富樫 かおり, 戸井 雅和 鳥井 雅恵, 片岡 正子, 高田 正泰, 石守 崇好, 中本 裕士, 三宅 可奈江, 片岡 竜貴, 桜井 孝規, 磯田 裕義, 富樫 かおり, 戸井 雅和 任意型検診における乳房専用PET集積の意義を問う マルチモダリティ画像の中での価値と臨床応用への課題 任意型検診における乳房専用PET集積の意義を問う マルチモダリティ画像の中での価値と臨床応用への課題 日本乳癌学会総会プログラム抄録集, 26回, 386-386 日本乳癌学会総会プログラム抄録集, 26回, 386-386 , 26回, 386-386 2018/05 日本語 公開
本田 茉也, 片岡 正子, 大西 奈都子, 金尾 昌太朗, 佐川 肇, 飯間 麻美, 三宅 可奈江, 戸井 雅和, 冨樫 かおり 本田 茉也, 片岡 正子, 大西 奈都子, 金尾 昌太朗, 佐川 肇, 飯間 麻美, 三宅 可奈江, 戸井 雅和, 冨樫 かおり 乳房ダイナミック造影MRI超早期相における背景乳腺の造影効果の検討 乳房ダイナミック造影MRI超早期相における背景乳腺の造影効果の検討 日本乳癌学会総会プログラム抄録集, 26回, 790-790 日本乳癌学会総会プログラム抄録集, 26回, 790-790 , 26回, 790-790 2018/05 日本語 公開
鈴木 瑞恵, 飯間 麻美, 片岡 正子, 三宅 可奈江, 阪口 怜奈, 大野 文美, 本田 茉也, 戸井 雅和, 富樫 かおり 鈴木 瑞恵, 飯間 麻美, 片岡 正子, 三宅 可奈江, 阪口 怜奈, 大野 文美, 本田 茉也, 戸井 雅和, 富樫 かおり 非ガウス拡散MRIを用いた浸潤性乳管癌と非浸潤性乳管癌の鑑別の有用性の検討 非ガウス拡散MRIを用いた浸潤性乳管癌と非浸潤性乳管癌の鑑別の有用性の検討 日本乳癌学会総会プログラム抄録集, 26回, 791-791 日本乳癌学会総会プログラム抄録集, 26回, 791-791 , 26回, 791-791 2018/05 日本語 公開
文元 方哉, 片岡 正子, 石川 翔, 矢野 浩二朗, 大橋 茜, 飯間 麻美, 戸井 雅和, 富樫 かおり 文元 方哉, 片岡 正子, 石川 翔, 矢野 浩二朗, 大橋 茜, 飯間 麻美, 戸井 雅和, 富樫 かおり 乳房MRIにおける腫瘤辺縁での定量評価 読影者間での再現性の検討 乳房MRIにおける腫瘤辺縁での定量評価 読影者間での再現性の検討 日本乳癌学会総会プログラム抄録集, 26回, 800-800 日本乳癌学会総会プログラム抄録集, 26回, 800-800 , 26回, 800-800 2018/05 日本語 公開
松本 純明, 関口 博之, 片岡 正子, 吉川 彩, 石井 智子, 高田 正泰, 浅尾 恭史, 八木 隆行, 桜井 孝規, 富樫 かおり, 椎名 毅, 戸井 雅和 松本 純明, 関口 博之, 片岡 正子, 吉川 彩, 石井 智子, 高田 正泰, 浅尾 恭史, 八木 隆行, 桜井 孝規, 富樫 かおり, 椎名 毅, 戸井 雅和 乳腺腫瘍を有する乳房内血流の光超音波酸素飽和度解析 乳腺腫瘍を有する乳房内血流の光超音波酸素飽和度解析 日本外科学会定期学術集会抄録集, 118回, 1044-1044 日本外科学会定期学術集会抄録集, 118回, 1044-1044 , 118回, 1044-1044 2018/04 日本語 公開
山賀 郁, 浅尾 恭史, 川口 展子, 松本 純明, 川島 雅央, 高田 正泰, 片岡 正子, 羽賀 博典, 富樫 かおり, 椎名 毅, 戸井 雅和 山賀 郁, 浅尾 恭史, 川口 展子, 松本 純明, 川島 雅央, 高田 正泰, 片岡 正子, 羽賀 博典, 富樫 かおり, 椎名 毅, 戸井 雅和 山賀 郁, 浅尾 恭史, 川口 展子, 松本 純明, 川島 雅央, 高田 正泰, 片岡 正子, 羽賀 博典, 富樫 かおり, 椎名 毅, 戸井 雅和 新しい超音波装置 光超音波イメージングを用いた乳癌診断法の開発 新しい超音波装置 光超音波イメージングを用いた乳癌診断法の開発 新しい超音波装置 光超音波イメージングを用いた乳癌診断法の開発 乳腺甲状腺超音波医学, 7, 2, 36-36 乳腺甲状腺超音波医学, 7, 2, 36-36 乳腺甲状腺超音波医学, 7, 2, 36-36 2018/03 日本語 公開
Akiko Hanai, Hiroshi Ishiguro, Takashi Sozu, Moe Tsuda, Ikuko Yano, Takayuki Nakagawa, Satoshi Imai, Masakazu Toi, Hidenori Arai, Tadao Tsuboyama Akiko Hanai, Hiroshi Ishiguro, Takashi Sozu, Moe Tsuda, Ikuko Yano, Takayuki Nakagawa, Satoshi Imai, Masakazu Toi, Hidenori Arai, Tadao Tsuboyama Akiko Hanai, Hiroshi Ishiguro, Takashi Sozu, Moe Tsuda, Ikuko Yano, Takayuki Nakagawa, Satoshi Imai, Masakazu Toi, Hidenori Arai, Tadao Tsuboyama The effects of icing on paclitaxel-induced peripheral neuropathy among breast cancer patients: a self-controlled trial The effects of icing on paclitaxel-induced peripheral neuropathy among breast cancer patients: a self-controlled trial The effects of icing on paclitaxel-induced peripheral neuropathy among breast cancer patients: a self-controlled trial ANNALS OF ONCOLOGY, 28, 90-90 ANNALS OF ONCOLOGY, 28, 90-90 ANNALS OF ONCOLOGY, 28, 90-90 2017/10 英語 研究発表要旨(国際会議) 公開
Masakazu Toi, Manabu Muto Masakazu Toi, Manabu Muto Masakazu Toi, Manabu Muto Plan for Cultivating Cancer Researchers and Medical Professionals to Lead the Next Generation Plan for Cultivating Cancer Researchers and Medical Professionals to Lead the Next Generation Plan for Cultivating Cancer Researchers and Medical Professionals to Lead the Next Generation ANNALS OF ONCOLOGY, 28, 32-32 ANNALS OF ONCOLOGY, 28, 32-32 ANNALS OF ONCOLOGY, 28, 32-32 2017/10 英語 研究発表要旨(国際会議) 公開
森本 卓, 佐藤 信昭, 増田 慎三, 上野 貴之, 神林 智寿子, 金子 耕司, 八十島 宏行, 佐藤 友威, 新宮 聖士, 田邊 匡, 尾崎 慎治, 笹野 公伸, 森田 智視, 大野 真司, 戸井 雅和 森本 卓, 佐藤 信昭, 増田 慎三, 上野 貴之, 神林 智寿子, 金子 耕司, 八十島 宏行, 佐藤 友威, 新宮 聖士, 田邊 匡, 尾崎 慎治, 笹野 公伸, 森田 智視, 大野 真司, 戸井 雅和 森本 卓, 佐藤 信昭, 増田 慎三, 上野 貴之, 神林 智寿子, 金子 耕司, 八十島 宏行, 佐藤 友威, 新宮 聖士, 田邊 匡, 尾崎 慎治, 笹野 公伸, 森田 智視, 大野 真司, 戸井 雅和 「それぞれの生」安全なレジメン管理 閉経後HR乳癌患者に対するレスポンスガイド下術前内分泌療法(JBCRG-11CPA) 「それぞれの生」安全なレジメン管理 閉経後HR乳癌患者に対するレスポンスガイド下術前内分泌療法(JBCRG-11CPA) 「それぞれの生」安全なレジメン管理 閉経後HR乳癌患者に対するレスポンスガイド下術前内分泌療法(JBCRG-11CPA) 日本癌治療学会学術集会抄録集, 55回, WS7-1 日本癌治療学会学術集会抄録集, 55回, WS7-1 日本癌治療学会学術集会抄録集, 55回, WS7-1 2017/10 日本語 公開
向井 博文, 清水 千佳子, 増田 慎三, 大谷 彰一郎, 大野 真司, 高橋 將人, 山本 豊, 西村 令喜, 佐藤 信昭, 大住 省三, 岩田 広治, 森 優子, 橋垣 学, Lu Dongrui R, 戸井 雅和 向井 博文, 清水 千佳子, 増田 慎三, 大谷 彰一郎, 大野 真司, 高橋 將人, 山本 豊, 西村 令喜, 佐藤 信昭, 大住 省三, 岩田 広治, 森 優子, 橋垣 学, Lu Dongrui R, 戸井 雅和 向井 博文, 清水 千佳子, 増田 慎三, 大谷 彰一郎, 大野 真司, 高橋 將人, 山本 豊, 西村 令喜, 佐藤 信昭, 大住 省三, 岩田 広治, 森 優子, 橋垣 学, Lu Dongrui R, 戸井 雅和 「それぞれの癌」難治性癌に対する治療戦略 乳腺 未治療ER+進行乳癌患者におけるpalbociclib第3相試験(PALOMA-2) 日本人subgroup解析 「それぞれの癌」難治性癌に対する治療戦略 乳腺 未治療ER+進行乳癌患者におけるpalbociclib第3相試験(PALOMA-2) 日本人subgroup解析 「それぞれの癌」難治性癌に対する治療戦略 乳腺 未治療ER+進行乳癌患者におけるpalbociclib第3相試験(PALOMA-2) 日本人subgroup解析 日本癌治療学会学術集会抄録集, 55回, WS13-1 日本癌治療学会学術集会抄録集, 55回, WS13-1 日本癌治療学会学術集会抄録集, 55回, WS13-1 2017/10 日本語 公開
藤澤 知巳, 川口 英俊, 増田 慎三, 中山 貴寛, 青儀 健二郎, 伊藤 良則, 大谷 彰一郎, 佐治 重衛, 長谷川 善枝, 服部 正也, 山下 年成, 山本 豊, 森田 智視, 戸井 雅和, 大野 真司 藤澤 知巳, 川口 英俊, 増田 慎三, 中山 貴寛, 青儀 健二郎, 伊藤 良則, 大谷 彰一郎, 佐治 重衛, 長谷川 善枝, 服部 正也, 山下 年成, 山本 豊, 森田 智視, 戸井 雅和, 大野 真司 藤澤 知巳, 川口 英俊, 増田 慎三, 中山 貴寛, 青儀 健二郎, 伊藤 良則, 大谷 彰一郎, 佐治 重衛, 長谷川 善枝, 服部 正也, 山下 年成, 山本 豊, 森田 智視, 戸井 雅和, 大野 真司 「それぞれの癌」難治性癌に対する治療戦略 乳腺 閉経後進行再発乳癌におけるフルベストラントの長期TTFに関わる検討 Safari試験 「それぞれの癌」難治性癌に対する治療戦略 乳腺 閉経後進行再発乳癌におけるフルベストラントの長期TTFに関わる検討 Safari試験 「それぞれの癌」難治性癌に対する治療戦略 乳腺 閉経後進行再発乳癌におけるフルベストラントの長期TTFに関わる検討 Safari試験 日本癌治療学会学術集会抄録集, 55回, WS13-4 日本癌治療学会学術集会抄録集, 55回, WS13-4 日本癌治療学会学術集会抄録集, 55回, WS13-4 2017/10 日本語 公開
A. Di Leo, M. Toi, M. Campone, J. Sohn, S. Paluch-Shimon, J. Huober, I. H. Park, O. Tredan, S-C. Chen, L. Manso, O. Freedman, G. G. Jaliffe, T. Forrester, M. Frenzel, S. Barriga, I. C. Smith, N. Bourayou, M. P. Goetz A. Di Leo, M. Toi, M. Campone, J. Sohn, S. Paluch-Shimon, J. Huober, I. H. Park, O. Tredan, S-C. Chen, L. Manso, O. Freedman, G. G. Jaliffe, T. Forrester, M. Frenzel, S. Barriga, I. C. Smith, N. Bourayou, M. P. Goetz A. Di Leo, M. Toi, M. Campone, J. Sohn, S. Paluch-Shimon, J. Huober, I. H. Park, O. Tredan, S-C. Chen, L. Manso, O. Freedman, G. G. Jaliffe, T. Forrester, M. Frenzel, S. Barriga, I. C. Smith, N. Bourayou, M. P. Goetz MONARCH 3: Abemaciclib as initial therapy for patients with HR+/HER2-advanced breast cancer MONARCH 3: Abemaciclib as initial therapy for patients with HR+/HER2-advanced breast cancer MONARCH 3: Abemaciclib as initial therapy for patients with HR+/HER2-advanced breast cancer ANNALS OF ONCOLOGY, 28 ANNALS OF ONCOLOGY, 28 ANNALS OF ONCOLOGY, 28 2017/09 英語 研究発表要旨(国際会議) 公開
H. Kawaguchi, K. Aogi, N. Masuda, T. Nakayama, Y. Ito, S. Ohtani, N. Sato, T. Takano, S. Saji, E. Tokunaga, Y. Hasegawa, M. Hattori, T. Fujisawa, S. Morita, H. Yamashita, T. Yamashita, Y. Yamamoto, D. Yotsumoto, M. Toi, S. Ohno H. Kawaguchi, K. Aogi, N. Masuda, T. Nakayama, Y. Ito, S. Ohtani, N. Sato, T. Takano, S. Saji, E. Tokunaga, Y. Hasegawa, M. Hattori, T. Fujisawa, S. Morita, H. Yamashita, T. Yamashita, Y. Yamamoto, D. Yotsumoto, M. Toi, S. Ohno H. Kawaguchi, K. Aogi, N. Masuda, T. Nakayama, Y. Ito, S. Ohtani, N. Sato, T. Takano, S. Saji, E. Tokunaga, Y. Hasegawa, M. Hattori, T. Fujisawa, S. Morita, H. Yamashita, T. Yamashita, Y. Yamamoto, D. Yotsumoto, M. Toi, S. Ohno Factors associated with prolonged time to treatment failure with fulvestrant 500mg in patients with postmenopausal estrogen receptor-positive advanced/metastatic breast cancer (JBCRG-C06; Safari): A subgroup analysis Factors associated with prolonged time to treatment failure with fulvestrant 500mg in patients with postmenopausal estrogen receptor-positive advanced/metastatic breast cancer (JBCRG-C06; Safari): A subgroup analysis Factors associated with prolonged time to treatment failure with fulvestrant 500mg in patients with postmenopausal estrogen receptor-positive advanced/metastatic breast cancer (JBCRG-C06; Safari): A subgroup analysis ANNALS OF ONCOLOGY, 28 ANNALS OF ONCOLOGY, 28 ANNALS OF ONCOLOGY, 28 2017/09 英語 研究発表要旨(国際会議) 公開
N. Masuda, S. Ohtani, T. Takano, K. Inoue, E. Suzuki, R. Nakamura, H. Bando, Y. Ito, K. Ishida, T. Yamanaka, K. Kuroi, H. Yasojima, H. Kasai, T. Takasuka, T. Sakurai, T. R. Kataoka, S. Morita, S. Ohno, M. Toi N. Masuda, S. Ohtani, T. Takano, K. Inoue, E. Suzuki, R. Nakamura, H. Bando, Y. Ito, K. Ishida, T. Yamanaka, K. Kuroi, H. Yasojima, H. Kasai, T. Takasuka, T. Sakurai, T. R. Kataoka, S. Morita, S. Ohno, M. Toi N. Masuda, S. Ohtani, T. Takano, K. Inoue, E. Suzuki, R. Nakamura, H. Bando, Y. Ito, K. Ishida, T. Yamanaka, K. Kuroi, H. Yasojima, H. Kasai, T. Takasuka, T. Sakurai, T. R. Kataoka, S. Morita, S. Ohno, M. Toi Neoadjuvant therapy with trastuzumab emtansine and pertuzumab in patients with HER2-positive primary breast cancer (A randomized, phase 2 study; JBCRG-20) Neoadjuvant therapy with trastuzumab emtansine and pertuzumab in patients with HER2-positive primary breast cancer (A randomized, phase 2 study; JBCRG-20) Neoadjuvant therapy with trastuzumab emtansine and pertuzumab in patients with HER2-positive primary breast cancer (A randomized, phase 2 study; JBCRG-20) ANNALS OF ONCOLOGY, 28 ANNALS OF ONCOLOGY, 28 ANNALS OF ONCOLOGY, 28 2017/09 英語 研究発表要旨(国際会議) 公開
西村 友美, 吉田 健一, 川田 有希子, 塩澤 裕介, 片岡 竜貴, 桜井 孝規, 白石 友一, 千葉 健一, 羽賀 博典, 宮野 悟, 戸井 雅和, 小川 誠司 西村 友美, 吉田 健一, 川田 有希子, 塩澤 裕介, 片岡 竜貴, 桜井 孝規, 白石 友一, 千葉 健一, 羽賀 博典, 宮野 悟, 戸井 雅和, 小川 誠司 西村 友美, 吉田 健一, 川田 有希子, 塩澤 裕介, 片岡 竜貴, 桜井 孝規, 白石 友一, 千葉 健一, 羽賀 博典, 宮野 悟, 戸井 雅和, 小川 誠司 異型増殖性病変から乳癌へのクローン進化 異型増殖性病変から乳癌へのクローン進化 異型増殖性病変から乳癌へのクローン進化 日本癌学会総会記事, 76回, P-2189 日本癌学会総会記事, 76回, P-2189 日本癌学会総会記事, 76回, P-2189 2017/09 英語 公開
Masakazu Toi, Norikazu Masuda, Yasuo Ohashi Masakazu Toi, Norikazu Masuda, Yasuo Ohashi Masakazu Toi, Norikazu Masuda, Yasuo Ohashi Adjuvant Capecitabine for Breast Cancer Reply Adjuvant Capecitabine for Breast Cancer Reply Adjuvant Capecitabine for Breast Cancer Reply NEW ENGLAND JOURNAL OF MEDICINE, 377, 8, 791-792 NEW ENGLAND JOURNAL OF MEDICINE, 377, 8, 791-792 NEW ENGLAND JOURNAL OF MEDICINE, 377, 8, 791-792 2017/08 英語 速報、短報、研究ノート等(学術雑誌) 公開
山口 絢音, 石黒 洋, 鳥井 雅恵, 松本 純明, 川口 展子, 高田 正泰, 鈴木 栄治, 竹内 恵, 佐藤 史顕, 戸井 雅和 山口 絢音, 石黒 洋, 鳥井 雅恵, 松本 純明, 川口 展子, 高田 正泰, 鈴木 栄治, 竹内 恵, 佐藤 史顕, 戸井 雅和 Basal-like乳がん症例におけるシスプラチン含む術前化学療法の予後への影響に関する後向き解析 Basal-like乳がん症例におけるシスプラチン含む術前化学療法の予後への影響に関する後向き解析 第25回日本乳癌学会総会プログラム抄録集, 352 第25回日本乳癌学会総会プログラム抄録集, 352 , 352 2017/07 日本語 研究発表要旨(全国大会、その他学術会議) 公開
真鍋 恵理子, 古武, 剛, 石黒, 洋, 竹内, 恵, 高田, 正泰, 戸井 雅和 真鍋 恵理子, 古武, 剛, 石黒, 洋, 竹内, 恵, 高田, 正泰, 戸井 雅和 乳癌に対するタキサン製剤投与時に生じるアレルギー様反応後の再投与可否についての検討 乳癌に対するタキサン製剤投与時に生じるアレルギー様反応後の再投与可否についての検討 第25回日本乳癌学会学術総会, 700 第25回日本乳癌学会学術総会, 700 , 700 2017/07 日本語 研究発表要旨(全国大会、その他学術会議) 公開
石川 翔, 片岡 正子, 矢野 浩二朗, 金尾 昌太郎, 大橋 茜, 飯間 麻美, 阪口 怜奈, 戸井 雅和, 富樫 かおり 石川 翔, 片岡 正子, 矢野 浩二朗, 金尾 昌太郎, 大橋 茜, 飯間 麻美, 阪口 怜奈, 戸井 雅和, 富樫 かおり 乳房MRIにおける腫瘤性病変の辺縁の評価 高解像度画像の意義および定量評価の有用性についての検討 乳房MRIにおける腫瘤性病変の辺縁の評価 高解像度画像の意義および定量評価の有用性についての検討 日本乳癌学会総会プログラム抄録集, 25回, 339-339 日本乳癌学会総会プログラム抄録集, 25回, 339-339 , 25回, 339-339 2017/07 日本語 公開
Edith A. Perez, Carlos H. Barrios, Wolfgang Eiermann, Masakazu Toi, Young-Hyuck Im, Pier Franco Conte, Miguel Martin, Tadeusz Pienkowski, Xavier B. Pivot, Howard A. Burris, Silke Hoersch, Monika Patre, Paul Anthony Ellis Edith A. Perez, Carlos H. Barrios, Wolfgang Eiermann, Masakazu Toi, Young-Hyuck Im, Pier Franco Conte, Miguel Martin, Tadeusz Pienkowski, Xavier B. Pivot, Howard A. Burris, Silke Hoersch, Monika Patre, Paul Anthony Ellis Edith A. Perez, Carlos H. Barrios, Wolfgang Eiermann, Masakazu Toi, Young-Hyuck Im, Pier Franco Conte, Miguel Martin, Tadeusz Pienkowski, Xavier B. Pivot, Howard A. Burris, Silke Hoersch, Monika Patre, Paul Anthony Ellis Phase III, randomized study of first-line trastuzumab emtansine (T-DM1) +/- pertuzumab (P) vs. trastuzumab plus taxane (HT) treatment of HER2-positive MBC: Final overall survival (OS) and safety from MARIANNE. Phase III, randomized study of first-line trastuzumab emtansine (T-DM1) +/- pertuzumab (P) vs. trastuzumab plus taxane (HT) treatment of HER2-positive MBC: Final overall survival (OS) and safety from MARIANNE. Phase III, randomized study of first-line trastuzumab emtansine (T-DM1) +/- pertuzumab (P) vs. trastuzumab plus taxane (HT) treatment of HER2-positive MBC: Final overall survival (OS) and safety from MARIANNE. JOURNAL OF CLINICAL ONCOLOGY, 35 JOURNAL OF CLINICAL ONCOLOGY, 35 JOURNAL OF CLINICAL ONCOLOGY, 35 2017/05 英語 研究発表要旨(国際会議) 公開
George W. Sledge, Masakazu Toi, Patrick Neven, Joohyuk Sohn, Kenichi Inoue, Xavier B. Pivot, Olga Nikolaevna Burdaeva, Meena Okera, Norikazu Masuda, Peter A. Kaufman, Han A. Koh, Eva-Maria Grischke, Martin Frenzel, Yong Lin, Susana Barriga, Ian C. Smith, Nawel Bourayou, Antonio Llombart-Cussac George W. Sledge, Masakazu Toi, Patrick Neven, Joohyuk Sohn, Kenichi Inoue, Xavier B. Pivot, Olga Nikolaevna Burdaeva, Meena Okera, Norikazu Masuda, Peter A. Kaufman, Han A. Koh, Eva-Maria Grischke, Martin Frenzel, Yong Lin, Susana Barriga, Ian C. Smith, Nawel Bourayou, Antonio Llombart-Cussac George W. Sledge, Masakazu Toi, Patrick Neven, Joohyuk Sohn, Kenichi Inoue, Xavier B. Pivot, Olga Nikolaevna Burdaeva, Meena Okera, Norikazu Masuda, Peter A. Kaufman, Han A. Koh, Eva-Maria Grischke, Martin Frenzel, Yong Lin, Susana Barriga, Ian C. Smith, Nawel Bourayou, Antonio Llombart-Cussac MONARCH 2: Abemaciclib in combination with fulvestrant in patients with HR+/HER2-advanced breast cancer who progressed on endocrine therapy MONARCH 2: Abemaciclib in combination with fulvestrant in patients with HR+/HER2-advanced breast cancer who progressed on endocrine therapy MONARCH 2: Abemaciclib in combination with fulvestrant in patients with HR+/HER2-advanced breast cancer who progressed on endocrine therapy JOURNAL OF CLINICAL ONCOLOGY, 35 JOURNAL OF CLINICAL ONCOLOGY, 35 JOURNAL OF CLINICAL ONCOLOGY, 35 2017/05 英語 研究発表要旨(国際会議) 公開
Kazuhiko Yamagami, Hajime Matsumoto, Takashi Hashimoto, Seiji Yanai, Sachiko Yuen, Hitomi Kuramitu, You Ichinose, Teruyuki Deai, Masakazu Toi Kazuhiko Yamagami, Hajime Matsumoto, Takashi Hashimoto, Seiji Yanai, Sachiko Yuen, Hitomi Kuramitu, You Ichinose, Teruyuki Deai, Masakazu Toi Kazuhiko Yamagami, Hajime Matsumoto, Takashi Hashimoto, Seiji Yanai, Sachiko Yuen, Hitomi Kuramitu, You Ichinose, Teruyuki Deai, Masakazu Toi Sentinel lymph node biopsy using indocyanine green fluorescence navigation method after neoadjuvant chemotherapy for patients with clinically node-positive breast cancer. Sentinel lymph node biopsy using indocyanine green fluorescence navigation method after neoadjuvant chemotherapy for patients with clinically node-positive breast cancer. Sentinel lymph node biopsy using indocyanine green fluorescence navigation method after neoadjuvant chemotherapy for patients with clinically node-positive breast cancer. JOURNAL OF CLINICAL ONCOLOGY, 35 JOURNAL OF CLINICAL ONCOLOGY, 35 JOURNAL OF CLINICAL ONCOLOGY, 35 2017/05 英語 研究発表要旨(国際会議) 公開
Kazutaka Narui, Toshinari Yamashita, Masahiro Kitada, Hidetoshi Kawaguchi, Masaya Hattori, Tetsuhiro Yoshinami, Nobuki Matsunami, Kazuhiro Yanagihara, Teru Kawasoe, Takeshi Nagashima, Hiroko Bando, Hiroshi Yano, Yoshie Hasegawa, Rikiya Nakamura, Masahiro Kashiwaba, Norikazu Masuda, Satoshi Morita, Shinji Ohno, Masakazu Toi Kazutaka Narui, Toshinari Yamashita, Masahiro Kitada, Hidetoshi Kawaguchi, Masaya Hattori, Tetsuhiro Yoshinami, Nobuki Matsunami, Kazuhiro Yanagihara, Teru Kawasoe, Takeshi Nagashima, Hiroko Bando, Hiroshi Yano, Yoshie Hasegawa, Rikiya Nakamura, Masahiro Kashiwaba, Norikazu Masuda, Satoshi Morita, Shinji Ohno, Masakazu Toi Kazutaka Narui, Toshinari Yamashita, Masahiro Kitada, Hidetoshi Kawaguchi, Masaya Hattori, Tetsuhiro Yoshinami, Nobuki Matsunami, Kazuhiro Yanagihara, Teru Kawasoe, Takeshi Nagashima, Hiroko Bando, Hiroshi Yano, Yoshie Hasegawa, Rikiya Nakamura, Masahiro Kashiwaba, Norikazu Masuda, Satoshi Morita, Shinji Ohno, Masakazu Toi Eribulin in combination with pertuzumab plus trastuzumab for HER2-positive advanced or recurrent breast cancer (JBCRG-M03). Eribulin in combination with pertuzumab plus trastuzumab for HER2-positive advanced or recurrent breast cancer (JBCRG-M03). Eribulin in combination with pertuzumab plus trastuzumab for HER2-positive advanced or recurrent breast cancer (JBCRG-M03). JOURNAL OF CLINICAL ONCOLOGY, 35 JOURNAL OF CLINICAL ONCOLOGY, 35 JOURNAL OF CLINICAL ONCOLOGY, 35 2017/05 英語 研究発表要旨(国際会議) 公開
M. Takada, M. Sugimoto, N. Masuda, H. Iwata, K. Kuroi, H. Yamashiro, S. Ohno, H. Ishiguro, T. Inamoto, M. Toi M. Takada, M. Sugimoto, N. Masuda, H. Iwata, K. Kuroi, H. Yamashiro, S. Ohno, H. Ishiguro, T. Inamoto, M. Toi M. Takada, M. Sugimoto, N. Masuda, H. Iwata, K. Kuroi, H. Yamashiro, S. Ohno, H. Ishiguro, T. Inamoto, M. Toi Development of mathematical prediction models to identify disease-free survival events for HER2-positive primary breast cancer patients treated by neoadjuvant chemotherapy and trastuzumab Development of mathematical prediction models to identify disease-free survival events for HER2-positive primary breast cancer patients treated by neoadjuvant chemotherapy and trastuzumab Development of mathematical prediction models to identify disease-free survival events for HER2-positive primary breast cancer patients treated by neoadjuvant chemotherapy and trastuzumab CANCER RESEARCH, 77 CANCER RESEARCH, 77 CANCER RESEARCH, 77 2017/02 英語 研究発表要旨(国際会議) 公開
L. W. C. Chow, M. Toi L. W. C. Chow, M. Toi L. W. C. Chow, M. Toi EndoPredict multigene test in the prediction of response and outcome after neoadjuvant hormonal treatment with letrozole adn palbociclib (OOTR-N007) EndoPredict multigene test in the prediction of response and outcome after neoadjuvant hormonal treatment with letrozole adn palbociclib (OOTR-N007) EndoPredict multigene test in the prediction of response and outcome after neoadjuvant hormonal treatment with letrozole adn palbociclib (OOTR-N007) CANCER RESEARCH, 77 CANCER RESEARCH, 77 CANCER RESEARCH, 77 2017/02 英語 研究発表要旨(国際会議) 公開
D. Yardley, S. Hurvitz, Z-F Jiang, M. Toi, H. Burris, M. Buyse, D. Slamon, A. Makhson, A. Elsaid, G. Lerzo, B. Hellerstedt, F. Nuzzo, J. Sohn, L. Manzyuk, D. Cabaribere, J. Lincy, A. Weimann, F. Noel-Baron, L. Pacaud, F. Andre D. Yardley, S. Hurvitz, Z-F Jiang, M. Toi, H. Burris, M. Buyse, D. Slamon, A. Makhson, A. Elsaid, G. Lerzo, B. Hellerstedt, F. Nuzzo, J. Sohn, L. Manzyuk, D. Cabaribere, J. Lincy, A. Weimann, F. Noel-Baron, L. Pacaud, F. Andre D. Yardley, S. Hurvitz, Z-F Jiang, M. Toi, H. Burris, M. Buyse, D. Slamon, A. Makhson, A. Elsaid, G. Lerzo, B. Hellerstedt, F. Nuzzo, J. Sohn, L. Manzyuk, D. Cabaribere, J. Lincy, A. Weimann, F. Noel-Baron, L. Pacaud, F. Andre Everolimus plus trastuzumab and paclitaxel as first-line therapy in women with HER2+advanced breast cancer: Overall survival results from BOLERO-1 Everolimus plus trastuzumab and paclitaxel as first-line therapy in women with HER2+advanced breast cancer: Overall survival results from BOLERO-1 Everolimus plus trastuzumab and paclitaxel as first-line therapy in women with HER2+advanced breast cancer: Overall survival results from BOLERO-1 CANCER RESEARCH, 77 CANCER RESEARCH, 77 CANCER RESEARCH, 77 2017/02 英語 研究発表要旨(国際会議) 公開
F-C Bidard, S. Michiels, V. Mueller, S. Riethdorf, L. J. Esserman, A. Lucci, B. Naume, J. Horiguchi, R. Gisbert-Criado, S. Sleijfer, M. Toi, Ja Garcia-Saenz, A. Hartkopf, D. Generali, F. Rothe, J. Smerage, L. Muinelo, J. Stebbing, P. Viens, M. Magbanua, C. S. Hall, O. Engebratenm, D. Takata, J. Vidal-Martinez, W. Onstenk, N. Fujisawa, E. Diaz-Rubio, F-A Taran, M. R. Cappelletti, M. Ignatiadis, N. Name, C. Proudhon, D. Wolf, J. Bowman Bauldry, E. Borgen, R. Nagaoka, V. Caranana, J. Kraan, M. Maestro, S. Y. Brucker, K. Weber, F. Reyal, D. Amara, M. Gopalkrishna Karhade, R. Ruud Mathiesen, H. Tokiniwa, A. Llombart-Cussac, K. D'Hollander, P. Cottu, J. W. Park, S. Loibl, J-Y Pierga, K. Pantel F-C Bidard, S. Michiels, V. Mueller, S. Riethdorf, L. J. Esserman, A. Lucci, B. Naume, J. Horiguchi, R. Gisbert-Criado, S. Sleijfer, M. Toi, Ja Garcia-Saenz, A. Hartkopf, D. Generali, F. Rothe, J. Smerage, L. Muinelo, J. Stebbing, P. Viens, M. Magbanua, C. S. Hall, O. Engebratenm, D. Takata, J. Vidal-Martinez, W. Onstenk, N. Fujisawa, E. Diaz-Rubio, F-A Taran, M. R. Cappelletti, M. Ignatiadis, N. Name, C. Proudhon, D. Wolf, J. Bowman Bauldry, E. Borgen, R. Nagaoka, V. Caranana, J. Kraan, M. Maestro, S. Y. Brucker, K. Weber, F. Reyal, D. Amara, M. Gopalkrishna Karhade, R. Ruud Mathiesen, H. Tokiniwa, A. Llombart-Cussac, K. D'Hollander, P. Cottu, J. W. Park, S. Loibl, J-Y Pierga, K. Pantel F-C Bidard, S. Michiels, V. Mueller, S. Riethdorf, L. J. Esserman, A. Lucci, B. Naume, J. Horiguchi, R. Gisbert-Criado, S. Sleijfer, M. Toi, Ja Garcia-Saenz, A. Hartkopf, D. Generali, F. Rothe, J. Smerage, L. Muinelo, J. Stebbing, P. Viens, M. Magbanua, C. S. Hall, O. Engebratenm, D. Takata, J. Vidal-Martinez, W. Onstenk, N. Fujisawa, E. Diaz-Rubio, F-A Taran, M. R. Cappelletti, M. Ignatiadis, N. Name, C. Proudhon, D. Wolf, J. Bowman Bauldry, E. Borgen, R. Nagaoka, V. Caranana, J. Kraan, M. Maestro, S. Y. Brucker, K. Weber, F. Reyal, D. Amara, M. Gopalkrishna Karhade, R. Ruud Mathiesen, H. Tokiniwa, A. Llombart-Cussac, K. D'Hollander, P. Cottu, J. W. Park, S. Loibl, J-Y Pierga, K. Pantel IMENEO: International MEta-analysis of circulating tumor cell detection in early breast cancer patients treated by NEOadjuvant chemotherapy IMENEO: International MEta-analysis of circulating tumor cell detection in early breast cancer patients treated by NEOadjuvant chemotherapy IMENEO: International MEta-analysis of circulating tumor cell detection in early breast cancer patients treated by NEOadjuvant chemotherapy CANCER RESEARCH, 77 CANCER RESEARCH, 77 CANCER RESEARCH, 77 2017/02 英語 研究発表要旨(国際会議) 公開
M. Toi, Y. Asao, M. Takada, M. Kataoka, T. Endo, M. Kawashima, I. Yamaga, Y. Nakayama, M. Tokiwa, E. Fakhrejahani, M. Torii, N. Kawaguchi-Sakita, S. Kanao, Y. Matsumoto, T. Yagi, T. Sakurai, K. Togashi, T. Shiina M. Toi, Y. Asao, M. Takada, M. Kataoka, T. Endo, M. Kawashima, I. Yamaga, Y. Nakayama, M. Tokiwa, E. Fakhrejahani, M. Torii, N. Kawaguchi-Sakita, S. Kanao, Y. Matsumoto, T. Yagi, T. Sakurai, K. Togashi, T. Shiina M. Toi, Y. Asao, M. Takada, M. Kataoka, T. Endo, M. Kawashima, I. Yamaga, Y. Nakayama, M. Tokiwa, E. Fakhrejahani, M. Torii, N. Kawaguchi-Sakita, S. Kanao, Y. Matsumoto, T. Yagi, T. Sakurai, K. Togashi, T. Shiina Development of photoacoustic vascular imaging system for breast cancer Development of photoacoustic vascular imaging system for breast cancer Development of photoacoustic vascular imaging system for breast cancer CANCER RESEARCH, 77 CANCER RESEARCH, 77 CANCER RESEARCH, 77 2017/02 英語 研究発表要旨(国際会議) 公開
M. Tsuda, H. Ishiguro, N. Toriguchi, N. Masuda, H. Bando, M. Ohgami, M. Homma, S. Morita, N. Yamamoto, K. Kuroi, T. Takano, S. Shimizu, M. Toi M. Tsuda, H. Ishiguro, N. Toriguchi, N. Masuda, H. Bando, M. Ohgami, M. Homma, S. Morita, N. Yamamoto, K. Kuroi, T. Takano, S. Shimizu, M. Toi M. Tsuda, H. Ishiguro, N. Toriguchi, N. Masuda, H. Bando, M. Ohgami, M. Homma, S. Morita, N. Yamamoto, K. Kuroi, T. Takano, S. Shimizu, M. Toi Duration of fasting before taking lapatinib is associated with skin toxicity in neoadjuvant treatment of HER2 positive breast cancer: A cohort study from JBCRG-16/Neo-LaTH Duration of fasting before taking lapatinib is associated with skin toxicity in neoadjuvant treatment of HER2 positive breast cancer: A cohort study from JBCRG-16/Neo-LaTH Duration of fasting before taking lapatinib is associated with skin toxicity in neoadjuvant treatment of HER2 positive breast cancer: A cohort study from JBCRG-16/Neo-LaTH CANCER RESEARCH, 77 CANCER RESEARCH, 77 CANCER RESEARCH, 77 2017/02 英語 研究発表要旨(国際会議) 公開
Tomoharu Sugie, Masakazu Toi Tomoharu Sugie, Masakazu Toi Tomoharu Sugie, Masakazu Toi Antitumor immunity and advances in cancer immunotherapy Antitumor immunity and advances in cancer immunotherapy Antitumor immunity and advances in cancer immunotherapy BREAST CANCER, 24, 1, 1-2 BREAST CANCER, 24, 1, 1-2 BREAST CANCER, 24, 1, 1-2 2017/01 英語 その他記事 公開
I. Fukada, Y. Ito, T. Shibayama, K. Kobayashi, N. Teruya, S. Takahashi, R. Horii, F. Akiyama, T. Iwase, M. Toi, S. Ohno I. Fukada, Y. Ito, T. Shibayama, K. Kobayashi, N. Teruya, S. Takahashi, R. Horii, F. Akiyama, T. Iwase, M. Toi, S. Ohno I. Fukada, Y. Ito, T. Shibayama, K. Kobayashi, N. Teruya, S. Takahashi, R. Horii, F. Akiyama, T. Iwase, M. Toi, S. Ohno Questionnaire survey on patients' preference for orally disintegrating tablets or granules of S-1 in postoperative adjuvant treatment for breast cancer Questionnaire survey on patients' preference for orally disintegrating tablets or granules of S-1 in postoperative adjuvant treatment for breast cancer Questionnaire survey on patients' preference for orally disintegrating tablets or granules of S-1 in postoperative adjuvant treatment for breast cancer ANNALS OF ONCOLOGY, 27 ANNALS OF ONCOLOGY, 27 ANNALS OF ONCOLOGY, 27 2016/12 英語 研究発表要旨(国際会議) 公開
A. Yamaguchi, H. Ishiguro, M. Torii, M. Takada, E. Suzuki, M. Takeuchi, F. Sato, M. Toi A. Yamaguchi, H. Ishiguro, M. Torii, M. Takada, E. Suzuki, M. Takeuchi, F. Sato, M. Toi A. Yamaguchi, H. Ishiguro, M. Torii, M. Takada, E. Suzuki, M. Takeuchi, F. Sato, M. Toi Cisplatin based preoperative chemotherapy regimens for basal-like breast cancer potentially improve prognosis even in patients without pCR: A retrospective analysis from a single-institution Cisplatin based preoperative chemotherapy regimens for basal-like breast cancer potentially improve prognosis even in patients without pCR: A retrospective analysis from a single-institution Cisplatin based preoperative chemotherapy regimens for basal-like breast cancer potentially improve prognosis even in patients without pCR: A retrospective analysis from a single-institution ANNALS OF ONCOLOGY, 27 ANNALS OF ONCOLOGY, 27 ANNALS OF ONCOLOGY, 27 2016/12 英語 研究発表要旨(国際会議) 公開
大神 正宏, 坂東 裕子, 石黒 洋, 鳥口 尚子, 津田 萌, 戸井 雅和, 増田 慎三, 三橋 彰一, 黒澤 豊彦, 本間 真人 大神 正宏, 坂東 裕子, 石黒 洋, 鳥口 尚子, 津田 萌, 戸井 雅和, 増田 慎三, 三橋 彰一, 黒澤 豊彦, 本間 真人 ラパチニブの血中濃度に及ぼす服用タイミングとタモキシフェン併用の影響(第2報) ラパチニブの血中濃度に及ぼす服用タイミングとタモキシフェン併用の影響(第2報) 第37回日本臨床薬理学会学術総会 プログラム・抄録集, 251 第37回日本臨床薬理学会学術総会 プログラム・抄録集, 251 , 251 2016/12 公開
H. Takuwa, F. Sato, J. Itou, M. Toi H. Takuwa, F. Sato, J. Itou, M. Toi H. Takuwa, F. Sato, J. Itou, M. Toi The let-7/Lin28 can be an early detection marker of anti-HER2 containing therapy sensitivity in HER2 positive breast cancer The let-7/Lin28 can be an early detection marker of anti-HER2 containing therapy sensitivity in HER2 positive breast cancer The let-7/Lin28 can be an early detection marker of anti-HER2 containing therapy sensitivity in HER2 positive breast cancer ANNALS OF ONCOLOGY, 27 ANNALS OF ONCOLOGY, 27 ANNALS OF ONCOLOGY, 27 2016/10 英語 研究発表要旨(国際会議) 公開
S. Saji, H. Ishiguro, S. Nomura, H. Iwata, S. Tanaka, T. Ueno, M. Onoue, T. Yamanaka, Y. Sasaki, M. Toi S. Saji, H. Ishiguro, S. Nomura, H. Iwata, S. Tanaka, T. Ueno, M. Onoue, T. Yamanaka, Y. Sasaki, M. Toi S. Saji, H. Ishiguro, S. Nomura, H. Iwata, S. Tanaka, T. Ueno, M. Onoue, T. Yamanaka, Y. Sasaki, M. Toi Phase I/II pharmacokinetics/pharmacodynamics study of irinotecan and S-1 for recurrent/metastatic breast cancer in patients with select UGT1A1 genotypes (the JBCRG-M01 study) Phase I/II pharmacokinetics/pharmacodynamics study of irinotecan and S-1 for recurrent/metastatic breast cancer in patients with select UGT1A1 genotypes (the JBCRG-M01 study) Phase I/II pharmacokinetics/pharmacodynamics study of irinotecan and S-1 for recurrent/metastatic breast cancer in patients with select UGT1A1 genotypes (the JBCRG-M01 study) ANNALS OF ONCOLOGY, 27 ANNALS OF ONCOLOGY, 27 ANNALS OF ONCOLOGY, 27 2016/10 英語 研究発表要旨(国際会議) 公開
R. Finn, Y. Jiang, H. Rugo, S. L. Moulder, S-A. Im, K. A. Gelmon, V. Dieras, M. Martin, A. A. Joy, M. Toi, E. Gauthier, D. R. Lu, C. H. Bartlett, D. Slamon R. Finn, Y. Jiang, H. Rugo, S. L. Moulder, S-A. Im, K. A. Gelmon, V. Dieras, M. Martin, A. A. Joy, M. Toi, E. Gauthier, D. R. Lu, C. H. Bartlett, D. Slamon R. Finn, Y. Jiang, H. Rugo, S. L. Moulder, S-A. Im, K. A. Gelmon, V. Dieras, M. Martin, A. A. Joy, M. Toi, E. Gauthier, D. R. Lu, C. H. Bartlett, D. Slamon Biomarker analyses from the phase 3 PALOMA-2 trial of palbociclib (P) with letrozole (L) compared with placebo (PLB) plus L in postmenopausal women with ER +/HER2-advanced breast cancer (ABC) Biomarker analyses from the phase 3 PALOMA-2 trial of palbociclib (P) with letrozole (L) compared with placebo (PLB) plus L in postmenopausal women with ER +/HER2-advanced breast cancer (ABC) Biomarker analyses from the phase 3 PALOMA-2 trial of palbociclib (P) with letrozole (L) compared with placebo (PLB) plus L in postmenopausal women with ER +/HER2-advanced breast cancer (ABC) ANNALS OF ONCOLOGY, 27 ANNALS OF ONCOLOGY, 27 ANNALS OF ONCOLOGY, 27 2016/10 英語 研究発表要旨(国際会議) 公開
川口 展子, 中川 薫, 川島 雅央, 杉本 昌弘, 常盤 麻里子, 梶原 茂樹, 藤田 雄一郎, 岩本 慎一, 戸井 雅和, 田中 耕一 川口 展子, 中川 薫, 川島 雅央, 杉本 昌弘, 常盤 麻里子, 梶原 茂樹, 藤田 雄一郎, 岩本 慎一, 戸井 雅和, 田中 耕一 川口 展子, 中川 薫, 川島 雅央, 杉本 昌弘, 常盤 麻里子, 梶原 茂樹, 藤田 雄一郎, 岩本 慎一, 戸井 雅和, 田中 耕一 MALDI-MSによる血清IgG Fc領域のN型糖鎖修飾プロファイリングを用いた乳がんの予測モデルの開発 MALDI-MSによる血清IgG Fc領域のN型糖鎖修飾プロファイリングを用いた乳がんの予測モデルの開発 MALDI-MSによる血清IgG Fc領域のN型糖鎖修飾プロファイリングを用いた乳がんの予測モデルの開発 日本癌学会総会記事, 75回, P-2337 日本癌学会総会記事, 75回, P-2337 日本癌学会総会記事, 75回, P-2337 2016/10 英語 公開
華井 明子, 石黒 洋, 寒水 孝司, 津田 萌, 中川 貴之, 今井 哲司, 浜辺 陽子, 戸井 雅和, 荒井 秀典, 坪山 直生 華井 明子, 石黒 洋, 寒水 孝司, 津田 萌, 中川 貴之, 今井 哲司, 浜辺 陽子, 戸井 雅和, 荒井 秀典, 坪山 直生 華井 明子, 石黒 洋, 寒水 孝司, 津田 萌, 中川 貴之, 今井 哲司, 浜辺 陽子, 戸井 雅和, 荒井 秀典, 坪山 直生 化学療法誘発性末梢神経障害に対する局所冷却の効果の検討 化学療法誘発性末梢神経障害に対する局所冷却の効果の検討 化学療法誘発性末梢神経障害に対する局所冷却の効果の検討 形態・機能, 15, 1, 28-28 形態・機能, 15, 1, 28-28 形態・機能, 15, 1, 28-28 2016/08 日本語 公開
Kosuke Kawaguchi, Eiji SUzuki, Masashi Inoue, Isao Kii, Tatsuki R. Karaoke, Masahiro Hiram, Keiko Iwaisako, Pu Fengling, Mariko Niche, Ayane Yamaguchi, Hironori Haga, Masatoshi Hagiwara, Masakazu Toi Kosuke Kawaguchi, Eiji SUzuki, Masashi Inoue, Isao Kii, Tatsuki R. Karaoke, Masahiro Hiram, Keiko Iwaisako, Pu Fengling, Mariko Niche, Ayane Yamaguchi, Hironori Haga, Masatoshi Hagiwara, Masakazu Toi Kosuke Kawaguchi, Eiji SUzuki, Masashi Inoue, Isao Kii, Tatsuki R. Karaoke, Masahiro Hiram, Keiko Iwaisako, Pu Fengling, Mariko Niche, Ayane Yamaguchi, Hironori Haga, Masatoshi Hagiwara, Masakazu Toi Neuropilin-1 expressing macrophages promote neuropilin-1 expression on lymphocytes by direct interaction and exert antitumor activity in HER2 positive breast cancer Neuropilin-1 expressing macrophages promote neuropilin-1 expression on lymphocytes by direct interaction and exert antitumor activity in HER2 positive breast cancer Neuropilin-1 expressing macrophages promote neuropilin-1 expression on lymphocytes by direct interaction and exert antitumor activity in HER2 positive breast cancer CANCER RESEARCH, 76 CANCER RESEARCH, 76 CANCER RESEARCH, 76 2016/07 英語 研究発表要旨(国際会議) 公開
Shun Kawaguchi, Eiji Suzuki, Kosuke Kawaguchi, Fengling Pu, Ayane Yamaguchi, Moe Tsuda, Masakazu Toi Shun Kawaguchi, Eiji Suzuki, Kosuke Kawaguchi, Fengling Pu, Ayane Yamaguchi, Moe Tsuda, Masakazu Toi Shun Kawaguchi, Eiji Suzuki, Kosuke Kawaguchi, Fengling Pu, Ayane Yamaguchi, Moe Tsuda, Masakazu Toi Humoral factors of breast tumor environment may boost PD-1 and CTLA4 gene expression of T cells, which has already been upregulated by CD28 stimulation Humoral factors of breast tumor environment may boost PD-1 and CTLA4 gene expression of T cells, which has already been upregulated by CD28 stimulation Humoral factors of breast tumor environment may boost PD-1 and CTLA4 gene expression of T cells, which has already been upregulated by CD28 stimulation CANCER RESEARCH, 76 CANCER RESEARCH, 76 CANCER RESEARCH, 76 2016/07 英語 研究発表要旨(国際会議) 公開
Masakazu Toi Masakazu Toi Masakazu Toi Target therapy combination for breast cancer Target therapy combination for breast cancer Target therapy combination for breast cancer ANNALS OF ONCOLOGY, 27 ANNALS OF ONCOLOGY, 27 ANNALS OF ONCOLOGY, 27 2016/07 英語 研究発表要旨(国際会議) 公開
Natsue Uehiro, Fumiaki Sato, Shigehira Saji, Masakazu Toi Natsue Uehiro, Fumiaki Sato, Shigehira Saji, Masakazu Toi Natsue Uehiro, Fumiaki Sato, Shigehira Saji, Masakazu Toi Twelve epigenetic marker panel for circulating DNA in plasma can detect early breast cancer Twelve epigenetic marker panel for circulating DNA in plasma can detect early breast cancer Twelve epigenetic marker panel for circulating DNA in plasma can detect early breast cancer CANCER RESEARCH, 76 CANCER RESEARCH, 76 CANCER RESEARCH, 76 2016/07 英語 研究発表要旨(国際会議) 公開
Eiji Suzuki, Masashi Inoue, Shinji Ito, Junko Satoh, Kosuke Kawaguchi, Ayane Yamaguchi, Moe Tsuda, Masakazu Toi Eiji Suzuki, Masashi Inoue, Shinji Ito, Junko Satoh, Kosuke Kawaguchi, Ayane Yamaguchi, Moe Tsuda, Masakazu Toi Eiji Suzuki, Masashi Inoue, Shinji Ito, Junko Satoh, Kosuke Kawaguchi, Ayane Yamaguchi, Moe Tsuda, Masakazu Toi Proteomics analysis of breast cancer cell-specific proteins that are transferred to immune cells via trogocytosis Proteomics analysis of breast cancer cell-specific proteins that are transferred to immune cells via trogocytosis Proteomics analysis of breast cancer cell-specific proteins that are transferred to immune cells via trogocytosis CANCER RESEARCH, 76 CANCER RESEARCH, 76 CANCER RESEARCH, 76 2016/07 英語 研究発表要旨(国際会議) 公開
Marina Kiso, Fumiaki Sato, Sunao Tanaka, Masakazu Toi Marina Kiso, Fumiaki Sato, Sunao Tanaka, Masakazu Toi Marina Kiso, Fumiaki Sato, Sunao Tanaka, Masakazu Toi VEGFA/NRP1 signal contributes to cell adhesion and motility in breast cancer cells VEGFA/NRP1 signal contributes to cell adhesion and motility in breast cancer cells VEGFA/NRP1 signal contributes to cell adhesion and motility in breast cancer cells CANCER RESEARCH, 76 CANCER RESEARCH, 76 CANCER RESEARCH, 76 2016/07 英語 研究発表要旨(国際会議) 公開
Ayane Yamaguchi, Eiji Suzuki, Kosuke Kawaguchi, Mariko Nishie, Moe Tsuda, Masakazu Toi Ayane Yamaguchi, Eiji Suzuki, Kosuke Kawaguchi, Mariko Nishie, Moe Tsuda, Masakazu Toi Ayane Yamaguchi, Eiji Suzuki, Kosuke Kawaguchi, Mariko Nishie, Moe Tsuda, Masakazu Toi Direct immune cell contact to basal-like triple negative breast cancer cells evokes downregulation of EGFR and PD-L1 Direct immune cell contact to basal-like triple negative breast cancer cells evokes downregulation of EGFR and PD-L1 Direct immune cell contact to basal-like triple negative breast cancer cells evokes downregulation of EGFR and PD-L1 CANCER RESEARCH, 76 CANCER RESEARCH, 76 CANCER RESEARCH, 76 2016/07 英語 研究発表要旨(国際会議) 公開
澤木 正孝, 山城 大泰, 増田 慎三, 奥村 恭博, 高野 利実, 徳永 えり子, 齊藤 毅, 相良 安昭, 山崎 弘資, 保野 慎治, 森田 智視, 大野 真司, 戸井 雅和, JBCRG 澤木 正孝, 山城 大泰, 増田 慎三, 奥村 恭博, 高野 利実, 徳永 えり子, 齊藤 毅, 相良 安昭, 山崎 弘資, 保野 慎治, 森田 智視, 大野 真司, 戸井 雅和, JBCRG 澤木 正孝, 山城 大泰, 増田 慎三, 奥村 恭博, 高野 利実, 徳永 えり子, 齊藤 毅, 相良 安昭, 山崎 弘資, 保野 慎治, 森田 智視, 大野 真司, 戸井 雅和, JBCRG 周術期トラスツズマブ治療歴を有する再発乳癌におけるトラスツズマブ投与の観察研究(JBCRG-C02) 周術期トラスツズマブ治療歴を有する再発乳癌におけるトラスツズマブ投与の観察研究(JBCRG-C02) 周術期トラスツズマブ治療歴を有する再発乳癌におけるトラスツズマブ投与の観察研究(JBCRG-C02) 日本乳癌学会総会プログラム抄録集, 24回, 247-247 日本乳癌学会総会プログラム抄録集, 24回, 247-247 日本乳癌学会総会プログラム抄録集, 24回, 247-247 2016/06 日本語 公開
矢内 勢司, 松本 純弘, 古武 剛, 林 雪, 高田 正泰, 鈴木 栄治, 竹内 恵, 石黒 洋, 佐藤 史顕, 戸井 雅和 矢内 勢司, 松本 純弘, 古武 剛, 林 雪, 高田 正泰, 鈴木 栄治, 竹内 恵, 石黒 洋, 佐藤 史顕, 戸井 雅和 乳腺間質肉腫の2例 乳腺間質肉腫の2例 日本乳癌学会総会プログラム抄録集24回, 618 日本乳癌学会総会プログラム抄録集24回, 618 , 618 2016/06 公開
西村 友美, 石黒 洋, 中木村 朋美, 福井 由紀子, 前川 佳奈, 仁尾 万里華, 山口 絢音, 中山 美恵, 林 雪, 古武 剛, 矢内 勢司, 松本 純明, 高田 正泰, 竹内 恵, 鈴木 栄治, 佐藤 史顕, 戸井 雅和 西村 友美, 石黒 洋, 中木村 朋美, 福井 由紀子, 前川 佳奈, 仁尾 万里華, 山口 絢音, 中山 美恵, 林 雪, 古武 剛, 矢内 勢司, 松本 純明, 高田 正泰, 竹内 恵, 鈴木 栄治, 佐藤 史顕, 戸井 雅和 日本人乳癌患者におけるオランザピン(アプレピタント非併用) の化学療法誘発性悪心嘔吐抑制効果 日本人乳癌患者におけるオランザピン(アプレピタント非併用) の化学療法誘発性悪心嘔吐抑制効果 第24回日本乳癌学会学術総会プログラム抄録集24回 第24回日本乳癌学会学術総会プログラム抄録集24回 2016/06 公開
山賀 郁, 高田 正泰, 浅尾 恭史, Fakhrejahani Elham, 常盤 麻里子, 鳥井 雅恵, 川島 雅央, 桜井 孝規, 金尾 昌太郎, 片岡 正子, 羽賀 博典, 椎名 毅, 富樫 かおり, 戸井 雅和 山賀 郁, 高田 正泰, 浅尾 恭史, Fakhrejahani Elham, 常盤 麻里子, 鳥井 雅恵, 川島 雅央, 桜井 孝規, 金尾 昌太郎, 片岡 正子, 羽賀 博典, 椎名 毅, 富樫 かおり, 戸井 雅和 山賀 郁, 高田 正泰, 浅尾 恭史, Fakhrejahani Elham, 常盤 麻里子, 鳥井 雅恵, 川島 雅央, 桜井 孝規, 金尾 昌太郎, 片岡 正子, 羽賀 博典, 椎名 毅, 富樫 かおり, 戸井 雅和 第2世代光超音波マンモグラフィによる腫瘍血管の描出および組織学的対比 第2世代光超音波マンモグラフィによる腫瘍血管の描出および組織学的対比 第2世代光超音波マンモグラフィによる腫瘍血管の描出および組織学的対比 日本乳癌学会総会プログラム抄録集, 24回, 337-337 日本乳癌学会総会プログラム抄録集, 24回, 337-337 日本乳癌学会総会プログラム抄録集, 24回, 337-337 2016/06 日本語 公開
Carlos H. Barrios, David Cella, Miguel Martin, Wolfgang Eiermann, Howard A. Burris, Young-Hyuck Im, Pier Franco Conte, Masakazu Toi, Tadeusz Pienkowski, Xavier B. Pivot, Benjamin Beckermann, Sven Franz Stanzel, Jennifer Petersen, Paul Anthony Ellis Carlos H. Barrios, David Cella, Miguel Martin, Wolfgang Eiermann, Howard A. Burris, Young-Hyuck Im, Pier Franco Conte, Masakazu Toi, Tadeusz Pienkowski, Xavier B. Pivot, Benjamin Beckermann, Sven Franz Stanzel, Jennifer Petersen, Paul Anthony Ellis Carlos H. Barrios, David Cella, Miguel Martin, Wolfgang Eiermann, Howard A. Burris, Young-Hyuck Im, Pier Franco Conte, Masakazu Toi, Tadeusz Pienkowski, Xavier B. Pivot, Benjamin Beckermann, Sven Franz Stanzel, Jennifer Petersen, Paul Anthony Ellis Patient-reported outcomes (PROs) from MARIANNE: A phase III study of trastuzumab emtansine (T-DM1) +/- pertuzumab (P) vs trastuzumab plus taxane (HT) for HER2-positive advanced breast cancer. Patient-reported outcomes (PROs) from MARIANNE: A phase III study of trastuzumab emtansine (T-DM1) +/- pertuzumab (P) vs trastuzumab plus taxane (HT) for HER2-positive advanced breast cancer. Patient-reported outcomes (PROs) from MARIANNE: A phase III study of trastuzumab emtansine (T-DM1) +/- pertuzumab (P) vs trastuzumab plus taxane (HT) for HER2-positive advanced breast cancer. JOURNAL OF CLINICAL ONCOLOGY, 34, 15 JOURNAL OF CLINICAL ONCOLOGY, 34, 15 JOURNAL OF CLINICAL ONCOLOGY, 34, 15 2016/05 英語 研究発表要旨(国際会議) 公開
Yutaka Yamamoto, Hiroji Iwata, Takayuki Ueno, Masahiro Kashiwaba, Naruto Taira, Masato Takahashi, Hiroshi Tada, Koichiro Tsugawa, Tatsuya Toyama, Naoki Niikura, Fumikata Hara, Tomomi Fujisawa, Tetsuhiro Yoshinami, Shigehira Saji, Toshimi Takano, Norikazu Masuda, Satoshi Morita, Masakazu Toi, Shinji Ohno Yutaka Yamamoto, Hiroji Iwata, Takayuki Ueno, Masahiro Kashiwaba, Naruto Taira, Masato Takahashi, Hiroshi Tada, Koichiro Tsugawa, Tatsuya Toyama, Naoki Niikura, Fumikata Hara, Tomomi Fujisawa, Tetsuhiro Yoshinami, Shigehira Saji, Toshimi Takano, Norikazu Masuda, Satoshi Morita, Masakazu Toi, Shinji Ohno Yutaka Yamamoto, Hiroji Iwata, Takayuki Ueno, Masahiro Kashiwaba, Naruto Taira, Masato Takahashi, Hiroshi Tada, Koichiro Tsugawa, Tatsuya Toyama, Naoki Niikura, Fumikata Hara, Tomomi Fujisawa, Tetsuhiro Yoshinami, Shigehira Saji, Toshimi Takano, Norikazu Masuda, Satoshi Morita, Masakazu Toi, Shinji Ohno PRECIOUS: A randomized, open-label phase III trial of pertuzumab retreatment in HER2-positive locally advanced/metastatic breast cancer patients who were previously treated with pertuzumab, trastuzumab, and chemotherapy. PRECIOUS: A randomized, open-label phase III trial of pertuzumab retreatment in HER2-positive locally advanced/metastatic breast cancer patients who were previously treated with pertuzumab, trastuzumab, and chemotherapy. PRECIOUS: A randomized, open-label phase III trial of pertuzumab retreatment in HER2-positive locally advanced/metastatic breast cancer patients who were previously treated with pertuzumab, trastuzumab, and chemotherapy. JOURNAL OF CLINICAL ONCOLOGY, 34, 15 JOURNAL OF CLINICAL ONCOLOGY, 34, 15 JOURNAL OF CLINICAL ONCOLOGY, 34, 15 2016/05 英語 研究発表要旨(国際会議) 公開
Akiko Hanai, Hiroshi Ishiguro, Takashi Sozu, Moe Tsuda, Takayuki Nakagawa, Satoshi Imai, Yoko Hamabe, Masakazu Toi, Hidenori Arai, Tadao Tsuboyama Akiko Hanai, Hiroshi Ishiguro, Takashi Sozu, Moe Tsuda, Takayuki Nakagawa, Satoshi Imai, Yoko Hamabe, Masakazu Toi, Hidenori Arai, Tadao Tsuboyama Akiko Hanai, Hiroshi Ishiguro, Takashi Sozu, Moe Tsuda, Takayuki Nakagawa, Satoshi Imai, Yoko Hamabe, Masakazu Toi, Hidenori Arai, Tadao Tsuboyama The effects of frozen gloves and socks on paclitaxel-induced peripheral neuropathy among patients with breast cancer: A self-controlled clinical trial. The effects of frozen gloves and socks on paclitaxel-induced peripheral neuropathy among patients with breast cancer: A self-controlled clinical trial. The effects of frozen gloves and socks on paclitaxel-induced peripheral neuropathy among patients with breast cancer: A self-controlled clinical trial. JOURNAL OF CLINICAL ONCOLOGY, 34, 15 JOURNAL OF CLINICAL ONCOLOGY, 34, 15 JOURNAL OF CLINICAL ONCOLOGY, 34, 15 2016/05 英語 研究発表要旨(国際会議) 公開
Naoto Kondo, Yoshinori Ito, Ippei Fukada, Shoichiro Ohtani, Masaya Hattori, Eriko Tokunaga, Nobuki Matsunami, Kohjiro Mashino, Taijiro Kosaka, Masahiko Tanabe, Daisuke Yotsumoto, Kosho Yamanouchi, Masataka Sawaki, Masahiro Kashiwaba, Hidetaka Kawabata, Katsumasa Kuroi, Satoshi Morita, Shinji Ohno, Masakazu Toi, Norikazu Masuda Naoto Kondo, Yoshinori Ito, Ippei Fukada, Shoichiro Ohtani, Masaya Hattori, Eriko Tokunaga, Nobuki Matsunami, Kohjiro Mashino, Taijiro Kosaka, Masahiko Tanabe, Daisuke Yotsumoto, Kosho Yamanouchi, Masataka Sawaki, Masahiro Kashiwaba, Hidetaka Kawabata, Katsumasa Kuroi, Satoshi Morita, Shinji Ohno, Masakazu Toi, Norikazu Masuda Naoto Kondo, Yoshinori Ito, Ippei Fukada, Shoichiro Ohtani, Masaya Hattori, Eriko Tokunaga, Nobuki Matsunami, Kohjiro Mashino, Taijiro Kosaka, Masahiko Tanabe, Daisuke Yotsumoto, Kosho Yamanouchi, Masataka Sawaki, Masahiro Kashiwaba, Hidetaka Kawabata, Katsumasa Kuroi, Satoshi Morita, Shinji Ohno, Masakazu Toi, Norikazu Masuda Efficacy study of sequential therapy with anthracycline, taxane, and eribulin in patients with HER2-negative locally advanced breast cancer (JBCRG-17). Efficacy study of sequential therapy with anthracycline, taxane, and eribulin in patients with HER2-negative locally advanced breast cancer (JBCRG-17). Efficacy study of sequential therapy with anthracycline, taxane, and eribulin in patients with HER2-negative locally advanced breast cancer (JBCRG-17). JOURNAL OF CLINICAL ONCOLOGY, 34, 15 JOURNAL OF CLINICAL ONCOLOGY, 34, 15 JOURNAL OF CLINICAL ONCOLOGY, 34, 15 2016/05 英語 研究発表要旨(国際会議) 公開
Kosuke Kawaguchi, Eiji Suzuki, Tatsuki R. Kataoka, Masahiro Hirata, Shinji Ohno, Hiroko Bando, Hiroshi Ishiguro, Kenichi Inoue, Naohito Yamamoto, Katsumasa Kuroi, Satoshi Morita, Norikazu Masuda, Masakazu Toi Kosuke Kawaguchi, Eiji Suzuki, Tatsuki R. Kataoka, Masahiro Hirata, Shinji Ohno, Hiroko Bando, Hiroshi Ishiguro, Kenichi Inoue, Naohito Yamamoto, Katsumasa Kuroi, Satoshi Morita, Norikazu Masuda, Masakazu Toi Kosuke Kawaguchi, Eiji Suzuki, Tatsuki R. Kataoka, Masahiro Hirata, Shinji Ohno, Hiroko Bando, Hiroshi Ishiguro, Kenichi Inoue, Naohito Yamamoto, Katsumasa Kuroi, Satoshi Morita, Norikazu Masuda, Masakazu Toi Analysis of tumor infiltrating lymphocytes in HER2-positive primary breast cancer treated with neoadjuvant lapatinib and trastuzumab: The NeoLath study (JBCRG-16). Analysis of tumor infiltrating lymphocytes in HER2-positive primary breast cancer treated with neoadjuvant lapatinib and trastuzumab: The NeoLath study (JBCRG-16). Analysis of tumor infiltrating lymphocytes in HER2-positive primary breast cancer treated with neoadjuvant lapatinib and trastuzumab: The NeoLath study (JBCRG-16). JOURNAL OF CLINICAL ONCOLOGY, 34, 15 JOURNAL OF CLINICAL ONCOLOGY, 34, 15 JOURNAL OF CLINICAL ONCOLOGY, 34, 15 2016/05 英語 研究発表要旨(国際会議) 公開
A. Sonnenblick, D. Agbor-Tarh, I. Bradbury, S. Di Cosimo, J. A. Zujewski, H. A. Azim, J. Judith, M. Andersson, T. Cufer, S. Simon, P. Salman, M. Toi, L. Harris, J. Gralow, K. Macoon, A. Moreno-Aspitia, M. Piccart, E. De Azambuja A. Sonnenblick, D. Agbor-Tarh, I. Bradbury, S. Di Cosimo, J. A. Zujewski, H. A. Azim, J. Judith, M. Andersson, T. Cufer, S. Simon, P. Salman, M. Toi, L. Harris, J. Gralow, K. Macoon, A. Moreno-Aspitia, M. Piccart, E. De Azambuja A. Sonnenblick, D. Agbor-Tarh, I. Bradbury, S. Di Cosimo, J. A. Zujewski, H. A. Azim, J. Judith, M. Andersson, T. Cufer, S. Simon, P. Salman, M. Toi, L. Harris, J. Gralow, K. Macoon, A. Moreno-Aspitia, M. Piccart, E. De Azambuja The impact of diabetes and metformin usage on the outcome of HER2 positive primary breast cancer patients. Analysis from the ALTTO phase III randomized trial The impact of diabetes and metformin usage on the outcome of HER2 positive primary breast cancer patients. Analysis from the ALTTO phase III randomized trial The impact of diabetes and metformin usage on the outcome of HER2 positive primary breast cancer patients. Analysis from the ALTTO phase III randomized trial EUROPEAN JOURNAL OF CANCER, 57, S28-S28 EUROPEAN JOURNAL OF CANCER, 57, S28-S28 EUROPEAN JOURNAL OF CANCER, 57, S28-S28 2016/04 英語 研究発表要旨(国際会議) 公開
N. Kondo, Y. Yamamoto, H. Yamashiro, M. Kashiwaba, R. Nakamura, M. Takahashi, U. Toh, K. Tsugawa, K. Narui, K. Tamaki, T. Yoshinami, S. Ohtani, Y. Kai, T. Takano, Y. Yanagita, S. Morita, M. Toi, S. Ohno N. Kondo, Y. Yamamoto, H. Yamashiro, M. Kashiwaba, R. Nakamura, M. Takahashi, U. Toh, K. Tsugawa, K. Narui, K. Tamaki, T. Yoshinami, S. Ohtani, Y. Kai, T. Takano, Y. Yanagita, S. Morita, M. Toi, S. Ohno N. Kondo, Y. Yamamoto, H. Yamashiro, M. Kashiwaba, R. Nakamura, M. Takahashi, U. Toh, K. Tsugawa, K. Narui, K. Tamaki, T. Yoshinami, S. Ohtani, Y. Kai, T. Takano, Y. Yanagita, S. Morita, M. Toi, S. Ohno Prospective observational cohort study of bevacizumab combined with paclitaxel as the first-or second-line chemotherapy for locally advanced or metastatic breast cancer (Study JBCRG-C05: B-SHARE) Prospective observational cohort study of bevacizumab combined with paclitaxel as the first-or second-line chemotherapy for locally advanced or metastatic breast cancer (Study JBCRG-C05: B-SHARE) Prospective observational cohort study of bevacizumab combined with paclitaxel as the first-or second-line chemotherapy for locally advanced or metastatic breast cancer (Study JBCRG-C05: B-SHARE) EUROPEAN JOURNAL OF CANCER, 57, S92-S92 EUROPEAN JOURNAL OF CANCER, 57, S92-S92 EUROPEAN JOURNAL OF CANCER, 57, S92-S92 2016/04 英語 研究発表要旨(国際会議) 公開
H. Kawaguchi, N. Masuda, T. Nakayama, K. Aogi, K. Anan, Y. Ito, S. Ohtani, N. Sato, S. Saji, E. Tokunaga, S. Nakamura, Y. Hasegawa, M. Hattori, T. Fujisawa, S. Morita, M. Yamaguchi, T. Yamashita, Y. Yamamoto, S. Ohno, M. Toi H. Kawaguchi, N. Masuda, T. Nakayama, K. Aogi, K. Anan, Y. Ito, S. Ohtani, N. Sato, S. Saji, E. Tokunaga, S. Nakamura, Y. Hasegawa, M. Hattori, T. Fujisawa, S. Morita, M. Yamaguchi, T. Yamashita, Y. Yamamoto, S. Ohno, M. Toi H. Kawaguchi, N. Masuda, T. Nakayama, K. Aogi, K. Anan, Y. Ito, S. Ohtani, N. Sato, S. Saji, E. Tokunaga, S. Nakamura, Y. Hasegawa, M. Hattori, T. Fujisawa, S. Morita, M. Yamaguchi, T. Yamashita, Y. Yamamoto, S. Ohno, M. Toi Search for appropriate treatment strategy using fulvestrant for postmenopausal ER-positive advanced or recurrent breast cancer patients in Japan (JBCRG-C06; Safari) Search for appropriate treatment strategy using fulvestrant for postmenopausal ER-positive advanced or recurrent breast cancer patients in Japan (JBCRG-C06; Safari) Search for appropriate treatment strategy using fulvestrant for postmenopausal ER-positive advanced or recurrent breast cancer patients in Japan (JBCRG-C06; Safari) EUROPEAN JOURNAL OF CANCER, 57, S109-S109 EUROPEAN JOURNAL OF CANCER, 57, S109-S109 EUROPEAN JOURNAL OF CANCER, 57, S109-S109 2016/04 英語 研究発表要旨(国際会議) 公開
川口 展子, 中川 薫, 川島 雅央, 杉本 昌弘, 梶原 茂樹, 藤田 雄一郎, 岩本 慎一, 戸井 雅和, 田中 耕一 川口 展子, 中川 薫, 川島 雅央, 杉本 昌弘, 梶原 茂樹, 藤田 雄一郎, 岩本 慎一, 戸井 雅和, 田中 耕一 川口 展子, 中川 薫, 川島 雅央, 杉本 昌弘, 梶原 茂樹, 藤田 雄一郎, 岩本 慎一, 戸井 雅和, 田中 耕一 MALDI-MSにて同定した乳がん患者で特徴的な血清中IgG Fc N型糖鎖修飾 MALDI-MSにて同定した乳がん患者で特徴的な血清中IgG Fc N型糖鎖修飾 MALDI-MSにて同定した乳がん患者で特徴的な血清中IgG Fc N型糖鎖修飾 日本外科学会定期学術集会抄録集, 116回, OP-009 日本外科学会定期学術集会抄録集, 116回, OP-009 日本外科学会定期学術集会抄録集, 116回, OP-009 2016/04 日本語 公開
高田 正泰, 杉本 昌弘, 増田 慎三, 岩田 広治, 黒井 克昌, 山城大泰, 大野 真司, 石黒 洋, 稲本 俊, 戸井 雅和 高田 正泰, 杉本 昌弘, 増田 慎三, 岩田 広治, 黒井 克昌, 山城大泰, 大野 真司, 石黒 洋, 稲本 俊, 戸井 雅和 乳癌術前薬物療法後の乳房温存手術の現状と問題点HER2陽性乳癌の術前療法後の局所療法個別化を目指した治療効果予測ツール開発と今後の課題 乳癌術前薬物療法後の乳房温存手術の現状と問題点HER2陽性乳癌の術前療法後の局所療法個別化を目指した治療効果予測ツール開発と今後の課題 日本外科学会定期学術集会妙録集116回, ws-14-3 日本外科学会定期学術集会妙録集116回, ws-14-3 , ws-14-3 2016/04 公開
高田 正泰, 山賀 郁, 片岡 正子, 金尾 昌太郎, 川島 雅央, 浅尾 恭史, 羽賀 博典, 椎名 毅, 富樫 かおり, 戸井 雅和 高田 正泰, 山賀 郁, 片岡 正子, 金尾 昌太郎, 川島 雅央, 浅尾 恭史, 羽賀 博典, 椎名 毅, 富樫 かおり, 戸井 雅和 高田 正泰, 山賀 郁, 片岡 正子, 金尾 昌太郎, 川島 雅央, 浅尾 恭史, 羽賀 博典, 椎名 毅, 富樫 かおり, 戸井 雅和 光と超音波の融合によるイメージングモダリティの新展開 光超音波マンモグラフィを用いた乳腺腫瘍における光音響像の形態的特徴に関する検討 光と超音波の融合によるイメージングモダリティの新展開 光超音波マンモグラフィを用いた乳腺腫瘍における光音響像の形態的特徴に関する検討 光と超音波の融合によるイメージングモダリティの新展開 光超音波マンモグラフィを用いた乳腺腫瘍における光音響像の形態的特徴に関する検討 超音波医学, 43, Suppl., S232-S232 超音波医学, 43, Suppl., S232-S232 超音波医学, 43, Suppl., S232-S232 2016/04 日本語 公開
M. Toi, S-J Lee, E. S. Lee, S. Ohtani, Y-H Im, S-A Im, B-W Park, S-B Kim, Y. Yanagita, S. Takao, S. Ohno, K. Aogi, H. Iwata, A. Kim, H. Sasano, I. Yokota, Y. Ohashi, N. Masuda M. Toi, S-J Lee, E. S. Lee, S. Ohtani, Y-H Im, S-A Im, B-W Park, S-B Kim, Y. Yanagita, S. Takao, S. Ohno, K. Aogi, H. Iwata, A. Kim, H. Sasano, I. Yokota, Y. Ohashi, N. Masuda M. Toi, S-J Lee, E. S. Lee, S. Ohtani, Y-H Im, S-A Im, B-W Park, S-B Kim, Y. Yanagita, S. Takao, S. Ohno, K. Aogi, H. Iwata, A. Kim, H. Sasano, I. Yokota, Y. Ohashi, N. Masuda A phase Ill trial of adjuvant capecitabine in breast cancer patients with HER2-negative pathologic residual invasive disease after neoadjuvant chemotherapy (CREATE-X, JBCRG-04) A phase Ill trial of adjuvant capecitabine in breast cancer patients with HER2-negative pathologic residual invasive disease after neoadjuvant chemotherapy (CREATE-X, JBCRG-04) A phase Ill trial of adjuvant capecitabine in breast cancer patients with HER2-negative pathologic residual invasive disease after neoadjuvant chemotherapy (CREATE-X, JBCRG-04) CANCER RESEARCH, 76 CANCER RESEARCH, 76 CANCER RESEARCH, 76 2016/02 英語 研究発表要旨(国際会議) 公開
K. Kawaguchi, E. Suzuki, Y. Yamamoto, K. Saito, M. Toi K. Kawaguchi, E. Suzuki, Y. Yamamoto, K. Saito, M. Toi K. Kawaguchi, E. Suzuki, Y. Yamamoto, K. Saito, M. Toi Upregulation of the interleukin 17/granulocyte-colony stimulating factor/fibroblast growth factor axis in breast cancer and its negative association with treatment outcome Upregulation of the interleukin 17/granulocyte-colony stimulating factor/fibroblast growth factor axis in breast cancer and its negative association with treatment outcome Upregulation of the interleukin 17/granulocyte-colony stimulating factor/fibroblast growth factor axis in breast cancer and its negative association with treatment outcome CANCER RESEARCH, 76 CANCER RESEARCH, 76 CANCER RESEARCH, 76 2016/02 英語 研究発表要旨(国際会議) 公開
L. Molinero, J. Yu, C. Li, R. Deurloo, R. A. Dent, R. Bell, J. Brown, M. Parmar, M. Toi, T. Suter, G. Steger, X. Pivot, J. Mackey, C. Jackisch, P. Hall, P. Hegde, C. Bais, D. Cameron L. Molinero, J. Yu, C. Li, R. Deurloo, R. A. Dent, R. Bell, J. Brown, M. Parmar, M. Toi, T. Suter, G. Steger, X. Pivot, J. Mackey, C. Jackisch, P. Hall, P. Hegde, C. Bais, D. Cameron L. Molinero, J. Yu, C. Li, R. Deurloo, R. A. Dent, R. Bell, J. Brown, M. Parmar, M. Toi, T. Suter, G. Steger, X. Pivot, J. Mackey, C. Jackisch, P. Hall, P. Hegde, C. Bais, D. Cameron Analysis of molecular prognostic factors associated with tumor immune and stromal microenvironment in BEATRICE, an open-label phase 3 trial in early triple-negative breast cancer (eTNBC) Analysis of molecular prognostic factors associated with tumor immune and stromal microenvironment in BEATRICE, an open-label phase 3 trial in early triple-negative breast cancer (eTNBC) Analysis of molecular prognostic factors associated with tumor immune and stromal microenvironment in BEATRICE, an open-label phase 3 trial in early triple-negative breast cancer (eTNBC) CANCER RESEARCH, 76 CANCER RESEARCH, 76 CANCER RESEARCH, 76 2016/02 英語 研究発表要旨(国際会議) 公開
K. Kawaguchi, E. Suzuki, Y. Yamamoto, K. Saito, M. Toi K. Kawaguchi, E. Suzuki, Y. Yamamoto, K. Saito, M. Toi K. Kawaguchi, E. Suzuki, Y. Yamamoto, K. Saito, M. Toi Upregulation of the interleukin 17/granulocyte-colony stimulating factor/fibroblast growth factor axis in breast cancer and its negative association with treatment outcome Upregulation of the interleukin 17/granulocyte-colony stimulating factor/fibroblast growth factor axis in breast cancer and its negative association with treatment outcome Upregulation of the interleukin 17/granulocyte-colony stimulating factor/fibroblast growth factor axis in breast cancer and its negative association with treatment outcome CANCER RESEARCH, 76 CANCER RESEARCH, 76 CANCER RESEARCH, 76 2016/02 英語 研究発表要旨(国際会議) 公開
M. Takada, M. Kawashima, M. Kataoka, S. Kanao, I. Yamaga, M. Torii, M. Tokiwa, E. Fakhrejahani, T. Sakurai, Y. Asao, H. Haga, T. Shiina, K. Togashi, M. Toi M. Takada, M. Kawashima, M. Kataoka, S. Kanao, I. Yamaga, M. Torii, M. Tokiwa, E. Fakhrejahani, T. Sakurai, Y. Asao, H. Haga, T. Shiina, K. Togashi, M. Toi M. Takada, M. Kawashima, M. Kataoka, S. Kanao, I. Yamaga, M. Torii, M. Tokiwa, E. Fakhrejahani, T. Sakurai, Y. Asao, H. Haga, T. Shiina, K. Togashi, M. Toi Detection of the tumor vasculature and the hypoxic status of breast lesions using second-generation photoacoustic mammography: An exploratory study Detection of the tumor vasculature and the hypoxic status of breast lesions using second-generation photoacoustic mammography: An exploratory study Detection of the tumor vasculature and the hypoxic status of breast lesions using second-generation photoacoustic mammography: An exploratory study CANCER RESEARCH, 76 CANCER RESEARCH, 76 CANCER RESEARCH, 76 2016/02 英語 研究発表要旨(国際会議) 公開
高田正泰, 竹内恵, 鈴木栄治, 松本純明, 佐藤史顕, 中山美恵, 奥田智子, 西野裕人, 瀬尾智, 波多野悦朗, 波多野悦朗, 戸井雅和 高田正泰, 竹内恵, 鈴木栄治, 松本純明, 佐藤史顕, 中山美恵, 奥田智子, 西野裕人, 瀬尾智, 波多野悦朗, 波多野悦朗, 戸井雅和 高田正泰, 竹内恵, 鈴木栄治, 松本純明, 佐藤史顕, 中山美恵, 奥田智子, 西野裕人, 瀬尾智, 波多野悦朗, 波多野悦朗, 戸井雅和 可視光術野投影装置を用いた乳癌蛍光色素法センチネルリンパ節生検に関する探索的試験 可視光術野投影装置を用いた乳癌蛍光色素法センチネルリンパ節生検に関する探索的試験 可視光術野投影装置を用いた乳癌蛍光色素法センチネルリンパ節生検に関する探索的試験 日本癌治療学会学術集会(Web), 54th, ROMBUNNO.WS18‐4 (WEB ONLY) 日本癌治療学会学術集会(Web), 54th, ROMBUNNO.WS18‐4 (WEB ONLY) 日本癌治療学会学術集会(Web), 54th, ROMBUNNO.WS18‐4 (WEB ONLY) 2016 日本語 公開
K. Kawaguchi, Y. Yamamoto, E. Suzuki, K. Saito, M. Toi K. Kawaguchi, Y. Yamamoto, E. Suzuki, K. Saito, M. Toi K. Kawaguchi, Y. Yamamoto, E. Suzuki, K. Saito, M. Toi Upregulation of the interleukin 17/granulocyte-colony stimulating factor/fibroblast growth factor axis and its correlation with indoleamine 2,3-dioxygenase in breast cancer Upregulation of the interleukin 17/granulocyte-colony stimulating factor/fibroblast growth factor axis and its correlation with indoleamine 2,3-dioxygenase in breast cancer Upregulation of the interleukin 17/granulocyte-colony stimulating factor/fibroblast growth factor axis and its correlation with indoleamine 2,3-dioxygenase in breast cancer ANNALS OF ONCOLOGY, 26, 11-11 ANNALS OF ONCOLOGY, 26, 11-11 ANNALS OF ONCOLOGY, 26, 11-11 2015/12 英語 研究発表要旨(国際会議) 公開
Masahiro Takada, Masahiro Sugimoto, Norikazu Masuda, Hiroji Iwata, Katsumasa Kuroi, Hiroyasu Yamashiro, Shinji Ohno, Hiroshi Ishiguro, Takashi Inamoto, Masakazu Toi Masahiro Takada, Masahiro Sugimoto, Norikazu Masuda, Hiroji Iwata, Katsumasa Kuroi, Hiroyasu Yamashiro, Shinji Ohno, Hiroshi Ishiguro, Takashi Inamoto, Masakazu Toi Masahiro Takada, Masahiro Sugimoto, Norikazu Masuda, Hiroji Iwata, Katsumasa Kuroi, Hiroyasu Yamashiro, Shinji Ohno, Hiroshi Ishiguro, Takashi Inamoto, Masakazu Toi Predictions of pathological response after preoperative chemotherapy plus trastuzumab in HER2-positive breast cancer Predictions of pathological response after preoperative chemotherapy plus trastuzumab in HER2-positive breast cancer Predictions of pathological response after preoperative chemotherapy plus trastuzumab in HER2-positive breast cancer ANNALS OF ONCOLOGY, 26, 78-78 ANNALS OF ONCOLOGY, 26, 78-78 ANNALS OF ONCOLOGY, 26, 78-78 2015/11 英語 研究発表要旨(国際会議) 公開
Ayane Yamaguchi, Hiroshi Ishiguro, Masayasu Takada, Masahiro Kawashima, Masae Torii, Masakazu Toi Ayane Yamaguchi, Hiroshi Ishiguro, Masayasu Takada, Masahiro Kawashima, Masae Torii, Masakazu Toi Ayane Yamaguchi, Hiroshi Ishiguro, Masayasu Takada, Masahiro Kawashima, Masae Torii, Masakazu Toi Dose escalation of eribulin plus cisplatin as induction chemotherapy in chemo-refractory triple negative breast cancer Dose escalation of eribulin plus cisplatin as induction chemotherapy in chemo-refractory triple negative breast cancer Dose escalation of eribulin plus cisplatin as induction chemotherapy in chemo-refractory triple negative breast cancer ANNALS OF ONCOLOGY, 26, 127-127 ANNALS OF ONCOLOGY, 26, 127-127 ANNALS OF ONCOLOGY, 26, 127-127 2015/11 英語 研究発表要旨(国際会議) 公開
Megumi Uchida, Chikao Sugie, Michio Yoshimura, Eiji Suzuki, Yuta Shibamoto, Masahiro Hiraoka, Masakazu Toi, Tatsuo Akechi Megumi Uchida, Chikao Sugie, Michio Yoshimura, Eiji Suzuki, Yuta Shibamoto, Masahiro Hiraoka, Masakazu Toi, Tatsuo Akechi Megumi Uchida, Chikao Sugie, Michio Yoshimura, Eiji Suzuki, Yuta Shibamoto, Masahiro Hiraoka, Masakazu Toi, Tatsuo Akechi THE EXPERIENCES AND PREFERENCES OF SHARED DECISION MAKING AND THEIR ASSOCIATED FACTORS AMONG CANCER PATIENTS UNDERGOING RADIATION THERAPY THE EXPERIENCES AND PREFERENCES OF SHARED DECISION MAKING AND THEIR ASSOCIATED FACTORS AMONG CANCER PATIENTS UNDERGOING RADIATION THERAPY THE EXPERIENCES AND PREFERENCES OF SHARED DECISION MAKING AND THEIR ASSOCIATED FACTORS AMONG CANCER PATIENTS UNDERGOING RADIATION THERAPY Asia-Pacific Journal of Clinical Oncology, 11, 145-145 Asia-Pacific Journal of Clinical Oncology, 11, 145-145 Asia-Pacific Journal of Clinical Oncology, 11, 145-145 2015/11 英語 研究発表要旨(国際会議) 公開
Kosuke Kawaguchi, Eiji Suzuki, Ayane Yamaguchi, Mariko Nishie, Masakazu Toi Kosuke Kawaguchi, Eiji Suzuki, Ayane Yamaguchi, Mariko Nishie, Masakazu Toi Kosuke Kawaguchi, Eiji Suzuki, Ayane Yamaguchi, Mariko Nishie, Masakazu Toi Immune signatures may differ between early operable breast cancer and metastatic breast cancer patients Immune signatures may differ between early operable breast cancer and metastatic breast cancer patients Immune signatures may differ between early operable breast cancer and metastatic breast cancer patients ANNALS OF ONCOLOGY, 26, 77-77 ANNALS OF ONCOLOGY, 26, 77-77 ANNALS OF ONCOLOGY, 26, 77-77 2015/11 英語 研究発表要旨(国際会議) 公開
鈴木 栄治, 山口 絢音, 河口 浩介, 平田 勝啓, 片岡 竜貴, 西江 万梨子, 羽賀 博典, 戸井 雅和 鈴木 栄治, 山口 絢音, 河口 浩介, 平田 勝啓, 片岡 竜貴, 西江 万梨子, 羽賀 博典, 戸井 雅和 鈴木 栄治, 山口 絢音, 河口 浩介, 平田 勝啓, 片岡 竜貴, 西江 万梨子, 羽賀 博典, 戸井 雅和 乳癌微小環境におけるトロゴサイトーシスの役割 乳癌微小環境におけるトロゴサイトーシスの役割 乳癌微小環境におけるトロゴサイトーシスの役割 日本癌治療学会誌, 50, 3, 552-552 日本癌治療学会誌, 50, 3, 552-552 日本癌治療学会誌, 50, 3, 552-552 2015/09 英語 公開
河口 浩介, 鈴木 栄治, 片岡 竜樹, 平田 勝啓, 山口 絢音, 西江 万梨子, 羽賀 博典, 戸井 雅和 河口 浩介, 鈴木 栄治, 片岡 竜樹, 平田 勝啓, 山口 絢音, 西江 万梨子, 羽賀 博典, 戸井 雅和 河口 浩介, 鈴木 栄治, 片岡 竜樹, 平田 勝啓, 山口 絢音, 西江 万梨子, 羽賀 博典, 戸井 雅和 乳癌における原発巣と転移巣のPD-L1発現状況についての検討 乳癌における原発巣と転移巣のPD-L1発現状況についての検討 乳癌における原発巣と転移巣のPD-L1発現状況についての検討 日本癌治療学会誌, 50, 3, 555-555 日本癌治療学会誌, 50, 3, 555-555 日本癌治療学会誌, 50, 3, 555-555 2015/09 英語 公開
Kosuke Kawaguchi, Eiji Suzuki, Isao Kii, Tatsuki R. Kataoka, Masahiro Hirata, Hironori Haga, Masatoshi Hagiwara, Masakazu Toi Kosuke Kawaguchi, Eiji Suzuki, Isao Kii, Tatsuki R. Kataoka, Masahiro Hirata, Hironori Haga, Masatoshi Hagiwara, Masakazu Toi Kosuke Kawaguchi, Eiji Suzuki, Isao Kii, Tatsuki R. Kataoka, Masahiro Hirata, Hironori Haga, Masatoshi Hagiwara, Masakazu Toi Knockdown of neuropilin-1 in monocytes impaired lymphocyte migration and anti-tumor activity in a humanized mouse model Knockdown of neuropilin-1 in monocytes impaired lymphocyte migration and anti-tumor activity in a humanized mouse model Knockdown of neuropilin-1 in monocytes impaired lymphocyte migration and anti-tumor activity in a humanized mouse model CANCER RESEARCH, 75 CANCER RESEARCH, 75 CANCER RESEARCH, 75 2015/08 英語 研究発表要旨(国際会議) 公開
Ayane Yamaguchi, Kosuke Kawaguchi, Eiji Suzuki, Mariko Nishie, Masakazu Toi Ayane Yamaguchi, Kosuke Kawaguchi, Eiji Suzuki, Mariko Nishie, Masakazu Toi Ayane Yamaguchi, Kosuke Kawaguchi, Eiji Suzuki, Mariko Nishie, Masakazu Toi Upregulation of mRNA of CD80, FOXP3, NKG2D and PD-L1 in peripheral blood mononuclear cells is associated with metastatic breast cancer patients Upregulation of mRNA of CD80, FOXP3, NKG2D and PD-L1 in peripheral blood mononuclear cells is associated with metastatic breast cancer patients Upregulation of mRNA of CD80, FOXP3, NKG2D and PD-L1 in peripheral blood mononuclear cells is associated with metastatic breast cancer patients CANCER RESEARCH, 75 CANCER RESEARCH, 75 CANCER RESEARCH, 75 2015/08 英語 研究発表要旨(国際会議) 公開
Mariko Nishie, Eiji Suzuki, Kosuke Kawaguchi, Keiko Sakamoto, Yuji Fukushima, Masakazu Hattori, Tomoharu Sugie, Masakazu Toi Mariko Nishie, Eiji Suzuki, Kosuke Kawaguchi, Keiko Sakamoto, Yuji Fukushima, Masakazu Hattori, Tomoharu Sugie, Masakazu Toi Mariko Nishie, Eiji Suzuki, Kosuke Kawaguchi, Keiko Sakamoto, Yuji Fukushima, Masakazu Hattori, Tomoharu Sugie, Masakazu Toi Downregulation of ATP6V1B1 in HER2-overexpressing human breast cancer cell line leads resistance against trastuzumab-mediated antibody-dependent cellular cytotoxicity Downregulation of ATP6V1B1 in HER2-overexpressing human breast cancer cell line leads resistance against trastuzumab-mediated antibody-dependent cellular cytotoxicity Downregulation of ATP6V1B1 in HER2-overexpressing human breast cancer cell line leads resistance against trastuzumab-mediated antibody-dependent cellular cytotoxicity CANCER RESEARCH, 75 CANCER RESEARCH, 75 CANCER RESEARCH, 75 2015/08 英語 研究発表要旨(国際会議) 公開
Eiji Suzuki, Ayane Yamaguchi, Tatsuki R. Kataoka, Masahiro Hirata, Kosuke Kawaguchi, Mariko Nishie, Masakazu Toi Eiji Suzuki, Ayane Yamaguchi, Tatsuki R. Kataoka, Masahiro Hirata, Kosuke Kawaguchi, Mariko Nishie, Masakazu Toi Eiji Suzuki, Ayane Yamaguchi, Tatsuki R. Kataoka, Masahiro Hirata, Kosuke Kawaguchi, Mariko Nishie, Masakazu Toi EGFR is transferred from triple negative breast cancer cells to immune cells via trogocytosis and expression of EGFR on immune cells is associated with high tumor grade of triple negative breast cancer patients EGFR is transferred from triple negative breast cancer cells to immune cells via trogocytosis and expression of EGFR on immune cells is associated with high tumor grade of triple negative breast cancer patients EGFR is transferred from triple negative breast cancer cells to immune cells via trogocytosis and expression of EGFR on immune cells is associated with high tumor grade of triple negative breast cancer patients CANCER RESEARCH, 75 CANCER RESEARCH, 75 CANCER RESEARCH, 75 2015/08 英語 研究発表要旨(国際会議) 公開
Hiroyasu Yamshiro, Hiroji Iwata, Norikazu Masuda, Naohito Yamamoto, Reiki Nishimura, Shoichiro Ohtani, Nobuaki Sato, Masato Takahashi, Takako Kamio, Kosuke Yamazaki, Tsuyoshi Saito, Makoto Kato, Tecchuu Lee, Shinji Ohno, Katsumasa Kuroi, Toshimi Takano, Masahiro Takada, Shinji Yasuno, Satoshi Morita, Masakazu Toi Hiroyasu Yamshiro, Hiroji Iwata, Norikazu Masuda, Naohito Yamamoto, Reiki Nishimura, Shoichiro Ohtani, Nobuaki Sato, Masato Takahashi, Takako Kamio, Kosuke Yamazaki, Tsuyoshi Saito, Makoto Kato, Tecchuu Lee, Shinji Ohno, Katsumasa Kuroi, Toshimi Takano, Masahiro Takada, Shinji Yasuno, Satoshi Morita, Masakazu Toi Hiroyasu Yamshiro, Hiroji Iwata, Norikazu Masuda, Naohito Yamamoto, Reiki Nishimura, Shoichiro Ohtani, Nobuaki Sato, Masato Takahashi, Takako Kamio, Kosuke Yamazaki, Tsuyoshi Saito, Makoto Kato, Tecchuu Lee, Shinji Ohno, Katsumasa Kuroi, Toshimi Takano, Masahiro Takada, Shinji Yasuno, Satoshi Morita, Masakazu Toi Outcomes of trastuzumab therapy in HER2-positive early breast cancer patients (vol 20, pg 709, 2015) Outcomes of trastuzumab therapy in HER2-positive early breast cancer patients (vol 20, pg 709, 2015) Outcomes of trastuzumab therapy in HER2-positive early breast cancer patients (vol 20, pg 709, 2015) INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 20, 4, 723-724 INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 20, 4, 723-724 INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 20, 4, 723-724 2015/08 英語 その他記事 公開
高田 正泰, 杉本 昌弘, 佐藤 信昭, 露木 茂, 坂東 裕子, 森口 喜生, 戸井 雅和 高田 正泰, 杉本 昌弘, 佐藤 信昭, 露木 茂, 坂東 裕子, 森口 喜生, 戸井 雅和 高田 正泰, 杉本 昌弘, 佐藤 信昭, 露木 茂, 坂東 裕子, 森口 喜生, 戸井 雅和 データマイニング手法により開発した新規予測モデルの実臨床における精度評価 データマイニング手法により開発した新規予測モデルの実臨床における精度評価 データマイニング手法により開発した新規予測モデルの実臨床における精度評価 日本乳癌学会総会プログラム抄録集, 23回, 312-312 日本乳癌学会総会プログラム抄録集, 23回, 312-312 日本乳癌学会総会プログラム抄録集, 23回, 312-312 2015/07 日本語 公開
増田 慎三, 深田 一平, 近藤 直人, 大谷 彰一郎, 服部 正也, 小坂 泰二郎, 田辺 真彦, 増野 浩二郎, 松並 展輝, 澤木 正孝, 柏葉 匡寛, 川端 英孝, 相良 安昭, 黒井 克昌, 森田 智視, 大野 真司, 戸井 雅和, 伊藤 良則 増田 慎三, 深田 一平, 近藤 直人, 大谷 彰一郎, 服部 正也, 小坂 泰二郎, 田辺 真彦, 増野 浩二郎, 松並 展輝, 澤木 正孝, 柏葉 匡寛, 川端 英孝, 相良 安昭, 黒井 克昌, 森田 智視, 大野 真司, 戸井 雅和, 伊藤 良則 増田 慎三, 深田 一平, 近藤 直人, 大谷 彰一郎, 服部 正也, 小坂 泰二郎, 田辺 真彦, 増野 浩二郎, 松並 展輝, 澤木 正孝, 柏葉 匡寛, 川端 英孝, 相良 安昭, 黒井 克昌, 森田 智視, 大野 真司, 戸井 雅和, 伊藤 良則 HER2陰性局所進行乳癌に対するアンスラサイクリン-タキサン-エリブリン逐次療法の有用性確認試験(JBCRG-17) HER2陰性局所進行乳癌に対するアンスラサイクリン-タキサン-エリブリン逐次療法の有用性確認試験(JBCRG-17) HER2陰性局所進行乳癌に対するアンスラサイクリン-タキサン-エリブリン逐次療法の有用性確認試験(JBCRG-17) 日本乳癌学会総会プログラム抄録集, 23回, 407-407 日本乳癌学会総会プログラム抄録集, 23回, 407-407 日本乳癌学会総会プログラム抄録集, 23回, 407-407 2015/07 日本語 公開
高田 正泰, 杉本 昌弘, 増田 慎三, 岩田 広浩, 黒井 克昌, 山城 大泰, 大野 真司, 石黒 洋, 稲本 俊, 戸井 雅和 高田 正泰, 杉本 昌弘, 増田 慎三, 岩田 広浩, 黒井 克昌, 山城 大泰, 大野 真司, 石黒 洋, 稲本 俊, 戸井 雅和 HER2陽性乳癌における術前トラスツマブ+抗癌薬併用療法後の治療効果を予測する数理モデルの開発 HER2陽性乳癌における術前トラスツマブ+抗癌薬併用療法後の治療効果を予測する数理モデルの開発 日本臨床腫瘍学会プログラム抄録集13回, 252 日本臨床腫瘍学会プログラム抄録集13回, 252 , 252 2015/07 公開
山口 絢音, 石黒 洋, 高田 正泰, 川島 雅央, 鳥井 雅恵, 戸井 雅和 山口 絢音, 石黒 洋, 高田 正泰, 川島 雅央, 鳥井 雅恵, 戸井 雅和 化学療法抵抗性trinple negative 乳癌患者におけるシスプラチン併用時のエリブリン投与量斬新的漸増法の検討 化学療法抵抗性trinple negative 乳癌患者におけるシスプラチン併用時のエリブリン投与量斬新的漸増法の検討 日本臨床腫瘍学会プログラム抄録集13回, 196 日本臨床腫瘍学会プログラム抄録集13回, 196 , 196 2015/07 公開
山本 尚人, 増田 慎三, 近藤 直人, 坂東 裕子, 黒井 克昌, 大野 真司, 宮本 健志, 檜垣 健二, 高野 利実, 井上 賢一, 中村 力也, 清水 哲, 石黒 洋, 青儀 健二郎, 天野 定雄, 山城 大泰, 笠井 宏委, 森田 智視, 桜井 孝規, 戸井 雅和 山本 尚人, 増田 慎三, 近藤 直人, 坂東 裕子, 黒井 克昌, 大野 真司, 宮本 健志, 檜垣 健二, 高野 利実, 井上 賢一, 中村 力也, 清水 哲, 石黒 洋, 青儀 健二郎, 天野 定雄, 山城 大泰, 笠井 宏委, 森田 智視, 桜井 孝規, 戸井 雅和 pCRの意義を問う HER2陽性乳癌における術前Dual-HER2 blockage療法±ホルモン療法の検討(Neo-LaTH、JBCRG-16試験) pCRの意義を問う HER2陽性乳癌における術前Dual-HER2 blockage療法±ホルモン療法の検討(Neo-LaTH、JBCRG-16試験) 日本乳癌学会総会プログラム抄録集23回 シンポジウムSY-2-11-04, 49 日本乳癌学会総会プログラム抄録集23回 シンポジウムSY-2-11-04, 49 , 49 2015/07 公開
山口 絢音, 鈴木 栄治, 川島 雅央, 高田 正泰, 竹内 恵, 石黒 洋, 佐藤 史顕, 戸井 雅和 山口 絢音, 鈴木 栄治, 川島 雅央, 高田 正泰, 竹内 恵, 石黒 洋, 佐藤 史顕, 戸井 雅和 腫瘍浸潤EGFR陽性免疫細胞とトリプルネガティブ乳癌の組織グレードとの関連性 腫瘍浸潤EGFR陽性免疫細胞とトリプルネガティブ乳癌の組織グレードとの関連性 日本乳癌学会学術総会プログラム抄録集23回, 532 日本乳癌学会学術総会プログラム抄録集23回, 532 , 532 2015/07 公開
河口 浩介, 鈴木 栄治, 喜井 勲, 片岡 竜貴, 平田 勝啓, 羽賀 博典, 萩原 正敏, 戸井 雅和 河口 浩介, 鈴木 栄治, 喜井 勲, 片岡 竜貴, 平田 勝啓, 羽賀 博典, 萩原 正敏, 戸井 雅和 河口 浩介, 鈴木 栄治, 喜井 勲, 片岡 竜貴, 平田 勝啓, 羽賀 博典, 萩原 正敏, 戸井 雅和 Neuropollin-1陽性免疫細胞はトラスツズマブによる免疫応答を惹起し抗腫瘍活性を誘導する Neuropollin-1陽性免疫細胞はトラスツズマブによる免疫応答を惹起し抗腫瘍活性を誘導する Neuropollin-1陽性免疫細胞はトラスツズマブによる免疫応答を惹起し抗腫瘍活性を誘導する 日本乳癌学会総会プログラム抄録集, 23回, 352-352 日本乳癌学会総会プログラム抄録集, 23回, 352-352 日本乳癌学会総会プログラム抄録集, 23回, 352-352 2015/07 日本語 公開
Matthew P. Goetz, Masakazu Toi, Suzanne Klise, Martin Frenzel, Nawel Bourayou, Angelo Di Leo Matthew P. Goetz, Masakazu Toi, Suzanne Klise, Martin Frenzel, Nawel Bourayou, Angelo Di Leo Matthew P. Goetz, Masakazu Toi, Suzanne Klise, Martin Frenzel, Nawel Bourayou, Angelo Di Leo MONARCH 3: A randomized phase III study of anastrozole or letrozole plus abemaciclib, a CDK4/6 inhibitor, or placebo in first-line treatment of women with HR+, HER2-locoregionally recurrent or metastatic breast cancer (MBC). MONARCH 3: A randomized phase III study of anastrozole or letrozole plus abemaciclib, a CDK4/6 inhibitor, or placebo in first-line treatment of women with HR+, HER2-locoregionally recurrent or metastatic breast cancer (MBC). MONARCH 3: A randomized phase III study of anastrozole or letrozole plus abemaciclib, a CDK4/6 inhibitor, or placebo in first-line treatment of women with HR+, HER2-locoregionally recurrent or metastatic breast cancer (MBC). JOURNAL OF CLINICAL ONCOLOGY, 33, 15 JOURNAL OF CLINICAL ONCOLOGY, 33, 15 JOURNAL OF CLINICAL ONCOLOGY, 33, 15 2015/05 英語 研究発表要旨(国際会議) 公開
Tomoharu Sugie, Atsushi Kawaguchi, Takafumi Ikeda, Masakazu Toi Tomoharu Sugie, Atsushi Kawaguchi, Takafumi Ikeda, Masakazu Toi Tomoharu Sugie, Atsushi Kawaguchi, Takafumi Ikeda, Masakazu Toi Near infrared imaging using indocyanine green for sentinel lymph node biopsy in women with early breast cancer: Results of a meta-analysis. Near infrared imaging using indocyanine green for sentinel lymph node biopsy in women with early breast cancer: Results of a meta-analysis. Near infrared imaging using indocyanine green for sentinel lymph node biopsy in women with early breast cancer: Results of a meta-analysis. JOURNAL OF CLINICAL ONCOLOGY, 33, 15 JOURNAL OF CLINICAL ONCOLOGY, 33, 15 JOURNAL OF CLINICAL ONCOLOGY, 33, 15 2015/05 英語 研究発表要旨(国際会議) 公開
Dennis J. Slamon, Sara A. Hurvitz, David Chen, Fabrice Andre, Ling-Ming Tseng, Guy Heinrich Maria Jerusalem, Sharon Wilks, Ruth O'Regan, Claudine Isaacs, Masakazu Toi, Howard A. Burris, Wei He, Markus Riester, Douglas Robinson, Tanya Taran, Luca Gianni Dennis J. Slamon, Sara A. Hurvitz, David Chen, Fabrice Andre, Ling-Ming Tseng, Guy Heinrich Maria Jerusalem, Sharon Wilks, Ruth O'Regan, Claudine Isaacs, Masakazu Toi, Howard A. Burris, Wei He, Markus Riester, Douglas Robinson, Tanya Taran, Luca Gianni Dennis J. Slamon, Sara A. Hurvitz, David Chen, Fabrice Andre, Ling-Ming Tseng, Guy Heinrich Maria Jerusalem, Sharon Wilks, Ruth O'Regan, Claudine Isaacs, Masakazu Toi, Howard A. Burris, Wei He, Markus Riester, Douglas Robinson, Tanya Taran, Luca Gianni Predictive biomarkers of everolimus efficacy in HER2+advanced breast cancer: Combined exploratory analysis from BOLERO-1 and BOLERO-3. Predictive biomarkers of everolimus efficacy in HER2+advanced breast cancer: Combined exploratory analysis from BOLERO-1 and BOLERO-3. Predictive biomarkers of everolimus efficacy in HER2+advanced breast cancer: Combined exploratory analysis from BOLERO-1 and BOLERO-3. JOURNAL OF CLINICAL ONCOLOGY, 33, 15 JOURNAL OF CLINICAL ONCOLOGY, 33, 15 JOURNAL OF CLINICAL ONCOLOGY, 33, 15 2015/05 英語 研究発表要旨(国際会議) 公開
Natsue Uehiro, Fumiaki Sato, Sunao Tanaka, Fengling Pu, Junji Itou, Shigehira Saji, Masakazu Toi Natsue Uehiro, Fumiaki Sato, Sunao Tanaka, Fengling Pu, Junji Itou, Shigehira Saji, Masakazu Toi Natsue Uehiro, Fumiaki Sato, Sunao Tanaka, Fengling Pu, Junji Itou, Shigehira Saji, Masakazu Toi DNA methylation-based classification are mostly concordant with intrinsic subtypes of breast cancer DNA methylation-based classification are mostly concordant with intrinsic subtypes of breast cancer DNA methylation-based classification are mostly concordant with intrinsic subtypes of breast cancer CANCER RESEARCH, 75 CANCER RESEARCH, 75 CANCER RESEARCH, 75 2015/05 英語 研究発表要旨(国際会議) 公開
Paul Anthony Ellis, Carlos H. Barrios, Wolfgang Eiermann, Masakazu Toi, Young-Hyuck Im, Pier Franco Conte, Miguel Martin, Tadeusz Pienkowski, Xavier B. Pivot, Howard A. Burris, Alexander Strasak, Monika Patre, Edith A. Perez Paul Anthony Ellis, Carlos H. Barrios, Wolfgang Eiermann, Masakazu Toi, Young-Hyuck Im, Pier Franco Conte, Miguel Martin, Tadeusz Pienkowski, Xavier B. Pivot, Howard A. Burris, Alexander Strasak, Monika Patre, Edith A. Perez Paul Anthony Ellis, Carlos H. Barrios, Wolfgang Eiermann, Masakazu Toi, Young-Hyuck Im, Pier Franco Conte, Miguel Martin, Tadeusz Pienkowski, Xavier B. Pivot, Howard A. Burris, Alexander Strasak, Monika Patre, Edith A. Perez Phase III, randomized study of trastuzumab emtansine (T-DM1) +/- pertuzumab (P) vs trastuzumab plus taxane (HT) for first-line treatment of HER2-positive MBC: Primary results from the MARIANNE study. Phase III, randomized study of trastuzumab emtansine (T-DM1) +/- pertuzumab (P) vs trastuzumab plus taxane (HT) for first-line treatment of HER2-positive MBC: Primary results from the MARIANNE study. Phase III, randomized study of trastuzumab emtansine (T-DM1) +/- pertuzumab (P) vs trastuzumab plus taxane (HT) for first-line treatment of HER2-positive MBC: Primary results from the MARIANNE study. JOURNAL OF CLINICAL ONCOLOGY, 33, 15 JOURNAL OF CLINICAL ONCOLOGY, 33, 15 JOURNAL OF CLINICAL ONCOLOGY, 33, 15 2015/05 英語 研究発表要旨(国際会議) 公開
Sara A. Hurvitz, Fabrice Andre, Zefei Jiang, Zhimin Shao, Silvia P. Neciosup, Max S. Mano, Ling-Min Tseng, Qingyuan Zhang, Kunwei Shen, Donggeng Liu, Lydia M. Dreosti, Jifeng Feng, Howard A. Burris, Masakazu Toi, Marc E. Buyse, David Cabaribere, Mary-Ann Lindsay, Tiffany Kunz, Shantha Rao, Lida B. Pacaud, Tetiana Taran, Dennis Slamon Sara A. Hurvitz, Fabrice Andre, Zefei Jiang, Zhimin Shao, Silvia P. Neciosup, Max S. Mano, Ling-Min Tseng, Qingyuan Zhang, Kunwei Shen, Donggeng Liu, Lydia M. Dreosti, Jifeng Feng, Howard A. Burris, Masakazu Toi, Marc E. Buyse, David Cabaribere, Mary-Ann Lindsay, Tiffany Kunz, Shantha Rao, Lida B. Pacaud, Tetiana Taran, Dennis Slamon Sara A. Hurvitz, Fabrice Andre, Zefei Jiang, Zhimin Shao, Silvia P. Neciosup, Max S. Mano, Ling-Min Tseng, Qingyuan Zhang, Kunwei Shen, Donggeng Liu, Lydia M. Dreosti, Jifeng Feng, Howard A. Burris, Masakazu Toi, Marc E. Buyse, David Cabaribere, Mary-Ann Lindsay, Tiffany Kunz, Shantha Rao, Lida B. Pacaud, Tetiana Taran, Dennis Slamon Phase 3, randomized, double-blind, placebo-controlled multicenter trial of daily everolimus plus weekly trastuzumab and paclitaxel as first-line therapy in women with HER2+advanced breast cancer: BOLERO-1 Phase 3, randomized, double-blind, placebo-controlled multicenter trial of daily everolimus plus weekly trastuzumab and paclitaxel as first-line therapy in women with HER2+advanced breast cancer: BOLERO-1 Phase 3, randomized, double-blind, placebo-controlled multicenter trial of daily everolimus plus weekly trastuzumab and paclitaxel as first-line therapy in women with HER2+advanced breast cancer: BOLERO-1 CANCER RESEARCH, 75 CANCER RESEARCH, 75 CANCER RESEARCH, 75 2015/05 英語 研究発表要旨(国際会議) 公開
Antonio Llombart, Masakazu Toi, Suzanne R. Klise, Martin Frenzel, Edward M. Chan, George W. Sledge Antonio Llombart, Masakazu Toi, Suzanne R. Klise, Martin Frenzel, Edward M. Chan, George W. Sledge Antonio Llombart, Masakazu Toi, Suzanne R. Klise, Martin Frenzel, Edward M. Chan, George W. Sledge A phase III study of abemaciclib (LY2835219) combined with fulvestrant in women with hormone receptor positive (HR plus ), human epidermal growth factor receptor 2 negative (HER2-) breast cancer (MONARCH 2) A phase III study of abemaciclib (LY2835219) combined with fulvestrant in women with hormone receptor positive (HR plus ), human epidermal growth factor receptor 2 negative (HER2-) breast cancer (MONARCH 2) A phase III study of abemaciclib (LY2835219) combined with fulvestrant in women with hormone receptor positive (HR plus ), human epidermal growth factor receptor 2 negative (HER2-) breast cancer (MONARCH 2) CANCER RESEARCH, 75 CANCER RESEARCH, 75 CANCER RESEARCH, 75 2015/05 英語 研究発表要旨(国際会議) 公開
川島雅央, 山賀郁, 鳥井雅恵, 常盤麻里子, 片岡正子, 金尾昌太郎, 高田正泰, 浅尾恭史, 浅尾恭史, 椎名毅, 戸井雅和 川島雅央, 山賀郁, 鳥井雅恵, 常盤麻里子, 片岡正子, 金尾昌太郎, 高田正泰, 浅尾恭史, 浅尾恭史, 椎名毅, 戸井雅和 第二世代光超音波マンモグラフィーにより向上した腫瘍血管・酸素飽和度の描出能 第二世代光超音波マンモグラフィーにより向上した腫瘍血管・酸素飽和度の描出能 超音波医学, 42, S226(J-STAGE) 超音波医学, 42, S226(J-STAGE) , 42, S226(J-STAGE) 2015/04/15 日本語 公開
E. Fakhrejahani, M. Torii, I. Yamaga, Y. Asao, T. Kitai, M. Kataoka, S. Kanao, M. Takada, T. Shiina, M. Toi E. Fakhrejahani, M. Torii, I. Yamaga, Y. Asao, T. Kitai, M. Kataoka, S. Kanao, M. Takada, T. Shiina, M. Toi E. Fakhrejahani, M. Torii, I. Yamaga, Y. Asao, T. Kitai, M. Kataoka, S. Kanao, M. Takada, T. Shiina, M. Toi Photoacoustic imaging of breast cancer and histological markers of angiogenesis Photoacoustic imaging of breast cancer and histological markers of angiogenesis Photoacoustic imaging of breast cancer and histological markers of angiogenesis BREAST, 24, S44-S44 BREAST, 24, S44-S44 BREAST, 24, S44-S44 2015/03 英語 研究発表要旨(国際会議) 公開
N. Uehiro, F. Sato, S. Saji, M. Toi N. Uehiro, F. Sato, S. Saji, M. Toi N. Uehiro, F. Sato, S. Saji, M. Toi Subtype specific DNA methylation in circulating DNA of metastatic breast cancer patients Subtype specific DNA methylation in circulating DNA of metastatic breast cancer patients Subtype specific DNA methylation in circulating DNA of metastatic breast cancer patients BREAST, 24, S42-S42 BREAST, 24, S42-S42 BREAST, 24, S42-S42 2015/03 英語 研究発表要旨(国際会議) 公開
Ian Tannock, Masakazu Toi, Louis W. C. Chow Ian Tannock, Masakazu Toi, Louis W. C. Chow Ian Tannock, Masakazu Toi, Louis W. C. Chow Autophagy is a mechanism of resistance to anticancer drugs that can be targeted to improve the effectiveness of cancer therapy Autophagy is a mechanism of resistance to anticancer drugs that can be targeted to improve the effectiveness of cancer therapy Autophagy is a mechanism of resistance to anticancer drugs that can be targeted to improve the effectiveness of cancer therapy INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 30, 1, E152-E153 INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 30, 1, E152-E153 INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 30, 1, E152-E153 2015/01 英語 その他記事 公開
Eiji Suzuki, Tatsuki R. Kataoka, Masahiro Hirata, Kosuke Kawaguchi, Mariko Nishie, Hironori Haga, Masakazu Toi Eiji Suzuki, Tatsuki R. Kataoka, Masahiro Hirata, Kosuke Kawaguchi, Mariko Nishie, Hironori Haga, Masakazu Toi Eiji Suzuki, Tatsuki R. Kataoka, Masahiro Hirata, Kosuke Kawaguchi, Mariko Nishie, Hironori Haga, Masakazu Toi A role of trogocytosis of immune cells in breast tumor microenvironment A role of trogocytosis of immune cells in breast tumor microenvironment A role of trogocytosis of immune cells in breast tumor microenvironment INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 36, S16-S16 INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 36, S16-S16 INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 36, S16-S16 2015 英語 研究発表要旨(国際会議) 公開
Masahiro Kawashima, Nobuko Kawaguchi-Sakita, Masahiro Sugimoto, Taka-Aki Sato, Koichi Tanaka, Masakazu Toi Masahiro Kawashima, Nobuko Kawaguchi-Sakita, Masahiro Sugimoto, Taka-Aki Sato, Koichi Tanaka, Masakazu Toi Masahiro Kawashima, Nobuko Kawaguchi-Sakita, Masahiro Sugimoto, Taka-Aki Sato, Koichi Tanaka, Masakazu Toi Abstract 4959: High-resolution MALDI imaging mass spectrometry demonstrated the correlation between phosphatidylinositol profiles and invasion/metastasis in human breast cancer Abstract 4959: High-resolution MALDI imaging mass spectrometry demonstrated the correlation between phosphatidylinositol profiles and invasion/metastasis in human breast cancer Abstract 4959: High-resolution MALDI imaging mass spectrometry demonstrated the correlation between phosphatidylinositol profiles and invasion/metastasis in human breast cancer Cancer Research, 74, 19 Supplement, 4959-4959 Cancer Research, 74, 19 Supplement, 4959-4959 Cancer Research, 74, 19 Supplement, 4959-4959 2014/11 英語 研究発表要旨(全国大会、その他学術会議) 公開
Eiji Suzuki, Mariko Nishie, Kosuke Kawaguchi, Sunao Tanaka, Masakazu Toi Eiji Suzuki, Mariko Nishie, Kosuke Kawaguchi, Sunao Tanaka, Masakazu Toi Eiji Suzuki, Mariko Nishie, Kosuke Kawaguchi, Sunao Tanaka, Masakazu Toi Loss of HER2 via trogocytosis by CD14+cells in HER2-overexpressing breast cancer cells is associated with diminishing of trastuzumab-mediated antibody-dependent cellular cytotoxicity Loss of HER2 via trogocytosis by CD14+cells in HER2-overexpressing breast cancer cells is associated with diminishing of trastuzumab-mediated antibody-dependent cellular cytotoxicity Loss of HER2 via trogocytosis by CD14+cells in HER2-overexpressing breast cancer cells is associated with diminishing of trastuzumab-mediated antibody-dependent cellular cytotoxicity CANCER RESEARCH, 74, 19 CANCER RESEARCH, 74, 19 CANCER RESEARCH, 74, 19 2014/10 英語 研究発表要旨(国際会議) 公開
Kosuke Kawaguchi, Eiji Suzuki, Masao Kawashima, Masakazu Toi Kosuke Kawaguchi, Eiji Suzuki, Masao Kawashima, Masakazu Toi Kosuke Kawaguchi, Eiji Suzuki, Masao Kawashima, Masakazu Toi High neuropilin-1 expression on monocytes is positively associated with trastuzumab-mediated antibody-dependent cellular cytotoxicity of the HER2-overexpressing breast cancer cell line High neuropilin-1 expression on monocytes is positively associated with trastuzumab-mediated antibody-dependent cellular cytotoxicity of the HER2-overexpressing breast cancer cell line High neuropilin-1 expression on monocytes is positively associated with trastuzumab-mediated antibody-dependent cellular cytotoxicity of the HER2-overexpressing breast cancer cell line CANCER RESEARCH, 74, 19 CANCER RESEARCH, 74, 19 CANCER RESEARCH, 74, 19 2014/10 英語 研究発表要旨(国際会議) 公開
Y. Nakamoto, S. Kanao, E. Suzuki, K. Nakatani, M. Toi, K. Togashi Y. Nakamoto, S. Kanao, E. Suzuki, K. Nakatani, M. Toi, K. Togashi Y. Nakamoto, S. Kanao, E. Suzuki, K. Nakatani, M. Toi, K. Togashi Early prediction of pathological complete remission after pre-operative neoadjuvant-therapy by dedicated-breast PET in patients with locally-advanced breast cancer Early prediction of pathological complete remission after pre-operative neoadjuvant-therapy by dedicated-breast PET in patients with locally-advanced breast cancer Early prediction of pathological complete remission after pre-operative neoadjuvant-therapy by dedicated-breast PET in patients with locally-advanced breast cancer EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 41, S468-S468 EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 41, S468-S468 EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 41, S468-S468 2014/10 英語 研究発表要旨(国際会議) 公開
Junichi Aratake, Eiji Suzuki, Natsue Uehiro, Mariko Nishie, Kosuke Kawaguchi, Fumiaki Sato, Masakazu Toi Junichi Aratake, Eiji Suzuki, Natsue Uehiro, Mariko Nishie, Kosuke Kawaguchi, Fumiaki Sato, Masakazu Toi Junichi Aratake, Eiji Suzuki, Natsue Uehiro, Mariko Nishie, Kosuke Kawaguchi, Fumiaki Sato, Masakazu Toi Trogocytosis of HER2 overexpressing human breast cancer cell lines may induce its dormancy without depending on HER family signal Trogocytosis of HER2 overexpressing human breast cancer cell lines may induce its dormancy without depending on HER family signal Trogocytosis of HER2 overexpressing human breast cancer cell lines may induce its dormancy without depending on HER family signal CANCER RESEARCH, 74, 19 CANCER RESEARCH, 74, 19 CANCER RESEARCH, 74, 19 2014/10 英語 研究発表要旨(国際会議) 公開
Shinji Ohno, Masakazu Toi, Katsumasa Kuroi, Hiroji Iwata, Norikazu Masuda Shinji Ohno, Masakazu Toi, Katsumasa Kuroi, Hiroji Iwata, Norikazu Masuda Shinji Ohno, Masakazu Toi, Katsumasa Kuroi, Hiroji Iwata, Norikazu Masuda THE CURRENT STATUS AND FUTURE PERSPECTIVES OF JBCRG IN JAPAN THE CURRENT STATUS AND FUTURE PERSPECTIVES OF JBCRG IN JAPAN THE CURRENT STATUS AND FUTURE PERSPECTIVES OF JBCRG IN JAPAN ANNALS OF ONCOLOGY, 25 ANNALS OF ONCOLOGY, 25 ANNALS OF ONCOLOGY, 25 2014/10 英語 研究発表要旨(国際会議) 公開
Lisa J. Mackenzie, Eiji Suzuki, Masakazu Ogura, Mariko Carey, Rob Sanson-Fisher, Hiromi Asada, Masakazu Toi, Masahiro Hiraoka, Catherine DEste Lisa J. Mackenzie, Eiji Suzuki, Masakazu Ogura, Mariko Carey, Rob Sanson-Fisher, Hiromi Asada, Masakazu Toi, Masahiro Hiraoka, Catherine DEste Lisa J. Mackenzie, Eiji Suzuki, Masakazu Ogura, Mariko Carey, Rob Sanson-Fisher, Hiromi Asada, Masakazu Toi, Masahiro Hiraoka, Catherine DEste JAPANESE CANCER PATIENTS' PREFERENCES FOR DISCUSSING LIFE EXPECTANCY WITH THEIR RADIATION ONCOLOGIST JAPANESE CANCER PATIENTS' PREFERENCES FOR DISCUSSING LIFE EXPECTANCY WITH THEIR RADIATION ONCOLOGIST JAPANESE CANCER PATIENTS' PREFERENCES FOR DISCUSSING LIFE EXPECTANCY WITH THEIR RADIATION ONCOLOGIST ANNALS OF ONCOLOGY, 25 ANNALS OF ONCOLOGY, 25 ANNALS OF ONCOLOGY, 25 2014/10 英語 研究発表要旨(国際会議) 公開
常盤麻里子, 高田正泰, 鳥井雅恵, 山賀郁, 金尾昌太郎, 片岡正子, 三上芳喜, 椎名毅, 浅尾恭史, 戸井雅和 常盤麻里子, 高田正泰, 鳥井雅恵, 山賀郁, 金尾昌太郎, 片岡正子, 三上芳喜, 椎名毅, 浅尾恭史, 戸井雅和 常盤 麻里子, 高田 正泰, 鳥井 雅恵, 山賀 郁, 金尾 昌太郎, 片岡 正子, 三上 芳喜, 椎名 毅, 浅尾 恭史, 戸井 雅和 光超音波マンモグラフィを用いた腫瘍内酸素飽和度の初期評価 光超音波マンモグラフィを用いた腫瘍内酸素飽和度の初期評価 光超音波マンモグラフィを用いた腫瘍内酸素飽和度の初期評価 日本乳癌学会学術総会プログラム・抄録集, 22nd, 368-368 日本乳癌学会学術総会プログラム・抄録集, 22nd, 368-368 日本乳癌学会総会プログラム抄録集, 22nd, 368-368 2014/07 日本語 公開
金尾昌太郎, 片岡正子, 河合真喜子, 飯間麻美, 大西奈都子, 三上芳喜, 戸井雅和, 富樫かおり 金尾昌太郎, 片岡正子, 河合真喜子, 飯間麻美, 大西奈都子, 三上芳喜, 戸井雅和, 富樫かおり 金尾 昌太郎, 片岡 正子, 河合 真喜子, 飯間 麻美, 大西 奈都子, 三上 芳喜, 戸井 雅和, 富樫 かおり 3.0T MRIを用いた乳癌術前薬物療法後の効果判定 3.0T MRIを用いた乳癌術前薬物療法後の効果判定 3.0T MRIを用いた乳癌術前薬物療法後の効果判定 日本乳癌学会学術総会プログラム・抄録集, 22nd, 354-354 日本乳癌学会学術総会プログラム・抄録集, 22nd, 354-354 日本乳癌学会総会プログラム抄録集, 22nd, 354-354 2014/07 日本語 公開
鳥井雅恵, 浅尾恭史, 山賀郁, FAKHREJAHANI Elham, 高田正泰, 鍛利幸, 杉江知治, 金尾昌太郎, 片岡正子, 三上芳喜, 椎名毅, 戸井雅和 鳥井雅恵, 浅尾恭史, 山賀郁, FAKHREJAHANI Elham, 高田正泰, 鍛利幸, 杉江知治, 金尾昌太郎, 片岡正子, 三上芳喜, 椎名毅, 戸井雅和 鳥井 雅恵, 浅尾 恭史, 山賀 郁, Fakhrejahani Elham, 高田 正泰, 鍛 利幸, 杉江 知治, 金尾 昌太郎, 片岡 正子, 三上 芳喜, 椎名 毅, 戸井 雅和 光超音波を用いた乳房血管イメージングの報告 光超音波を用いた乳房血管イメージングの報告 光超音波を用いた乳房血管イメージングの報告 超音波医学, 41, 3, 474-474 超音波医学, 41, 3, 474-474 超音波医学, 41, 3, 474-474 2014/05/15 日本語 公開
L. W. C. Chow, L. Biganzoli, A. Di Leo, K. Kuroi, H. S. Han, J. Patel, C. S. Huang, Y. S. Lu, L. Zhu, A. Y. S. Yip, S. Glueck, M. Toi L. W. C. Chow, L. Biganzoli, A. Di Leo, K. Kuroi, H. S. Han, J. Patel, C. S. Huang, Y. S. Lu, L. Zhu, A. Y. S. Yip, S. Glueck, M. Toi L. W. C. Chow, L. Biganzoli, A. Di Leo, K. Kuroi, H. S. Han, J. Patel, C. S. Huang, Y. S. Lu, L. Zhu, A. Y. S. Yip, S. Glueck, M. Toi TOXICITY PROFILES OF ADJUVANT DOCETAXEL-CYCLOPHOSPHAMIDE IN ASIAN COMPARED WITH CAUCASIAN PATIENTS WITH BREAST CANCER TOXICITY PROFILES OF ADJUVANT DOCETAXEL-CYCLOPHOSPHAMIDE IN ASIAN COMPARED WITH CAUCASIAN PATIENTS WITH BREAST CANCER TOXICITY PROFILES OF ADJUVANT DOCETAXEL-CYCLOPHOSPHAMIDE IN ASIAN COMPARED WITH CAUCASIAN PATIENTS WITH BREAST CANCER EUROPEAN JOURNAL OF CANCER, 50, E55-E56 EUROPEAN JOURNAL OF CANCER, 50, E55-E56 EUROPEAN JOURNAL OF CANCER, 50, E55-E56 2014/05 英語 研究発表要旨(国際会議) 公開
T. Sugie, T. Kinoshita, N. Masuda, T. Sawada, A. Yamauchi, K. Kuroi, T. Taguchi, H. Bando, H. Yamashiro, T. Lee, N. Shinkura, H. Kato, T. Ikeda, K. Yoshimura, H. Ueyama, M. Toi T. Sugie, T. Kinoshita, N. Masuda, T. Sawada, A. Yamauchi, K. Kuroi, T. Taguchi, H. Bando, H. Yamashiro, T. Lee, N. Shinkura, H. Kato, T. Ikeda, K. Yoshimura, H. Ueyama, M. Toi Indocyanine green fluorescence imaging system as an alternative to the conventional sentinel lymph node mapping using a radiotracer in breast cancer Indocyanine green fluorescence imaging system as an alternative to the conventional sentinel lymph node mapping using a radiotracer in breast cancer Indocyanine green fluorescence imaging system as an alternative to the conventional sentinel lymph node mapping using a radiotracer in breast cancer American Society of Clinical Oncology American Society of Clinical Oncology 2014/05 公開
F. Sato, T. Ueno, A. Myomoto, S. Takizawa, N. Masuda, K. Aogi, N. Kondo, Y. Mikami, S. Saji, M. Toi F. Sato, T. Ueno, A. Myomoto, S. Takizawa, N. Masuda, K. Aogi, N. Kondo, Y. Mikami, S. Saji, M. Toi F. Sato, T. Ueno, A. Myomoto, S. Takizawa, N. Masuda, K. Aogi, N. Kondo, Y. Mikami, S. Saji, M. Toi Development of microRNA-based prediction model of trastuzumab treatment response for HER2-positive breast cancer using FFPE specimens Development of microRNA-based prediction model of trastuzumab treatment response for HER2-positive breast cancer using FFPE specimens Development of microRNA-based prediction model of trastuzumab treatment response for HER2-positive breast cancer using FFPE specimens EUROPEAN JOURNAL OF CANCER, 50, S118-S119 EUROPEAN JOURNAL OF CANCER, 50, S118-S119 EUROPEAN JOURNAL OF CANCER, 50, S118-S119 2014/03 英語 研究発表要旨(国際会議) 公開
杉江知治, 戸井雅和, 木下貴之, 増田慎三, 沢田晃暢, 山内清明, 黒井克昌, 田口哲也, 坂東裕子, 山城大泰, 李哲柱, 新藏信彦, 加藤大典, 多賀谷信美, 山神和彦, 諏訪裕文, 池田隆文, 吉村健一, 多田春江, 上山華栄, 横橋祐子 杉江知治, 戸井雅和, 木下貴之, 増田慎三, 沢田晃暢, 山内清明, 黒井克昌, 田口哲也, 坂東裕子, 山城大泰, 李哲柱, 新藏信彦, 加藤大典, 多賀谷信美, 山神和彦, 諏訪裕文, 池田隆文, 吉村健一, 多田春江, 上山華栄, 横橋祐子 SUGIE TOMOHARU, TOI MASAKAZU, KINOSHITA TAKAYUKI, MASUDA SHINZO, SAWADA AKINOBU, YAMAUCHI AKIRA, KUROI KATSUMASA, TAGUCHI TETSUYA, BANDO HIROKO, YAMASHIRO HIROYASU, RI TETSUCHU, NIIKURA NOBUHIKO, KATO HIRONORI, TAGAYA NOBUMI, YAMAGAMI KAZUHIKO, SUWA HIROFUMI, IKEDA TAKAFUMI, YOSHIMURA KEN'ICHI, TADA HARUE, KAMIYAMA HANAE, YOKOHASHI YUKO ICG蛍光法によるセンチネルリンパ節同定法 ICG蛍光法によるセンチネルリンパ節同定法 ICG蛍光法によるセンチネルリンパ節同定法 日本乳癌学会学術総会プログラム・抄録集, 22nd, 205 日本乳癌学会学術総会プログラム・抄録集, 22nd, 205 日本乳癌学会学術総会プログラム・抄録集, 22nd, 205 2014 日本語 公開
E. Fakhrejahani, M. Torii, I. Yamaga, Y. Asao, T. Kitai, M. Kataoka, S. Kanao, M. Takada, T. Shiina, M. Toi E. Fakhrejahani, M. Torii, I. Yamaga, Y. Asao, T. Kitai, M. Kataoka, S. Kanao, M. Takada, T. Shiina, M. Toi E. Fakhrejahani, M. Torii, I. Yamaga, Y. Asao, T. Kitai, M. Kataoka, S. Kanao, M. Takada, T. Shiina, M. Toi Tissue hemoglobin oxygen saturation measured by photoacoustic mammography correlates with microvasculature properties assessed by histological image analysis, a preliminary study Tissue hemoglobin oxygen saturation measured by photoacoustic mammography correlates with microvasculature properties assessed by histological image analysis, a preliminary study Tissue hemoglobin oxygen saturation measured by photoacoustic mammography correlates with microvasculature properties assessed by histological image analysis, a preliminary study CANCER RESEARCH, 73 CANCER RESEARCH, 73 CANCER RESEARCH, 73 2013/12 英語 研究発表要旨(国際会議) 公開
S. Ohtani, N. Masuda, Y-H Im, B-W Park, S-B Kim, Y. Yanagita, S. Takao, S. Ohno, K. Aogi, H. Iwata, K. Yoshidome, R. Nishimura, Y. Ohashi, S-J Lee, M. Toi S. Ohtani, N. Masuda, Y-H Im, B-W Park, S-B Kim, Y. Yanagita, S. Takao, S. Ohno, K. Aogi, H. Iwata, K. Yoshidome, R. Nishimura, Y. Ohashi, S-J Lee, M. Toi S. Ohtani, N. Masuda, Y-H Im, B-W Park, S-B Kim, Y. Yanagita, S. Takao, S. Ohno, K. Aogi, H. Iwata, K. Yoshidome, R. Nishimura, Y. Ohashi, S-J Lee, M. Toi Adjuvant capecitabine in breast cancer patients with pathologic residual disease after neoadjuvant chemotherapy: First safety analysis of CREATE-X (JBCRG-04) Adjuvant capecitabine in breast cancer patients with pathologic residual disease after neoadjuvant chemotherapy: First safety analysis of CREATE-X (JBCRG-04) Adjuvant capecitabine in breast cancer patients with pathologic residual disease after neoadjuvant chemotherapy: First safety analysis of CREATE-X (JBCRG-04) CANCER RESEARCH, 73 CANCER RESEARCH, 73 CANCER RESEARCH, 73 2013/12 英語 研究発表要旨(国際会議) 公開
N. Sato, N. Masuda, K. Higaki, T. Morimoto, Y. Yanagita, M. Mizutani, S. Ohtani, K. Kaneko, T. Fujisawa, M. Takahashi, T. Kadoya, N. Matsunami, Y. Yamamoto, S. Ohno, T. Takano, S. Morita, S. Tanaka, M. Toi N. Sato, N. Masuda, K. Higaki, T. Morimoto, Y. Yanagita, M. Mizutani, S. Ohtani, K. Kaneko, T. Fujisawa, M. Takahashi, T. Kadoya, N. Matsunami, Y. Yamamoto, S. Ohno, T. Takano, S. Morita, S. Tanaka, M. Toi N. Sato, N. Masuda, K. Higaki, T. Morimoto, Y. Yanagita, M. Mizutani, S. Ohtani, K. Kaneko, T. Fujisawa, M. Takahashi, T. Kadoya, N. Matsunami, Y. Yamamoto, S. Ohno, T. Takano, S. Morita, S. Tanaka, M. Toi Randomized phase II study of preoperative docetaxel and cyclophosphamide-containing chemotherapy for luminal-type breast cancer Randomized phase II study of preoperative docetaxel and cyclophosphamide-containing chemotherapy for luminal-type breast cancer Randomized phase II study of preoperative docetaxel and cyclophosphamide-containing chemotherapy for luminal-type breast cancer CANCER RESEARCH, 73 CANCER RESEARCH, 73 CANCER RESEARCH, 73 2013/12 英語 研究発表要旨(国際会議) 公開
H. Yasojima, T. Sugie, N. Masuda, T. Kinoshita, T. Sawada, A. Yamauchi, K. Kuroi, T. Taguchi, H. Bando, H. Yamashiro, T. Lee, N. Shinkura, H. Kato, T. Ikeda, K. Yoshimura, H. Tada, H. Ueyama, Y. Yokohashi, M. Toi H. Yasojima, T. Sugie, N. Masuda, T. Kinoshita, T. Sawada, A. Yamauchi, K. Kuroi, T. Taguchi, H. Bando, H. Yamashiro, T. Lee, N. Shinkura, H. Kato, T. Ikeda, K. Yoshimura, H. Tada, H. Ueyama, Y. Yokohashi, M. Toi H. Yasojima, T. Sugie, N. Masuda, T. Kinoshita, T. Sawada, A. Yamauchi, K. Kuroi, T. Taguchi, H. Bando, H. Yamashiro, T. Lee, N. Shinkura, H. Kato, T. Ikeda, K. Yoshimura, H. Tada, H. Ueyama, Y. Yokohashi, M. Toi Interim analysis of the validation study on the clinical usefulness of the ICG fluorescence method for detecting sentinel lymph nodes in early breast cancer compared with the RI method (flCG-BR02) Interim analysis of the validation study on the clinical usefulness of the ICG fluorescence method for detecting sentinel lymph nodes in early breast cancer compared with the RI method (flCG-BR02) Interim analysis of the validation study on the clinical usefulness of the ICG fluorescence method for detecting sentinel lymph nodes in early breast cancer compared with the RI method (flCG-BR02) CANCER RESEARCH, 73 CANCER RESEARCH, 73 CANCER RESEARCH, 73 2013/12 英語 研究発表要旨(国際会議) 公開
M. Toi, N. Masuda, F. Andre, H. Ishiguro, A. Fasolo, B. Xu, G. Jerusalem, K. Shen, S. Wilks, R. O'Regan, C. Isaacs, Y. Zhang, T. Taran, Y-S Yap M. Toi, N. Masuda, F. Andre, H. Ishiguro, A. Fasolo, B. Xu, G. Jerusalem, K. Shen, S. Wilks, R. O'Regan, C. Isaacs, Y. Zhang, T. Taran, Y-S Yap M. Toi, N. Masuda, F. Andre, H. Ishiguro, A. Fasolo, B. Xu, G. Jerusalem, K. Shen, S. Wilks, R. O'Regan, C. Isaacs, Y. Zhang, T. Taran, Y-S Yap BOLERO-3: Everolimus plus trastuzumab and vinorelbine in Asian patients with HER2-positive metastatic breast cancer BOLERO-3: Everolimus plus trastuzumab and vinorelbine in Asian patients with HER2-positive metastatic breast cancer BOLERO-3: Everolimus plus trastuzumab and vinorelbine in Asian patients with HER2-positive metastatic breast cancer CANCER RESEARCH, 73 CANCER RESEARCH, 73 CANCER RESEARCH, 73 2013/12 英語 研究発表要旨(国際会議) 公開
C. Isaacs, M. Ozguroglu, G. Jerusalem, B. Xu, I. Lang, R. O'Regan, M. White, A. Fasolo, J. Litton, M. Toi, K. Shen, F. Andre, P. Vuylsteke, Y. Zhang, J. Zhang, T. Taran, S. Wilks C. Isaacs, M. Ozguroglu, G. Jerusalem, B. Xu, I. Lang, R. O'Regan, M. White, A. Fasolo, J. Litton, M. Toi, K. Shen, F. Andre, P. Vuylsteke, Y. Zhang, J. Zhang, T. Taran, S. Wilks C. Isaacs, M. Ozguroglu, G. Jerusalem, B. Xu, I. Lang, R. O'Regan, M. White, A. Fasolo, J. Litton, M. Toi, K. Shen, F. Andre, P. Vuylsteke, Y. Zhang, J. Zhang, T. Taran, S. Wilks BOLERO-3: Quality-of-life maintained in patients with metastatic breast cancer treated with everolimus plus trastuzumab plus vinorelbine BOLERO-3: Quality-of-life maintained in patients with metastatic breast cancer treated with everolimus plus trastuzumab plus vinorelbine BOLERO-3: Quality-of-life maintained in patients with metastatic breast cancer treated with everolimus plus trastuzumab plus vinorelbine CANCER RESEARCH, 73 CANCER RESEARCH, 73 CANCER RESEARCH, 73 2013/12 英語 研究発表要旨(国際会議) 公開
G. von Minckwitz, H. Bear, H. Bonnefoi, M. Colleoni, K. Gelmon, M. Gnant, S-B Kim, S. Loibl, A. Makris, M. Martin, V. Nekljudova, H. Rugo, K. S. Saini, M. Toi, M. Untch, G. Werutsky G. von Minckwitz, H. Bear, H. Bonnefoi, M. Colleoni, K. Gelmon, M. Gnant, S-B Kim, S. Loibl, A. Makris, M. Martin, V. Nekljudova, H. Rugo, K. S. Saini, M. Toi, M. Untch, G. Werutsky G. von Minckwitz, H. Bear, H. Bonnefoi, M. Colleoni, K. Gelmon, M. Gnant, S-B Kim, S. Loibl, A. Makris, M. Martin, V. Nekljudova, H. Rugo, K. S. Saini, M. Toi, M. Untch, G. Werutsky PENELOPE: Phase III study evaluating palbociclib (PD-0332991), a cyclin-dependent kinase (CDK) 4/6 inhibitor in patients with hormone-receptor-positive, HER2-normal primary breast cancer with high relapse risk after neoadjuvant chemotherapy (GBG-781BIG1-13) PENELOPE: Phase III study evaluating palbociclib (PD-0332991), a cyclin-dependent kinase (CDK) 4/6 inhibitor in patients with hormone-receptor-positive, HER2-normal primary breast cancer with high relapse risk after neoadjuvant chemotherapy (GBG-781BIG1-13) PENELOPE: Phase III study evaluating palbociclib (PD-0332991), a cyclin-dependent kinase (CDK) 4/6 inhibitor in patients with hormone-receptor-positive, HER2-normal primary breast cancer with high relapse risk after neoadjuvant chemotherapy (GBG-781BIG1-13) CANCER RESEARCH, 73 CANCER RESEARCH, 73 CANCER RESEARCH, 73 2013/12 英語 研究発表要旨(国際会議) 公開
N. Masuda, H. Mukai, H. Ishiguro, A. Mitsuma, T. Shibata, J. Yamamura, M. Toi, A. Watabe, A. Sarashina, R. Ebisawa, M. Uttenreuther-Fischer, Y. Ando N. Masuda, H. Mukai, H. Ishiguro, A. Mitsuma, T. Shibata, J. Yamamura, M. Toi, A. Watabe, A. Sarashina, R. Ebisawa, M. Uttenreuther-Fischer, Y. Ando N. Masuda, H. Mukai, H. Ishiguro, A. Mitsuma, T. Shibata, J. Yamamura, M. Toi, A. Watabe, A. Sarashina, R. Ebisawa, M. Uttenreuther-Fischer, Y. Ando Phase I trial of afatinib plus vinorelbine in Japanese patients with advanced solid tumors including breast cancer Phase I trial of afatinib plus vinorelbine in Japanese patients with advanced solid tumors including breast cancer Phase I trial of afatinib plus vinorelbine in Japanese patients with advanced solid tumors including breast cancer CANCER RESEARCH, 73 CANCER RESEARCH, 73 CANCER RESEARCH, 73 2013/12 英語 研究発表要旨(国際会議) 公開
K. Kawaguchi, H. Ishiguro, I. Yano, H. Yamashiro, M. Toi K. Kawaguchi, H. Ishiguro, I. Yano, H. Yamashiro, M. Toi K. Kawaguchi, H. Ishiguro, I. Yano, H. Yamashiro, M. Toi THERAPEUTIC DRUG MONITORING OF DOCETAXEL FOR A LIVING DONOR LIVER TRANSPLANTATION RECIPIENT THERAPEUTIC DRUG MONITORING OF DOCETAXEL FOR A LIVING DONOR LIVER TRANSPLANTATION RECIPIENT THERAPEUTIC DRUG MONITORING OF DOCETAXEL FOR A LIVING DONOR LIVER TRANSPLANTATION RECIPIENT ANNALS OF ONCOLOGY, 24 ANNALS OF ONCOLOGY, 24 ANNALS OF ONCOLOGY, 24 2013/11 英語 研究発表要旨(国際会議) 公開
川島 雅央, 川口 展子, 杉本 昌弘, 上野 貴之, 寺澤 和哉, 佐藤 孝明, 田中 耕一, 清水 一治, 戸井 雅和 川島 雅央, 川口 展子, 杉本 昌弘, 上野 貴之, 寺澤 和哉, 佐藤 孝明, 田中 耕一, 清水 一治, 戸井 雅和 川島 雅央, 川口 展子, 杉本 昌弘, 上野 貴之, 寺澤 和哉, 佐藤 孝明, 田中 耕一, 清水 一治, 戸井 雅和 高解像度イメージングマススペクトロメトリーにより同定した乳癌組織中におけるフォスファチジルイノシトールの不均一な分布様式(High-Resolution-Imaging Mass Spectrometry Identifies Heterogeneous Distribution of Phophatidylinositols in Breast Cancer) 高解像度イメージングマススペクトロメトリーにより同定した乳癌組織中におけるフォスファチジルイノシトールの不均一な分布様式(High-Resolution-Imaging Mass Spectrometry Identifies Heterogeneous Distribution of Phophatidylinositols in Breast Cancer) 高解像度イメージングマススペクトロメトリーにより同定した乳癌組織中におけるフォスファチジルイノシトールの不均一な分布様式(High-Resolution-Imaging Mass Spectrometry Identifies Heterogeneous Distribution of Phophatidylinositols in Breast Cancer) 日本癌学会総会記事, 72回, 184-184 日本癌学会総会記事, 72回, 184-184 日本癌学会総会記事, 72回, 184-184 2013/10 英語 公開
河合 真喜子, 片岡正子, 金尾昌太郎, 飯間麻美, 戸井雅和, 三上芳喜, 富樫かおり 河合 真喜子, 片岡正子, 金尾昌太郎, 飯間麻美, 戸井雅和, 三上芳喜, 富樫かおり nodularPASHの3例 nodularPASHの3例 Three cases of nodular PASH 第49回日本医学放射線学会秋期臨床大会 第49回日本医学放射線学会秋期臨床大会 2013/10 英語 公開
河合真喜子, 片岡正子, 金尾昌太郎, 飯間麻美, 戸井雅和, 三上芳喜, 富樫かおり 河合真喜子, 片岡正子, 金尾昌太郎, 飯間麻美, 戸井雅和, 三上芳喜, 富樫かおり 河合 真喜子, 片岡 正子, 金尾 昌太郎, 飯間 麻美, 戸井 雅和, 三上 芳喜, 富樫 かおり Nodular PASH(Pseudoangiomatous stromal hyperplasia)のMRI所見―3例の検討― Nodular PASH(Pseudoangiomatous stromal hyperplasia)のMRI所見―3例の検討― Nodular PASH(Pseudoangiomatous stromal hyperplasia)のMRI所見 3例の検討 日本医学放射線学会秋季臨床大会抄録集, 49th, S541-S541 日本医学放射線学会秋季臨床大会抄録集, 49th, S541-S541 日本医学放射線学会秋季臨床大会抄録集, 49th, S541-S541 2013/09/11 日本語 公開
G. Jerusalem, F. Andre, D. Chen, D. Robinson, M. Ozguroglu, I. Lang, M. White, M. Toi, T. Taran, L. Gianni G. Jerusalem, F. Andre, D. Chen, D. Robinson, M. Ozguroglu, I. Lang, M. White, M. Toi, T. Taran, L. Gianni G. Jerusalem, F. Andre, D. Chen, D. Robinson, M. Ozguroglu, I. Lang, M. White, M. Toi, T. Taran, L. Gianni Evaluation of everolimus (EVE) in HER2+advanced breast cancer (BC) with activated PI3K/mTOR pathway: Exploratory biomarker observations from the BOLERO-3 trial Evaluation of everolimus (EVE) in HER2+advanced breast cancer (BC) with activated PI3K/mTOR pathway: Exploratory biomarker observations from the BOLERO-3 trial Evaluation of everolimus (EVE) in HER2+advanced breast cancer (BC) with activated PI3K/mTOR pathway: Exploratory biomarker observations from the BOLERO-3 trial EUROPEAN JOURNAL OF CANCER, 49, S8-S8 EUROPEAN JOURNAL OF CANCER, 49, S8-S8 EUROPEAN JOURNAL OF CANCER, 49, S8-S8 2013/09 英語 研究発表要旨(国際会議) 公開
鳥井 雅恵, 石黒 洋, 高田 正泰, 杉江 知治, 鈴木 栄治, 竹内 恵, 上野 貴之, 金尾 昌太郎, 三上 芳喜, 戸井 雅和 鳥井 雅恵, 石黒 洋, 高田 正泰, 杉江 知治, 鈴木 栄治, 竹内 恵, 上野 貴之, 金尾 昌太郎, 三上 芳喜, 戸井 雅和 基底様(basal-like)乳癌における術前化学療法の検討 基底様(basal-like)乳癌における術前化学療法の検討 日本乳癌学会総会プログラム抄録集21回 P226 日本乳癌学会総会プログラム抄録集21回 P226 2013/06 公開
山賀郁, 鳥井雅恵, 高田正泰, 鍛利幸, 金尾昌太郎, 片岡正子, 杉江知治, 三上秀喜, 椎名毅, 戸井雅和, FAKREJAHANI Elham, 浅尾恭史 山賀郁, 鳥井雅恵, 高田正泰, 鍛利幸, 金尾昌太郎, 片岡正子, 杉江知治, 三上秀喜, 椎名毅, 戸井雅和, FAKREJAHANI Elham, 浅尾恭史 山賀 郁, 鳥井 雅恵, 高田 正泰, 鍛 利幸, 金尾 昌太郎, 片岡 正子, 杉江 知治, 三上 芳喜, 椎名 毅, 戸井 雅和, Fakrejahani Elham, 浅尾 恭史 光超音波マンモグラフィとCD31およびCA9との対比 光超音波マンモグラフィとCD31およびCA9との対比 光超音波マンモグラフィとCD31およびCA9との対比 日本乳癌学会学術総会プログラム・抄録集, 21st, 414-414 日本乳癌学会学術総会プログラム・抄録集, 21st, 414-414 日本乳癌学会総会プログラム抄録集, 21st, 414-414 2013/06 日本語 公開
Katsumasa Kuroi, Shinji Ohno, Seigo Nakamura, Hiroji Iwata, Norikazu Masuda, Nobuaki Sato, Masakazu Toi Katsumasa Kuroi, Shinji Ohno, Seigo Nakamura, Hiroji Iwata, Norikazu Masuda, Nobuaki Sato, Masakazu Toi Katsumasa Kuroi, Shinji Ohno, Seigo Nakamura, Hiroji Iwata, Norikazu Masuda, Nobuaki Sato, Masakazu Toi Is ypT0/isn0 acceptable for Japanese population? JBCRG's perception Is ypT0/isn0 acceptable for Japanese population? JBCRG's perception Is ypT0/isn0 acceptable for Japanese population? JBCRG's perception JOURNAL OF CLINICAL ONCOLOGY, 31, 15 JOURNAL OF CLINICAL ONCOLOGY, 31, 15 JOURNAL OF CLINICAL ONCOLOGY, 31, 15 2013/05 英語 研究発表要旨(国際会議) 公開
Ruth O'Regan, Mustafa Ozguroglu, Fabrice Andre, Masakazu Toi, Guy Heinrich Maria Jerusalem, Sharon Wilks, Claudine Isaacs, Binghe Xu, Norikazu Masuda, Francis P. Arena, Denise Aysel Yardley, Yoon Sim Yap, Pabak Mukhopadhyay, Shyanne Douma, Mona El-Hashimy, Tanya Taran, Tarek Sahmoud, David Edward Lebwohl, Luca Gianni Ruth O'Regan, Mustafa Ozguroglu, Fabrice Andre, Masakazu Toi, Guy Heinrich Maria Jerusalem, Sharon Wilks, Claudine Isaacs, Binghe Xu, Norikazu Masuda, Francis P. Arena, Denise Aysel Yardley, Yoon Sim Yap, Pabak Mukhopadhyay, Shyanne Douma, Mona El-Hashimy, Tanya Taran, Tarek Sahmoud, David Edward Lebwohl, Luca Gianni Ruth O'Regan, Mustafa Ozguroglu, Fabrice Andre, Masakazu Toi, Guy Heinrich Maria Jerusalem, Sharon Wilks, Claudine Isaacs, Binghe Xu, Norikazu Masuda, Francis P. Arena, Denise Aysel Yardley, Yoon Sim Yap, Pabak Mukhopadhyay, Shyanne Douma, Mona El-Hashimy, Tanya Taran, Tarek Sahmoud, David Edward Lebwohl, Luca Gianni Phase III, randomized, double-blind, placebo-controlled multicenter trial of daily everolimus plus weekly trastuzumab and vinorelbine in trastuzumab-resistant, advanced breast cancer (BOLERO-3). Phase III, randomized, double-blind, placebo-controlled multicenter trial of daily everolimus plus weekly trastuzumab and vinorelbine in trastuzumab-resistant, advanced breast cancer (BOLERO-3). Phase III, randomized, double-blind, placebo-controlled multicenter trial of daily everolimus plus weekly trastuzumab and vinorelbine in trastuzumab-resistant, advanced breast cancer (BOLERO-3). JOURNAL OF CLINICAL ONCOLOGY, 31, 15 JOURNAL OF CLINICAL ONCOLOGY, 31, 15 JOURNAL OF CLINICAL ONCOLOGY, 31, 15 2013/05 英語 研究発表要旨(国際会議) 公開
Kenji Higaki, Norikazu Masuda, Toshimi Takano, Nobuki Matsunami, Takashi Morimoto, Shoichiro Ohtani, Makiko Mizutani, Takeshi Miyamoto, Katsumasa Kuroi, Shinji Ohno, Satoshi Morita, Masakazu Toi Kenji Higaki, Norikazu Masuda, Toshimi Takano, Nobuki Matsunami, Takashi Morimoto, Shoichiro Ohtani, Makiko Mizutani, Takeshi Miyamoto, Katsumasa Kuroi, Shinji Ohno, Satoshi Morita, Masakazu Toi Kenji Higaki, Norikazu Masuda, Toshimi Takano, Nobuki Matsunami, Takashi Morimoto, Shoichiro Ohtani, Makiko Mizutani, Takeshi Miyamoto, Katsumasa Kuroi, Shinji Ohno, Satoshi Morita, Masakazu Toi Phase II study of neoadjuvant chemotherapy with a metronomic regimen of paclitaxel plus cyclophosphamide plus capecitabine followed by 5-fluorouracil plus epirubicin plus cyclophosphamide in operable triple-negative breast cancer (JBCRG-13 study) Phase II study of neoadjuvant chemotherapy with a metronomic regimen of paclitaxel plus cyclophosphamide plus capecitabine followed by 5-fluorouracil plus epirubicin plus cyclophosphamide in operable triple-negative breast cancer (JBCRG-13 study) Phase II study of neoadjuvant chemotherapy with a metronomic regimen of paclitaxel plus cyclophosphamide plus capecitabine followed by 5-fluorouracil plus epirubicin plus cyclophosphamide in operable triple-negative breast cancer (JBCRG-13 study) JOURNAL OF CLINICAL ONCOLOGY, 31, 15 JOURNAL OF CLINICAL ONCOLOGY, 31, 15 JOURNAL OF CLINICAL ONCOLOGY, 31, 15 2013/05 英語 研究発表要旨(国際会議) 公開
Richard S. Finn, Veronique Dieras, Karen A. Gelmon, Nadia Harbeck, Stephen E. Jones, Maria Koehler, Miguel Martin, Hope S. Rugo, Seock-Ah Im, Masakazu Toi, Eric Roland Gauthier, Xin Huang, Sophia Randolph, Dennis J. Slamon Richard S. Finn, Veronique Dieras, Karen A. Gelmon, Nadia Harbeck, Stephen E. Jones, Maria Koehler, Miguel Martin, Hope S. Rugo, Seock-Ah Im, Masakazu Toi, Eric Roland Gauthier, Xin Huang, Sophia Randolph, Dennis J. Slamon Richard S. Finn, Veronique Dieras, Karen A. Gelmon, Nadia Harbeck, Stephen E. Jones, Maria Koehler, Miguel Martin, Hope S. Rugo, Seock-Ah Im, Masakazu Toi, Eric Roland Gauthier, Xin Huang, Sophia Randolph, Dennis J. Slamon A randomized, multicenter, double-blind phase III study of palbociclib (PD-0332991), an oral CDK 4/6 inhibitor, plus letrozole versus placebo plus letrozole for the treatment of postmenopausal women with ER(+), HER2(-) breast cancer who have not received any prior systemic anticancer treatment for advanced disease. A randomized, multicenter, double-blind phase III study of palbociclib (PD-0332991), an oral CDK 4/6 inhibitor, plus letrozole versus placebo plus letrozole for the treatment of postmenopausal women with ER(+), HER2(-) breast cancer who have not received any prior systemic anticancer treatment for advanced disease. A randomized, multicenter, double-blind phase III study of palbociclib (PD-0332991), an oral CDK 4/6 inhibitor, plus letrozole versus placebo plus letrozole for the treatment of postmenopausal women with ER(+), HER2(-) breast cancer who have not received any prior systemic anticancer treatment for advanced disease. JOURNAL OF CLINICAL ONCOLOGY, 31, 15 JOURNAL OF CLINICAL ONCOLOGY, 31, 15 JOURNAL OF CLINICAL ONCOLOGY, 31, 15 2013/05 英語 研究発表要旨(国際会議) 公開
Nobuko Kawaguchi-Sakita, Rafaat Abd El-Aal Bakheet Mohamed, Fumiaki Sato, Takayuki Ueno, Masahiro Kawashima, Noriyuki Yoshida, Wen Zhao Li, Tomoharu Suaie, Yoshiki Mikami, Shigehira Saji, Takashi Inamoto, Masakazu Toi Nobuko Kawaguchi-Sakita, Rafaat Abd El-Aal Bakheet Mohamed, Fumiaki Sato, Takayuki Ueno, Masahiro Kawashima, Noriyuki Yoshida, Wen Zhao Li, Tomoharu Suaie, Yoshiki Mikami, Shigehira Saji, Takashi Inamoto, Masakazu Toi Nobuko Kawaguchi-Sakita, Rafaat Abd El-Aal Bakheet Mohamed, Fumiaki Sato, Takayuki Ueno, Masahiro Kawashima, Noriyuki Yoshida, Wen Zhao Li, Tomoharu Suaie, Yoshiki Mikami, Shigehira Saji, Takashi Inamoto, Masakazu Toi Nuclear localization of S6K is associated with unfavorable disease-free survival in hormone-receptor positive breast cancer cases Nuclear localization of S6K is associated with unfavorable disease-free survival in hormone-receptor positive breast cancer cases Nuclear localization of S6K is associated with unfavorable disease-free survival in hormone-receptor positive breast cancer cases CANCER RESEARCH, 73, 8 CANCER RESEARCH, 73, 8 CANCER RESEARCH, 73, 8 2013/04 英語 研究発表要旨(国際会議) 公開
戸井 雅和, Slamon Dennis J, 柏葉 匡寛, 増田 慎三, 山本 豊 戸井 雅和, Slamon Dennis J, 柏葉 匡寛, 増田 慎三, 山本 豊 戸井 雅和, Slamon Dennis J, 柏葉 匡寛, 増田 慎三, 山本 豊 乳癌に対する抗HER2療法 乳癌に対する抗HER2療法 乳癌に対する抗HER2療法 Cancer Board 乳癌, 6, 1, 33-43 Cancer Board 乳癌, 6, 1, 33-43 Cancer Board 乳癌, 6, 1, 33-43 2013/04 日本語 公開
Masahiro Kawashima, Noriko Iwamoto, Nobuko Kawaguchi-Sakita, Masahiro Sugimoto, Takayuki Ueno, Kazuya Terasawa, Taka-Aki Sato, Koichi Tanaka, Kazuharu Shimizu, Masakazu Toi Masahiro Kawashima, Noriko Iwamoto, Nobuko Kawaguchi-Sakita, Masahiro Sugimoto, Takayuki Ueno, Kazuya Terasawa, Taka-Aki Sato, Koichi Tanaka, Kazuharu Shimizu, Masakazu Toi Masahiro Kawashima, Noriko Iwamoto, Nobuko Kawaguchi-Sakita, Masahiro Sugimoto, Takayuki Ueno, Kazuya Terasawa, Taka-Aki Sato, Koichi Tanaka, Kazuharu Shimizu, Masakazu Toi Abstract 3932: High resolution imaging mass spectrometry reveals the breast cancer cell-related profiles of phosphatidylinositol unsaturation. Abstract 3932: High resolution imaging mass spectrometry reveals the breast cancer cell-related profiles of phosphatidylinositol unsaturation. Abstract 3932: High resolution imaging mass spectrometry reveals the breast cancer cell-related profiles of phosphatidylinositol unsaturation. Cancer Research, 73, 8 Supplement, 3932-3932 Cancer Research, 73, 8 Supplement, 3932-3932 Cancer Research, 73, 8 Supplement, 3932-3932 2013/04 英語 研究発表要旨(全国大会、その他学術会議) 公開
M. Sugimoto, M. Takada, S. Ohno, K. Kuroi, N. Sato, H. Bando, N. Masuda, H. Iwata, M. Kondo, H. Sasano, T. Inamoto, Y. Naito, M. Tomita, M. Toi M. Sugimoto, M. Takada, S. Ohno, K. Kuroi, N. Sato, H. Bando, N. Masuda, H. Iwata, M. Kondo, H. Sasano, T. Inamoto, Y. Naito, M. Tomita, M. Toi M. Sugimoto, M. Takada, S. Ohno, K. Kuroi, N. Sato, H. Bando, N. Masuda, H. Iwata, M. Kondo, H. Sasano, T. Inamoto, Y. Naito, M. Tomita, M. Toi DEVELOPMENT OF WEB TOOLS TO PREDICT PATHOLOGICAL RESPONSE TO NEOADJUVANT CHEMOTHERAPY AND AXILLARY LYMPH NODE METASTASIS IN BREAST CANCER PATIENTS DEVELOPMENT OF WEB TOOLS TO PREDICT PATHOLOGICAL RESPONSE TO NEOADJUVANT CHEMOTHERAPY AND AXILLARY LYMPH NODE METASTASIS IN BREAST CANCER PATIENTS DEVELOPMENT OF WEB TOOLS TO PREDICT PATHOLOGICAL RESPONSE TO NEOADJUVANT CHEMOTHERAPY AND AXILLARY LYMPH NODE METASTASIS IN BREAST CANCER PATIENTS EUROPEAN JOURNAL OF CANCER, 49, S6-S7 EUROPEAN JOURNAL OF CANCER, 49, S6-S7 EUROPEAN JOURNAL OF CANCER, 49, S6-S7 2013/03 英語 研究発表要旨(国際会議) 公開
E. Fakhrejahani, Y. Asao, I. Yamaga, M. Torii, M. Takada, T. Kitai, T. Sugie, M. Toi E. Fakhrejahani, Y. Asao, I. Yamaga, M. Torii, M. Takada, T. Kitai, T. Sugie, M. Toi E. Fakhrejahani, Y. Asao, I. Yamaga, M. Torii, M. Takada, T. Kitai, T. Sugie, M. Toi EVALUATION OF BREAST TISSUE MICROVASCULATURE WITH DIGITAL PATHOLOGY AND IMAGE ANALYSIS BRINGS NEW INSIGHTS INTO TUMOUR ANGIOGENESIS ASSESSMENT EVALUATION OF BREAST TISSUE MICROVASCULATURE WITH DIGITAL PATHOLOGY AND IMAGE ANALYSIS BRINGS NEW INSIGHTS INTO TUMOUR ANGIOGENESIS ASSESSMENT EVALUATION OF BREAST TISSUE MICROVASCULATURE WITH DIGITAL PATHOLOGY AND IMAGE ANALYSIS BRINGS NEW INSIGHTS INTO TUMOUR ANGIOGENESIS ASSESSMENT EUROPEAN JOURNAL OF CANCER, 49, S22-S22 EUROPEAN JOURNAL OF CANCER, 49, S22-S22 EUROPEAN JOURNAL OF CANCER, 49, S22-S22 2013/03 英語 研究発表要旨(国際会議) 公開
N. Masuda, H. Yamashiro, H. Iwata, R. Nishimura, N. Sato, T. Kamio, T. Saito, T. Lee, S. Yasuno, M. Toi N. Masuda, H. Yamashiro, H. Iwata, R. Nishimura, N. Sato, T. Kamio, T. Saito, T. Lee, S. Yasuno, M. Toi N. Masuda, H. Yamashiro, H. Iwata, R. Nishimura, N. Sato, T. Kamio, T. Saito, T. Lee, S. Yasuno, M. Toi COHORT STUDY EVALUATING TRASTUZUMAB IN HER2 POSITIVE EARLY BREAST CANCER IN JAPAN; JBCRG-C01 COHORT STUDY EVALUATING TRASTUZUMAB IN HER2 POSITIVE EARLY BREAST CANCER IN JAPAN; JBCRG-C01 COHORT STUDY EVALUATING TRASTUZUMAB IN HER2 POSITIVE EARLY BREAST CANCER IN JAPAN; JBCRG-C01 BREAST, 22, S90-S91 BREAST, 22, S90-S91 BREAST, 22, S90-S91 2013/03 英語 研究発表要旨(国際会議) 公開
Kiyotsugu Yoshikawa, Yoshiaki Matsumoto, Junji Ito, Yoshie Shiojiri, Ellis Reinherz, Masakazu Toi Kiyotsugu Yoshikawa, Yoshiaki Matsumoto, Junji Ito, Yoshie Shiojiri, Ellis Reinherz, Masakazu Toi Kiyotsugu Yoshikawa, Yoshiaki Matsumoto, Junji Ito, Yoshie Shiojiri, Ellis Reinherz, Masakazu Toi Application of sensitive EMT reporter to identification of breast cancer stem cell-related genes Application of sensitive EMT reporter to identification of breast cancer stem cell-related genes Application of sensitive EMT reporter to identification of breast cancer stem cell-related genes CANCER RESEARCH, 73 CANCER RESEARCH, 73 CANCER RESEARCH, 73 2013/02 英語 研究発表要旨(国際会議) 公開
上山 華栄, 多田 春江, 榎本 佳代子, 池田 隆文, 杉江 知治, 戸井 雅和, 川上 浩司 上山 華栄, 多田 春江, 榎本 佳代子, 池田 隆文, 杉江 知治, 戸井 雅和, 川上 浩司 先進医療制度下の臨床試験へのサンプリング施設訪問モニタリングの導入 先進医療制度下の臨床試験へのサンプリング施設訪問モニタリングの導入 「日本臨床試験研究会第4回学術集会総会」 2013年2月7日-8日, 札幌 「日本臨床試験研究会第4回学術集会総会」 2013年2月7日-8日, 札幌 2013/02 公開
Monica Chan, Lin Wang, Niramol Chanplakorn, Kentaro Tamaki, Takayuki Ueno, Masakazu Toi, Wings Loo, Louis W. C. Chow, Takashi Suzuki, Hironobu Sasano Monica Chan, Lin Wang, Niramol Chanplakorn, Kentaro Tamaki, Takayuki Ueno, Masakazu Toi, Wings Loo, Louis W. C. Chow, Takashi Suzuki, Hironobu Sasano Monica Chan, Lin Wang, Niramol Chanplakorn, Kentaro Tamaki, Takayuki Ueno, Masakazu Toi, Wings Loo, Louis W. C. Chow, Takashi Suzuki, Hironobu Sasano Comment and reply on: Vasohibin-1 and its emerging role in the evolution and progression of systemic tumors besides renal cell carcinomas Response Comment and reply on: Vasohibin-1 and its emerging role in the evolution and progression of systemic tumors besides renal cell carcinomas Response Comment and reply on: Vasohibin-1 and its emerging role in the evolution and progression of systemic tumors besides renal cell carcinomas Response EXPERT OPINION ON THERAPEUTIC TARGETS, 17, 1, 106-106 EXPERT OPINION ON THERAPEUTIC TARGETS, 17, 1, 106-106 EXPERT OPINION ON THERAPEUTIC TARGETS, 17, 1, 106-106 2013/01 英語 速報、短報、研究ノート等(学術雑誌) 公開
杉江知治, 増田慎三, 木下貴之, 澤田晃暢, 山内清明, 黒井克昌, 田口哲也, 坂東裕子, 山城大泰, 李哲柱, 新藏信彦, 加藤大典, 池田隆文, 吉村健一, 多田春江, 上田華栄, 横橋祐子, 戸井雅和 杉江知治, 増田慎三, 木下貴之, 澤田晃暢, 山内清明, 黒井克昌, 田口哲也, 坂東裕子, 山城大泰, 李哲柱, 新藏信彦, 加藤大典, 池田隆文, 吉村健一, 多田春江, 上田華栄, 横橋祐子, 戸井雅和